Abstract
Virology has developed with such rapidity in recent years that it is increasingly difficult to maintain an adequate knowledge of more than a small part of the science. There is therefore a need for reference works which assess the established knowledge and make some record of past achievement. It is hoped that this work will fulfil this purpose in the case of the influenza viruses. The work is primarily intended for the virologist, and the clinical, pathological and epidemiological aspects of influenza are dealt with only in so far as they relate to the properties of the viruses.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Ackermann, W. W.: The role of 1-methionine in virus propagation. J. exp. Med. 93, 337–343 (1951).
Ackermann, W. W.: Concerning the relation of the Krebs cycle to virus synthesis. J. biol. Chem. 189, 421–428 (1951).
Ackermann, W. W.: The relation of the Krebs cycle to virus synthesis. 2. The effect of sodium fluoroacetate on the propagation of influenza virus in mice. J. exp. Med. 93, 635–642 (1951).
Ackermann, W. W.: α-aminosulphonic acids and viral propagation. Proc. Soc. exp. Biol. (N.Y.) 80, 362–367 (1952).
Ackermann, W. W.: Mechanisms of persistent and masked infections in tissue cultures. Ann. N.Y. Acad. Sci. 67, 392–402 (1957).
Ackermann, W. W.: Cellular aspects of the cell-virus relationship. Bact. Rev. 22, 223–239 (1958).
Ackermann, W. W.: Biochemical studies of virus-infected cells. Ann. N.Y. Acad. Sci. 81, 188–192 (1959).
Ackermann, W. W.: Comparative study of the reactive surfaces of polyoma and influenza viruses. Ext. Acta Un. int. Cancer 19 (1963).
Ackermann, W. W., and S. Dinka: Concerning the nature of the viral neutralising activity of bovine serum. Acta virol. 9, 526–533 (1965).
Ackermann, W. W., N. Ishida, and H. F. Maassab: Growth characteristics of influenza virus concerning the binding of virus by host cells. J. exp. Med. 102, 545–554 (1955).
Ackermann, W. W., and R. B. Johnson: Some energy relations in a host-virus system. J. exp. Med. 97, 315–322 (1953).
Ackermann, W. W., and H. Kurtz: A new host-virus system. Proc. Soc. exp. Biol. (N.Y.) 81, 421–423 (1952).
Ackermann, W. W., and P. C. Loh: Chemistry of viral infected cells. Ann. N.Y. Acad. Sci. 88, 1298–1307 (1960).
Ackermann, W. W., and H. F. Maassab: Growth characteristics of influenza virus: The influence of a sulphonic acid. J. exp. Med. 99, 105–117 (1954).
Ackermann, W. W., and H. F. Maassab: Growth characteristics of influenza virus. Biochemical differentiation of stages of development. J. exp. Med. 100, 329–339 (1954).
Ackermann, W. W., and H. F. Maassab: Growth characteristics of influenza virus. Biochemical differentiation of stages of development. 2. J. exp. Med. 102, 393–402 (1955).
Ada, G. L.: Ribonucleic acid in influenza virus. Ciba Found. Symp. “The nature of viruses” 104-122 (1957).
Ada, G. L., M. Donnelley, and J. Pye: Studies on the complement fixing antigen of influenza virus. 1. Purification of antigen. Aust. J. exp. Biol. med. Sci. 30, 301–311 (1952).
Ada, G. L., and A. Gottschalk: The component sugars of the influenza virus particle. Biochem. J. 62, 686–689 (1956).
Ada, G. L., and P. E. Lind: Neuraminidase in the chorioallantois of the chick embryo. Nature (Lond.) 190, 1169–1171 (1961).
Ada, G. L., P. E. Lind, L. Larkin, and F. M. Burnet: Failure to recover infective ribonucleic acid from myxovirus preparations. Nature (Lond.) 184, 360–361 (1959).
Ada, Gr. L., P. E. Lind, and W. G. Laver: An immunological study of avian, viral, and bacterial neuraminidase based on specific inhibition of enzyme by antibody. J. gen. Microbiol. 32, 225–232 (1963).
Ada, G. L., and B. T. Perry: Studies on the soluble complement fixing antigens of influenza virus. 3. The nature of the antigens. Aust. J. exp. Biol. med. Sci. 32, 177–185 (1954).
Ada, G. L., and B. T. Perry: The nucleic acid content of influenza virus. Aust. J. exp. Biol. med. Sci. 32, 453 (1954).
Ada, G. L., and B. T. Perry: Infectivity and nucleic acid content of influenza virus. Nature (Lond.) 175, 209–210 (1955).
Ada, G. L., and B. T. Perry: Specific differences in the nucleic acids from A and B strains of influenza virus. Nature (Lond.) 175, 854 (1955).
Ada, G. L., and B. T. Perry: Influenza virus nucleic acid: Relationship between biological characters of the virus particle and properties of the nucleic acid. J. gen. Microbiol. 14, 623–633 (1956).
Ada, G. L., and B. T. Perry: Properties of the nucleic acid of the Eyan strain of filamentous influenza virus. J. gen. Microbiol. 19, 40–54 (1958).
Ada, G. L., B. T. Perry, and A. Abbot: Biological and physical properties of the Eyan strain of filamentous influenza virus. J. gen. Microbiol. 19, 23–39 (1958).
Ada, G. L., B. T. Perry, and M. Edney: Infectivity of influenza virus filaments. Nature (Lond.) 180, 1134 (1957).
Ada, G. L., B. T. Perry, and J. Pye: Studies on the soluble complement fixing antigen of influenza viruses. 2. Serological behaviour of the antigen. Aust. J. exp. Biol. med. Sci. 31, 391–403 (1953).
Ada, G. L., and J. D. Stone: Effect of haemagglutinating viruses on the electrophoretic mobility of human erythrocytes. Nature (Lond.) 165, 189–190 (1950).
Ada, G. L., and J. D. Stone: Electrophoretic studies of virus-red cell interaction: Mobility gradient of cells treated with influenza viruses and the receptor destroying enzyme of V. cholerae. Brit. J. exp. Path. 31, 263–274 (1950).
Addamiano, L., B. Babudieri, and C. Moscovici: Morphological forms of the influenza virus (Italian). R.C. Ist. sup. Sanità 19, 161–167 (1956).
Ado, A. D., and T. M. Alekseyeva: On the toxic effect of influenza virus on the sympathetic nervous system. Acta virol. 1, 161–166 (1957).
Ado, A. D., T. A. Alekseyeva, A. Kh. Kanchurin, and S. M. Titova: Problems of the pathogenesis of influenza in the light of pathophysiological investigations (Russian). “Problemy grippa i ostrykh respiratornykh zabolevanii.” Tez. dokl. nauch. Sess. Inst. AMN SSSK, Moscow (1959).
Ado, A. D., and S. M. Titova: A study of influenza in dogs. Probl. Virol. (N.Y.) 4, 36–41 (1959).
Agapov, S. I.: The pathogenic properties of swine and human influenza viruses (Russian). Zh. Mikrobiol. (Mosk.) 17, 543 (1935).
Ahsbel, S. I., N. G. Stolpetskaya, and V. G. Sokolova: Experience in the treatment of virus influenza and the chemoprophylaxis of this disease under industrial conditions (Russian). Sovetsk. Med. 3, 22–23 (1954).
Akao, Y., T. Matsui, E. Sano, H. Shimojo, A. Sugiura, and C. Enomoto: Bull. Inst. publ. Hlth Tokyo 9, 27–34 (1960).
Albaladejo, J., and G. Berenguer: The pH reaction and its value for the diagnosis of the phases of influenza virus (Spanish). Microbiol. esp. 11, 119–133 (1958).
Albrecht, P., O. Krizanova, and J. Szanto: Location of influenza virus haemagglutination inhibitor demonstrated in chick embryo cells by fluorescent antibodies. Acta virol. 5, 232–235 (1961).
Alekperov, M. A.: Functional state of adrenal cortex in influenza (Russian). Sovetsk. Med. 23, 70–73 (1959).
Aleksandrova, G. I.: Comparative characteristics of A2 influenza virus strains isolated in the epidemics of 1957 and 1959 (Russian). “Problemy grippa i ostrykh respiratornykh zabolevanii”. Tez. Dokl. nauch Sess. Inst. AMN SSSE Moscow 20-21 (1959).
Aleksandrova, G. I.: Reactogenic and immunogenic properties and epidemiological effectivity of additionally attenuated vaccine strains of influenza virus (Russian). Vop. Virus 1, 67–73 (1965).
Aleksandrova, G. I., and A.A. Smorodintsev: Obtaining of an additionally attenuated vaccinating cryophil influenza strain. Rev. Roumaine Intramicrobiol 2, 179–186 (1965).
Alekseeva, T. E., A. I. Mel’nikova, M. A. Nogicheva, and A. S. Shadrin: A study of the anti-influenza antibody content in different epidemic periods in the sera of blood donors, placental sera, and in gamma globulins (Russian). “Problemy grippa i ostrykh respiratornykh zabolevanii.” Tez. dokl. nauch. Sess. Inst. AMN SSSE, Moscow 159-160 (1959).
Alford, R. H., J. A. Kasel, P. J. Gerone, and V. Knight: Human influenza resulting from aerosol inhalation. Proc. Soc. exp. Biol. (N.Y.) 122, 800–804 (1966).
Allen, R., R. A. Finkelstein, and S. E. Sulkin: Viral inhibitors in normal animal sera. Tex. Eep. Biol. Med. 16, 391–421 (1958).
Allison, A. C.: Observations on the inactivation of viruses by sulphydryl reagents. Virology 17, 176–183 (1962).
Allison, A. C., F. E. Buckland, and C. H. Andrewes: Effects of sulphydryl reagents on infectivity of some viruses. Virology 17, 171–175 (1962).
Almeida, J. D., and A. P. Waterson: Some observations on the envelope of an influenza virus. J. gen. Microbiol. 46, 107–110 (1967).
Altucci, P., F. Coraggio, G. Margherita, and C Galeota: The multiplication of influenza virus A (PR8) in chorioallantoic tissue culture (Italian). Riv. Ist. sieroter. ital. 30, 90–110 (1961).
Amelunxen, R. E., and A. A. Werder: Quantitative considerations of influenza virus neutralisation. 1. Number of antibody molecules per virus particle. J. Bact. 80, 271–277 (1960).
American Institute of Biological Sciences. “An annotated bibliography of influenza”. Waverly Press, Baltimore 1957-1960.
Aminoff, D.: Methods for the quantitative estimation of N-acetyl-neuraminic acid and their application to hydrolysates of sialomucoids. Biochem. J. 81, 384–392 (1961).
Amos, H., and E. Vollmayer: Inhibition of influenza virus synthesis by 2-thiouracil. Virology 6, 337–347 (1955).
Ananthanarayan, R.: The fabric of virus elementary bodies. Brit. J. exp. Path. 35, 381–388 (1954).
Ananthanarayan, E., and C. K. J. Paniker: Non-specific inhibitors of influenza viruses in normal sera. Bull. Wld Hlth Org. 22, 409–419 (1960).
Anderson, S. G.: The breadth of antibody response following influenza A infection. Aust. J. exp. Biol. med. Sci. 25, 243–246 (1947).
Anderson, S. G.: Mucins and mucoids in relation to influenza virus action. 1. Inactivation by R.D.E. and by viruses of the influenza group of the serum inhibitor of haemagglutination. Aust. J. exp. Biol. med. Sci. 26, 347–354 (1948).
Anderson, S. G., and F. M. Burnet: Sporadic and minor epidemic incidence of influenza A in Victoria 1945–46. 1. Phase behaviour of influenza A strains in relation to epidemic characteristics. Aust. J. exp. Biol. med. Sci. 25, 235–242 (1947).
Anderson, S. G., F. M. Burnet, S. Fazekas de St Groth, J. F. McCrea, and J. D. Stone: Mucins and mucoids in relation to influenza virus action. 6. General discussion. Aust. J. exp. Biol. med. Sci. 26, 403–411 (1948).
Anderson, S. G., F. M. Burnet, and J.D. Stone: A modified Salk test for in vitro titration of influenza antibodies. Aust. J. exp. Biol. med. Sci. 24, 269–275 (1946).
Andrewes, C. H.: Interference by one virus with the growth of another in tissue culture. Brit. J. exp. Path. 23, 214–220 (1942).
Andrewes, C.H.: Adventures among viruses. 1. Some properties of viruses. A67 2. Epidemic influenza. New Engl. J. Med. 242, 161–166 and 197-203 (1950).
Andrewes, C. H.: Epidemiology of influenza in the light of the 1951 outbreak. Proc. roy. Soc. Med. 44, 803–804 (1951).
Andrewes, C. H.: The place of viruses in Nature. Proc. roy. Soc. Med. 139, 313–326 (1952).
Andrewes, C. H.: Prospects for prevention of influenza. Trans. Coll. Phycns. Philad. June, 20 (1952).
Andrewes, C. H.: Epidemiology of influenza. Bull. Wld Hlth Org. 8, 595–612 (1953).
Andrewes, C. H.: Influenza: Theme and variations. Calif. Med. 84, 375–380 (1956).
Andrewes, C. H., F. B. Bang, and F. M. Burnet: A short description of the myxovirus group (influenza and related viruses). Virology 1, 176–184 (1955).
Andrewes, C. H., and R. E. Glover: Spread of infection from the respiratory tract of the ferret. 1. Transmission of influenza A virus. Brit. J. exp. Path. 22, 91–97 (1941).
Andrewes, C. H., R. E. Glover, F. Himmelweit, and W. Smith: Influenza virus as a laboratory contaminant. Brit. J. exp. Path. 25, 130–134 (1944).
Andrewes, C. H., and D. M. Horstmann: The susceptibility of viruses to ethyl ether. J. gen. Microbiol. 3, 290–297 (1949).
Andrewes, C. H., and A. Isaacs: Antigenic variation among influenza viruses in relation to the production use and standardisation of vaccines. Proc. 3rd int. Meet. Biol. Stand. Opatija 73-75 (1957).
Andrewes, C. H., A. Isaacs, and B. P. Marmion: Neutralising action of human nasal secretions on neurotropic influenza virus. Brit. J. exp. Path. 35, 264–269 (1954).
Andrewes, C. H., H. King, and M. Van den Ende: Chemotherapeutic experiments with the viruses of influenza A, lymphogranuloma venereum and vaccinia. J. Path. Bact. 55, 173–181 (1943).
Andrewes, C. H., P. P. Laidlaw, and W. Smith: The susceptibility of mice to the viruses of human and swine influenza. Lancet 859-862 (1934).
Andrewes, C. H., and W. Smith: Influenza: Further experiments on the active immunisation of mice. Brit. J. exp. Path. 18, 43 (1937).
Andrewes, C. H., and W. Smith: The effect of foreign tissue extracts on the efficacy of influenza virus vaccines. Brit. J. exp. Path. 20, 305–315 (1939).
Andrewes, C. H., and G. Worthington: Some new or little known respiratory viruses. Bull. Wld Hlth Org. 20, 435–443 (1959).
Andrews, B. E., A. S. Beare, J. C. McDonald, A. J. Zuckermann, and D. A. J. Tyrrell: Further trials of live influenza vaccine. Brit. med. J. 637-640 (1966).
Angela, G. C., and G. Giuliani: The antiviral activity of an analogue of sialic acid (Simo). Action on the influenza virus. Panminerva med. 4, 187–189 (1962).
Angulo, J. J.: On the identity of the so-called filamentous forms of influenza and fowl pest viruses. Arch. ges. Virusforsch. 4, 199–206 (1951).
Ansheles, I. M.: Material for the epidemiological characterisation of the winter outbreak of influenza in Leningrad 1943/44 (Russian). Rabot. Leningrad vrach. v. god. Otech. voyny Leningrad 6, 36 (1945).
Ansheles, I. M.: Material on the epidemiology and specific prophylaxis of influenza Type A (Russian). “Virusnyye infektsii.” Tr. Inst. epidemiol. mikrobiol. i gig imeni Pasteria i Inst. eksper. med. AMN SSSR Leningrad 142-160 (1953).
Ansheles, I. M., E. A. Fridman, T. A. Klushina, E. S. Stenina, L. B. Khazenson, and E. F. Tarasova: The influenza pandemic in 1957. Some epidemiological and virological features of influenza in Leningrad (Russian). Vop. Virus 4, 38–43 (1959).
Ansheles, I. M., N. N. Romanenko, N. S. Klyuchereva, and Z. N. Danilova: Experience in the study of immunisation against influenza in Leningrad in 1952–53 (Russian). Zh. Mikrobiol. (Mosk.) 10, 63 (1953).
Apostolov, K., and T. H. Flewett: Internal structure of influenza virus. Virology 26, 506–508 (1965).
Appleby, J. C.: The isolation and properties of a modified strain of neurotropic influenza A virus. Brit. J. exp. Path. 33, 280–287 (1952).
Appleby, J. C., and C. H. Stuart-Harris: The use of filtrates of vibrio Cholerae in the classification of influenza virus strains. Brit. J. exp. Path. 31, 797–805 (1950).
Archetti, I.: Laboratory trial of vaccination against influenza (Italian). Ext. R.C. It. sup. Sanità 17, 991–998 (1954).
Archetti, I.: Appearances associated with filamentous forms of influenza viruses. Arch. ges. Virusforsch. 6, 29–35 (1955).
Archetti, I.: Further studies on antigenic variation of influenza A virus. Proc. Soc. exp. Biol. (N.Y.) 80, 212–214 (1952).
Archetti, I., and D. S. Bocciarelli: On the structure of filamentous forms of influenza virus. Arch. ges. Virusforsch. 11, 599–606 (1961).
Archetti, I., and D. S. Bocciarelli: Contribution to the study of the structure of influenza virus (Italian). Ext. R.C. Ist. sup. Sanità 24, 546–552 (1961).
Archetti, I., and F. L. Horsfall: Persistent antigenic variation of influenza A viruses after incomplete neutralisation in ovo with heterologous immune serum. J. exp. Med. 92, 441–462 (1950).
Archetti, I., A. Jemolo, and D. S. Bocciarelli: On the fine structure of influenza viruses. Arch. ges. Virusforsch. 20, 133–136 (1967).
Ari, A. B.: Attempt at rapid isolation of influenza virus from throat washings collected from patients during the 1952–53 influenza epidemic by inoculation of embryonated eggs with concentrated viruses on red blood cells. Türk Ij. tecr. Biyol. Derg. 15, 226–230 (1955).
Arkhangelsky, D. C., U. I. Savchenko, and Kh. Dj. Zhumatov: Cytomorphology and cytochemistry of experimental RNA influenza infection. Abstr. 9th int. Congr. Microbiol. Moscow 391 (1966).
Arya, S. C.: Haemadsorption followed by fluorochrome staining. Brit. med. J. 98-100 (1963).
Atkins, E., and W. C. Huang: Studies on the pathogenesis of fever with influenzal viruses. 1. The appearance of an endogenous pyrogen in the blood following intravenous injection of virus.
2. The effect of endogenous pyrogen in normal and virus-tolerant recipients.
3. The relation of tolerance to the production of endogenous pyrogen. J. exp. Med. 107, 383-401, 403-414, 415-435 (1958).
Avetisian, V. A.: Data on the etiology of influenza in Erivan and on some properties of strains isolated in 1958 and 1959 (Russian). “Problemy grippa i ostrykh respiratornykh zabolevanii.” Tez. dokl. nauch. Sess. Inst. AMN SSSR Moscow 33-34 (1959).
Azadova, N. B.: Synthesis of structural proteins of myxoviruses. Abstr. 9th int. Congr. Microbiol. Moscow 498-499 (1966).
Badinsky, G., and I. Bruckner: Contribution to the study of filtrable viruses. Attempts to cultivate the viruses of human influenza, climatic bubo, and Aujeszky’s disease on the chorioallantoic membrane of chick embryos (French). Arch. roum. Path. exp. 10, 341–368 (1937).
Bang, F. B.: Synergistic action of Haemophilus Influenzae Suis and the swine influenza virus on the chick embryo. J. exp. Med. 77, 7–20 (1943).
Bang, F. B., and A. Isaacs: Morphological aspects of virus cell relationships in influenza, mumps and Newcastle (myxovirus). Ciba Found. Symp. “The nature of viruses” 249-262 (1957).
Bankowski, R. A., and T. Mikami: An apparently new respiratory disease of turkeys. Proc. 68th Ann. Meet U.S. Livestock Sanit. Ass. 495-517 (1965).
Barb, K., G. J. Koteler, F. Antoni, and Gr. Takatsi: Studies on the nucleic acid metabolism of chorioallantoic membrane cells after influenza virus infection. Acta microbiol. Acad. Sci. hung. 11, 185–192 (1964).
Baron, S., and K. E. Jensen: Evidence for genetic interaction between noninfectious and infectious influenza A viruses. J. exp. Med. 102, 677–697 (1955).
Baroyan, O. V.: Basic epidemiological characteristics of influenza after the 1957 pandemic (Russian). “Problemy grippa i ostrykh respiratornykh zabolevanii.” Tez. Dokl. nauch Sess. AMN SSSR Moscow 74-76 (1959).
Baroyan, O. V., and V. G. Slepushkin: Evaluation of a live monovalent anti-influenza vaccine (Russian). “Problemy grippa i ostrykh respiratornykh zabolevanii.” Tez. Dokl. nauch Sess. AMN SSSR Moscow 119-121 (1959).
Barry, R. D.: Equilibrium sedimentation of influenza virus in caesium chloride density gradients. Aust. J. exp. Biol. med. Sci. 38, 499–507 (1960).
Barry, R. D.: The multiplication of influenza virus. 1. The formation of incomplete virus. Virology 14, 389–397 (1961).
Barry, R. D.: The multiplication of influenza virus. 2. Multiplicity reactivation of ultraviolet irradiated virus. Virology 14, 398–405 (1961).
Barry, R. D.: The multiplication of influenza virus. 3. Heterologous interference. Virology 14, 406–409 (1961).
Barry, R. D.: Effects of inhibitors of nucleic acid synthesis on the production of myxoviruses. Ciba Found. Symp. “Cellular Biology of Myxovirus infections” 51-75 (1964).
Barry, R. D., D. R. Ives, and J. G. Cruikshank: Participation of deoxyribonucleic acid in the multiplication of influenza virus. Nature (Lond.) 194, 1139–1140 (1962).
Bartolomei-Corsi, O.: Eelations between A2 influenza virus and non-specific inhibitors (Italian). Sperimentale 109, 549–572 (1959).
Barua, D., and B. Fauconnier: Non enzymatic elution of influenza virus (French). Ann. Inst. Pasteur 97, 479–496 (1959).
Barykin, V., Z. Shaklmaliteva, and Ye. Bauer: Cultivation of the influenza virus (Russian). Zh. Mikrobiol. (Mosk.) 17, 548 (1936).
Bateman, J. B., M. S. Davis, and P. A. McCaffrey: Influence of influenza haemagglutinin on haemolysis rates. Proc. Soc. exp. Biol. (N.Y.) 80, 720–722 (1952).
Bateman, J. B., M. S. Davis, and P. A. McCaffrey: Eate of reaction of red blood cells with influenza virus haemagglutinin. Amer. J. Hyg. 62, 342–348 (1955).
Bateman, J. B., M. S. Davis, and P. A. McCaffrey: A note on the reaction of heated influenza virus protein with red blood cells. Amer. J. Hyg. 62, 349–354 (1955).
Bateman, J. B., A. Zellner, M. S. Davis, and P. A. McCaffrey: The electrophoretic properties of red blood cells after reaction with influenza virus haemagglutinin. Arch. Biochem. 60, 384–391 (1956).
Bauer, D. J.: Multiplication of the animal viruses. Nature (Lond.) 164, 767 (1949).
Bauer, D. J.: Possible correlation between virus particle size and activity of antiviral agents. Nature (Lond.) 209, 639–640 (1966).
Bayandina, S. A., A. K. Svetlova, and V. V. Eitova: Clinical peculiarities of the course of influenza A2 in infants (Russian). Pediatriya 36, 38–43 (1958).
Baydakova, Z. L., and L. A. Zil’ber: Adaptive variability of influenza virus (Russian). Zh. Mikrobiol. (Mosk.) 12, 86 (1948).
Baydakova, Z. L., and L. A. Zil’ber: Influenza virus variability (Russian). Vop. Virus. 2, 204 (1949).
Bayer, M. E., and E. Mannweiler: Antigen antibody reactions of influenza virus as seen in the electron microscope. Arch. ges. Virusforsch. 13, 541–547 (1963).
Beale, A. J.: A comparison of the soluble antigen production by tissues infected with preparations of extracellular and intracellular influenza virus. J. Hyg. (Lond.) 52, 225–229 (1954).
Beale, A. J., and N. B. Finter: The infectivity of chorioallantoic membrane influenza virus and incomplete influenza virus by the six hour soluble antigen production test. J. Hyg. (Lond.) 54, 68–78 (1956).
Beard, J. W., D. G. Sharp, A. R. Taylor, I. W. McLean, D. Beard, E. Feller, and J. H. Dingle: Ultracentrifugal, chemical, and electron microscopic identification of the influenza virus. Sth. med. J. 37, 313–320 (1944).
Becker, W. B.: Electron microscopy of Tern virus. S. Afr. J. Lab. clin. Med. 8, 163–164 (1962).
Becker, W. B.: The morphology of Tern virus. Virology 20, 318–327 (1963).
Becker, W. B.: The isolation and classification of Tern virus. Influenza virus A/Tern/South Africa/1961. J. Hyg. (Lond.) 64, 309–320 (1966).
Becker, W. B.: Experimental infection of common terns with Tern virus. J. Hygiene (Lond.) 65, 61–65 (1967).
Becker, W. B., C. Dauguet, and F. Delahaye: Electron morphology of Tern virus. Enantiomorphic nucleocapsid (French). Ann. Inst. Pasteur 106, 575–580 (1964).
Bedson, S. P.: The mode of virus multiplication and the susceptibility of these agents to the antibiotics. J. clin. Path. 9, 83–93 (1956).
Belikov, P. F.: Complement fixation reaction as an index of immunity in influenza (Russian). Arkh. biol. nauk. 59, 44 (1940).
Belyavin, Gr.: Influenza complement fixation. A simple quantitative micro method. J. Hyg. (Lond.) 51, 492–501 (1953).
Belyavin, G.: The direct flocculation of influenza virus. Lancet, 698-701 (1955).
Belyavin, G.: Normal serum inhibitors of influenza virus flocculation. Brit. J. exp. Path. 37, 75–80 (1956).
Belyavin, G.: The influenza virus flocculation reaction as a method of antigenic typing. J. Hyg. (Lond.) 55, 281–289 (1957).
Belyavin, G., and A. Cohen: Chromatography of influenza virus haemagglutination inhibitors. Virology 18, 144–145 (1962).
Bennet, I. L., and R. R. Wagner: Production of fever by influenza viruses. 5. Effect of nitrogen mustard HN2. Bull. Johns Hopk. Hosp. 97, 43–46 (1955).
Bennet, I. L., R. R. Wagner, and V. S. LeQuire: The production of fever by influenza viruses. 2. Tolerance in rabbits to the pyrogenic effect of influenza viruses. J. exp. Med. 90, 335–347 (1949).
Berganini, L., and O. Bartolomei-Corsi: Activity of a bacterial mucinase on some inhibitors of influenza virus haemagglutination (Italian). Sperimentale 106, 76–87 (1956).
Berlin, B. S.: Gross physical properties of emulsified influenza virus vaccines and the adjuvant response. J. Immunol. 85, 81–89 (1960).
Berlin, B. S.: Antibody responses induced by aqueous and emulsified influenza virus vaccines in mice exposed daily to X rays. J. Immunol. 89, 906–909 (1962).
Berlin, B. S.: Antibody responses after injection of aqueous and emulsified influenza virus vaccines in mice chronically exposed to gamma rays. Radiation Res. 18, 223–230 (1963).
Berlin, B. S.: The nature of antibodies in mice injected with influenza virus vaccine. Proc. Soc. exp. Biol. (N.Y.) 113, 1013–1016 (1963).
Berlin, B. S.: Interruption of macroglobulin synthesis in mice by exposure to X rays. J. Immunol. 93, 315–318 (1964).
Berlin, B. S.: Sparing effect of X rays for mice inoculated intranasally with egg-adapted influenza virus, CAM strain. Proc. Soc. exp. Biol. (N.Y.) 117, 864–869 (1964).
Berlin, B. S.: Eadiosensitivity of YM antibody response in mice injected with killed influenza virus. Radiation Res. 26, 554–566 (1965).
Berlin, B. S.: Early antibody responses of mice given a single injection of emulsified influenza virus vaccine. J. Immunol. 96, 424–429 (1966).
Berlyant, M. L., and F. G. Epshteyn: Some material on influenza therapy (Russian). Vo.-med. Zh. 12, 74–75 (1953).
Berlyant, M. L., and N. N. Orlova: Epidemiological observations in influenza (Russian). Vo.-med. Zh. 4, 79 (1951).
Bernkopf, H.: Differences in haemagglutination by strains of influenza virus in the presence of egg white and normal serum. Proc. Soc. exp. Biol. (N.Y.) 71, 160–163 (1949).
Bernkopf, H.: Cultivation of influenza virus in the chorioallantoic membrane of de-embryonated eggs. Proc. Soc. exp. Biol. (N.Y.) 72, 680–682 (1949).
Bernkopf, H.: Study of infectivity and haemagglutination of influenza virus in de-embryonated eggs. J. Immunol. 65, 571–583 (1950).
Bernkopf, H.: Experiences with the laboratory diagnosis of Asian influenza in Israel. Israel med. J. 17, 209–212 (1958).
Berry, L. J., R. B. Mitchell, and D. Rubenstein: Effect of acclimatisation to altitude on susceptibility of mice to influenza A virus infection. Proc. Soc. exp. Biol. (N.Y.) 88, 543–548 (1955).
Beutler, E., and H. M. Gezon: The effect of total body X irradiation on the susceptibility of mice to influenza A virus infection. J. Immunol. 68, 227–242 (1952).
Beveridge, W. I. B.: Lack of increase of antibody after second injection of influenza virus in man. Aust. J. exp. Biol. med. Sci. 22, 301–305 (1944).
Beveridge, W. I. B.: Some topical comments on influenza in horses. Vet. Rec. 77, 427–428 (1965).
Beveridge, W. I. B.: Public health significance of animal influenza. Int. Congr. comp. Path. Beirut (1966).
Beveridge, W. I. B., and F. M. Burnet: The cultivation of viruses and Rickettsia in the chick embryo. Med. Res. Counc. Rep. 256 (1946).
Beveridge, W. I. B., L. W. Mahaffey, and M. A. Rose: Influenza in horses. Vet. Rec. 77, 57–59 (1965).
Biddle, F., and G. Belyavin: The haemagglutination inhibitor in edible bird nest: Its biological and physical properties. J. gen. Microbiol. 31, 31–44 (1963).
Biddle, F., and A. Cohen: Erythrocyte receptors for type A2 influenza viruses. Nature (Lond.) 196, 297–298 (1962).
Biddle, F., and J. P. Stevenson: Flocculation of influenza viruses by horse serum inhibitor. Nature (Lond.) 209, 1223–1225 (1966).
Bieling, R., and L. Oelrichs: On the influenza virus inhibitor of hens eggs and on the immunity of the offspring of parents immunised against that virus. Z. Hyg. Infekt.-Kr. 127, 592–603 (1948).
Birch-Andersen, A., and K. Paucker: Studies on the structure of influenza virus. 2. Ultrathin sections of infectious and non-infectious particles. Virology 8, 21–40 (1959).
Birkovskaya, E. A.: Oxygen treatment of patients with influenza and pneumonia during the influenza pandemic in 1957 (Russian). Aziatskii gripp (Sborn. nauch. rabot) Kiev, 237-240 (1958).
Bjorkmann, S. E., and F. L. Horsfall: The production of a persistent alteration in influenza virus by Lanthanum or ultraviolet irradiation. J. exp. Med. 88, 445–461 (1948).
Blaskovic, D.: Influenza A and B antibodies in mothers and their infants up to six months after birth. (Czech). Čas. Lék. čes. (Prague) 89, 1195–1199 (1950).
Blaskovic, D.: Some properties of S and G antigens and haemagglutinins of myxoviruses (German). Zbl. Bakt. I. Abt. Kef. 175, 396 (1960).
Blaskovic, D., P. Albrecht, V. Lackovic, J. Lesso, V. Rathova, and B. Styk: The use of fluorescent antibody method for rapid diagnosis during an epidemic of influenza (Czech). Čs. Epidem. 12, 129–139 (1963).
Blaskovic, D., L. Borecky, and V. Rathova: An attempt to prove the circulation of influenza virus in a pre-epidemic period by means of susceptible animals. Čs. Epidem. 8, 376–387 (1959).
Blaskovic, D., N. A. Maksimovic, B. Styk, and P. Albrecht: Course of adaptation of the inhibitor resistant influenza virus A2 to ferrets. Čs. Epidem. 10, 158–165 (1961).
Blaskovic, D., and V. Rathova: Influenza virus A, A prime, B, C, and Shope Iowa 15 antibody titres in population of Czechoslovakia. Čs. Epidem. 5, 113 (1956).
Blaskovic, D., V. Rathova, and L. Borecky: Antigenic relationships to myxoviruses of a virus isolated from a respiratory infection in ducks. Acta virol. 3, 17–24 (1959).
Blaskovic, D., and J. E. Salk: A method applicable to the standardisation of influenza virus vaccines. Proc. Soc. exp. Biol. (N.Y.) 65, 352–359 (1947).
Blaskovic, D., A. A. Smorodintsev, and B. Styk: Problems of pathogenesis and immunology of virus infections. Acta virol. 3, 97–106 (1959).
Blaskovic, D., and F. Sokol: Some properties of the G antigen and haomagglutinin of influenza virus A/FE/Singapore/1957 (Czech). Biol. Prace 4, 75–77 (1958).
Blaskovic, D., J. Szanto, P. Albrecht, E. Sadecky, and V. Lackovic: Demonstration of swine influenza virus in pigs by the fluorescent antibody method. Acta virol. 8, 401–409 (1964).
Blough, H. A.: The role of the surface state in the morphogenesis of influenza virus filaments. Virology 19, 112–114 (1963).
Blough, H. A.: The effect of vitamin A on influenza virus in ovo: Morphological aspects. Biochem. J. 88, 11 (1963).
Blough, H. A.: The effect of vitamin A alcohol on the morphology of myxoviruses. 1. The production and comparison of artificially produced filamentous virus. Virology 19, 349–358 (1963).
Blough, H. A.: A molecular approach to teratogenesis: Effect of vitamin A on influenza virus in ovo. Nature (Lond.) 199, 33–35 (1963).
Blough, H. A.: Role of the surface state in the development of myxoviruses. Ciba Found. Symp. “Cellular biology of myxovirus infections” 120-151 (1964).
Blough, H. A.: Selective inactivation of biological activity of myxovirus by glutaraldehyde. J. Bact. 92, 266–268 (1966).
Blyumberg, N. A.: Adaption variability of the influenza virus (Russian). Dissertation, Moscow (1949).
Boand, A. V., and J. E. Kempf: The identification of influenza virus antibodies by means of the collodion particle agglutination reaction. J. Lab. clin. Med. 37, 914–923 (1951).
Boand, A. V., J. E. Kempf, and R. J. Hanson: Phagocytosis of influenza virus. 1. In vitro observations. J. Immunol. 79, 416–421 (1957).
Bodily, H. L., M. Corey, and M. D. Eaton: Precipitation and concentration of influenza virus with alum. Proc. Soc. exp. Biol. (N.Y.) 52, 165–168 (1943).
Bodily, H. L., and M. D. Eaton: Specificity of the antibody response of human beings to strains of influenza virus. J. Immunol. 45, 193–204 (1942).
Bogoch, S., P. Lynch, and A. S. Levine: Influence of brain ganglioside upon the neurotoxic effect of influenza virus in mouse brain. Virology 7, 161–169 (1959).
Bohm, P., J. Ross, and L. Baumeister: The cleavage of N-acetyl neuraminic acid from serum by influenza B virus and by Clostridium Welchii A toxin (German). Hoppe-Seylers Z. physiol. Chem. 308, 181–182 (1957).
Boldasov, V. K.: Studies on the enzymic properties of inhibitor sensitive and inhibitor resistant strains of A2 influenza viruses. Acta virol. 7, 361–367 (1963).
Boldyreva, A. S., and I. A. Kiseleva: Comparative evaluation of methods used for the removal of non-specific inhibitors in the HI reaction (Russian). “Problemy grippa i ostrykh respiratornykh zabolevanii.” Tez. dokl. nauch. Sess. Inst. AMN SSSE. Moscow, 50-51 (1959).
Bordet, P., and L. Quersin-Thiry: Enhancing effect of influenza virus on associated infections (French). Ann. Inst. Pasteur 81, 394–406 (1951); 84, 695-702 (1953).
Borecky, L.: On the question of virus receptors. The selective agglutinability of erythrocytes of the ground squirrel (Citellus Citellus). Folia biol. (Prague) 2, 344–350 (1956).
Borecky, L.: The sensitivity of A-FE influenza viruses to inhibitors in normal animal sera (Czech). Biol. Prace 4, 32–38 (1958).
Borecky, L.: A factor destroying virus receptors in pneumococcal cultures. 2. The effect of pneumococcal factor 103 on erythrocyte receptors and inhibitors. Acta virol. 2, 201–207 (1958).
Borecky, L.: A factor destroying virus receptors in pneumococcal cultures. 3. The effect of pneumococcal factor 103 in experiments in vivo. Acta virol. 3, 9–16 (1959).
Boreckt, L., D. Kociskova, and L. Hana: An attempt to affect the level of serum inhibitors of myxoviruses in vivo. 1. Effect of ethionine administration on the level of inhibitors in guinea-pig sera. Acta virol. 5, 236–244 (1961).
Borecky, L., V. Lackovic, and E. Mrena: The effect of trypsin on influenza virus. Acta virol. 8, 555 (1964).
Borecky, L., and V. Rathova: Investigations of possible cross-reactions between preparations of salmonellae containing Vi antigen and inhibitors or antibodies against myxoviruses. Acta virol. 7, 339–349 (1963).
Borecky, L., V. Rathova, and D. Kociskova: Attempt to affect the level of serum inhibitors of myxoviruses in vivo. 2. Effect of ethionine administration on virus multiplication. Acta virol. 6, 97–104 (1962).
Borecky, L., V. Rathova, D. Kociskova, and L. Hana: Effect of dl ethionine on some factors of non-specific resistance to myxoviruses. J. Hyg. Epidem. (Praha) 6, 65–70 (1962).
Borecky, L., and J. Zavada: Effect of anti-cellular sera on infection with myxoviruses. 1. The effect of antichorioallantoic serum. Acta virol. 4, 110–123 (1960).
Boretti, G., A. Di Marco, and P. Julita: Preparation and characterisation of an influenza virus inhibitor from horse serum. G. Microbiol. (Naples) 12, 55–69 (1964).
Borghans, J. G. A., O. Maksteinieks, J. Versteeg, and J. D. Verlinde: A mixed epidemiological outbreak of acute respiratory disease caused by influenza A virus and APC virus in a group previously vaccinated against influenza A (Dutch). Ned. T. Geneesk. 100, 2110–2116 (1956).
Boudreault, A., and V. Pavilanis: Eelationship between cytopathogenic, haemadsorption, and haemagglutination properties of influenza virus (French). Canad. J. Microbiol. 7, 347–353 (1961).
Boudreault, A., and Y. Pavilanis: The development of some biological properties of 4 influenza virus strains after successive passage at 29°C and 41°C. Eesearch on cold mutants. Rev. Canad. Biol. 23, 253–260 (1964).
Boug, J., C. A. De Bock, H. D. Moed, and A. J. Klein: Antiviral action of derivatives of w-aminoacetophenone. Brit. J. Pharmacol. 13, 404–410 (1958).
Bovarnick, M., and P. M. De Burgh: Virus haemagglutination. Science, 105, 550–552 (1947).
Bowers, R. H., O. L. Davies, and W. Hurst: A comparison between intranasal instillation and natural inhalation as a means of infecting mice with influenza virus. Brit. J. exp. Path. 33, 601–609 (1952).
Bozzo, A.: Studies of the antigenic composition of influenza B viruses. Bull. Wld Hlth Org. 5, 149–163 (1952).
Bozzo, A., A. Jacono, S. Ricciardi, and G. Starace: Serological study of four strains of influenza virus isolated in various parts of south Italy in 1953 (Italian). Rev. Inst. Sieroter. ital. 28, 424–435 (1953).
Brandao, H.: Use of the Do unit (zero mortality) in virus titrations (Portuguese). Rev. Inst. Med. trop. S. Paulo 4, 343–350 (1962).
Brans, L. M.: Studies on the antigenic composition of influenza virus B strains. Onderzoek. Mededel. Inst. praevent. Geneesk. (Leiden) No 9 (1952).
Brans, L. M., E. Hertzberger, and J. L. Binkhorst: Studies on the elimination of non-specific inhibitors in sera against influenza viruses with the aid of filtrates of Vibrio Cholerae. Antonie v. Leeuwenhoek 19, 309–323 (1953).
Breitenfeld, P. M., and W. Schafer: The formation of fowl plague virus antigens in infected cells as studied with fluorescent antibodies. Virology 4, 328–345 (1957).
Brenner, S., and R. W. Horne: A negative staining method for high resolution electron microscopy of viruses. Biochim. biophys. Acta (Amst.) 34, 103–110 (1959).
Brightman, I. J., and J. D. Trask: Recovery of a filtrable virus from children sick with influenza. 1. Epidemiologic and clinical observations.
2. The experimental disease in ferrets. Amer. J. Dis. Child. 52, 67-77 and 78-91 (1936).
Briody, B. A.: Haemagglutination by influenza virus. 1. Modification of the 0 phase of influenza A virus. J. infect. Dis. 83, 283–287 (1948).
2. The existence of two phases of influenza B virus.
3. The XO phase of influenza A virus. J. exp. Med. 83, 288-292 and 293-298 (1948).
Briody, B. A.: Variation in influenza viruses. Bact. Rev. 14, 65–95 (1950).
Briody, B. A., and W. A. Cassel: Adaptation of influenza virus to mice. 2. Changes in the growth curve of an A prime strain of influenza virus. J. Immunol. 74, 37–40 (1955).
Briody, B. A., W. A. Cassel, and M. A. Medill: Adaptation of influenza virus to mice. 3. Development of resistance to B inhibitor. J. Immunol. 74, 41–45 (1955).
Broncova, O., and V. Bydzovsky: Effect of some 5-arylpyrimidines on influenza, vaccinia and Newcastle disease viruses (Czech). Čs. Epidem 11, 179–188 (1962).
Bronitki, A., A. Petrescu, P. Petrescu, L. Rothschild, and P. Athanasiu-Storescu: The isolation of a strain of influenza virus of predominantly neurotropic character (Eumanian). Stud. Cercet. Inframicrobiol. 8, 561–569 (1957).
Brudnaya, E. I., L. Ya. Zakstel’skaya, and K. K. Luneva: Serological reactions in persons vaccinated a live anti-influenza A2 vaccine (Russian). Vop. Virus 5, 133–135 (1958).
Brunner, K. T.: The formation of anti endotoxin in rabbits after injection of influenza virus (German). Path. et Microbiol. (Basle) 25, 91–100 (1962).
Bruno-Lobo, M.: “Gripe Asiatica” Inst. Microbiol. Universidade do Brasil (Portuguese). Rio de Janeiro (1958).
Bruno-Lobo, G. G., M. Bruno-Lobo, J. V. Vasconcellos, and J. Travassos: Studies on Asian influenza in Rio de Janeiro. 3. Sensitivity of the virus to non-specific inhibitors (Portuguese). An. Microbiol. 5, 69–93 (1957).
Bruno-Lobo, M., and J. Travassos: Studies on Asian influenza in Rio de Janeiro. 6. Post-vaccinal immunity (Portuguese). An. Microbiol. 6, 151–176 (1958).
Bryans, J. T.: Viral respiratory disease of horses. Scientific Proceed. 101st Ann. Meet. Amer. vet. Med. Ass. July 1964.
Buddingh, G. J.: Experimental combined viral and bacterial infection (influenza C and Haemophilus influenzae type B) in embryonated eggs. J. exp. Med. 104, 947–958 (1956).
Bukrinskaya, A. G.: Direct detection of influenza virus in human embryo tissue cultures (Russian). Vop. Virus. 3, 162–165 (1958).
Bukrinskaya, A. G.: Behaviour of influenza virus type A2 in tissue cultures of man and animals (Russian). Vop. Virus. 5, 61–68 (1958).
Bukrinskaya, A. G.: Formation of incomplete influenza A2 virus and multiplication of virus in tissue cultures of variable sensitivity. Probl. Virol. (N.Y.) 5, 481–485 (1960).
Bukrinskaya, A. G.: Resistance of synthesis of influenza virus ribonucleic acid to the action of actinomycin D. Nature (Lond.) 204, 205–206 (1964).
Bukrinskaya, A. G., E. A. Vladimerceva, A. K. Gitelman, and Y. A. Smirnov: Myxovirus induced early RNA and early proteins. Abstr. 9th int. Congr. Microbiol. Moscow, 494 (1966).
Bukrinskaya, A. G., and G. K. Vorbunova: Reproduction of influenza virus RNA in the presence of low concentrations of actinomycin D (Russian). Vop. Virus. 6, 657 (1964).
Bull, D. R., and F. M. Burnet: Experimental immunisation of volunteers against influenza virus B. Med. J. Aust. 1, 389–394 (1943).
Burke, D. C., and A. Isaacs: Further studies on interferon. Brit. J. exp. Path. 39, 78–84 (1958).
Burke, D. C., and A. Isaacs: Interferon: Relation to heterologous interference and lack of antigenicity. Acta virol. 4, 215–219 (1960).
Burke, D. C., A. Isaacs, and J. Walker: The nucleic acid content of influenza virus. Biochim. et biophys. Acta (Amst.) 26, 576–584 (1957).
Burke, D. C., and J. M. Morrison: Interferon production in chick embryo cells. 2. The role of DNA. Virology 28, 108–114 (1966).
Burke, D. C., and J. Ross: Molecular weight of chick interferon. Nature (Lond.) 208, 1297–1299 (1965).
Burnet, F. M.: Influenza virus isolated from an Australian epidemic. Med. J. Aust. 2, 651–653 (1935).
Burnet, F. M.: Propagation of the virus of epidemic influenza on the developing egg. Med. J. Aust. 2, 687–689 (1935).
Burnet, F. M.: Influenza virus on the developing egg. 1. Changes associated with the development of an egg-passage strain of virus. Brit. J. exp. Path. 17, 282–293 (1936).
Burnet, F. M.: Influenza virus on the developing egg. 5. Differentiation of two antigenic types of human influenza virus. Aust. J. exp. Biol. med. Sci. 15, 369–374 (1937).
Burnet, F. M.: Influenza virus infections of the chick embryo lung. Brit. J. exp. Path. 21, 147–153 (1940).
Burnet, F. M.: Influenza virus infection of the chick embryo by the amniotic route. 1. General character of the infections.
2. Titration and serum neutralisation tests. Aust. J. exp. Biol. med. Sci. 18, 353-360, and 19, 39-44 (1940).
Burnet, F. M.: Influenza virus A infections of Cynomolgous monkeys. Aust. J. exp. Biol. med. Sci. 19, 281–290 (1941).
Burnet, F. M.: Influenza virus B. 1. Observations on the growth in chick embryos and on the occurrence of antibodies in Australian serum.
2. Immunisation of human volunteers with living attenuated virus. Med. J. Aust. 1, 671-673 and 673-674 (1942).
Burnet, F. M.: Immunisation against epidemic influenza with living and attenuated virus. Med. J. Aust. 1, 385–389 (1943).
Burnet, F. M.: Characteristics of the influenza virus-antibody reaction as tested by the method of allantoic inoculation. Aust. J. exp. Biol. med. Sci. 21, 231–238 (1943).
Burnet, F. M.: Modification of human red cells by virus action. 3. A sensitive test for mumps antibody in human serum by the agglutination of human red cells coated with a virus antigen. Brit. J. exp. Path. 27, 244–247 (1946).
Burnet, F. M.: Mucins and mucoids in relation to influenza virus action. 3. Inhibition of virus haemagglutination by glandular mucins. B168 4. Inhibition by purified mucoid of infection and haemagglutination with the virus strain WSE.
5. The destruction of “Francis inhibitor” activity in a purified mucoid by virus action. Aust. J. exp. Biol. med. Sci. 26, 371-379, 381-387, and 389-402 (1948).
Burnet, F. M.: The initiation of cellular infection by influenza and related viruses. Lancet 7-11 (1948).
Burnet, F. M.: Inactivation of the receptor destroying enzyme of V. Cholerae by immune sera. Aust. J. exp. Biol. med. Sci. 27, 217–222 (1949).
Burnet, F. M.: The effect of periodate on the virus-inhibiting qualities of mucoids in solution. Aust. J. exp. Biol. med. Sci. 27, 361–374 (1949).
Burnet, F. M.: Inhibition of influenza virus haemagglutination by mucoids. 3. Specific relation between active virus and the corresponding indicator strains in studies of soluble inhibitors. Aust. J. exp. Biol. med. Sci. 27, 575–579 (1949).
Burnet, F. M.: The interaction of virus and cell surface. Proc. roy. Soc. Ser. B 138, 47–44 (1951).
Burnet, F. M.: Some biological implications of studies on influenza viruses. 1. The process of infection by the virus.
2. Reproduction and variation in influenza viruses. Bull. Johns Hopk. Hosp. 88, 119-137 and 137-157 (1951).
Burnet, F. M.: Mucoproteins in relation to virus action. Physiol. Rev. 31, 131–150 (1951).
Burnet, F. M.: A genetic approach to variation in influenza viruses. 1. The characters of three sub-strains of influenza A virus (WS).
Burnet, F. M.: 2 Variation in the strain NWS on allantoic passage. J. gen. Microbiol. 5, 46–53 and 54-58 (1951).
Burnet, F. M.: Irreversible binding of influenza virus to the red cell surface. Aust. J. exp. Biol. med. Sci. 30, 119–128 (1952).
Burnet, F. M.: Influenza virus group. Ann. N.Y. Acad. Sci. 56, 567 (1953).
Burnet, F. M.: Virulence in animal viruses. Lancet, 559 563 (1954).
Burnet, F. M.: The riddle of influenza virus. Endeavour 14, 5–11 (1955).
Burnet, F. M.: Filamentous forms of influenza. Nature (Lond.) 177, 130 (1956).
Burnet, F. M.: Structure of influenza virus. Science 123, 1101–1104 (1956).
Burnet, F. M.: Genetics of animal viruses. Handbuch Virusforsch. 4, 3, Erg.-Bd. (1958). Springer-Verlag, Wien.
Burnet, F. M., and S. G. Anderson: Modification of human red cells by virus action. 2. Agglutination of modified human red cells by sera from cases of infectious mononucleosis. Brit. J. exp. Path. 27, 236–244 (1946).
Burnet, F. M., and W. I. B. Beveridge: Titration of antibody against influenza by allantoic inoculation of the developing chick embryo. Aust. J. exp. Biol. med. Sci. 21, 71–77 (1943).
Burnet, F. M., W. I. B. Beveridge, and D.R. Bull: Study of a strain of influenza B virus isolated by chick embryo inoculation. Aust. J. exp. Biol. med. Sci. 22, 9–16 (1944).
Burnet, F. M., W. I. B. Beveridge, D. R. Bull, and E. Clarke: Investigation of an influenza epidemic in military camps in Victoria, May 1942. Med. J. Aust. 2, 371–376 (1942).
Burnet, F. M., W. I. B. Beveridge, J. McEwin, and W. C. Brake: Studies on the Hirst haemagglutination reaction with influenza and Newcastle disease viruses. Aust. J. exp. Biol. med. Sci. 23, 177–192 (1945).
Burnet, F. M., and D.R. Bull: Changes in influenza virus associated with adaptation to passage in chick embryos. Aust. J. exp. Biol. med. Sci. 21, 55–69 (1943).
Burnet, F. M., and E. Clarke: Influenza; A survey of the last 50 years in the light of modern work on the virus of epidemic influenza. Monograph No. 4, Walter and Eliza Hall Inst. Melbourne, 1942.
Burnet, F. M., and M. Edney: Recombinant viruses obtained from double infections with the influenza A viruses. Aust. J. exp. Biol. med. Sci. 29, 353–362 (1951).
Burnet, F. M., and M. Edney: Influence of ions on the interaction of influenza virus and cellular receptors or soluble inhibitors of haemagglutination. Aust. J. exp. Biol. med. Sci. 30, 105–118 (1952).
Burnet, F. M., and M. Foley: The results of intranasal inoculation of modified and unmodified influenza virus strains in human volunteers. Med. J. Aust. 2, 655–659 (1940).
Burnet, F. M., and M. Foley: Two methods for the detection of influenza virus in human throat washings without the use of ferrets. Med. J. Aust. 3, 68–72 (1941).
Burnet, F. M., and K. B. Fraser: Studies on recombination with influenza viruses in the chick embryo. 1. Invasion of the chick embryo by influenza viruses. Aust. J. exp. Biol. med. Sci. 30, 447–558 (1952).
Burnet, F. M., K. B. Fraser, and P. E. Lind: Genetic interaction between influenza viruses. Nature (Lond.) 171, 163 (1953).
Burnet, F. M., and P. E. Lind: A genetic approach to variation in influenza viruses.
3. Recombination of characters in influenza virus strains used in mixed infections. 4. Recombination of characters between influenza virus A strain NWS and strains of different serological sub-types. J. gen. Microbiol. 5, 59-66 and 67-82 (1951).
Burnet, F. M., and P. E. Lind: Studies on recombination with influenza viruses in the chick embryo. 3. Reciprocal genetic interaction between two influenza virus strains. Aust. J. exp. Biol. med. Sci. 30, 469–477 (1952).
Burnet, F. M., and P. E. Lind: Reactivation of heat-inactivated influenza virus by recombination. Aust. J. exp. Biol. med. Sci. 32, 133–143 (1954).
Burnet, F. M., and P. E. Lind: Recombination of influenza viruses in the de-embryonated egg. 1. The use of periodate-treated sera for in vitro characterisation of influenza virus strains. Aust. J. exp. Biol. med. Sci. 32, 145–151 (1954).
Burnet, F. M., and P. E. Lind: Becombination of influenza viruses in the de-embryonated egg. 2. The conditions for recombination and the evidence for the possible existence of diploid influenza virus. Aust. J. exp. Biol. med. Sci. 32, 153–163 (1954).
Burnet, F. M., and P. E. Lind: Genetics of virulence in influenza viruses. Nature (Lond.) 173, 627–630 (1954).
Burnet, F. M., and P.E. Lind: Reversion to virulence in an influenza virus mutant. Aust. J. exp. Biol. med. Sci. 35, 225–239 (1957).
Burnet, F. M., and P. E. Lind: Studies on the filamentous forms of influenza virus with special reference to the use of dark-ground microscopy. Arch. ges. Virsuforsch. 7, 413–428 (1957).
Burnet, F. M., P. E. Lind, and B. Perry: The action of ribonuclease on the multiplication of influenza viruses in the de-embryonated egg. Aust. J. exp. Biol. med. Sci. 35, 517–529 (1957).
Burnet, F. M., P. E. Lind, and K.M. Stevens: Production of incomplete influenza virus in the de-embryonated egg. Aust. J. exp. Biol. med. Sci. 33, 127–141 (1955).
Burnet, F. M., and D. Lush: Influenza virus on the developing egg. 8. A comparison of two antigenically dissimilar strains of human influenza virus after full adaptation to the egg membrane. Aust. J. exp. Biol. med. Sci. 16, 261–274 (1938).
Burnet, F. M., and D. Lush: Influenza virus strains isolated from the Melbourne 1939 epidemic. Aust. J. exp. Biol. med. Sci. 18, 49–55 (1940).
Burnet, F. M., D. Lush, and A. V. Jackson: A virus inactivating agent from human nasal secretion. Brit. J. exp. Path. 20, 377–385 (1939).
Burnet, F. M., and J. F. McCrea: Inhibitory and inactivating action of normal ferret sera against an influenza virus strain. Aust. J. exp. Biol. med. Sci. 24, 277–282 (1946).
Burnet, F. M., J. F. McCrea, and J.D. Stone: Modification of human red cells by virus action. 1. The receptor gradient for virus action in human red cells. Brit. J. exp. Path. 27, 228–236 (1946).
Burnet, F. M., and J. D. Stone: The significance of primary isolation of influenza virus by inoculation of mice or of the allantoic cavity of chick embryos. Aust. J. exp. Biol. med. Sci. 23, 147–150 (1945).
Burnet, F. M., and J. D. Stone: Further studies on the O-D change in influenza virus A. Aust. J. exp. Biol. med. Sci. 23, 151–160 (1945).
Burnet, F. M., and J. D. Stone: A method for the isolation of influenza virus from throat washings without filtration. Aust. J. exp. Biol. med. Sci. 23, 161–163 (1945).
Burnet, F. M., and J. D. Stone: Serological response to influenza B infection in human beings. Differentiation of specific and non-specific type reactions. Aust. J. exp. Biol. med. Sci. 24, 207–212 (1946).
Burnet, F. M., and J. D. Stone: The receptor destroying enzyme of V. cholerae. Aust. J. exp. Biol. med. Sci. 25, 227–233 (1947).
Burnet, F. M., J. D. Stone, and S. G. Anderson: An epidemic of influenza B in Australia. Lancet 807-811 (1946).
Burnet, F. M., J. D. Stone, A. Isaacs, and M. Edney: The genetic character of the O-D change in influenza A. Brit. J. exp. Path. 30, 419–425 (1949).
Buslenko, A. I.: Epidemiologic and clinical characteristics of the course of influenza in T.B. patients (Russian). “Problemy grippa i ostrykh respiratornykh zabolevanii.” Tez. dokl. nauch, Sess. Inst. AMN SSSR Moscow, 201-202 (1959).
Buzzell, A., F.B. Brandon, and M. A. Lauffer: Effects of X radiation on influenza virus. Arch. Biochem. 58, 318–331 (1955).
Cairns, H. J. F.: Protection by receptor destroying enzyme against infection with a neurotropic variant of influenza virus. Nature (Lond.) 167, 335 (1951).
Cairns, H. J. F.: The growth of influenza viruses and Newcastle disease virus in mouse brain. Brit. J. exp. Path. 32, 110–117 (1951).
Cairns, H. J. F.: Quantitative aspects of influenza virus multiplication. 3. Average liberation time. J. Immunol. 69, 168–173 (1952).
Cairns, H. J. F.: The limited growth of influenza viruses in mouse brain. Aust. J. exp. Biol. med. Sci. 32, 123–128 (1954).
Cairns, H. J. F.: Multiplicity reactivation of influenza virus. J. Immunol. 75, 326–329 (1955).
Cairns, H. J. F.: Site of the chorioallantoic inhibitor of influenza virus haemagglutinin. Nature (Lond.) 178, 744–745 (1956).
Cairns, H. J. F.: The asynchrony of infection by influenza virus. Virology 3, 1–14 (1957).
Cairns, H. J. F., and M. Edney: Quantitative aspects of influenza virus multiplication. 1. Production of incomplete virus. J. Immunol. 69, 155–160 (1952).
Cairns, H. J. F., and S. Fazekas de St Groth: The number of allantoic cells in the chick embryo. J. Immunol. 78, 191–200 (1957).
Cairns, H. J. F., and P. J. Mason: Production of influenza A virus in the cell of the allantois. J. Immunol. 71, 38–40 (1953).
Cajal, N., O. Burducea, S. Mateascu, G. Marinescu, M. Cepleanu, and Y. Cepelovici: The development of experimental virus infections (influenza, poliomyelitis, Coxsackie, rabies, and herpes) under the influence of radioactive phosphorus P 32 and radioactive iodine I 131 (Rumanian). Stud. Cercet. Inframicrobiol. 12, 29–37 (1961).
Canchola, J. G., R. M. Chanock, B. C. Jeffries, E. E. Christmas, H. W. Kim, A. J. Vargosco, and R. H. Parrot: Recovery and identification of human myxoviruses. Bact. Rev. 29, 496–503 (1965).
Carlinfanti, E.: Studies of the receptor destroying factor from different viruses (Italian). Riv. Ist. sieroter. ital. 23, 141–150 (1948).
Carlinfanti, E.: Rapid liberation of influenza virus from red cells by Newcastle disease virus. Riv. Ist. sieroter. ital. 23, 151–155 (1948).
Carson, S., and A. W. Frisch: The inactivation of influenza viruses by tannic acid and related compounds. J. Bact. 66, 572–575 (1953).
Carubelli, R., V. P. Bhavanandan, and A. Gottschalk: Studies on glycoproteins. 11. The O-glycosidic linkage of N-acetylgalactosamine to seryl and threonyl residues in ovine submaxillary gland glycoprotein. Biochim. biophys. Acta (Amst.) 101, 67–82 (1965).
Cateigne, G.: Anti-influenza vaccine (French). Rev. Prat. (Paris) 8, 1446–1451 (1958).
Cateigne, G., C. Hannoun, and R. Panthier: Antigenic characters of influenza virus in the 1948–49 epidemic (French). C. R. Soc. Biol. (Paris) 143, 812–814 (1949).
Cateigne, G., and P. Reculard: Work on the adaptation of two strains of influenza virus A to chick embryo cells in vitro (French). Ann. Inst. Pasteur 11, 229–234 (1966).
Centanni, E., and O. Savunozzi: (1900) Cited by Stubbs, E. L. in “Diseases of poultry” 4th edit. Biester and Schwartz, Iowa State Univ. Press.
Chagnon, A., J. C. Gilker, and A. Boudreault: Infectivity and haemagglutinating properties of influenza virus at varying pH (French). Canad. J. Microbiol. 11, 845–851 (1965).
Chalkina, O. M.: Immunological changes in the blood of people vaccinated with the virus of epidemic influenza (Russian). Arkh. biol. nauk. 52, 125 (1938).
Chalkina, O. M.: Susceptibility of white rats to the influenza virus (Russian). Zh. Mikrobiol. (Mosk.) 10-11, 23 (1943).
Chalkina, O. M.: Increase in the immunogenic power of influenza vaccine with a biologic stimulator (Russian). Yop. Virus 2, 235 (1949).
Chalkina, O. M., S. A. Burov, and N. A. Ilin: The evaluation of the epidemiologic effectiveness of live anti-influenza vaccine during the 1959 outbreaks of influenza A2 and B (Russian). “Problemy grippa i ostrykh respiratornykh zabolevanii.” Tez. dokl. nauch. Sess. Inst. AMN SSSE, Moscow, 80-82 (1959).
Chalkina, O. M., and A. G. Gulamov: The use of white rats for the laboratory diagnosis of influenza (Russian). Zh. Mikrobiol. (Mosk.) 10-11, 26 (1943).
Chalkina, O. M., and O. S. Zak: Yirological characterisation of a Type A influenza outbreak (Russian). “Bibliografiya i annotatsii rabot otdela virusologii.” Inst. Eksper. med. AMN SSSE Za, 1947–1949, Leningrad (1950).
Chambers, L. A., and W. Henle: Precipitation of active influenza A virus from extra-embryonic fluids by protamine. Proc. Soc. exp. Biol. (N.Y.) 48, 481–483 (1941).
Chambers, L. A., and W. Henle: Studies on the nature of the virus of influenza. 1. The dispersion of the virus of influenza A in tissue emulsions and in extraembryonic fluids of the chick.
2. The size of the infectious unit in influenza A. J. exp. Med. 77, 251-264, and 265-276 (1943).
Chang, H. T., and J. E. Kempf: The hypotensive action of influenza virus on rats. J. Immunol. 65, 75–84 (1950).
Chang, S. S., and C. Y. Chen: Inhibitor spectra and effects of various treatments on the inhibitors of influenza virus haemagglutination. J. Formosan Med. Ass. 59, 1110–1122 (1960).
Chapman, J., and R. R. Hyde: Antigenic differences in viruses from cases of influenza and colds. Amer. J. Hyg. 31, 46–68 (1940).
Cheburkina, N. V.: Study of cell metabolism in virus infections (Russian). Annot. rabot. Inst. virusol. AMN SSSR za 1949, Moscow, 8 (1950).
Cheburkina, N. V., and L. Ya. Zakstelskaya: Metabolism in the chick embryo in influenzal infection (Russian). Zh. Mikrobiol. (Mosk.) 9, 15 (1960).
Cheburkina, N. V., and L. Ya. Zakstelskaya: Metabolism in the developing chick embryo in influenzal infection (Russian). Probl. obshch. virusol. Tez. dokl. 6-y Inst. virusol. AMN SSSR Moscow 58 (1953).
Chen, C. Y., W. F. Kuo, and S. S. Chang: Studies on the strains of A2 (asian) influenza virus isolated in Taiwan. Mem. Coll. Med. Taiwan Univ. 11, 1–10 (1965).
Chernukh, A. M., I. S. Rudakova, N. S. Tolmacheva, and A. M. Prochorova: A comparative study of the effect produced by esculamine and aminoadamantane on the experimental influenza. Abstr. 9th int. Congr. Microbiol., Moscow 545 (1966).
Chesbro, W. R., and L. R. Hadrick: Comparison of the tendency to stick to glass and haemagglutination produced in erythrocyte suspensions by ferric chloride and by influenza virus. Nature (Lond.) 182, 1164 (1958).
Chevance, L. G., and G. Cateigne: A new test for the study of influenza virus (French). Ann. Inst. Pasteur 104, 264–273 (1963).
Choppin, P. W.: Plaque formation by influenza A2 virus in monkey kidney cells. Virology 18, 332–334 (1962).
Choppin, P. W.: On the emergence of influenza virus filaments from host cells. Virology 21, 278–281 (1963).
Choppin, P. W.: Multiplication of two kinds of influenza A2 virus particles in monkey kidney cells. Virology 21, 342–352 (1963).
Choppin, P. W., J. S. Murphy, and W. Stoekenius: The surface structure of influenza virus filaments. Virology 13, 548–550 (1961).
Choppin, P. W., S. Osterhout, and I. Tamm: Immunological characteristics of N.Y. strains of influenza virus from the 1957 pandemic. Proc. Soc. exp. Biol. (N.Y.). 98, 513–520 (1958).
Choppin, P. W., and W. Stoekenius: Interactions of ether-disrupted influenza A2 virus with erythrocytes, inhibitors, and antibodies. Virology 22, 482–492 (1964).
Choppin, P. W., and I. Tamm: Studies of two kinds of virus particles which comprise influenza A2 virus strains. 1. Characterisation of stable homogeneous substrains in reactions with specific antibody mucoprotein inhibitors, and erythrocytes.
2. Reactivity with virus inhibitors in normal sera.
3. Morphological characteristics: Independence of morphological and functional traits. J. exp. Med. 112, 895-920, 921-944, and 945-952 (1960).
Chu, C. M.: Agglutination of red blood cells of different animal species by influenza and Newcastle disease viruses. J. Hyg. (Lond.) 46, 239–246 (1948).
Chu, C. M.: Enzyme action of viruses and bacterial products on human red cells. Nature (Lond.) 162, 606–607 (1948).
Chu, C. M.: Inactivation of haemagglutinin and infectivity of influenza and Newcastle disease viruses by heat and by formalin. J. Hyg. (Lond.) 46, 247–251 (1948).
Chu, C. M.: The action of normal mouse serum on influenza virus. J. gen. Microbiol. 5, 739–757 (1951).
Chu, C. M.: The etiology and epidemiology of influenza: An analysis of the 1957 epidemic. J. Hyg. Epidem. (Praha) 2, 1–8 (1958).
Chu, C. M., C. H. Andrewes, and A. W. Gledhill: Influenza in 1948–49. Bull. Wld Hlth Org. 3, 197–214 (1950).
Chu, C. M., I. M. Dawson, and W. J. Elford: Filamentous forms associated with newly isolated influenza virus. Lancet 602 (1949).
Chu, C. M., C. Shao, and C. C. Hou: Study of strains of influenza viruses isolated during the 1957 epidemic in Changchun (Russian). Vop. Virus 2, 278–281 (1957).
Clark, R. J., A. Isaacs, and J. Walker: Derivatives of 3:4 xylidine and related compounds as inhibitors of influenza virus: Relationships between chemical structure and biological activity. Brit. J. Pharmacol. 13, 424–435 (1958).
Clarke, E., and F. P. O. Nagler: Haemagglutination by viruses. The range of susceptible cells with special reference to agglutination by vaccinia virus. Aust. J. exp. Biol. med. Sci. 21, 103–106 (1943).
Clarke, S. K. R., and D. A. J. Tyrrell: The neutralisation of influenza and other viruses by homologous immune serum. Studies in roller tube tissue cultures. Arch. ges. Virusforsch. 8, 453–468 (1958).
Cleeland, R., and A. P. McKee: Antigenic variation of Asian influenza virus. Proc. Soc. exp. Biol. (N.Y.) 99, 371–374 (1958).
Cleeland, R., and J.Y. Sugg: Effect of trypsin on a susceptible strain of influenza virus. J. Immunol. 85, 539–545 (1960).
Cleeland, R., and J. Y. Sugg: Inactivation of haemagglutinating capacity of type A influenza virus by trypsin treatment. Proc. Soc. exp. Biol. (N.Y.) 112, 913–917 (1963).
Cleeland, R., and J. Y. Sugg: Serologic and antigenic properties of type A influenza virus after trypsin treatment. J. Immunol. 93, 414–419 (1964).
Cochran, K. W., H. F. Maassab, A. Tsunoda, and B.S. Berlin: Studies on the antiviral activity of amantadine hydrochloride. Ann. N. Y. Acad. Sci. 130, 432–439 (1965).
Cocito, C., P. Laduron, and P. De Somer: Nucleotide composition of RNA viruses. Proc. Soc. gen. Microbiol. April 1963.
Coffey, J. P., and W. J. Jessop: Maternal influenza and congenital deformities. Lancet 935-938 (1959).
Coggeshall, L. T., and J. Maier: Effect of various sulphonamides, sulphones, and other compounds against experimental influenza and poliomyelitis infection in white mice. J. Pharmacol. 76, 161–166 (1942).
Cohen, A.: Protection of mice against Asian influenza virus infection by a normal horse serum inhibitor. Lancet 791-794 (1960).
Cohen, A., and G. Belyavin: Haemagglutination-inhibition of Asian influenza viruses: A new pattern of response. Virology 7, 59–74 (1959).
Cohen, A., and G. Belyavin: The influenza virus haemagglutination inhibitors of normal rabbit serum. 1. Separation of the inhibitory components. Virology 13, 58–67 (1961).
Cohen, A., and G. Belyavin: An automatic titration method for influenza haemagglutination inhibitors and its application to large scale antibody surveys. Abstr. 9th int. Congr. Microbiol. Moscow 379 (1966).
Cohen, A., G. Belyavin, and S. E. Newland: Analysis of the horse serum inhibitor of A2 influenza virus haemagglutination and infectivity. Abstr. D 30.4. 8th int. Congr. Microbiol. (1962).
Cohen, A., and F. Biddle: The effect of passage in different hosts on the inhibitor sensitivity of an Asian influenza virus strain. Virology 11, 458–473 (1960).
Cohen, A., F. Biddle, and S. E. Newland: Analysis of horse serum inhibitors of A2 influenza virus haemagglutination. Brit. J. exp. Path. 46, 497–513 (1965).
Cohen, A., and J. Dorman: Non-specific inhibitors of A2 influenza virus in human sera. Acta virol. 9, 519–525 (1965).
Cohen, A., and W. Smith: The heterogeneity of influenza virus particles within a single influenza virus strain. Brit. J. exp. Path. 38, 385–395 (1957).
Cohn, Z. A.: Quantitative distribution of phosphorus in chorioallantoic membrane as affected by infection with influenza virus. Proc. Soc. exp. Biol. (N.Y.) 79, 566–568 (1952).
Colville, J. M., J.M. Dunbar, and H. R. Morgan: Temperature and host cell factors in the growth of influenza virus (PR8 strain) in avian tissues in vitro. J. Immunol. 76, 264–269 (1956).
Commission on acute respiratory diseases. Endemic influenza. Amer. J. Hyg. 47, 290-296 (1948).
Commission on acute respiratory diseases. Influenza B. Study of a localised outbreak preceding the 1945 epidemic. Amer. J. Hyg. 47, 297-303 (1948).
Commission on influenza. Vaccination against Asian influenza. J. Amor. med. Ass. 165, 2054-2058 (1957).
Committee on standard serological procedures in influenza diagnostic studies. An agglutination-inhibition test proposed as a standard of reference in influenza diagnostic studies. J. Immunol. 65, 347-353 (1950).
Coto, V., C. A. Galeota, and F. Coraggio: Inhibition of interferon production by a halogenated pyrimidine derivative 5-fluoro-2-deoxyuridine. Tex. Rep. Biol. Med. 24, 158–163 (1966).
Cox, H. R., J. Van der Scheer, S. Aiston, and E. Bohnel: The purification and concentration of influenza virus by means of alcohol precipitation. J. Immunol. 56, 149–166 (1947).
Cox, C. D., A. Zerschling, and R. Melroy: Haemolysis of PR8 virus sensitised erythrocytes. Proc. Soc. exp. Biol. (N.Y.) 84, 693–696 (1953).
Creighton, C.: A history of epidemics in Britain. Cambridge University Press 2 vols. 1891 and 1894.
Csaky, T. Z., F. Lanni, and J. W. Beard: Purification of the egg white inhibitor of influenza virus haemagglutination by filtration. Proc. Soc. exp. Biol. (N.Y.) 75, 105–108 (1950).
Csonka, A., and A. Koch: Effects of formaldehyde on influenza virus. 3. Effects on the virus as antigen. Acta microbiol. Acad. Sci. hung. 9, 89–96 (1962).
Culver, J. D., E. H. Lennette, G. Navarre, and G. A. Donahue: The recall phenomenon in the antibody response to influenza virus vaccines. J. Immunol. 81, 452–459 (1958).
Culver, J. O., E. H. Lennette, G. Navarre, and C. H. Kempe: The response to influenza vaccines as determined by levels of complement fixing antibody in the acute phase of patients with respiratory disease. J. Immunol. 84, 98–105 (1960).
Culver, O., E. H. Lennette. T. E. Stevens, and R. E. Nitz: Antibody response to influenza vaccines containing the Asian strain. J. Immunol. 85, 197–202 (1960).
Curtain, C. C.: The action of urea on the urinary inhibitor of influenza virus haemagglutination. Aust. J. exp. Biol. med. Sci. 31, 615–622 (1953).
Curtain, C. C.: The nature of the bond split by the influenza virus enzyme. Aust. J. exp. Biol. med. Sci. 31, 623–630 (1953).
Curtain, C. C.: The adsorption of influenza virus by haemagglutination inhibitors coupled to powdered cellulose. Brit. J. exp. Path. 35, 255–263 (1954).
Curtain, C. C., E. L. French, and J. Pye: The preparation and properties of an inhibitor of influenza virus haemagglutination from human meconium. Aust. J. exp. Biol. med. Sci. 31, 349–360 (1953).
Curtain, C. C., B. P. Marmion, and J. Pye: Separation of an inhibitor of influenza virus haemagglutination from human sputum. Nature (Lond.) 171, 33–34 (1953).
Curtain, C. C., and J. Pye: A mucoprotein from bovine submaxillary glands with restricted inhibitory action against influenza virus haemagglutination. Aust. J. exp. Biol. med. Sci. 33, 315–322 (1955).
Cutting, W. C., R. H. Dreisbach, R. M. Halpern, E. A. Irwin, D. W. Jenkins, F. Proescher, and H.B. Tripi: Chemotherapy in virus infections. J. Immunol. 57, 379–390 (1947).
Dachy, H. A.: Influenza virus and staphylococcal infection (French). 17th Congr. Ass. pediat. lang. franç. Montpellier, 1958.
Dales, S., and P. W. Choppin: Attachment and penetration of influenza virus. Virology 18, 489–493 (1962).
Daniels, J. B., M. D. Eaton, and M. E. Perry: Effect of glucose on the growth of influenza virus in de-embryonated eggs and in tissue cultures. J. Immunol. 69, 321–329 (1952).
Danon, D., Z. Jerushalmy, A. Kohn, and A. De Vries: In vitro phagocytosis by leucocytes of influenza virus adsorbed onto erythrocytes. Electron microscopic and cinematographic observations. Virology 15, 258–262 (1961).
Danon, D., Z. Jerushalmy, and A. De Vries: Incorporation of influenza virus in human blood platelets in vitro. Electron microscopical observations. Virology 9, 719–722 (1959).
Davenport, F. M.: Alternate passage of influenza virus. A comparison of the effects of serial passage and alternate passage of type B influenza virus in hamsters. J. Immunol. 67, 83–92 (1951).
Davenport, F. M.: Reliability of 50% egg infectivity titrations with suspensions of influenza viruses prepared from mouse lungs. Proc. soc. exp. Biol. (N.Y.) 82, 1–5 (1953).
Davenport, F. M.: The inequality of potential in influenza virus for adaptation to mice. J. Immunol. 72, 485–488 (1954).
Davenport, F. M.: Vaccination against respiratory diseases caused by viruses. J. Mich. med. Soc. 57, 702–705 (1958).
Davenport, F. M.: Control of influenza by vaccination. Proc. 6th int. Congr. trop. Med. Malaria 5, 454–466 (1959).
Davenport, F. M.: Inactivated influenza virus vaccines. Amer. Rev. resp. Dis. 83, 146–150 (1961).
Davenport, F. M.: Pathogenesis of influenza. Bact. Rev. 25, 294–300 (1961).
Davenport, F. M.: Influenza. Industry and Tropical Hlth 4 (1961).
Davenport, F. M.: Current knowledge of influenza vaccine. J. Amer. med. Ass. 182, 11–13 (1962).
Davenport, F. M.: Factors of importance in the control of influenza. Medical clinics of North America 47, 1185–1190 (1963).
Davenport, F. M., and T. Francis: A comparison of the growth curves of adapted and unadapted lines of influenza virus. J. exp. Med. 93, 129–137 (1951).
Davenport, F. M., and A. V. Hennessy: A serologic recapitulation of past experiences with influenza A; Antibody response to monovalent vaccine. J. exp. Med. 104, 85–97 (1956).
Davenport, F. M., and A. V. Hennessy: Predetermination by infection and by vaccination of antibody response to influenza virus vaccines. J. exp. Med. 106, 835–850 (1957).
Davenport, F. M., and A. V. Hennessy: The clinical epidemiology of Asian influenza. Ann. intern. Med. 49, 493–501 (1958).
Davenport, F. M., A. V. Hennessy, and J. A. Bell: Immunologic advantages of emulsified influenza virus vaccines. Milit. Med. 127, 95–100 (1962).
Davenport, F. M., A. V. Hennessy, S. H. Bernstein, O. F. Harper, and W. H. Klingensmith: Comparative incidence of influenza A-prime in 1953 in completely vaccinated and unvaccinated military groups. Amer. J. publ. Hlth 45, 1138–1146 (1955).
Davenport, F. M., A. V. Hennessy, F. M. Brandon, R. G. Webster, C. D. Barrett, and Gr. O. Lease: Comparisons of serologic and febrile responses in humans to vaccination with influenza A viruses or their haemagglutinins. J. Lab. clin. Med. 63, 5–13 (1964).
Davenport, F. M., A. V. Hennessy, J. Drescher, J. Mulder, and T. Francis: Further observations on the relevance of serologic recapitulation of human infection with influenza viruses. J. exp. Med. 120, 1087–1097 (1964).
Davenport, F. M., A. V. Hennessy, and T. Francis: Epidemiologic and immunologic significance of age distribution of antibody to antigenic variants of influenza virus. J. exp. Med. 98, 641–656 (1953).
Davenport, F. M., A. V. Hennessy, and T. Francis: Influence of primary antigenic experience upon the development of a broad immunity to influenza. Trans. Ass. Amer. Phycns 70, 81–90 (1957).
Davenport, F. M., A. V. Hennessy, H. B. Houser, and W. F. Cryns: An evaluation of an adjuvant influenza virus vaccine tested against influenza B in 1954–55. Amer. J. Hyg. 64, 304–313 (1956).
Davenport, F. M., A. V. Hennessy, C H. Stuart-Harris, and T. Francis: Epidemiology of influenza: Comparative serological observations in England and the USA. Lancet 469 (1955).
Davenport, F. M., and F. L. Horsfall: The associative reactions of pneumonia virus of mice (PVM) and influenza viruses: The effects of pH and electrolytes upon virus-host cell combinations. J. exp. Med. 88, 621–644 (1948).
Davenport, F. M., R. Rott, and W. Schafer: Physical and biological properties of influenza virus components obtained after ether treatment. Fed. Proc. 18, 563 (1959).
also: J. exp. Med. 112, 765–782 (1960).
Davies, P., and R. D. Barry: Nucleic acid of influenza virus. Nature (Lond.) 211, 384–387 (1966).
Davies, W. L., R. R. Grunert, R. F. Haff, J. W. McGahen, E. M. Neumayer, M. Paulstock, J. C. Watts, T. R. Wood, E. C. Hermann, and C.E. Hoffmann: Antiviral activity of 1-adamantanamine (amantadine). Science 144, 862–863 (1964).
Davies, W. L., R. R. Grunert, and C. E. Hoffmann: Influenza virus growth and antibody response in amantadine treated mice. J. Immunol. 95, 1090–1094 (1965).
Davoli, R., and O. Bartolomei-Corsi: Antibodies against the Asian influenza virus in the normal population (Italian). Sperimentale 107, 358–362 (1957).
Dawson, C. R., M. A. Epstein, and K. Hummeler: Cytochemical and electron microscopical observations on the presence and origin of adenosine triphosphatase-like activity at the surface of two myxoviruses. J. Bact. 89, 1526–1532 (1965).
Dawson, I. M., and W. J. Elford: Electron microscope studies on the interaction of certain viruses with fowl red cell membranes. Nature (Lond.) 163, 63–64 (1949).
Dawson, I. M., and W. J. Elford: The investigation of influenza related viruses in the electron microscope by a new technique. J. gen. Microbiol. 3, 298–311 (1949).
De Burgh, P. M., P. C. Yu, C. Howe, and M. Bovarnick: Preparation from human red cells of a substance inhibiting virus haemagglutination. J. exp. Med. 87, 1–9 (1948).
DeMeio, J. L., E. L. Wooldridge, J. E. Whiteside, and J. E. Seal: Epidemic influenza B and C in Navy recruits 1953–54. 2. Antigenic studies on influenza virus type C. Proc. Soc. exp. Biol. (N.Y.) 88, 436–438 (1955).
Dempster, G., and B. Buchner: Seriological pattern of influenza virus strains isolated in Canada from 1948–1951. Canad. med. Ass. J. 69, 119–124 (1953).
Denk, H, and W. Kovac: Immunofluorescence studies of the growth of influenza virus in mouse lung. 1. Studies of infection with mouse-adapted virus (German). Arch. ges. Virusforsch. 17, 641 (1965).
Denk, H., and W. Kovac: Immunofluorescence studies of the growth of influenza virus in mouse lung. 2. Studies of infection with non mouse-adapted virus. Arch. ges. Virusforsch. 18, 244–252 (1966).
Denk, H., and W. Kovac: Immunofluorescence studies on intranasal influenza virus infection in immunised mice (German). Arch. ges. Virusforsch. 18, 294–303 (1966).
Depoux, E., and P. Fiset: Serological behaviour of influenza viruses. 1. The effect of different fowl erythrocytes on the results of serological tests. Bull. Wld Hlth Org. 11, 981–986 (1954).
Depoux, R., and A. Isaacs: Interference between influenza and vaccinia viruses. Brit. J. exp. Path. 35, 415–418 (1954).
Depoux, R., and A. Isaacs: Effect of inhibitors on interference between influenza and vaccinia viruses. Brit. J. exp. Path. 35, 419–425 (1954).
Depoux, R., and M. V. Mussett: Attempts to potentiate immunity to influenza in mice. J. Hyg. (Lond.) 52, 469–474 (1954).
Derevici, A.: Action of certain metals on haemagglutination (Rumanian). Comunicarilo Acad. R.P.R. 2, 375–376 (1952).
Derevici, A., A. Petrescu, L. Eothschild, and A. Bronitki: Epidemiologic and ecologic aspects of summer influenza in 1957 in the Romanian Peoples Republic (Rumanian). Stud. Cercet. Inframicrobiol. 9, 21–30 (1958).
Derevici, A., D. Sarateanu, A. Bronitki, A. Petrescu, L. Rothschild, N. Draganescu, C. Satmari, J. Petrusca, A. Stangu, A. Timerman, and M. Pironcof: The dynamic of serial influenzal antibodies in infants and adults vaccinated with “autochtone” vaccine (Rumanian). Stud. Cercet. Inframicrobiol. 6, 429–441 (1955).
Derevici, A., D. Sarateanu, L. Rothschild, A. Petrescu, A. Bronitki, J. Selevartz, and O. Moscovivi: Laboratory investigations during the 1967 influenza epidemic in the Romanian Peoples Republic (Rumanian). Stud. Cercet. Inframicrobiol. 8, 507–516 (1957).
De Ritis, F., G. Giusti, and V. Villari: The effect of N-ethyl maleimide on influenza virus multiplication (Italian). Arch. ges. Virusforsch. 5, 432–440 (1954).
Dick, G. W. A., and R. M. Taylor: Bovine plasma albumin in buffered saline as a diluent for viruses. J. Immunol. 62, 311–317 (1949).
Dickinson, L.: The formaldehyde derivatives of aminoacids and the mode of action of a formaldehyde-tyrosine derivative against influenza A virus in ovo. Brit. J. Pharmacol. 10, 56–60 (1955).
Diebel, R., and J. E. Hotchin: Quantitative application of fluorescent antibody technique to influenza virus infected cell cultures. Virology 8, 367–380 (1959).
Dinter, Z.: A variant of the fowl plague virus in Bayern (German). Tierärztl. Umsch. 4, 185–186 (1949).
Ditchfield, J. N. W. MacPherson, and A. Zbitnew: Upper respiratory disease in thoroughbred horses: Studies of its viral etiology in the Toronto area 1960 to 1963. Ann. J. comp. Med. Vet. Sci. 29, 18–22 (1965).
Doll, E. R.: Influenza of horses. Amer. Rev. resp. Dis. 83, 48–50 (1961).
Domracheva, Z. V.: An influenza A2 outbreak in men and horses (Russian). “Problemy grippa i ostrykh respiratornykh zabolevanii.” Tez. dokl. nauch. Sess. Inst. AMN SSSR Moscow 47 (1959).
Donald, H. B., and A. Isaacs: Some properties of influenza virus filaments shown by electron microscopic particle counts. J. gen. Microbiol. 11, 325–331 (1954).
Donald, H. B., and A. Isaacs: Counts of influenza virus particles. J. gen. Microbiol. 10, 457–464 (1954).
Dorman, D. C.: Effect of urea on A2 influenza virus. Nature (Lond.) 203, 789–791 (1964).
Dowdle, W. R., W. B. Yarbrough, and R. Q. Robinson: U.S. epizootic of equine influenza 1963. Publ. Hlth Rep. (Wash.) 79, 398–402 (1964).
Draganov, K. I.: Hypothesis on the nature of elementary bodies and “NV” bodies in cultures of influenza virus (Russian). J. gen. Biol. Moscow 17, 13–22 (1956).
Draganov, K. I.: New electron microscopic data on the study of the influenza virus (Russian). Byull. Eksper. biol. i med. 10, 53 (1953).
Draganov, K. I., and A. N. Slepushkin: Comparative electron microscopic study of the influenza virus cultivated in the chorioallantoic cavity and in tissue culture (Russian). Vop. Virus. 4, 64 (1954).
Drescher, J.: Determination of haemagglutinin and antibody content. 1. Description of photometric procedure for determining virus content.
2. Investigations on inhibitory antibody and description of a photometric method for determining antibody content (German). Zbl. Bakt. 1. Abt. Orig. 169, 314-348 and 461-470 (1957).
Drescher, J.: The influenza pandemic of 1957. Reports and discussions at a meeting of specialists Nov. 1957 in Berlin. Concerning A/Asia/57 Y-aluminium oxide vaccines. Abhandl. Bundesgesundheitsamt 1, 42–49 (1958).
Drescher, J.: Adsorption phenomena as a means of differentiating viral species. Zbl. Bakt. I. Abt. Orig. 176, 295–301 (1959).
Drescher, J.: Comparison of the adsorption of influenza virus strain B/Berlin/2/55 on aluminium oxide and on aluminium hydroxide. Amer. J. Hyg. 74, 104–118 (1961).
Drescher, J., F. M. Davenport, and A. V. Hennessy: Photometric methods for the measurement of haemagglutinating viruses and antibody. 2. Further experience with antibody determinations and the description of a technique for analysis of virus mixtures. J. Immunol. 89, 805–814 (1962).
Drescher, J., A. V. Hennessy, and F. M. Davenport: Photometric methods for the measurement of haemagglutinating viruses and antibody. 1. Further experience with a novel photometric method for measuring haemagglutinins. J. Immunol. 89, 794–804 (1962).
Drescher, J., and F. C. Lange: The determination of haemagglutinin and antibody. 4. Description of a photometric procedure for the determination of specific and unspecific inhibiting antibodies (German). Zbl. Bakt. I. Abt. Orig. 173, 185–195 (1958).
Drevo, M., A. Spousta, B. Blasco, and D. Slonim: Preparation of specific equine serum against influenza (Czech.). Čs. Epidem. 7, 175–181 (1958).
Dreyzin, R. S.: Method of preparing concentrated and purified influenza virus by the method of elution with formolised erythrocytes (Russian). Gripp. Tr. AMN SSSR Moscow 28, 82 (1953).
Dreyzin, R. S.: Conditions of reaction of the influenza virus with susceptible erythrocytes in the presence of specific antibodies (Russian). Gripp. Tr. AMN SSSR Moscow 28, 198 (1953).
Dreyzin, R. S.: The methods of studying the effect of chemotherapeutic preparations on an experimental influenza model (Russian). Vop. Virus. 4, 344 (1954).
Dreyzin, R. A., A. A. Davydova, E. E. Zolotarskaya, and A. G. Bukrinskaya: Differential diagnostic methods for adenoviruses and the viruses of herpes, influenza and poliomyelitis (Russian). Vop. Virus. 5, 178–183 (1958).
Dreyzin, R. S., and M. I. Karlina: The effect of an iodine preparation and apple pectin on experimental influenzal infection (Russian). Vop. Virus. 4, 331 (1954).
Dreyzin, R. S., and N. N. Sokolova: The effect of eucalyptus leaf extracts on the multiplication of influenza virus in the developing chick embryo (Russian). Vop. Virus 4, 323 (1954).
Dreyzin, R. S., and Ye. S. Zalmanzan: Serological diagnosis of fatal cases of influenzal pneumonias. Vop. Virus 4, 290 (1954).
Drzeniek, R.: Inhibition of neuraminidase by polyanions. Nature (Lond.) 211, 1205–1206 (1966).
Drzeniek, R., J. C. Seto, and R. Rott: Characterisation of neuraminidases from myxoviruses. Biochim. biophys. Acta (Amst.) 128, 547–558 (1966).
Dubakina, A. V., I. A. Sutina, and B. S. Vul’vovich: Efficacy of immunisation against influenza with dry live vaccine in Stalingrad in 1952 (Russian). Zh. Mikrobiol. (Mosk.) 10, 63 (1953).
Dubakina, A. V., and E. E. Kushnareva: Some features of the 1957 influenza outbreak in the Stalingrad district (Russian). Vop. Virus 4, 162–164 (1959).
Dubinakova, A. M.: Data on haematology and rhinocytology of influenza in 1957 (Russian). Vop. Virus 5, 83–86 (1958).
Dubrovina, T. Ya.: Conditions of isolation of infectious ribonucleic acid from influenza virus. Acta virol. 10, 117–123 (1966).
Duc-Nguyen, H., H. M. Rose, and C. Morgan: An electron microscopic study of changes at the surface of influenza-infected cells as revealed by ferritin conjugated antibodies. Virology 28, 404–412 (1966).
Dudgeon, J. A., H. Mellanby, R. E. Glover, and C. H. Andrewes: Influenza in Groat Britain in 1946–47. Brit. J. exp. Path. 29, 132–141 (1948).
Dudgeon, J. A., C. H. Stuart-Harris, R. E. Glover, C. H. Andrewes, and W.H. Bradley: Influenza B in 1945–46. Lancet 627-631 (1946).
Dujarric De La Riviere, R., and J. Cheve: Influenza virus in ferrets. Study of different French strains of influenza virus (French). Ann. Inst. Pasteur 59, 445–456 (1937).
Dulbecco, R., and M. Vogt: Plaque formation and isolation of pure lines with poliomyelitis viruses. J. exp. Med. 99, 167–182 (1954).
Dulbecco, R., and M. Yogt: One step growth curves of Western Equine encephalomyelitis virus on chicken embryo cells grown in vitro and analysis of virus yields from single cells. J. exp. Med. 99, 183–199 (1954).
Duncan, I. B. R., M. O. Creighton, and B. Jeans: Epidemic Type A influenza in Southwestern Ontario in 1963. Canad. med. Ass. J. 91, 541 (1964).
Dunham, W. B., and W. J. MacNeal: Inactivation of influenza virus by mild antiseptics. J. Immunol. 49, 123–128 (1944).
Durand, P.: The susceptibility of certain Tunisian rodents to influenza virus (French). C.R. Soc. Biol. (Paris) 139, 718–719 (1945).
Dzagurov, S. G.: Experimental study of the effect of antibiotics on microbes encountered in influenza and on the influenza A virus (Russian). Tr. ob’yed. nauch. Sess. AMN SSSR, Moscow, 162-171 (1953).
Eaton, M. D.: Transmission of epidemic influenza virus by contact in mice. J. Bact. 39, 220–241 (1940).
Eaton, M. D.: Experimental immunisation of mice with the virus of epidemic influenza. 1. Quantitative studies on the antigenicity of active and inactive virus. J. Immunol. 39, 43–45 (1940).
Eaton, M. D.: Strain specificity of complement fixation with sera of mice immune to the virus of influenza A and swine influenza. J. Immunol. 41, 383–389 (1941).
Eaton, M. D., L. T. Adler, P. Bond, and A. R. Scala: The effect of thyroxin on respiration and virus growth in chick embryo tissue cultures. J. infect. Dis. 98, 239–248 (1956).
Eaton, M. D., L. T. Adler, and M. E. Perry: Virus growth and cellular energy production. Effect of substances chemically related to thyroxin on influenza viruses. Proc. Soc. exp. Biol. (N.Y.) 84, 57–60 (1953).
Eaton, M. D., and M. D. Beck: Experimental immunisation of mice with the virus of epidemic influenza. 2. Immunity after intranasal inoculation of mouse passage, tissue culture, and ferret passage strains. J. Immunol. 39, 57–64 (1940).
Eaton, M. D., and M. D. Beck: A new strain of virus of influenza B isolated during an epidemic in California. Proc. Soc. exp. Biol. (N.Y.) 48, 177–180 (1941).
Eaton, M. D., M. Corey, W. Van Herick, and G. Meiklejohn: A comparison of various methods of demonstrating influenza virus in throat washings. Proc. Soc. exp. Biol. (N.Y.) 58, 6–9 (1945).
Eaton, M. D., C. G. Levenson, and M. Perry: Inhibition of the growth of viruses in the chick embryo by aromatic diamidines. J. Immunol. 68, 1–9 (1952).
Eaton, M. D., I. E. Low, A. R. Scala, and S. Uretsky: Inhibition by ammonium ion of the growth of influenza virus in chorioallantoic tissue. Virology 18, 102–108 (1962).
Eaton, M. D., B. Magasanik, M.E. Perry, and D. Karibian: Inhibition of influenza and mumps viruses in tissue culture by basic aminoacids. Proc. Soc. exp. Biol. (N.Y.) 77, 505–508 (1951).
Eaton, M. D., and W.P. Martin: Personnel of Naval Lab. Res. unit No. 1. Immunisation with inactive virus of influenza B. Comparison of antibody response with that produced by infection. Publ. Hlth Rep. (Wash.) 57, 445–451 (1942).
Eaton, M. D., and G. Meiklejohn: Vaccination against influenza: A study in California during the epidemic of 1943–44. Amer. J. Hyg. 42, 28–44 (1945).
Eaton, M. D., and M.E. Perry: Further observations on the effect of 2,4-dinitrophenol on the growth of influenza virus. J. infect. Dis. 93, 269–277 (1953).
Eaton, M. D., M.E. Perry, C. G. Levenson, and I. M. Gocke: Studies on the mode of action of aromatic diamidines on influenza and mumps virus in tissue culture. J. Immunol. 68, 321–334 (1952).
Eaton, M. D., and A. R. Scala: Reversible effect of hypotonic solutions on the growth of influenza virus in tissue cultures. Proc. Soc. exp. Biol. (N.Y.) 92, 289–297 (1956).
Eaton, M. D., and A. R. Scala: Interrelated effects of cysteine, thyroxin, and substrate on the growth of influenza virus in tissue cultures. Arch. ges. Virus-forsch. 7, 274–283 (1957).
Eaton, M. D., and A. R. Scala: Inhibitory effect of glutamine and ammonia on replication of influenza virus in ascites tumour cells. Virology 13, 300–307 (1961).
Eaton, M. D., A. R. Scala, and I. E. Low: Aminoacid imbalance and incomplete virus replication. Arch. ges. Virusforsch. 14, 583–598 (1964).
Eckert, E. A.: Envelope proteins derived from influenza virus. J. Bact. 91, 1907–1910 (1966).
Eckert, E. A.: Characterisation of a low molecular weight antigenic protein from the envelope of influenza virus. J. Bact. 92, 1430–1434 (1966).
Eckert, E. A., F. Lanni, D. Beard, and J. W. Beard: Effect of swine influenza virus on the viscosity of the egg-white inhibitor of haemagglutination. Science 109, 463–464 (1949).
Eddy, B. E.: A study of influenza virus vaccines by a serum-virus neutralisation test and by active immunisation. J. Immunol. 57, 195–202 (1949).
Eddy, B. E., and R. W. G. Wyckoff: Influenza virus in sectioned tissues. Proc. Soc. exp. Biol. (N.Y.) 75, 290–293 (1950).
Edmunds, P. N.: Immunity to old and new strains of influenza A virus. Brit. med. J. 155-156 (1951).
Edney, M.: The influence of calcium ion on the reaction of the V. Cholerae enzyme RDE and influenza virus with specific mucopolysaccharides. Aust. J. exp. Biol. med. Sci. 27, 253–264 (1949).
Edney, M.: Genetic analysis of the development of serum resistance in an influenza virus strain. J. gen. Microbiol. 17, 25–38 (1957).
Edney, M., and F. M. Burnet: Influence of ions on thermal inactivation and modification of an influenza virus. Aust. J. exp. Biol. med. Sci. 30, 129–138 (1952).
Edney, M., and A. Isaacs: Interference between active and inactive influenza viruses in the chick embryo. 3. Inhibition of virus haemagglutination in the chorioallantoic membrane. Aust. J. exp. Biol. med. Sci. 28, 603–612 (1951).
Edward, D. G. ff.: Resistance of influenza viruses to drying and its demonstration on dust. Lancet 664-666 (1941).
Edward, D. G. ff., W. J. Elford, and P. P. Laidlaw: Studies on air-borne infection. 1. Experimental technique and preliminary observations on influenza and infectious ectromelia. J. Hyg. (Lond.) 43, 1–10 (1943).
Edward, D. G. ff., D. Lush, and R. B. Bourdillon: Studies on air-borne virus infections. 2. The killing of virus aerosols by ultraviolet radiation. J. Hyg. (Lond.) 43, 11–15 (1943).
Efimova, K. V., L. V. Zakharova, and E. N. Milyaeva: Epidemiologic characteristics of influenza in Kuibyshev from 1957–1959 (Russian). “Problemy Gripp. i ostrykh respiratornykh zabolevanii.” Tez. dokl. nauch. Sess. Inst. AMN SSSR, Moscow, 90-92 (1959).
Efimova, V. A., and L. Ya. Zakstel’skaya: The mechanism of anamnestic reactions to A influenza virus strains (Russian). “Problemy grippa i ostrykh respiratornykh zabolevanii.” Tez. dokl. nauch. Sess. Inst. AMN SSSR, Moscow, 167-168 (1959).
Elford, W. J., and C. H. Andrewes: Centrifugation studies: Viruses of vaccinia, influenza, and Eous sarcoma. Brit. J. exp. Path. 17, 422–430 (1936).
Elford, W. J., C. H. Andrewes, and F. F. Tang: The sizes of the viruses of human and swine influenza as determined by ultrafiltration. Brit. J. exp. Path. 17, 51–53 (1936).
Enders, J. F., and H.E. Pearson: Resistance of chicks to infection with influenza virus. Proc. Soc. exp. Biol. (N.Y.) 48, 143–146 (1941).
Epshteyn, F. G., A. S. Gorbunova, and P. M. Karakuyumchan: Skin test in influenza (Russian). Yop. Virus. 4, 298 (1954).
Epshteyn, F. G., and V. S. Panasyuk: Experience in the treatment of influenza with atabrine (Russian). Vo.-med. Zh. 4, 32–34 (1951).
Epshteyn, F. G., N. V. Sergeev, and E. J. Sorokina: The clinical course of Asian influenza in adults (Russian). Klin. med. Moskva. 36, 35–42 (1958).
Evans, C. A., and E. R. Rickard: The toxic effect of influenca virus in the rabbit eye. Proc. Soc. exp. Biol. (N.Y.) 58, 74–75 (1945).
Fadeyeva, L. L.: Study of the properties of the influenza virus cultivated in tissues outside the body (Russian). Problemy grippa i OKVDP. Tez. dokl. ob’yed. Sess. Inst. AMN SSSR, Moscow 12 (1952).
Fadeyeva, L. L.: Isolation of the influenza virus by means of the tissue culture method (Russian). Problemy grippa i OKVDP. Tez. dokl. ob’yed. Sess. Inst. AMN SSSR, Moscow 22 (1952).
Fadeyeva, L. L.: Biological properties of the influenza virus cultured in animal and human tissues (Russian). Dissertation, Moscow (1952).
Fadeyeva, L. L.: Tissue cultures of the influenza virus (Russian). Zh. Mikrobiol. (Mosk.) 2, 47 (1953).
Fadeyeva, L., and A. I. Davientzo: Epidemiological testing of influenza tissue vaccine (Russian). Zh. Mikrobiol. (Mosk.) 10, 25 (1953).
Fadeyeva, L. L., V. V. Ritova, and L. Ya. Zakstel’skaya: Perfection of an influenza tissue vaccine (Russian). Vop. Virus 4, 393 (1954).
Faillard, H.: Isolation of N-acetylneuraminic acid from mucin by means of receptor destroying enzyme of V. Cholerae (German). Hoppe-Seylers Z. physiol. Chem. 305, 145–148 (1956).
Faillard, H.: Liberation of N-acetylneuraminic acid from mucin by the receptor destroying enzyme of V. Cholerae (German). Hoppe-Seylers Z. physiol. Chem. 307, 62–86 (1957).
Fairbrother, R. W., and L. Hoyle: Observations on the aetiology of influenza. J. Path. Bact. 44, 213–223 (1937).
Fairbrother, R. W., and L. Hoyle: Active immunisation against influenza: The use of heat-killed elementary body suspensions. Brit. J. exp. Path. 18, 430–436 (1937).
Fairbrother, R. W., and A. E. Martin: Serologic studies in epidemic influenza with particular reference to the persistence of antibodies after infection. Lancet 718 (1938).
Fairbrother, R. W., and A. E. Martin: Further observations on the value of heated elementary body suspensions in immunisation against experimental influenza. Arch. ges. Virusforsch. 1, 114–119 (1939).
Falkovich, L. I., M. I. Ignetova, G. A. Piskunova, and Ye. V. Arkhina: Study of the virus of epidemic influenza. Experiment in vaccination of people with the influenza virus (Russian). Tr. Mosk. oblet. Inst. Infekt. bolezn. imeni. Mechnikova, Moscow, 239 (1939).
Farkas, E., and G. Takatsy: Isolation of strains of influenza virus (Hungarian). Nepegeszsegugy Budapest 30, 402–409 (1949).
Fauconnier, B.: Changes in pH of allantoic fluid inoculated with influenza virus, growth of virus in slightly acid allantoic fluid (French). Ann. Inst. Pasteur 85, 222–229 (1953).
Fauconnier, B.: Development of influenza virus and pH of the allantoic fluid of embryonated egg. 5. Acidifying and inhibitory effect of ammonium salts (French). Ann. Inst. Pasteur 90, 171–181 (1955).
Fauconnier, B.: Spontaneous variation of type A influenza virus towards serum inhibitors of normal animals (French). Ann. Inst. Pasteur 97, 377–384 (1959).
Fauconnier, B., and H. Beauchamp: A study of the duration of viraemia in mice inoculated with influenza virus (French). Ann. Inst. Pasteur 86, 660–663 (1954).
Fauconnier, B., and M. Chaigneau: Inhibition of influenza virus multiplication by thioparatoluidine and certain of its derivatives (French). Ann. Inst. Pasteur 94, 514–516 (1958).
Fauconnier, B., R. M. Lartitegui, and D. Barua: Experimental adaptation of influenza virus to inhibitors of normal sera. 1. Isolation of a non-sensitive variant by cultivation of the sensitive strain in the presence of its inhibitor (French). Ann. Inst. Pasteur 97, 473–478 (1959).
Fazekas De St Groth, S.: Destruction of influenza receptors in the mouse lung by an enzyme from V. Cholerae. Aust. J. exp. Biol. med. Sci. 26, 29–36 (1948).
Fazekas De St Groth, S.: Regeneration of virus receptors in mouse lungs after artificial destruction. Aust. J. exp. Biol. med. Sci. 26, 271–285 (1948).
Fazekas De St Groth, S.: Viropexis: The mechanism of influenza virus infection. Nature (Lond.) 162, 294–295 (1948).
Fazekas De St Groth, S.: Modification of virus receptors by metaperiodate. 1. The properties of IO4 treated red cells. Aust. J. exp. Biol. med. Sci. 27, 65–81 (1949).
Fazekas De St Groth, S.: Influenza: A study in mice. Lancet 1101-1105 (1950).
Fazekas De St Groth, S.: Studies in experimental immunology of influenza. 1. The state of virus receptors and inhibitors in the respiratory tract. Aust. J. exp. Biol. med. Sci. 28, 15–29 (1950).
6. The duration of induced immunity. Aust. J. exp. Biol. med. Sci. 28, 559-568 (1950).
9. The mode of action of pathotopic adjuvants. Aust. J. exp. Biol. med. Sci. 29, 339-352 (1951)
Fazekas De St Groth, S.: Quick test for the early diagnosis of influenza. Nature (Lond.) 167, 43 (1951).
Fazekas De St Groth, S.: Production of non-infective particles among influenza viruses: Do changes in virulence accompany the Von Magnus phenomenon? J. Hyg. (Lond.) 53, 276–291 (1955).
Fazekas De St Groth, S.: Evaluation of quantal neutralisation tests. Nature (Lond.) 191, 891–893 (1961).
Fazekas De St Groth, S.: Steric inhibition: Neutralisation of a virus-borne enzyme. Ann. N.Y. Acad. Sci. 103, 674–687 (1963).
Fazekas De St Groth, S., and H. J. F. Cairns: Quantitative aspects of influenza multiplication. 4. Definition of constants and general discussion. J. Immunol. 69, 173–181 (1952).
Fazekas De St Groth, S., and M. Donnelley: Studies in experimental immunology of influenza. 2. Production of viral antigens. Aust. J. exp. Biol. med. Sci. 28, 31–44 (1950).
3. The antibody response. Aust. J. exp. Biol. med. Sci. 28, 45-60 (1950).
4. The protective value of active immunisation. Aust. J. exp. Biol. med. Sci. 28, 61-75 (1950).
5. Enhancement of immunity by pathotopic vaccination. Aust. J. exp. Biol. med. Sci. 28, 77-85 (1950).
8. Pathotopic adjuvants. Aust. J. exp. Biol. med. Sci. 29, 323-337 (1951).
Fazekas De St Groth, S., and M. Edney: Quantitative aspects of influenza virus multiplication. 2. Heterologous interference. J. Immunol. 69, 160–168 (1952).
Fazekas De St Groth, S., and A. Gottschalk: Ovomucin: A substrate for the enzyme of influenza virus. 2. Demonstration of its inhomogeneity. Brit. J. exp. Path. 32, 21–24 (1951).
Fazekas De St Groth, S., and A. Gottschalk: Studies on glycoproteins. 10. Equilibrium measurements on influenza virus-glycoprotein systems. Biochim. biophys. Acta (Amst.) 78, 248–257 (1963).
Fazekas De St Groth, S., and D. M. Graham: Modification of virus receptors by metaperiodate. 2. Infection through modified receptors. Aust. J. exp. Biol. med. Sci. 27, 83–98 (1949).
Fazekas De St Groth, S., and D. M. Graham: Absence of incomplete virus production in certain influenza strains. Nature (Lond.) 172, 1193 (1953).
Fazekas De St Groth, S., and D. M. Graham: Artificial production of incomplete influenza virus. Nature (Lond.) 173, 637 (1954).
Fazekas De St Groth, S., and D. M. Graham: The production of incomplete virus particles among influenza strains: Experiments in eggs. Brit. J. exp. Path. 35, 60–74 (1954).
Fazekas De St Groth, S., and D. M. Graham: Studies on experimental immunology of influenza. 0. Passive immunity and its enhancement. Aust. J. exp. Biol. med. Sci. 32, 369–386 (1954).
Fazekas De St Groth, S., and D. M. Graham: The production of incomplete virus particles among influenza strains: Chemical induction of the Von Magnus phenomenon. Brit. J. exp. Path. 36, 205–213 (1955).
Fazekas De St Groth, S., and R. G. Webster: The neutralisation of animal viruses. 3. Equilibrium conditions in the influenza virus antibody system. J. Immunol. 90, 140–150 (1963).
4. Parameters of the influenza virus-antibody system. J. Immunol. 90, 151-164 (1963).
Fazekas De St Groth, S., and R. G. Webster: The antibody response. Ciba Found. Symp. “Cellular biology of myxovirus infections” 246-271 (1964).
Fazekas De St Groth, S., and R. G. Webster: Disquisition on original antigenic sin. 1. Evidence in man.
2. Proof in lower creatures. J. exp. Med. 124, 331-345, and 347-361 (1966).
Fazekas De St Groth, S., and D. O. White: An improved assay for the infectivity of influenza viruses. J. Hyg. (Lond.) 56, 151–162 (1958).
Fazekas De St Groth, S., and D. O. White: The dose-response relationship between influenza viruses and the surviving allantois. J. Hyg. (Lond.) 56, 523–534 (1958).
Fazekas De St Groth, S., and D. O. White: Comparison of the infectivity of influenza viruses in two host systems: The allantois of intact eggs and surviving allantois-on-shell. J. Hyg. (Lond.) 56, 535–546 (1958).
Fazekas De St Grotii, S., J. Withell, and K. J. Lafferty: An improved assay method for neutralising antibodies against influenza viruses. J. Hyg. (Lond.) 56, 415–426 (1958).
Fedorov, Ye. A.: Cytology of impressions from the nasal mucosa in influenza and in catarrhs of the respiratory tract (Russian). Zh. Mikrobiol. (Mosk.) 6, 25 (1951).
Fedorov, Ye. A.: Clinical-laboratory diagnosis of influenza (Russian). Zh. Mikrobiol. (Mosk.) 1, 56 (1952).
Fedova, D., and L. Zelenkova: The use of the fluorescent antibody method for the rapid identification of influenza virus in the epithelial cell sediment of allantoic or amniotic fluid of infected chick embryos.
2. The identification of influenza virus in nasal smears by the fluorescent antibody technique. J. Hyg. Epidem. (Praha) 9, 127-134, and 135-146 (1965).
Feldman, H. A., and S. S. Wang: Sensitivity of various viruses to chloroform. Proc. Soc. exp. Biol. (N.Y.) 106, 736–738 (1961).
Feltynowski, A.: An aluminium replica method for the study on the red cell surface, especially of influenza virus adsorption on intact chicken red cells (Polish). Medycyna Doswiadczalna 4, 423–438 (1953).
Fenner, F.: The reactivation of animal viruses. Brit. med. J. 135-142 (1962).
Fenner, F., and J. F. Sambrook: The genetics of animal viruses. Ann. Rev. Microbiol. 18, 47–94 (1964).
Filippova-Nutrikrina, Z. L.: Therapy with cortisone during virus influenza (Russian). “Kliniya i Meditsina.” Moscow, 149-153 (1954).
Finland, M., and M.W. Barnes: Laboratory experiences with influenza in Boston during the winter 1949–50. J. infect. Dis. 97, 48–56 (1955).
Finland, M., and M.W. Barnes: Influenza A in Boston in 1951 and 1953. Isolation of virus and serological studies in patients, including a study of antigenic relationships among strains of influenza A virus isolated in Boston from 1943 through 1953. Amer. J. Hyg. 62, 1–20 (1955).
Finter, N. B.: Studies on interferon. Abstr. Proc. Soc. gen. Microbiol. Jan. 1965.
Finter, N. B., and A. J. Beale: The 6-hour soluble antigen production test for comparing the infectivity of influenza virus preparations. J. Hyg. (Lond.) 54, 58–67 (1956).
Finter, N. B., O. C. Liu, and W. Henle: Studies on host-virus interaction in the chick embryo influenza virus system. 0. An experimental analysis of the Von Magnus phenomenon. J. exp. Med. 101, 461–478 (1955).
Finter, N. B., O. C. Liu, M. Liebermann, and W. Henle: Studies on host-virus interaction in the chick embryo influenza virus system. 8. An experimental analysis of various de-embryonation techniques. J. exp. Med. 100, 33–52 (1954).
Fiset, P., and E. Depoux: Serological behaviour of influenza viruses. 2. Patterns of antigenic relationship. Bull. Wld Hlth Org. 11, 987–993 (1954).
Fiset, P., and H.B. Donald: A method for influenza antibody absorption. Brit. J. exp. Path. 34, 616–620 (1953).
Fisher, T. N., and H. S. Ginsberg: Eeactions of influenza viruses with guineapig polymorphonuclear leucocytes. 2. The reduction of white blood cell glycosis by influenza viruses and receptor destroying enzyme (EDE).
3. Studies on the mechanism by which influenza viruses inhibit phagocytosis. Virology 2, 637-655 and 656-664 (1956).
Fleischer, M. S.: The effect of various dyes in vitro and in vivo upon influenza virus infection in mice. J. Immunol. 62, 245–255 (1949).
Fletcher, E. D., J. E. Hirschfield, and M. Forbes: Effect of 2-diethyl-aminoethyl-4-methylpiperazine-1-carboxylate on influenza viruses in tissue culture. Proc. Soc. exp. Biol. (N.Y.) 121, 68–72 (1966).
Flick, J. A., B. Sanford, and S. Mudd: The effect of salt concentration on the interaction of influenza A virus and erythrocytes. J. Immunol. 61, 65–77 (1949).
Florman, A. L., A.B. Weiss, and F.E. Council: Effect of large doses of streptomycin and influenza viruses on chick embryos. Proc. Soc. exp. Biol. (N.Y.) 61, 16–18 (1946).
Fong, J.: Sulphur mustard-inactivated influenza virus as interfering agent. J. Immunol. 71, 241–245 (1953).
Fong, J., and E. Bernal: In vitro action of mustards on the infective and toxic components of influenza A (PR8) virus. J. Immunol. 70, 89–96 (1953).
F8a_Fong, J., and E. Bernal: In vitro action of sulphur mustard and chloroethylainine derivatives upon antigenicity of influenza A (PES) virus. J. Immunol. 70, 97–102 (1953).
Fong, J., and B. Blum: Action of mustards on interfering, haemagglutinating and eluting capacities of influenza A (PR8) virus. J. Immunol. 71, 26–29 (1953).
Fong, J., K. Louis, and C. Ching: Effect of interfering virus and RDE upon development of toxic reactions. Proc. Soc. exp. Biol. (N.Y.) 84, 246–248 (1953).
Fortuin, G. J., and J. D. Verlinde: Vaccination against influenza (Dutch). Ned. T. Geneesk. 98, No. 31 (1954).
Francis, T.: Transmission of influenza by filtrable virus. Science 80, 457–459 (1934).
Francis, T.: Immunological relationships of strains of filtrable viruses recovered from cases of human influenza. Proc. Soc. exp. Biol. (N.Y.) 32, 1172–1175 (1935).
Francis, T.: Quantitative relationship between the immunising dose of epidemic influenza virus and the resulting immunity. J. exp. Med. 69, 283–300 (1939).
Francis, T.: The inactivation of epidemic influenza virus by nasal secretions of human individuals. Science 91, 198–199 (1940).
Francis, T.: A new type of virus from epidemic influenza. Science 91, 405–408 (1940).
Francis, T.: Differentiation of influenza A and influenza B by the complement fixation reaction. Proc. Soc. exp. Biol. (N.Y.) 45, 861–863 (1940).
Francis, T.: The problem of epidemic influenza. Trans. Coll. Phycns. Philad. 8, 218–227 (1941).
Francis, T.: The development of the 1943 vaccination study of the Commission on influenza. Amer. J. Hyg. 42, 1–11 (1945).
Francis, T.: Dissociation of haemagglutinating and antibody measuring capacities of influenza virus. J. exp. Med. 85, 1–7 (1947).
Francis, T.: Apparent serological variation within a strain of influenza virus. Proc. Soc. exp. Biol. (N.Y.) 65, 143–147 (1947).
Francis, T.: The significance of multiple immunological types of influenza virus. Cincinn. J. Med. 31, 97–101 (1950).
Francis, T.: Plan for the evaluation of vaccination against influenza. Amer. J. publ. Hlth 41, No. 8 (1951).
Francis, T.: Significance of antigenic variation of influenza viruses in relation to vaccination in man. Fed. Proc. 11, 808–812 (1952).
Francis, T.: Influenza: The newe acquayntance. Ann. intern. Med. 39, 203–221 (1953).
Francis, T.: The current status of the control of influenza. Ann. intern. Med. 43, 534–538 (1955).
Francis, T.: Mobilisation against influenza. Science 126, 1–2 (1957).
Francis, T.: Influenza in perspective. Amer. Rev. resp. Dis. 83, 98–104 (1961).
Francis, T.: Epidemic influenza. Amer. Rev. resp. Dis. 88, 148–151 (1963).
Francis, T., and T. P. Magill: Immunological studies with the virus of influenza. J. exp. Med. 62, 505–516 (1935).
Francis, T., and T.P. Magill: The incidence of neutralising antibodies for human influenza virus in the serum of human individuals of different ages. J. exp. Med. 63, 655–668 (1936).
Francis, T., and T. P. Magill: Direct transmission of human influenza virus to mice. Proc. Soc. exp. Biol. (N.Y.) 36, 132–133 (1937).
Francis, T., and T.P. Magill: Antigenic differences in strains of epidemic influenza virus. 2. Cross immunisation tests in mice. Brit. J. exp. Path. 19, 284–293 (1938).
Francis, T., T.P. Magill, E. T. Rickard, and D.M. Beck: Etiological and serological studies in epidemic influenza. Amer. J. publ. Hlth 27, 1141–1160 (1937).
Francis, T., and E. Minuse: Influence of saliva upon haemagglutination by influenza virus. Proc. Soc. exp. Biol. (N.Y.) 69, 291–294 (1948).
Francis, T., and H. E. Moore: A study of the neurotropic tendency in strains of the virus of epidemic influenza. J. exp. Med. 72, 717–728 (1940).
Francis, T., H.E. Pearson, J. E. Salk, and P.N. Brown: Immunity in human subjects artificially infected with influenza virus type B. Amer. J. publ. Hlth 34, 317–334 (1944).
Francis, T., H.E. Pearson, E.R. Sullivan, and P.M. Brown: The effect of subcutaneous vaccination with influenza virus upon the virus inactivating capacity of nasal secretion. Amer. J. Hyg. 37, 294–300 (1943).
Francis, T., and K. Penttinen: The failure of merdicien to modify influenza virus infections. J. Immunol. 63, 337–339 (1949).
Francis, T., J. J. Quilligan, and E. Minuse: Kesemblance of a strain of swine influenza virus to human A-prime strain. Proc. Soc. exp. Biol. (N.Y.) 71, 216–220 (1949).
Francis, T., J. J. Quilligan, and E. Minuse: Identification of another epidemic respiratory disease. Science 112, 495–497 (1950).
Francis, T., and J. E. Salk: A simplified procedure for the concentration and purification of influenza virus. Science 96, 499–500 (1942).
Francis, T., J. E. Salk, and W. M. Brace: The protective effect of vaccination against epidemic influenza B. J. Amer. med. Ass. 131, 275–278 (1946).
Francis, T., J. E. Salk, H. E. Pearson, and P. N. Brown: Protective effect of vaccination against induced influenza A. Proc. Soc. exp. Biol. (N.Y.) 55, 104–105 (1944).
Francis, T., J. E. Salk, and J. J. Quilligan: Experience with vaccination against influenza in the spring of 1947. Amer. J. publ. Hlth 37, 1013–1016 (1947).
Francis, T., and R. E. Shope: Neutralisation tests with sera of convalescent and immunised animals and the viruses of human and swine influenza. J. exp. Med. 63, 645–653 (1936).
Francis, T., and C.H. Stuart-Harris: Studies on the nasal histology of epidemic influenza virus infection in the ferret. 1. The development and repair of the nasal lesion.
2. Histological and serological observations on ferrets receiving repeated inoculations of epidemic influenza virus. J. exp. Med. 68, 789-801, and 813-830 (1938).
Francis, T., and M. Vicente de Torregrosa: Combined infection of mice with H. influenzae and influenza virus by the intranasal route. J. infect. Dis. 76, 70–77 (1945).
Franklin, R. M.: The synthesis of fowl plague virus products in a proflavine-inhibited tissue culture system. Virology 6, 525–539 (1958).
Franklin, R. M., and P. M. Breitenfeld: The abortive infection of Earle’s L cells by fowl plague virus. Virology 8, 293–307 (1959).
Franklin, R. M., and E. Wecker: Inactivation of some animal viruses by hydroxylamine and the structure of ribonucleic acid. Nature (Lond.) 184, 343–345 (1959).
Fraser, K. B.: Antibody to purified virus inhibitor. Brit. J. exp. Path. 32, 552–558 (1951).
Fraser, K. B.: Genetic interaction and interference between the MEL and NWS strains of influenza A virus. Brit. J. exp. Path. 34, 319–328 (1953).
Fraser, K. B.: Features of the MEL-NWS recombination systems in influenza A virus. 1. The effect of age of the mouse on the intracerebral growth of the MEL strain of influenza A virus.
2. The formation of NM recombinant strains of influenza A virus in mouse brain.
3. The pathogenicity of recombinant Neuro-MEL viruses grown in mouse brain and chick embryo brain.
4. Increments of virulence during successive cycles of double infection with two strains of influenza virus. Virology 9, 168-177, 178-190, 191-201, and 202-214 (1959).
Fraser, K. B.: Immunofluorescence of abortive and complete infections of influenza A virus in hamster BHK21 cells and mouse L cells. J. gen. Virol. 1, 1–12 (1967).
Fraser, K. B., and F.M. Burnet: Studies on recombination with influenza viruses in the chick embryo. 2. Genetic interaction between influenza virus strains in the chick embryo. Aust. J. exp. Biol. med. Sci. 30, 459–468 (1952).
Fraser, K. B., K. C. Nairn, M. G. McEntegart, and C. S. Chadwick: Neurotropic and non-neurotropic influenza A infection of mouse brain studied with fluorescent antibody. J. Path. Bact. 78, 423–433 (1959).
French, E. L.: The pyrogenic effect of the influenza-mumps group of viruses in the laboratory rabbit. Aust. J. exp. Biol. med. Sci. 30, 479–488 (1952).
French, E. L., and J. K. Dincen: Primary isolation of influenza A virus: The optimal conditions for amniotic infection. Aust. J. exp. Biol. med. Sci. 36, 257–265 (1958).
French, H.: Ministry of Health Eeport No. 4. H.M.S.O. London, 1920.
Fridman, E. A.: Some data on the problem of non-homogeneous structure of virus population (Russian). Virus infekt. 19, 67–75 (1959).
Fridman, E. A.: The heterogeneity of type A2 influenza virus population. Acta virol. 4, 274–282 (1960).
Fridman, E. A., I. M. Ansheles, E. S. Stenina, T. N. Davyova, B. I. Meitin, and T. A. Klushina: Analysis of epidemiological and immuno-virological data obtained during the 1957 and 1959 waves of influenza epidemic in Leningrad. “Problemy grippa i ostrykh respiratornykh zabolevanii.” Tez. dokl. nauch. Sess. Inst. AMN SSSR, Moscow, 114-117 (1959).
Friedewald, W. F.: The immunological response to influenza virus infection as measured by the complement fixation test. Eelation of the complement fixing antigen to the virus particle. J. exp. Med. 78, 347–366 (1943).
Friedewald, W. F.: Enhancement of the immunising capacity of influenza virus vaccines with adjuvants. Science 99, 453–454 (1944).
Friedewald, W. F.: Qualitative differences in the antigenic composition of influenza A virus strains. J. exp. Med. 79, 633–647 (1944).
Friedewald, W. F.: Adjuvants in immunisation with influenza virus vaccines. J. exp. Med. 80, 477–491 (1944).
Friedewald, W. F., and E. W. Hook: Influenza virus infection in the hamster. A study of inapparent infection and virus adaptation. J. exp. Med. 88, 343–353 (1948).
Friedewald, W. F., E.S. Miller, and L. E. Whatley: The nature of nonspecific inhibition of virus haemagglutination. J. exp. Med. 86, 65–75 (1947).
Friedewald, W. F., and E. G. Pickels: Size of infective particle and haemagglutinin of influenza virus as determined by centrifugal analysis. Froc. Soc. exp. Biol. (N.Y.) 52, 261–262 (1943).
Friedewald, W. F., and E. G. Pickels: Centrifugation and ultrafiltration studies on allantoic fluid preparations of influenza virus. J. exp. Med. 79, 301–317 (1944).
Friedman, R. M., and J.A. Sonnabend: Inhibition of interferon action by puromycin. J. Immunol. 95, 696–703 (1965).
Frisch, A. W., and J. Carson: Mode of inactivation of influenza virus by tannic acid. J. Bact. 66, 576–580 (1953).
Frisch-Niggemeyer, W.: Absolute amount of ribonucleic acid in viruses. Nature (Lond.) 178, 307–308 (1956).
Frisch-Niggemeyer, W.: Chemical composition and internal structure of influenza virus with particular regard to the so-called “soluble antigen” (German). Zbl. Bakt. I. Abt. Orig. 183, 294–317 (1961).
Frisch-Niggemeyer, W., and L. Hoyle: The nucleic acid and carbohydrate content of influenza virus A and of virus fractions produced by ether disintegration. J. Hyg. (Lond.) 54, 201–212 (1956).
Frommhagen, L. H., N. K. Freeman, and C. A. Knight: The lipid constituents of influenza virus, chick allantoic membrane, and sedimentable allantoic protein. Virology 5, 173–174 (1958).
Frommhagen, L. H., and C. A. Knight: The polysaccharide and ribonucleic acid content of purified influenza virus. Virology 2, 430–431 (1956).
Frommhagen, L. H., and C. A. Knight: Column purification of influenza virus. Virology 8, 198–208 (1959).
Frommhagen, L. H., C. A. Knight, and N. K. Freeman: The ribonucleic acid, lipid, and polysaccharide constituents of influenza virus preparations. Virology 8, 176–197 (1959).
Frommhagen, L. H., and E. H. Lennette: Spontaneous dissappearance of the slow-sedimenting component of influenza virus preparations. Virology 7, 247–248 (1959).
Fukumi, H.: Studies on the P-Q phases of A/Asian/57 influenza viruses. Bull. Wld Hlth Org. 20, 421–434 (1959).
Fulton, F.: Growth cycle of influenza virus. Nature (Lond.) 164, 189 (1949).
Fulton, F.: The titration of influenza virus neutralising antibodies. J. Hyg. (Lond.) 50, 265–274 (1952).
Fulton, F., and P. Armitage: Surviving tissue suspensions for influenza virus titrations. J. Hyg. (Lond.) 49, 247–262 (1951).
Fulton, F., and K. E. Dumbell: The serological comparison of strains of influenza virus. J. gen. Microbiol. 3, 97–110 (1949).
Fulton, F., and A. Isaacs: Influenza virus multiplication in the chick chorioallantoic membrane. J. gen. Microbiol. 9, 119–131 (1953).
Furer, N. M., I. P. Fomina, O. I. Artanomova, and T. I. Balezina: Antiviral action of antibiotics obtained from cultures of actinomyces violaceus. Antibiotiki, Moscow 4, 30–35 (1959).
Furesz, J.: Studies on inhibitors of influenza virus haemagglutination in normal rabbit and ferret sera. Canad. J. Microbiol. 5, 505–511 (1959).
Gajdusek, D. C.: Suspended cell tissue cultures for study of virus growth kinetics. Proc. Soc. exp. Biol. (N.Y.) 83, 621–624 (1953).
Galeazzi, F., and G. Visio: Studies on the synergism between influenza virus and bacteria. 2. Organotropism of staphylococcus aureus in mice inoculated with influenza virus (Italian). Riv. Ist. sieroter. ital. 33, 47–58 (1958).
Galper, G. S.: Experience in atabrine prophylaxis of influenza (Russian). Vo.-med. Zh. 11, 78 (1953).
Gamburg, V. P.: New data concerning the thermostable serum inhibitor (Russian). “Problemy grippa i ostrykh respiratornykh zabolevanii.” Tez. Dokl. nauch Sess. Inst. AMN SSSR, Moscow, 55-57 (1959).
Gard, S.: Haemagglutination as a diagnostic method. Theoretical aspects. Acta path. Suppl. 91, 107–117 (1951).
Gard, S.: Aspects of the formation of incomplete virus. 2nd Symp. Soc. gen. Microbiol. 211-244 (1953).
Gard, S., and P. Von Magnus: Studies on interference in experimental influenza. 2. Purification and centrifugation experiments. Ark. Kemi. Mineral. Geol. 24b, No. 8 (1947).
Gard, S., P. Von Magnus, A. Svedmyr, and A. Birch-Andersen: Studies on the sedimentation of influenza virus. Arch. ges. Virusforsch. 4, 591–611 (1952).
Gausch, C. R., and J. S. Younger: A tissue culture color test for measuring influenza virus and antibody. Proc. Soc. exp. Biol. (N.Y.) 101, 853–856 (1951).
Gavrilov, V. I.: Study of influenza A virus variability under experimental conditions (Russian). Probl. obshch. virol. Tez. Dokl. 6-y Sess. Inst. Virusol. AMN SSSR, Moscow, 37 (1953).
Gavrilov, V. I.: Influenza A virus variation in passage through the bodies of immunised mice (Russian). Dissertation, Moscow (1954).
Gaydamaka, M. G.: Study of the effectiveness of specific substances in the prophylaxis of influenza during the 1957 epidemic in Kharkov (Russian). Aziatskii Gripp (sborn. nauch. rabot) Kiev 266-268 (1958).
Gaydamaka, M. G., E. M. Mikulinskaya, D. D. Fyadina, and A. S. Dromashko: Data on the epidemiological effectiveness of anti-influenza vaccination in Kharkov in 1957 (Russian). Vop. Virus. 5, 135–140 (1958).
Gaydamaka, M. G., G. P. Vaganov, A. S. Dromashko, B. D. Shvetskaya, and D. P. Fyalina: Disease of the upper respiratory tract in horses following the human influenza epidemic in 1957. Bull Wld Hlth Org. 20, 505–508 (1959).
Gent, W. L. G., N. A. Gregson, D. B. Gammack, and J. H. Raper: The lipid-protein unit in myelin. Nature (Lond.) 204, 553–555 (1964).
Gerber, P., and E. Adams: Development of resistance of influenza B virus to polysaccharides. Science 128, 1571 (1958).
Gerber, P., D. Hamre, and C. G. Loosli: Antigenic variants of influenza A virus (PR8). 2. Serological and immunological characteristics of variants derived from variants. J. exp. Med. 103, 413–424 (1956).
Gerber, P., C. G. Loosli, and D. Hamre: Antigenic variants of influenza A virus (PR8). 1. Their development during serial passage in the lungs of partially immune mice. J. exp. Med. 101, 627–638 (1955).
Germanova, K. I., and T. Ya. Goncharskaya: Antiviral properties of streptothricins A B C D and F. Abstr. 9th Int. Congr. Microbiol. 537 (1966).
Gerngross, O. G., T. V. Pysina, and L. N. Serebryakova: Etiology of influenza outbreaks in Vladivostock in 1957–59 and antigenic structure of the isolated strains (Russian). “Problemy grippa i ostrykh respiratornykh zabolevanii.” Tez. dokl. nauch. Sess. Inst. AMN SSSR, Moscow, 24-26 (1959).
Gerone, P. J., T. G. Ward, and W. A. Chappel: Combined infection in mice with influenza virus and diplococcus pneumoniae. Amer. J. Hyg. 66, 331–341 (1957).
Gierer, A., and G. Schramm: Infectivity of ribonucleic acid from tobacco mosaic virus. Nature (Lond.) 177, 702–703 (1956).
Gierer, A., and G. Schramm: Infectivity of ribonucleic acid from tobacco mosaic virus (German). Z. Naturforsch. 11b, 138–142 (1956).
Ginsberg, H. S.: Comparison of quantities of egg and mouse adapted influenza viruses required to infect each host. Proc. Soc. exp. Biol. (N.Y.) 84, 249–252 (1953).
Ginsberg, H. S.: Formation of non-infectious influenza virus in mouse lungs: Its dependence upon extensive pulmonary consolidation initiated by the viral inoculum. J. exp. Med. 100, 581–603 (1954).
Ginsberg, H. S.: Production of pulmonary lesions by influenza viruses in immunised mice. J. Immunol. 72, 24–29 (1954).
Ginsberg, H. S.: Suppression of influenza viral pneumonia in mice by the nonspecific action of Xerosin. J. Immunol. 75, 430–440 (1955).
Ginsberg, H. S., and J.R. Blackburn: Reactions of influenza viruses with guineapig polymorphonuclear leucocytes. 1. Virus-cell interaction. Virology 2, 618–636 (1956).
Ginsberg, H. S., and F. L. Horsfall: A labile component of normal serum which combines with various viruses. Neutralisation of infectivity and inhibition of haemagglutination by the component. J. exp. Med. 90, 475–495 (1949).
Ginsberg, H. S., and F. L. Horsfall: Quantitative aspects of the multiplication of influenza A virus in the mouse lung. Relation between the degree of viral multiplication and the extent of pneumonia. J. exp. Med. 95, 135–145 (1952).
Ginsberg, H. S., and A. T. Wilson: Inactivation of several viruses by liquid ethylene oxide. Proc. Soc. exp. Biol. (N.Y.) 73, 614–616 (1950).
Giordano, G., and G. Pino: Researches on anti-influenza vaccination. 2. Comparison of immune responses to one and two doses of vaccine given intradermally (Italian). Riv. Ist. sieroter. ital. 28, 501–509 (1953).
Girardi, A. J., H. McMichael, and W. Henle: The use of HeLa cells in suspension for the quantitative study of virus propagation. Virology 2, 532–544 (1956).
Gitelman, A. K., O. Burducea, and A. G. Bukrinskaya: Inhibitory effect of histones and actinomycin D on myxovirus reproduction with a special reference to input multiplicity of infection. Abstr. 9th int. Congr. Microbiol. 531 (1966).
Glover, R. E.: Spread of infection from the respiratory tract of the ferret. 2. Association of influenza A virus and streptococcus group C. Brit. J. exp. Path. 22, 98–107 (1941).
Golbert, Z. V., and O.P. Peterson: Histopathologic changes in white mice after the intraperitoneal injection of large doses of influenza virus (Russian). Vop. Virus. 1, 190 (1948).
Gompels, A. E. H.: Antigenic relationships of swine influenza virus. J. gen. Microbiol. 9, 140–148 (1953).
Gorbunova, A. S.: Biological properties of the influenza viruses and problems of their classification (Russian). Zh. Mikrobiol. (Mosk.) 2, 39 (1953).
Gorbunova, A. S.: Antigenic relationships between influenza viruses of the types A, A1 and A2 (Russian). Vop. Virus. 4, 401–406 (1959).
Gorbunova, A. S., and V. I. Gavrilov: Evaluation of the complement fixation reaction as a method of serological differentiation of influenza virus strains (Russian). Vop. Virus. 4, 55 (1954).
Gorbunova, A. S., and V. A. Isachenko: Peculiarities of identification of strains of A 2 influenza viruses isolated in 1957 (Russian). Vop. Virus. 5, 48-53 (1958).
Gorbunova, A. S., A. N. Lozhkina, V. M. Stakhanova, V. I. Isachenko, T. P. Voronina, A. I. Simakov, and A. A. Kopeikin: Antigenic pattern of A2 influenza viruses according to materials from the strain service of the Regional Influenza Centre of the USSR (Russian). Vop. Virus 5, 25–35 (1958).
Gorbunova, A. S., and S. E. Marennikova: The problem of the O and D variants of the influenza virus (Russian). Byull. eksp. Biol. Med. 10, 292 (1949).
Gorbunova, A. S., and S. E. Marennikova: The problem of the O and D variants of the influenza virus (Russian). Annot. rabot. Inst. virol. AMN SSSR Za 1949, Moscow (1950).
Gorbunova, A. S., E. V. Molibog, F. K. Gonsovsky, G. I. Fjodorova, U. A. Abenova, and N. A. Maximovitch: Influenza virus strains different in their enzymic activity and character of their interaction with cells. Abstr. 9th int. Congr. Microbiol. 373 (1966).
Gordon, I.: Demonstration of antigenic differences between different strains of influenza B. J. Immunol. 44, 231–236 (1942).
Gorev, N. E.: The use of broth culture filtrates of Pseudomonas fluorescens for the destruction of non-specific thermostable (At 56°C) influenza virus inhibitors in human and animal sera. Acta virol. 2, 171–178 (1958).
Gostling, J. V. T.: Growth of influenza A virus in cultured cells of embryo mouse lung. Brit. J. exp. Path. 39, 679–684 (1958).
Gotlieb, T., and G. K. Hirst: The experimental production of combination forms of virus. 3. The formation of doubly antigenic particles from influenza A and B virus and a study of the ability of individual particles of X virus to yield two separate strains. J. exp. Med. 99, 307–320 (1954).
Gotlieb, T., and G. K. Hirst: The experimental production of combination forms of virus. 6. Reactivation of influenza viruses after inactivation by ultraviolet light. Virology 2, 235–248 (1956).
Goto, H.: Virological and immunological studies of Asian influenza in 1960 (Japanese). Sapporo Med. J. 24, 205–210 (1963).
Gottschalk, A.: N-substituted isoglucosamine released from mucoproteins by the influenza virus enzyme. Nature (Lond.) 167, 845–847 (1951).
Gottschalk, A.: The influenza virus enzyme and its mucoprotein substrate. Yale J. Biol. Med. 26, 352–364 (1954).
Gottschalk, A.: The synthesis of 2-carboxypyrrole from D-glucosamine and pyruvic acid: Its bearing on the structure of neuraminic acid. Arch. Biochem. 69, 37–44 (1957).
Gottschalk, A.: The influenza virus neuraminidase. Nature (Lond.) 181, 377–378 (1958).
Gottschalk, A.: On the mechanism underlying initiation of influenza virus infection. Ergebn. Mikrobiol. 32, 1–22 (1959).
Gottschalk, A.: The molecular structure of ovine submaxillary gland glycoprotein. Proc. Internat. Conf. “Salivary glands and their secretions”, Washington, Pergamon Press 351-364 (1964).
Gottschalk, A., and S. Fazekas De St Groth: On the relationship between the indicator profile and prosthetic group of mucoproteins inhibitory for influenza virus haemagglutinin. J. gen. Microbiol. 22, 690–696 (1960).
Gottschalk, A., and E. R. B. Graham: A neuraminidase susceptible disaccharide from bovine salivary mucoprotein. Z. Naturforsch. 13b, 821–822 (1958).
Gottschalk, A., and E. R. B. Graham: 6-a-D-sialyl-N-acetylgalactosamine: The neuraminidase-susceptible prosthetic group of bovine salivary mucoprotein. Biochim. biophys. Acta (Amst.) 34, 380–391 (1959).
Gottschalk, A., and P. E. Lind: Ovomucin, a substrate for the enzyme of influenza virus. 1. Ovomucin as an inhibitor of haemagglutination by heated Lee virus. Brit. J. exp. Path. 30, 85–92 (1949).
Gottschalk, A., and P. E. Lind: Product of interaction between influenza virus enzyme and ovomucin. Nature (Lond.) 164, 232–233 (1949).
Gottschalk, A., and B. T. Perry: Ovomucin, a substrate for the enzyme of influenza virus. 3. Enzyme activity as an integral function of the influenza virus particle. Brit. J. exp. Path. 32, 408–413 (1951).
Graham, A. F.: The chemical analysis of purified influenza virus A (PR8 strain) containing radioactive phosphorus. Canad. J. Res. 28, 186–195 (1950).
Graham, A. F.: The fractionation of phosphorus containing constituents in the allantoic membrane of the embryonated egg. Canad. J. Res. 28, 271–280 (1950).
Graham, A. F., G. Dempster, and B. Buchner: The toxicity of P32 for normal and influenza infected embryos. J. Bact. 63, 426–427 (1952).
Graham, A. F., and L. McClelland: Uptake of radioactive phosphorus by influenza virus. Nature (Lond.) 163, 949 (1949).
Graham, A. F., and L. McClelland: The uptake of radioactive phosphorus by influenza virus A (PES strain). Canad. J. Kes. 28, 121–134 (1950).
Granoff, A.: Plaque formation with influenza strains. Virology 1, 252 (1955).
Granoff, A., and D.W. Kingsbury: Effect of actinomycin D on the replication of Newcastle disease and influenza viruses. Ciba Found. Symp. “Cellular biology of myxovirus infections” 96-119 (1964).
Granoff, A., O. C. Liu, and W. Henle: A small haemagglutinating component in preparations of Newcastle disease virus. Proc. Soc. exp. Biol. (N.Y.) 75, 684–691 (1950).
Green, I. J., M. Lieberman, and W. J. Mogabgab: The behavior of influenza viruses in various tissue culture systems. J. Immunol. 78, 233–239 (1957).
Green, E. H., A. F. Rasmussen, and J. E. Smadel: Chemoprophylaxis of experimental influenza infection in eggs. Publ. Hlth Rep. (Wash.) 61, 1401–1403 (1946).
Green, M., and M. A. Stahmann: Virus inhibition by some aminoacid analogues. Arch. Biochem. 55, 63–70 (1955).
Green, R. H., and D. W. Woolley: Inhibition by certain polysaccharides of haemagglutination and of multiplication of influenza virus. J. exp. Med. 86, 55–64 (1947).
Grist, N. R., J. B. Landsman, and T. Anderson: Studies in the aetiology of pneumonia in Glasgow 1950–51. Lancet 640 (1962).
Grieff, D., H. Blumenthal, M. Chiga, and H. Pinkerton: The effects on biological materials of freezing and drying by vacuum sublimination. 2. Effect on influenza virus. J. exp. Med. 100, 89–101 (1954).
Gross, W. O.: Properties of two strains of virus from the influenza epidemics of 1952 and 1953 (German). Z. Hyg. Infekt.-Kr. 138, 224–245 (1953).
Gross, W.O.: Can an influenza virus after isolation be identified with the prevalent epidemic strain? (German). Z. Hyg. Infekt.-Kr. 138, 246–260 (1953).
Grossberg, S. E.: Cytocidal assay and propagation of human influenza viruses in cultured primary hamster kidney cells. Proc. Soc. exp. Biol. (N.Y.) 113, 546–553 (1963).
Grossberg, S. E.: Human influenza A viruses: Rapid plaque assay in hamster kidney cells. Science 144, 1246–1247 (1964).
Grossberg, S. E., E. W. Hook, and R. R. Wagner: Haemorrhagic encephalopathy in chicken embryos infected with influenza virus. 3. Viral interference at a distant site induced by prior allantoic infection. J. Immunol. 88, 1–8 (1962).
Grossgebauer, K.: Dark field and phase contrast microscopic observations in connection with serological investigations on myxoviruses (German). Zbl. Bakt. I. Abt. Orig. 171, 430–439 (1958).
Groupe, V., C. G. Engle, P. E. Gaffney, and R. A. Manaker: Virucidal activity of representative anti-infective agents against influenza and vaccinia viruses. Appl. Microbiol. 3, 333–336 (1955).
Groupe, V., and E.C. Hermann: Modification of the neurotoxic effect of influenza virus in mice by Xerosin. J. Immunol. 74, 249–254 (1955).
Groupe, V., and L. H. Pugh: Inactivation of influenza virus and of viral haemagglutinin by the ciliate tetrahymena geleii. Science 115, 307–308 (1952).
Groupe, V., and L. H. Pugh: Interference between influenza virus and infectious bronchitis of chickens. J. Bact. 63, 295–296 (1952).
Grubb, T. C., M. L. Miesse, and B. Puetzer: The inactivation of influenza virus by certain vapors. J. Bact. 53, 61–66 (1947).
Grunert, R. R., J. W. McGahen, and W. L. Davies: The in vivo antiviral activity of 1-adamantanamine (Amantadine). 1. Prophylactic and therapeutic activity against influenza viruses. Virology 26, 262–269 (1965).
Gulrajani, T. S.: Studies on respiratory diseases of pigs. 3. Persistence of influenza viruses in the respiratory tract. J. comp. Path. Therap. 61, 101–107 (1951).
Gustyrev, V. P.: Immunologic and epidemiologic effectiveness of inoculations against influenza with live vaccine (Russian). “Problemy grippa i ostrykh respiratornykh zabolevanii.” Tez. dokl. nauch. Sess. Inst. AMN SSSR, Moscow, 128-129 (1959).
Gutman, N. R., and L. Mentkevich: Significance of the A prime virus in the influenza epidemic process (Russian). Zh. Mikrobiol. (Mosk.) 9, 38 (1954).
Guzhiyenko, G. N., and M. A. Morozenko: Treatment of influenza in children with dry influenza antiserum (Russian). “Virusnyye Infecktsii” Moscow, 207-212 (1953).
Haas, R., and H. Wulff: The growth of influenza virus in tissue cultures of ferret kidney cells (German). G. Microbiol. 1, 65–71 (1955).
Haas, R., and H. Wulff: Multiplication of influenza virus in cultures of calf kidney tissue (German). Z. Hyg. Infekt.-Kr. 143, 568–577 (1957).
Hachisuka, Y., and N. Kato: The inhibitory effect of 4-aminopterin on influenza virus propagation in tissue culture. Nagoya J. med. Sci. 18, 29–31 (1955).
Haff, K. F., P. W. Schriver, C. G. Engle, and B. C. Stewart: Pathogenesis of influenza in ferrets. 1. Tissue and blood manifestations of disease. J. Immunol. 96, 659–667 (1966).
Haff, R. F., P. W. Schriver, and K. C. Stewart: Pathogenesis of influenza in ferrets. Nasal manifestations of disease. Brit. J. exp. Path. 47, 435–444 (1966).
Haff, E. F., and E.C. Stewart: Role of sialic acid receptors in adsorption of influenza virus to chick embryo cells. J. Immunol. 94, 842–851 (1965).
Hahnemann, F. V., and V. Eeinecke: In ovo production of interferon induced by influenza virus of varying degrees of incompleteness. Acta path. microbiol. scand. 63, 241–248 (1965).
Hale, W. M., and A. P. McKee: The value of influenza vaccination when done at the beginning of an epidemic. Amer. J. Hyg. 42, 21–27 (1945).
Hale, W. M., and A. P. McKee: The intracranial toxicity of influenza virus for mice. Proc. Soc. exp. Biol. (N.Y.) 59, 81–84 (1945).
Hallauer, C.: Variants and mutants in viruses pathogenic for animals. Bull. Schweiz. Akad. med. Wiss. 16, 173–184 (1960).
Halonen, P.: Amantadine hydrochloride in the prophylaxis of respiratory virus infections. Abstr. 9th int. Congr. Microbiol. Moscow, 548 (1966).
Hamburger, V., and K. Habel: Teratogenic and lethal effects of influenza A and mumps viruses on early chick embryos. Proc. Soc. exp. Biol. (N.Y.) 66, 608–617 (1947).
Hamre, D., J. Appel, and C. G. Loosli: Viraemia in mice with pulmonary influenza A virus infection. J. Lab. clin. Med. 47, 182–193 (1955).
Hamre, D., C. G. Loosli, and E. C. Ewert: Antigenic variants of influenza A virus (PR8 strain). 6. Results of repeated passages of the same variant in mice immunised with monovalent homologous vaccine or polyvalent vaccine. J. infect. Dis. 108, 151–162 (1961).
Hamre, D., C. G. Loosli, and P. Gerber: Antigenic variants of influenza A virus (PR8 strain). 3. Serological relationships of a line of variants derived in sequence in mice given homologous vaccine. H16 4. Serological characters of a second line of variants developed in mice given polyvalent vaccine. J. exp. Med. 107, 829-844, and 845-855 (1958).
Hana, L., and L. Hoyle: The disintegration of the internal ribonucleoprotein of influenza virus A with the production of serologically distinct components. Acta virol. 10, 506–512 (1966).
Hana, L., O. Krizanova, B. Styk, and F. Sokol: Some data on the nature of the cofactor enhancing the activity of imperfect antibodies against A2 influenza virus strains. Acta virol. 5, 325 (1961).
Hana, L., and B. Styk: Some properties of influenza C virus inhibitor from rat serum. Acta virol. 3, 85–90 (1959).
Hana, L., and B. Styk: Influence of delipidisation on the haemagglutination inhibiting activity of rat serum against influenza type C viruses. Acta virol. 4, 392–393 (1960).
Hana, L., and B. Styk: Lipoids as inhibitors of haemagglutinating-inhibiting activity against “avid” strains of A2 influenza. Acta virol. 5, 190–192 (1961).
Hana, L., and B. Styk: Characterisation of antibodies, cofactor, and non-specific viral inhibitors on sephadex G-200. Acta virol. 6, 479 (1962).
Hana, L., and B. Styk: An attempt to differentiate Beta-inhibitor from co-factor occurring in bovine serum. Acta virol. 6, 77–83 (1962).
Hana, L., B. Styk, and D. Kociskova: Estimation of the distribution and the character of inhibitors against “avid” A2 influenza virus strains in protein fractions of guineapig and horse sera obtained by paper electrophoresis. Acta virol. 4, 356–364 (1960).
Hana, L., B. Styk, and S. Schramek: Studies on the size of antibodies, co-factor, and non-specific inhibitors of influenza virus using separation on sephadex G-200. Science Tools 10, 4–7 (1963).
Hanan, E.: The effect of tocopherol esters on influenza virus. Proc. Soc. exp. Biol. (N.Y.) 75, 440–444 (1950).
Hanig, M., and H. Bernkopf: The sedimentable components of influenza virus propagated in de-embryonated eggs. J. Immunol. 65, 585–590 (1950).
Hanig, M., and J. M. Steim: The difference in effective hydrodynamic diameters of “FAST” and “SLOW” influenza viruses propagated in de-embryonated eggs. Virology 12, 499–510 (1960).
Hannoun, C.: Action of purine and pyrimidine analogues on the multiplication of influenza virus in chick embryos (French). Atti Congr. Int. Microbiol. 6th Congr. Eome 1, 431–432 (1953).
Hannoun, C.: Effect of conjunctival instillation of influenza virus in rabbits and mice (French). Ann. Inst. Pasteur 96, 170–177 (1959).
Hanson, R. J., J. E. Kempf, and A. V. Boand: Phagocytosis of influenza virus. 2. Its occurrence in normal and immune mice. J. Immunol. 79, 422–427 (1957).
Harboe, A.: The course in Norway of the influenza pandemic caused by the virus of type A/Asia/57. (Norwegian). Saertrykk Nordisk Med. 60, 1701 (1958).
Harboe, A.: HI antibodies in ferrets cross-infected with distantly related influenza viruses. Acta path. microbiol. scand. 57, 211–221 (1963).
Harboe, A.: The influenza virus haemagglutination inhibition by antibody to host material. Acta path. microbiol. scand. 57, 317–330 (1963).
Harboe, A.: The normal allantoic antigen which neutralises the influenza virus HI antibody to host material. Acta path. microbiol. scand. 57, 488–492 (1963).
Harboe, A., and R. Reenaas: The course of antibody development to influenza A2 strains. Acta path, microbiol. scand. 46, 266–272 (1959).
Harboe, A., R. Reenaas, and M. Oppedal: Studies on Francis inhibitor of influenza virus haemagglutination in rabbit serum fractions obtained by electrophoresis on starch grain. Acta path, microbiol. scand. 44, 92–105 (1958).
Harboe, R., F. Rost, K. Juul, and T. Madland: Percentage of individuals presenting antibody to A/Asia/57 after an influenza outbreak in a military camp in October 1957. Arch. ges. Virusforsch. 8, 446–452 (1958).
Hardy, P. H., and F. L. Horsfall: Eeactions between influenza virus and a component of normal allantoic fluid. J. exp. Med. 88, 463–484 (1948).
Hare, R.: The effect of passive immunisation on experimental virus influenza in mice. J. Path. Bact. 49, 411–428 (1939).
Hare, R., and M. Curl: Adsorption of influenza virus. Canad. J. Res. 25, 43–52 (1947).
Hare, R., M. Curl, and L. McClelland: The efficiency of the red cell adsorption and elution method for the preparation of influenza vaccine. Canad. J. publ. Hlth 37, 284–291 (1941).
Hare, R., and D. M. Mackenzie: The standardisation of influenza vaccine by red cell agglutination and antigenic tests in mice. Canad. J. publ. Hlth 38, 141–148 (1947).
Hare, L., L. McClelland, and J. Morgan: A method for the concentration of influenza virus. Canad. J. publ. Hlth 33, 325–331 (1942).
Hare, L., and W. C. Ricken: Long-term variation in the titre of neutralising antibody for influenza virus in the sera of adults and children. J. Immunol. 40, 253–266 (1941).
Harford, C. G., and A. Hamlin: Effect of influenza virus on cilia and epithelial cells in the bronchi of mice. J. exp. Med. 95, 173–190 (1952).
Harford, C. G., A. Hamlin, and E. Parker: Electron microscopy of early cytoplasmic changes duo to influenza virus. J. exp. Med. 101, 577–589 (1955).
Harford, C. G., and M. Hara: Pulmonary oedema in influenzal pneumonia of the mouse and the relation of fluid in the lung to the inception of pneumococcal pneumonia. J. exp. Med. 91, 245–257 (1950).
Harford, C. G., V. Leidler, and M. Hara: Effect of the lesion due to influenza virus on the resistance of mice to inhaled pneumococci. J. exp. Med. 89, 53–68 (1949).
Harford, C. G., M.E.Smith, C. McLeod, and W. B. Wood: Infection of rats with the virus of influenza. J. Immunol. 53, 163–169 (1946).
Harris, S., and W. Henle: Lymphocytopenia in rabbits following intravenous injection of influenza virus. J. Immunol. 59, 9–20 (1948).
Hatch, L. A.: An analysis of 101 strains of influenza A virus isolated in England and Wales during the winter of 1955–56 by the laboratories of the Public Health Laboratory Service. Mth. Bull. Minist. Hlth Lab. Serv. 16, 138–141 (1957).
Haukenes, Gl., A. Harboe, and K. Mortensson-Egnund: A uronic and sialic acid free chick allantoic mucopolysaccharide sulphate which combines with influenza virus HI-antibody to host material. 1. Purification of the substance.
2. Chemical composition. Acta path. microbiol. scand. 64, 534-542 (1965) and 66. 510-518 (1966).
Hausen, P., H. Hausen, R. Rott, C. Scholtissek, and W.Schäfer: Early events in the reproduction cycle of animal viruses. Viruses, Nucleic acids, and Cancer. 282-295 (1963), Univ. Texas.
Hausler, W. J., and E.C. Dick: The purification and concentration of influenza A virus (PR8) by a method of continuous extraction with glycine of a zinc-virus precipitate. J. infect. Dis. 107, 189–194 (1960).
Haussman, H. G., W. Simrock, and L. Betz: Clinical and serological diagnosis of epidemic influenza (German). Z. klin. Med. 147, 51–72 (1950).
Heath, R. B., and D. A. J. Tyrrell: The behaviour of some influenza viruses in tissue cultures of kidney cells of various species. Arch. ges. Virusforsch. 8, 577–591 (1959).
Heinmetz, F.: Studies with the electron microscope on the interaction of influenza virus and red cells. J. Bact. 55, 823–831 (1948).
Heller, L., A. Espmark, and P. Viriden: Immunological relationship between infectious cough in horses and human influenza A. Arch. ges. Virusforsch. 7, 120–124 (1956).
Henderson, J. R., and J. E. Kempf: Intracellular proteins associated with the synthesis of the influenza A virus. Virology 9, 72–83 (1959).
Henle, G., and W. Henle: Neurological signs in mice following intracerebral inoculation of influenza viruses. Science 100, 410–411 (1944).
Henle, G., and W. Henle: Studies on the toxicity of influenza viruses. 1. The effect of intracerebral injection of influenza viruses.
2. The effect of intra-abdominal and intravenous injection of influenza viruses. J. exp. Med. 84, 623-637, and 639-660 (1946).
Henle, G., A. Girardi, and W. Henle: A non-transmissible cytopathogenic effect of influenza virus in tissue culture accompanied by formation of noninfectious haemagglutinins. J. exp. Med. 101, 25–41 (1955).
Henle, W.: Studies on host-virus interaction in the chick embryo influenza virus system. 1. adsorption and recovery of seed virus.
2. The propagation of virus in conjunction with the host cells.
3. Development of infectivity, haemagglutination, and complement fixation activities during the first infectious cycle. J. exp. Med. 90, 1-11, 13-22, and 23-37 (1949).
Henle, W.: Interference phenomena between animal viruses. A review. J. Immunol. 64, 203–236 (1950).
Henle, W.: Status of vaccination against influenza. Mod. Med. 75-81 (1955).
Henle, W.: The use of phosphorus 32 in the study of incomplete forms of influenza virus. Trans. N.Y. Acad. Sci. 18, 255–260 (1956).
Henle, W.: Persistent infection of L cell cultures by myxoviruses. Ciba Found. Symp. “Cellular biology of myxovirus infections” 299-316 (1964).
Henle, W., and L. A. Chambers: The serological activity of extra embryonic fluids of chick infected with virus of influenza A. Proc. Soc. exp. Biol. (N.Y.) 46, 713–717 (1941).
Henle, W., and G. Henle: Interference of inactive virus with the propagation of the virus of influenza. Science 98, 87–89 (1943).
Henle, W., and G. Henle: Interference between inactive and active viruses of influenza. 1. The incidental occurrence and artificial induction of the phenomenon.
2. Factors influencing the phenomenon. Amer. J. med. Sci. 207, 705-717 and 717-733 (1944).
3. Cross-interference between various related and unrelated viruses.
4. The nature of the interfering agent. Amer. J. med. Sci. 210, 362-369 and 369-374 (1945).
Henle, W., and G. Henle: The toxicity of influenza viruses. Science 102, 398–400 (1945).
Henle, W., and G. Henle: Effects of adjuvants on vaccination of human beings against influenza. Proc. Soc. exp. Biol. (N.Y.) 59, 179–181 (1945).
Henle, W., and G. Henle: The effect of ultraviolet irradiation on various properties of influenza viruses. J. exp. Med. 85, 347–364 (1947).
Henle, W., and G. Henle: Studies on the toxicity of influenza viruses. 3. Immunisation of mice against the toxic effects of influenza virus A. A new potency test for the assay of vaccines of influenza virus. J. Immunol. 59, 45–58 (1948).
Henle, W., G. Henle, F. Deinhardt, and V. V. Bergs: Studies on persistent infections of tissue cultures. 4. Evidence for the production of an interferon in MCN cells by myxoviruses. J. exp. Med. 110, 525–541 (1959).
Henle, W., and G. Henle, V. Groupe, and L. A. Chambers: Studies on complement fixation with the viruses of influenza. J. Immunol. 48, 163–180 (1944).
Henle, W., G. Henle, B. Hampill, E. D. Maris, and J. Stokes: Experiments on vaccination of human beings against epidemic influenza. J. Immunol. 53, 75–93 (1946).
Henle, W., G. Henle, and M. W. Kirber: Interference between inactive and active viruses of influenza. 5. Effect of irradiated virus on the host cells. Amer. J. med. Sci. 214, 529–541 (1947).
Henle, W., G. Henle, and E. B. Rosenberg: The demonstration of one-step growth curves of influenza virus through the blocking effect of irradiated virus on further infection. J. exp. Med. 86, 423–437 (1947).
Henle, W., G. Henle, J. Stokes, and E. P. Maris: Experimental exposure of human subjects to the viruses of influenza. J. Immunol. 52, 145–165 (1946).
Henle, W., and P. S. Lief: Antigenic analysis of influenza viruses by complement fixation. 4. Strain-specific V antigens in the serodiagnosis of influenza. J. Immunol. 84, 491–500 (1960).
Henle, W., F. S. Lief, and A. Pabiyi: Strain specific complement fixation test in antigenic analysis and serodiagnosis of influenza. Lancet 818-820 (1958).
Henle, W., and O. C. Liu: Studies on host-virus interactions in the chick embryo influenza virus system. J. exp. Med. 94, 305–322 (1951).
Henle, W., O. C. Liu, and N. B. Pinter: Studies on host-virus interactions in the chick embryo influenza virus system. 9. The period of liberation of virus from infected cells. J. exp. Med. 100, 53–70 (1954).
Henle, W., O. C. Liu, K. Paucker, and F.S. Lief: Studies on host-virus interactions in the chick embryo influenza virus system. 4. The relation between tissue bound and liberated virus materials under various conditions of infection. J. exp. Med. 103, 799–822 (1956).
Henle, W., and K. Paucker: Interference between inactivated and active influenza viruses in the chick embryo. 1. A re-evaluation of factors of dosage and timing using infectivity titrations for assay. Virology 6. 181–197 (1958).
Henle, W., and E. B. Rosenberg: One-step growth curves of various strains of influenza A and B viruses and their inhibition by inactivated virus of the homologous type. J. exp. Med. 89, 279–285 (1949).
Henle, W., and M. Wiener: Complement fixation antigens of influenza viruses types A and B. Proc. Soc. exp. Biol. (N.Y.) 57, 176–179 (1944).
Hennessen, W. A.: Antigenic analysis of influenza B strains isolated in 1952. Bull. Wld Hlth Org. 6, 481–485 (1952).
Hennessy, A. V.: Prevention of influenza by vaccination in infants and children. Quart. Rev. Pediat. 17, 91–94 (1962).
Hennessy, A. V., and F.M. Davenport: Epidemiologic implications of the distribution by age of antibody response to experimental influenza virus vaccines. J. Immunol. 80, 114–121 (1958).
Hennessy, A. V., and F.M. Davenport: Relative merits of aqueous and adjuvant influenza vaccines when used in a two-dose schedule. Publ. Hlth Rep. (Wash.) 76, 411–419 (1961).
Hennessy, A. V., and F.M. Davenport: Eelative antigenic potency in man of polyvalent influenza virus vaccines containing isolated haemagglutinins or intact viruses. J. Immunol. 97, 235–238 (1966).
Hennessy, A. V., F.M. Davenport, and T. Francis: Studies of antibodies to strains of influenza virus in persons of different ages in sera collected in a postepidemic period. J. Immunol. 75, 401–409 (1955).
Hennessy, A. V., F. M. Davenport, R. J. M. Horton, J. A. Napier, and T. Francis: Asian influenza. Occurrence and recurrence, a community and family study. Milit. Medicine 129, 38–50 (1964).
Hennessy, A. V., E. Minuse, and F.M. Davenport: A twenty-one-year experience with antigenic variation among influenza B viruses. J. Immunol 94, 301–306 (1965).
Hennessy, A. V., E. Minuse, F.M. Davenport, and T. Francis: An experience with vaccination against influenza B in 1952 by use of monovalent vaccine. Amer. J. Hyg. 58, 165–173 (1953).
Henry, C., and J. S. Younger: Influence of normal animal sera on influenza viruses in cultures of trypsin-dispersed monkey kidney cells. J. Immunol. 78, 214–221 (1957).
Hers, J. F. P.: The histopathology of the respiratory tract in human influenza. H. Stenpert Kroese, Leiden (1955).
Hers, J. F. P., and J. Mulder: Rapid tentative post-mortem diagnosis of influenza with the aid of cytological smears of the tracheal epithelium. J. Path. Bact. 43, 329–332 (1951).
Herzberg, K., G. May, and H. Beck: Immunity in influenza. 1. Behaviour of the PR8 and FM1 strains. Z. Immun.-Forsch. 112, 409–419 (1955).
Herzberg, K., G. May, and H. Beck: The isolation of seven strains of influenza virus from the epidemic of 1955 (German). Z. Hyg. Infekt.-Kr. 142, 1–14 (1955).
Heymann, H., Z. R. Gulick, C. J. De Boer, G. Stevens, and R.L. Mayer: The inhibition of ribonuclease by acidic polymers and their use as possible antiviral agents. Arch. Biochem. 73, 366–383 (1958).
Hildebrandt, H. M., H. F. Maassab, and P. W.Willis: Influenza virus pericarditis. Amer. J. Dis. Child. 104, 579–582 (1962).
Hilleman, M. R.: System for measuring and designating antigenic components of influenza viruses with analyses of recently isolated strains. Proc. Soc. exp. Biol. (N.Y.) 78, 208–215 (1951).
Hilleman, M. R.: A pattern of antigenic variation. Fed. Proc. 11, 798–803 (1952).
Hilleman, M. R., E. L. Buescher, and J. E. Smadel: Preparation of dried antigen and antiserum for the agglutination inhibition test for virus influenza. Publ. Hlth Rep. (Wash.) 66, 1195–1203 (1951).
Hilleman, M. R., F. J. Flatley, S. A. Anderson, H. L. Luecking, and D. J. Levinson: Distribution and significance of Asian and other influenza antibodies in the human population. New Engl. J. Med. 258, 969–974 (1958).
Hilleman, M. R., and F. L. Horsfall: Comparison of the antigenic patterns of influenza A virus strains determined by in ovo neutralisation and haemagglutination-inhibition. J. Immunol. 69, 343–356 (1952).
Hilleman, M. R., R. P. Mason, and E. L. Buescher: Antigenic pattern of strains of influenza A and B. Proc. Soc. exp. Biol. (N.Y.) 75, 829–835 (1950).
Hilleman, M. R., R. P. Mason, and N. G. Rogers: Laboratory studies on the 1950 outbreak of influenza. Publ. Hlth Rep. (Wash.) 65, 771–777 (1950).
Hilleman, M. R., and J. H. Werner: Influence of non-specific inhibitor on the diagnostic haemagglutination-inhibition test for influenza. J. Immunol. 71, 110–117 (1953).
Himmelweit, F.: Influenza B virus isolated from a fatal case of pneumonia. Lancet 793-794 (1943).
Hinz, R. W., and J. T. Syverton: Mammalian cell cultures for study of influenza viruses. 1. Preparation of monolayer cultures with collagenase.
2. Virus propagation. Proc. Soc. exp. Biol. (N.Y.) 101, 19-22, and 22-26 (1959).
Hirsch, A.: Handbook of geographical and historical pathology. The New Sydenham Society. London Vol. 1 (1883).
Hirst, G. K.: Agglutination of red cells by allantoic fluid of chick embryos infected with influenza virus. Science 94, 22–23 (1941).
Hirst, G. K.: The quantitative determination of influenza virus and antibodies by means of red cell agglutination. J. exp. Med. 75, 47–64 (1942).
Hirst, G. K.: In ovo titrations of influenza virus and of neutralising antibodies in chick embryos. J. Immunol. 45, 285–292 (1942).
Hirst, G. K.: Direct isolation of influenza virus in chick embryos. J. Immunol. 45, 293–302 (1942).
Hirst, G. K.: Adsorption of influenza haemagglutinins and virus by red blood cells. J. exp. Med. 76, 195–209 (1942).
Hirst, G. K.: Adsorption of influenza virus on cells of the respiratory tract. J. exp. Med. 78, 99–109 (1943).
Hirst, G. K.: Studies of antigenic differences among strains of influenza A by means of red cell agglutination. J. exp. Med. 78, 407–423 (1943).
Hirst, G. K.: Direct isolation of influenza virus in chick embryos. Proc. Soc. exp. Biol. (N.Y.) 58, 155–157 (1945).
Hirst, G. K.: Studies on the mechanism of adaptation of influenza virus to mice. J. exp. Med. 86, 357–366 (1947).
Hirst, G. K.: Comparisons of influenza virus strains from three epidemics. J. exp. Med. 86, 367–381 (1947).
Hirst, G. K.: The nature of the virus receptors of red cells. 1. Evidence on the chemical nature of the virus receptors of red cells and of the existence of a closely analogous substance in normal serum.
2. The effect of partial heatinactivation of influenza virus on the destruction of red coll receptors and the use of inactivated virus in the measurement of serum inhibition. J. exp. Med. 87, 301-314, and 315-328 (1948).
3. Partial purification of the virus agglutination inhibitor in human plasma.
4. Effect of sodium periodate on the elution of influenza virus from red cells. J. exp. Med. 89, 223-232, and 233-243 (1949).
Hirst, G. K.: Receptor destruction by viruses of the mumps-NDV-influenza group. J. exp. Med. 91, 161–175 (1950).
Hirst, G. K.: The relationship of the receptors of a new strain of virus to those of the mumps-NDV-influenza group. J. exp. Med. 91, 177–184 (1950).
Hirst, G. K.: Strain-specific elements in influenza antigens. J. exp. Med. 96, 589–603 (1952).
Hirst, G. K.: Studies of mixed infections with NDV, poliovirus and influenza. 9th Symp. Soc. gen. Microbiol. “Virus growth and variation” 82-101 (1959).
Hirst, G. K.: Genetic recombination with Newcastle disease virus, polioviruses and influenza. Cold Spr. Harb. Symp. quant. Biol. 27, 303–310 (1962).
Hirst, G. K., and T. Gotlieb: The experimental production of combination forms of virus. 1. The occurrence of combination forms after simultaneous inoculation of the allantoic sac with two distinct strains of influenza virus.
2. A study of serial passage in the allantoic sac of agents that contain the antigens of two distinct influenza A strains. J. exp. Med. 98, 41-52, and 53-70 (1953).
5. Alterations in the virulence of neurotropic influenza virus as a result of mixed infection. Virology 1, 221-235 (1955).
Hirst, G. K., T. Gotlieb, and A. Granoff: Studies on mixed infections with influenza virus. Ciba Found. Symp. “The nature of viruses” 191-201 (1957).
Hirst, G. K., and E. G. Pickels: A method for titration of influenza haemagglutinins and influenza antibodies with the aid of a photoelectric densitometer. J. Immunol. 45, 273–283 (1942).
Hirst, G. K., N. Plummer, and W. F. Friedewald: Human immunity following vaccination with formalinised influenza virus. Amer. J. Hyg. 42, 45–56 (1945).
Hirst, G. K., E. R. Rickard, and L. Whitman: A new method for concentrating influenza virus from allantoic fluid. Proc. Soc. exp. Biol. (N.Y.) 50, 129–133 (1942).
Hirst, G. K., E. R. Rickard, L. Whitman, and F. L. Horsfall: Antibody response of human beings following vaccination with influenza viruses. J. exp. Med. 75, 495–511 (1942).
Hirst, G. K., A. Vilches, O. Rogers, and C. L. Robbins: The effect of vaccination on the incidence of influenza B. Amer. J. Hyg. 45, 96–101 (1947).
Hobson, D.: The strain-specific serological activity of a non-haemagglutinating fraction of influenza viruses. Brit. J. exp. Path. 47, 257–265 (1966).
Hoffman, C. E., E. M. Neumayer, R. F. Haff, and R. A. Goldsby: Mode of action of the antiviral activity of amantadine in tissue culture. J. Bact. 90, 623–628 (1965).
Holland, W. W., A. Isaacs, S. K. R. Clarke, and R. B. Heath: A serological trial of Asian influenza vaccine after the autumn epidemic. Lancet 820-822 (1958).
Hollos, I.: Inhibition of the multiplication of influenza virus by Francis inhibitor coupled to aniline derivatives. Acta microbiol. Acad. Sci. hung. 7, 231–242 (1960).
Holtermann, O. A., W. D. Hillis, and M. A. J. Moffat: The development of soluble (S) and viral (V) antigens of influenza A virus in tissue culture as studied by the fluorescent antibody technique. Acta path. microbiol. scand. 50, 398–429 (1960).
Holtermann, O. A., and K. B. Petersen: On the strain specificity of the antibody response in influenza A, as measured by complement fixation using purified antigens, and its relation to in ovo neutralising antibodies. Acta path. microbiol. scand. 50, 430–442 (1960).
Hook, E. W., and R. R. Wagner: The resistance-promoting activity of endotoxins and other microbial products. 2. Protection against the neurotoxic action of influenza virus. J. Immunol. 83, 310–317 (1959).
Horikawa, T., and T. Suzuki: Studies on the substrates having influenza virus adsorption capacities: 1. Combining factors of fowl erythrocytes. J. Mie Med. Coll. Otanicho 1, 1–4 (1950).
Horikawa, T., T. Suzuki, and H. Fuzita: Isolation of influenza and Newcastle disease viruses at interepidemic period. Mie med. J. 4, 95–102 (1954).
Horne, R. W., and P. Wildy: Symmetry in virus architecture. Virology 15, 348–373 (1961).
Horsfall, F. L.: Neutralisation of epidemic influenza virus. The linear relationship between the quantity of serum and the quantity of virus neutralised. J. exp. Med. 70, 209–222 (1939).
Horsfall, F. L.: Viral multiplication. Fed. Proc. 8, 518–522 (1949).
Horsfall, F. L.: On the reproduction of influenza virus. Quantitative studies with procedures which enumerate infective and haemagglutinating virus particles. J. exp. Med. 100, 135–161 (1954).
Horsfall, F. L.: Eeproduction of influenza viruses. Quantitative investigations with particle enumeration procedures on the dynamics of influenza A and B virus reproduction. J. exp. Med. 102, 441–473 (1955).
Horsfall, F. L., and H. S. Ginsberg: An improved CO2 cabinet for low temperature storage of infectious agents with gaseous CO2 excluded from the specimen compartment. J. Bact. 61, 443–451 (1951).
Horsfall, F. L., and E. H. Lennette: A complex vaccine effective against different strains of influenza virus. Science 91, 492–494 (1940).
Horsfall, F. L., E. H. Lennette, and E. R. Rickard: A complex vaccine against influenza A virus. Quantitative analysis of the antibody response produced in man. J. exp. Med. 73, 335–355 (1941).
Horsfall, F. L., and I. Tamm: Variation demonstrable by methods other than serological. Bull. N.Y. Acad. Med. 28, 765–768 (1952).
Horvath, S.: A new sensitive method of the rolling drum type for influenza virus titration. Acta microbiol. Acad. Sci. hung. 1, 481–494 (1954).
Horvath, S.: Study on the cyclic multiplication of influenza and ND viruses in tissue cultures. Acta microbiol. Acad. Sci. hung. 5, 123–131 (1958).
Horvath, S.: Tissue culture and influenza virus studies (German). Z. ges. inn. Med. 9, 316 (1958).
Horvath, S., and V. Balazs: Influenza in Szeged 1953–54. Acta microbiol. Acad. Sci. hung. 3, 241–246 (1956).
Horvath, I., E. Szollosy, and G. Ivanovics: Distribution of the receptor substance of the influenza and related viruses in the tissue elements of different animal species. Acta physiol. hung. 2, 77–86 (1950).
Hotchin, J. E., S. Cohen, H. Ruska, and C. Ruska: The adsorption of influenza virus to erythrocytes in the electron microscope (German). Dsch. med. Wschr. 84, 849 (1959).
Hotchin, J. E., S. M. Cohen, H. Ruska, and C. Ruska: Electron microscopical aspects of haemadsorption in tissue cultures infected with influenza virus. Virology 6, 689–701 (1958).
Hotchin, J. E., R. Deibel, and L.M. Benson: Location of noncytopathic myxovirus plaques by haemadsorption. Virology 10, 275–280 (1960).
Hotz, G., and F. B. Bang: Electron microscope studies of ferret respiratory cells infected with influenza. Bull. Johns Hopk. Hosp. 101, 175–208 (1957).
Hotz, G., and W. Schafer: Ultrahistological studies on the multiplication of the virus of fowl plague (German). Z. Naturforsch. 10b, 1–5 (1955).
Howe, C.: The influenza virus receptor and blood group antigens of human erythrocyte stroma. J. Immunol. 66, 9–35 (1951).
Howe, C., L. T. Lee, A. Harboe, and G. Haukenes: Immunochemical study of influenza virus and associated host tissue components. J. Immunol. 98, 543–557 (1967).
Howe, C., H. M. Rose, and L. T. Lee: Observations on the relationship between haemagglutinin and neuraminidase of influenza virus. Proc. Soc. exp. Biol. (N.Y.) 108, 420–425 (1961).
Howe, C., H. M. Rose, and L. Schneider: Enzymic action of influenza virus on human erythrocyte stroma components. Proc. Soc. exp. Biol. (N.Y.) 96, 88–94 (1957).
Hoyle, L.: A report on the aetiology of the recent influenza epidemic. Mth. Bull. Minist. Hlth Lab. Serv. 3, 58–61 (1944).
Hoyle, L.: An analysis of the complement fixation reaction in influenza. J. Hyg. (Lond.) 44, 170–178 (1945).
Hoyle, L.: Technique of the complement fixation reaction in influenza. Mth. Bull. Minist. Hlth Lab. Serv. 7, 114–116 (1948).
Hoyle, L.: The growth cycle of influenza A. A study of the relations between virus, soluble antigen and host cell in fertile eggs inoculated with influenza virus. Brit. J. exp. Path. 29, 390–399 (1948).
Hoyle, L.: The effect of triphenylmethane dyes on the intracellular growth of influenza A. Brit. J. exp. Path. 30, 123–129 (1949).
Hoyle, L.: Growth cycle of influenza A. Nature (Lond.) 164, 1137 (1949).
Hoyle, L.: The multiplication of influenza viruses in the fertile egg. J. Hyg. (Lond.) 48, 277–297 (1950).
Hoyle, L.: The multiplication of complement fixing antigen and red-cell agglutinin in the chorio-allantoic membrane of fertile eggs inoculated with influenza virus. J. Path. Bact. 64, 419–422 (1952).
Hoyle, L.: Structure of the influenza virus. The relation between biological activity and chemical structure of virus fractions. J. Hyg. (Lond.) 50, 229–245 (1952).
Hoyle, L.: The multiplication of the influenza virus considered in relation to the general problem of biological multiplication. 2nd Symp. Soc. gen. Microbiol. “The nature of virus multiplication.” 225-248 (1952).
Hoyle, L.: The release of influenza virus from the infected cell. J. Hyg. (Lond) 52, 180–188 (1954).
Hoyle, L.: The use of radioactive influenza virus to determine the fate of the infecting particle on entry into the host cell. Ciba Foundation Symp. “The nature of viruses.” 211-218 (1956).
Hoyle, L.: Nucleotide composition of influenza virus ribonucleic acid. Abst. VIIth int. Congr. Microbiol. 239 (1958).
Hoyle, L.: The nucleic acid of the influenza virus. Symp. VII, IVth int. Congr. Biochem., Vienna (1958).
Hoyle, L.: The entry of myxoviruses into the cell. Cold Spr. Harb. Symp. quant. Biol. 27, 113–121 (1962).
Hoyle, L.: Effect of progressive iodination of influenza virus on its biological properties. Ciba Foundation Symposium, “Cellular biology of myxovirus infections”. 152-162 (1964).
Hoyle, L., and S. P. Davies: Amino-acid composition of the protein components of influenza virus A. Virology 13, 53–57 (1961).
Hoyle, L., and R. W. Fairbrother: Isolation of the influenza virus and the relation of antibodies to infection and immunity. Brit. med. J. 655 (1937).
Hoyle, L., and R. W. Fairbrother: Antigenic structure of influenza viruses; The preparation of elementary body suspensions and the nature of the complement fixing antigen. J. Hyg. (Lond.) 37, 512–519 (1937).
Hoyle, L., and R. W. Fairbrother: Further studies of complement fixation in influenza: Antigen production in egg-membrane culture and the occurrence of a zone phenomenon. Brit. J. exp. Path. 18, 425–429 (1937).
Hoyle, L., and R. W. Fairbrother: Serological diagnosis of epidemic influenza by the complement fixation reaction. Brit. med. J. 991 (1947).
Hoyle, L., and N. B. Finter: The use of influenza virus labelled with radio-sulphur in studies of the early stages of the interaction of virus with the host cell. J. Hyg. (Lond.) 55, 290–297 (1957).
Hoyle, L., and W. Frisch-Niggemeyer: The disintegration of influenza virus particles on entry into the host cell. J. Hyg. (Lond.) 53, 474–486 (1955).
Hoyle, L., and L. Hana: The chemical reactions of influenza virus proteins. J. Path. Bact. 92, 447–460 (1966).
Hoyle, L., R. W. Horne, and A. P. Waterson: The structure and composition of the myxoviruses. II. Components released from the influenza virus particle by ether. Virology 13, 448–459 (1961).
Hoyle, L., R. W. Horne, and A. P. Waterson: The structure and composition of the myxoviruses. III. The interaction of influenza virus particles with cytoplasmic particles derived from normal chorio-allantoic membrane cells. Virology 17, 533–542 (1962).
Hoyle, L., B. Jolles, and R.B. Mitchell: The incorporation of radioactive phosphorus in the influenza virus and its distribution in serologically active virus fractions. J. Hyg. (Lond.) 52, 119–127 (1954).
Hoyle, L., R. Reed, and W. T. Astbury: Electron microscope studies of the structure of the influenza virus. Nature (Lond.) 171, 256 (1956).
Huang, J. S., and F. B. Bang: The susceptibility of chick embryo organ cultures to influenza virus following excess vitamin A. J. exp. Med. 120, 129–147 (1964).
Hudson, N. P., M. M. Sigel, and F. S. Markham: Antigenic relationship of British swine influenza strains to standard human and swine influenza viruses. The use of chicken and ferret antisera in red cell agglutination. J. exp. Med. 77, 467–471 (1943).
Hulton, J. V., and A. P. McKee: Fixation of “neutralised” influenza virus by susceptible cells. J. Bact. 63, 437–447 (1952).
Hummeler, K., L. Kravis, and M. M. Sigel: A rapid method of identification of newly isolated influenza viruses. J. Bact. 64, 253–257 (1952).
Hurrell, J. M. W.: Methods of storing viruses at low temperatures with particular reference to the myxovirus group. J. med. Lab. Technol. 24, 30–41 (1967).
Hurst, E.W.: Approaches to the chemotherapy of virus diseases. J. Pharm. Pharmacol. 9, 273–292 (1957).
Hurst, E. W., and R. Hull: The chemotherapy of virus diseases, with brief consideration of the influence of dietary, hormonal and other factors in virus infections. Pharmacol. Rev. 8, 199–263 (1956).
Hyde, R. A.: Behaviour of influenza A viruses in the rabbit, rat, and guineapig. Amer. J. Hyg. 36, 338–353 (1942).
Hyde, R. R., and A. Chapman: Behaviour of certain filterable agents from cases of colds and influenza isolated directly from man to chick membranes. Amer. J. Hyg. 26, 116 (1937).
Inglot, A., and F. M. Davenport: Studies on the role of leucocytes in infection with influenza virus. J. Immunol. 88, 55–65 (1962).
Isaacs, A.: Eeactivation of neutral mixtures of influenza virus and serum by virus inactivated by heat. Brit. J. exp. Path. 29, 529–530 (1948).
Isaacs, A.: The 1951 influenza viruses. Proc. roy. Soc. Med. 44, 801–803 (1951).
Isaacs, A.: P-Q variation in influenza viruses. Lancet 676-678 (1953).
Isaacs, A.: Eecent evolution and spread of strains of influenza A virus. Lancet 960-961 (1956).
Isaacs, A.: Antibodies to influenza viruses in the sera of Nigerians. J. Hyg. (Lond.) 55, 485–488 (1957).
Isaacs, A.: Viral interference. 9th Symp. Soc. gen. Microbiol. “Virus growth and variation” 102-121 (1959).
Isaacs, A.: Production and action of interferon. Cold Spr. Harb. Symp. quant. Biol. “Basic mechanisms in animal virus biology” 343-349 (1962).
Isaacs, A., and C. H. Andrewes: The spread of influenza. Evidence from 1950–1951. Brit. med. J. 921 (1951).
Isaacs, A., and I. Arciietti: Pathways of influenza spread. Lancet 457-459 (1954).
Isaacs, A., and A. Bozzo: The use of V. cholerae filtrates in the destruction of non-specific inhibitor in ferret sera. Brit. J. exp. Path. 32, 325–335 (1951).
Isaacs, A., and D. C. Burke: Mode of action of interferon. Nature (Lond.) 182, 1073–1074 (1958).
Isaacs, A., D. C. Burke, and L. Fadeyeva: Effect of interferon on the growth of viruses on the chick chorion. Brit. J. exp. Path. 39, 447–458 (1958).
Isaacs, A., R. A. Cox, and Z. Rotem: Foreign nucleic acid as the stimulus to make interferon. Lancet 113-116 (1963).
Isaacs, A., R. Depoux, and P. Fiset: The viruses of the 1952–53 influenza epidemic. Bull. Wld Hlth Org. 11, 967–979 (1954).
Isaacs, A., and H.B. Donald: Particle counts of haemagglutinating viruses. J. gen. Microbiol. 12, 241–247 (1955).
Isaacs, A., and M. Edney: Variation in laboratory strains of influenza viruses. 1. Biological characters of the variants.
2. Genetic aspects of the variations. Brit. J. exp. Path. 31, 196-208, and 209-216 (1950).
Isaacs, A., and M. Edney: Interference between inactive and active influenza viruses in the chick embryo. 1. Quantitative aspects of interference.
2. The site of interference.
4. The early stages of virus multiplication and interference.
5. The behaviour of different strains of challenge virus.
6. The behaviour of different strains of interfering virus. Aust. J. exp. Biol. med. Sci. 28, 219-230, 231-238, and 635-645 (1950). Also 29, 169-178, and 179-186 (1951).
Isaacs, A., and F. Fulton: Growth of influenza virus in the chick chorion. Nature (Lond.) 171, 90 (1953).
Isaacs, A., and F. Fulton: Interference in the chick chorion. J. gen. Microbiol. 9, 132–139 (1953).
Isaacs, A., A. W. Gledhill, and C. H. Andrewes: Influenza A viruses. Laboratory studies with special reference to the European outbreak of 1950–51. Bull. Wld Hlth Org. 6, 287–315 (1952).
Isaacs, A., and G. Hitchcock: Role of interferon in recovery from virus infection. Lancet 69-71 (1960).
Isaacs, A., and J. Lindenmann: Virus interference. 1. The interferon. Proc. roy. Soc. B 147, 258–267 (1957).
Isaacs, A., J. Lindenmann, and R. C. Valentine: Virus interference. 2. Some properties of interferon. Proc. roy. Soc. B 147, 268–273 (1957).
Isaacs, A., G. Negroni, and D. A. J. Tyrrell: Infection of volunteers with Asian influenza Virus. Lancet 886-887 (1957).
Isaacs, A., and A. T. Roden: Administration of live influenza virus to volunteers. Lancet 697-699 (1956).
Isaacs, A., and A. A. de C. Sampaio: The effect of adaptation to mice on the antigenicity of influenza virus. J. Path. Bact. 45, 613–615 (1953).
Isaacs, A., and J.D. Stone: Influenza virus-antibody union. Aust. J. exp. Biol. med. Sci. 27, 423–428 (1949).
Isaciienko, V. A.: The properties of avidity and sensitivity to inhibitors in influenza A2 viruses (Russian). “Problemy grippa i ostrykh respiratornykh zabolevanii.” Tez. dokl. nauch. Sess. Inst. AMN SSSE, Moscow, 49-50 (1959).
Isaciienko, V. A., G. A. Smirnova, and A. S. Gorbunova: Isolation of an inhibitor-sensitive variant from an inhibitor-resistant culture of influenza A2 virus by gel-filtration in Sephadex (Russian). Vop. Virus. 1, 97–99 (1965).
Isayeva, E. S., and Kh. Zh. Zhumatov: Isolation of infectious RNA from type A and B influenza viruses and study of its properties. Abstr. Inst. All-Union Biochem. Congr. 11, 168 (1964).
Ishida, N., and W. W. Ackermann: Growth characteristics of influenza virus. Properties of the initial cell-virus complex. J. exp. Med. 104, 501–515 (1956).
Ishida, N., T. Morizuka, and Y. Haniema: Virus antigens in kidneys of mice infected with influenza A. Nature (Lond.) 201, 421–422 (1964).
Ishida, N., and T. Osato: Initial reactions during influenza A invasion into L cells. Growth characteristics of myxoviruses in tissue cultures. Tohoku J. exp. Med. 73, 46–55 (1960).
Ishida, N., and H. Tozawa: Specificity of a neuraminidase obtained from disrupted Sendai virus. Abstr. 9th Int. Congr. Microbiol. 498 (1966).
Ivanovics, G., S. Horvath, and E. Szollosy: The influenza virus adsorbing capacity of the vascular endothelium of various mammals. Acta Microbiol. Acad. Sci. hung. 2, 121–129 (1954).
Ivanovics, G., S. Horvath, and E. Szollosy: On the adsorption capacity of the inner lining of the blood vessels for influenza and related viruses. Sond. Naturwissensch. 20, 482 (1954) (German).
Jagger, J., and E. C. Pollard: Inactivation with fast charged particles of infectivity and haemagglutination in influenza A virus. Eadiation Res. 4, 1–19 (1956).
James, S. M., and P. Fiset: Serum inhibitors of Asian strains of influenza virus. Nature (Lond.) 184, 1656–1657 (1959).
Jameson, P., and A. S. Levine: Substrate specificity of neurotropic influenza virus neuraminidases. J. Bact. 90, 563–564 (1965).
Jandasek, L., and N. Volakova: Some properties of the haemagglutination inhibitor of type A2 influenza viruses contained in the serum of normal guineapigs. Acta virol. 4, 7–16 (1960).
Jensen, K. E.: Strain variations and cross-relationships in influenza virus. Amer. J. publ. Hlth 44, 1167–1173 (1954).
Jensen, K. E.: Immunologic significance of antigenic differences among strains of influenza A isolated during the same epidemic. J. Immunol. 78, 373–379 (1957).
Jensen, K. E.: New set of type A influenza viruses. J. Amer. med. Ass. 164, 2025–2029 (1957).
Jensen, K. E., F. M. Davenport, A. V. Hennessy, and T. Francis: Characterisation of influenza antibodies by serum absorption. J. exp. Med. 104, 199–209 (1956).
Jensen, K. E., F.L. Dunn, and R. Q. Robinson: Influenza 1957. A variant and the pandemic. Progr. med. Virol. N.Y. 1, 165–209 (1958).
Jensen, E. M., E. E. Force, and J. B. Unger: Inhibitory effect of ammonium ions on influenza virus in tissue cultures. Proc. Soc. exp. Biol. (N.Y.) 107, 447–451 (1961).
Jensen, K. E., and T. Francis: Antigen-antibody precipitates in solid medium with influenza virus. J. Immunol. 70, 321–325 (1953).
Jensen, K. E., and T. Francis: The antigenic composition of influenza virus measured by antibody-absorption. J. exp. Med. 98, 619–639 (1953).
Jensen, E. M., and O. C. Liu: Inhibitory effect of simple aliphatic amines on influenza virus in tissue culture. Proc. Soc. exp. Biol. (N.Y.) 112, 456–459 (1963).
Jensen, K. E., E. Minuse, and T. Francis: Serologic comparisons with lines of influenza virus isolated and serially transferred in different experimental hosts. J. Immunol. 78, 356–364 (1957).
Jensen, K. E., and W. D. Peterson: Comparative measurements of antigenic differences among human and swine influenza viruses. J. Immunol. 78, 365–372 (1957).
Jerushalmy, Z., A. Kohn, and A. De Yries: Interaction of myxoviruses with human blood platelets in vitro. Proc. Soc. exp. Biol. (N.Y.) 106, 462–466 (1961).
Johnson, R. B., and W. W. Ackermann: Intracellular pattern of nucleic acid in virus infection. Proc. Soc. exp. Biol. (N.Y.) 86, 318–321 (1954).
Johnston, E. J. D., R. G-. Kidd, H. J. Rylance, and R. G. Sommerville: The inhibition of neuraminidase and antiviral action. Brit. J. Pharmacol. 27, 415–425 (1966).
Jones, M.: Adaptation of influenza virus to heat. Proc. Soc. exp. Biol. (N.Y.) 58, 315–319 (1945).
Jones, T. C., and F. D. Maurer: Neutralisation studies of the viruses of influenza A, influenza B, and swine influenza with equine influenza convalescent serums. Amer. J. vet. Res. 3, 179–182 (1942).
Jordan, W. S., and S. G. Gaylin: The antigenic variation of influenza B viruses. Demonstration of an antigenic spectrum by use of titre ratios. J. Immunol. 70, 393–399 (1953).
Kaganskaya, Ye. S.: Experience in the use of the complement fixation reaction for the diagnosis of influenza (Russian). Zh. Mikrobiol. (Mosk.) 1, 41 (1952).
Kaji, M., R. Oseasohn, W. S. Jordan, and J. H. Dingle: Isolation of Asian virus from extrapulmonary tissues in fatal human influenza. Proc. Soc. exp. Biol. (N.Y.) 100, 272 (1959).
Kalinina, L. I., and Z. I. Pospelova: Experimental study of the prophylactic and therapeutic activity of influenza gamma globulin (Russian). “Problemy grippa i ostrykh respiratornykh zabolevanii.” Tez. dokl. nauch. Sess. Inst. AMN SSSR, Moscow. 142-143 (1959).
Kalter, S. S.: The effect of age upon susceptibility to infection with influenza virus. J. Immunol. 63, 17–22 (1949).
Kalter, S.S.: Host growth and its relation to influenza virus infection. J. Immunol. 63, 29–35 (1949).
Kalter, S. S.: A rapid method for detection of influenza virus during epidemics. Proc. Soc. exp. Biol. (N.Y.) 74, 607–608 (1950).
Kalter, S.S.: Inapparent infections with influenza viruses. Proc. Soc. exp. Biol. (N.Y.) 76, 570–571 (1951).
Kalter, S. S., G. Berg, J. E. Prier, K. A. Jocheim, and J. M. McKenna: Virus proliferation in the mouse. 1. Growth curves of influenza (mouse-adapted PR 8) and Theiler’s mouse encephalomyelitis (GD VII) viruses. J. Immunol. 75, 410–416 (1955).
Kalter, S. S., H. L. Casey, K. E. Jensen, R. Q. Robinson, and R. H. Gorrie: Evaluation of laboratory diagnostic procedures with A/Asian influenza. Proc. Soc. exp. Biol. (N.Y.) 100, 367–370 (1959).
Kalter, S. S., O. D. Chapman, D. A. Feeley, and S. L. MacDowell: An epidemic of influenza A due to an atypical strain. The relationship of this strain to other influenza viruses. J. Immunol. 59, 147–157 (1948).
Kalter, S. S., H. J. Smolin, J. McElankey, and J. Tepperman: Endocrines and their relation to influenza virus infection. J. exp. Med. 93, 529–538 (1951).
Kalter, S. S., and J. Tepperman: Influenza virus proliferation in hypoxic mice. Science 115, 621–622 (1952).
Kantorovich: Methods of detecting influenzal antigen in the blood and nasopharyngeal discharges of sick people (Russian). Gripp. Trudy AMN SSSR 28, 104 (1953).
Kaplan, M. M.: Discussion of paper on “Influenza of horses” by E. R. Doll. Amer. Rev. resp. Dis. 83, No. 211, 48–53 (1961).
Kaplan, M. M., and A. M. M. Payne: Serological survey in animals for type A influenza in relation to the 1957 pandemic. Bull. Wld Hlth Org. 20, 465–488 (1959).
Kasel, J. A., R. H. Alford, V. Knight, G. H. Waddell, and M. M. Sigel: Experimental infection of human volunteers with equine influenza virus. Nature (Lond.) 206, 41–43 (1965).
Kass, E. H., F. A. Neva, and M. Finland: Failure of ACTH to protect against acutely lethal toxins of influenza virus and rickettsiao. Proc. Soc. exp. Biol. (N.Y.) 76, 560 (1951).
Kates, M., A.C. Allison, D. A. J. Tyrrell, and A.T. James: Lipids of influenza virus and their relation to those of the host cell. Biochim. biophys. Acta (Amst.) 52, 455–466 (1961).
Kates, M., A.C. Allison, D. A. J. Tyrrell, and A.T. James: Origin of lipids in influenza virus. Cold Spr. Harb. Symp. quant. Biol. 27, 293–302 (1962).
Kathan, R. H.: Kelp extracts as antiviral substances. Ann. N.Y. Acad. Sci. 130, 390–397 (1965).
Kathan, R. H., L. J. M. Riff, and M. Real: Association between the erythrocyte haemagglutination inhibitor and the M-N blood group substances. Proc. Soc. exp. Biol. (N.Y.) 114, 90–92 (1963).
Kato, N., and H. Hara: The toxic effect on rabbits of influenza virus given intravenously. Brit. J. exp. Path. 42, 145–152 (1961).
Kato, N., and A. Okada: The relation of the toxic agent to the subunits of influenza virus particles. Brit. J. exp. Path. 42, 253–265 (1961).
Kato, N., K. Shimizu, and H. Hara: Local skin reactivity to influenza virus. Brit. J. exp. Path. 42, 445–454 (1961).
Kavanau, J. L.: Structure and function of biological membranes. Nature (Lond.) 198, 525–530 (1963).
Keil, A. W., H. Lippelt, F. Muller, and G. Brand: The O-D phase change in influenza A virus (German). Arch. ges. Virusforsch. 7, 36–46 (1956).
Kelly, R., and D. Greiff: The level of lactic dehydrogenase activity as an indication of the growth of influenza virus in the embryonate egg. J. exp. Med. 113, 125–129 (1961).
Kelly, R. T., and D. Greiff: Neuraminidase and neuraminidase-labile substrates in experimental influenza virus encephalitis. Biochim. biophys. Acta (Amst.) 110, 548–553 (1965).
Kelly, R., D. Greiff, and D. Anderson: Histochemical and biochemical changes in the chorioallantoic membranes and allantoic fluids of embryonate eggs infected with influenza virus. J. Immunol. 89, 815–822 (1962).
Kempf, J. E., and H. T. Chang: Hypotensive action of influenza A virus on rats. Proc. Soc. exp. Biol. (N.Y.) 72, 272–275 (1948).
Kempf, J. E., and E. T. Harkness: Observations on the toxin of influenza virus. Proc. Soc. exp. Biol. (N.Y.) 75, 80–83 (1950).
Khayt, S. L., A. S. Vinogradova, R. I. Kotina, and B. Ye. Edel’man: Experiment in active immunisation of people against influenza (Russian). Zh. Mikrobiol. (Mosk.) 3–4, 93 (1942).
Khayt, S. L., A. S. Vinogradova, and N. V. Nartsissov: Survival of laboratory strains of influenza virus on the human nasopharyngeal mucosa (Russian). Zh. Mikrobiol. (Mosk.) 1, 4 (1949).
Kiiersonskaya, R. Ya.: Experience in the therapeutic use of ecmoline in influenza (Russian). Tr. Ob’yed. nauch. Sess. AMN SSSR, Moscow, 171-174 (1953).
Kiiersonskaya, R. Ya.: The treatment of influenza and its complications (Russian). “Problemy grippa i ostrykh respiratornykh zabolevanii.” Tez. dokl. nauch. Sess. Inst. AMN SSSR, Moscow, 192-193 (1959).
Khoobyarian, N., and D. L. Walker: Induced resistance in mice to intravenous toxicity of influenza virus. Proc. Soc. exp. Biol. (N.Y.) 94, 74–78 (1957).
Khoobyarian, N., and D. L. Walker: Effect of cortisone on mouse resistance to intravenous toxicity of influenza virus. Proc. Soc. exp. Biol. (N.Y.) 94, 295–298 (1957).
Kilbourne, E. D.: The influence of cortisone on experimental viral infection. 1. Prolongation of survival time and suppression of inflammation in chick embryos infected with influenza B virus. J. Immunol. 74, 57–62 (1955).
2. Effects on antibody formation and acquired immunity. Proc. Soc. exp. Biol. (N.Y.) 90, 685-687 (1955).
3. Effects on certain dynamics of influenza virus increase.
4. Negation of interference as the mechanism by which cortisone induces increased virus yields.
5. Inhibition of influenza virus synthesis. J. exp. Med. 106, 851-862, 863-881, and 883-891 (1957).
Kilbourne, E. D.: Inhibition of influenza virus multiplication with a glucose anti-metabolic (2 deoxy-D-glucose). Nature (Lond.) 183, 271–272 (1959).
Kilbourne, E. D.: The inaccessibility of genetically active but non-infective influenza virus to the intracellular action of ribonuclease. Virology 11, 291–294 (1960).
Kilbourne, E. D.: Influenza virus genetics. Progr. med. Virol. 5, 79–126 (1963).
K4e_Kilbourne, E. D., H. C. Anderson, and F. L. Horsfall: Concurrent infection with influenza A and B viruses in a single epidemic of influenza. J. Immunol. 67, 547–558 (1951).
Kilbourne, E. D., and F. L. Horseall: Increased virus in eggs injected with cortisone. Proc. Soc. exp. Biol. (N.Y.) 76, 116–118 (1951).
Kilbourne, E. D., and F. L. Horsfall: Mouse-egg neutralisation. Neutralisation in the mouse of influenza viruses not adapted to the mouse. J. Immunol. 67, 431–436 (1951).
Kilbourne, E. D., and J.S. Murphy: Genetic studies of influenza viruses. 1. Viral morphology and growth capacity as exchangeable genetic traits. Rapid in ovo adaptation of early passage Asian strain isolates by combination with PE8. J. exp. Med. 111, 387–406 (1960).
Kilbourne, E. D., A. Sugiura, and S.C. Wong: Serial multiplication of an influenza virus (NWS) in certain human diploid cell strains. Proc. Soc. exp. Biol. (N.Y.) 116, 225–228 (1964).
Kirber, M. W., and W. Henle: A comparison of influenza complement fixation antigens derived from allantoic fluids and membranes. J. Immunol. 65, 229–244 (1950).
Klein, M.: The mechanism of the virucidal action of ascorbic acid. Science 101, 587–589 (1945).
Klein, M., H. Brewer, J.E. Perez, and B. Day: The inactivation of influenza virus by mercurials and the reactivation by sodium thioglycolate and BAL. J. Immunol. 59, 135–140 (1948).
Klein, M., S. Chaevsky, and M. Muller: A rapid agglutination test for the detection of antibodies to viruses of influenza. J. Immunol. 97, 131–137 (1966).
Klein, M., and J. E. Perez: The reversal in vivo by BAL of inactivation of influenza A virus and diplococcus pneumoniae by bichloride of mercury. J. Immunol. 60, 349–358 (1948).
Klein, M., and D. A. Stevens: In vitro and in vivo activity of synthetic detergents against influenza A virus. J. Immunol. 50, 265–273 (1945).
Klemperer, H. G.: An effect of phloridzin on influenza virus elution and on neuraminidase activity. Virology 12, 495–498 (1960).
Klemperer, H.: Glucose breakdown in chick embryo cells infected with influenza virus. Virology 13, 68–77 (1961).
Klenk, E., H. Faillard, and H. Lempfrid: The enzymatic activity of influenza virus (German). Hoppe-Seyler’s Z. physiol. Chem. 301, 235–246 (1955).
Klenk, E., and H. Lempfrid: The nature of the cell receptors for influenza virus (German). Hoppe-Seyler’s Z. physiol. Chem. 307, 278–283 (1957).
Kloene, W., F. B. Bang, M. R. Cooper, H. Kulemann, M. Ola, K. V. Shah, S. M. Chakraborty, and H. G. Pereira: Isolation of a new antigenic type of influenza B virus. Virology 28, 774–775 (1966).
Kluska, V., M. Macku, and J. Mensik: Demonstration of antibodies against swine influenza viruses in man. Čs. Pediat. 16, 408–414 (1961).
Knight, C. A.: A sedimentable component of allantoic fluid and its relationship to influenza viruses. J. exp. Med. 80, 83–100 (1944).
Knight, C. A.: The stability of the influenza virus in the presence of salts. J. exp. Med. 79, 285–290 (1944).
Knight, C. A.: The preparation of highly purified PR8 influenza virus from infected mouse lungs. J. exp. Med. 83, 11–24 (1946).
Knight, C. A.: Precipitin reactions of highly purified influenza viruses and related materials. J. exp. Med. 83, 281–294 (1946).
Knight, C.A.: The nucleic acid and carbohydrate of influenza virus. J. exp. Med. 85, 99–116 (1947).
Knight, C. A.: Aminoacid composition of highly purified particles of influenza A and B. J. exp. Med. 86, 125–129 (1947).
Knight, C. A., and W. M. Stanley: The effect of some chemicals on purified influenza virus. J. exp. Med. 79, 291–300 (1944).
Knowles, R. C., and H. C. King: The 1963 equine influenza epizootic. J. Amer. vet.-med. Ass. 143, 1108–1110 (1963).
Knyaseva, L. D.: Viroscopy as a method of early diagnosis of influenza (Russian). Probl. grippa Tez. dokl. ob’yed. nauch. Konf. Inst. AMN SSSR, Kiev, 57-58 (1955).
Koch, A.: Effects of formaldehyde on influenza virus. 4. Effects on the titratable groups of the virus. Acta microbiol. Acad. Sci. hung. 9, 97–102 (1962).
Koch, A., and E. Csonka: Effects of formaldehyde on influenza virus. 2. Effects on the infectivity of the virus. Acta microbiol. Acad. Sci. hung. 5, 311–316 (1958).
Koch, A., S. Horvath, and G. Ivanovics: An attempt to detect the virus infection of the chick embryo by registrating the refractive power of the allantoic fluid. Acta physiol. hung. 2, 525–531 (1951).
Kociskova, D., B. Styk, and L. Hana: The relation of properdin and complement to the thermolabile co-factor of normal serum necessary for the reaction of specific antibody with influenza A2 virus. Acta virol. 5, 19–25 (1961).
Koen, J. S.: A practical method for field diagnosis of swine diseases. Amer. J. Vet.-Med. 14, 468–470 (1919).
Kofman, S. Ya.: Latest in the treatment of influenza (Russian). “Virusnyye Infektsii.” Medgiz Leningrad, 213-218 (1953).
Kofman, S. Ya., M. I. Kal’yanova, and S. M. Lyubinskaya: Experience in the prophylaxis of influenza at an industrial enterprise using influenza antiserum inhalations (Russian). “Virusnyye Infektsii.” Tr. Inst. epidem. Mikrobiol. i gig. isneni Pastera i Inst. Eksper. med. AMN SSSE, Leningrad 13, 166 (1953).
Kohler, H. R.: The pathogenesis of influenza infection of the chick embryo after inoculation of virus into the allantoic sac (German). Zbl. Bakt. I. Abt. Orig. 163, 92–117 (1955).
Kohn, A., and D. Danon: Rapid titration of viral haemagglutinins and haemagglutination inhibition antibodies with the aid of a fragiligraph. Experientia (Basel) 21, 296–297 (1965).
Kolchurina, A. A.: The study of genetic characteristics of influenza virus strains in connection with their pathogenicity. Abstr. 9th Int. Congr. Microbiol. Moscow 385 (1966).
Kolchurina, A. A., and V. M. Bolotovskiy: Study of interaction of inhibitor sensitive and inhibitor resistant vaccine strains of virus of influenza A2 (Russian). Vop. Virus. 1, 61–66 (1965).
Koldatitskaya, Ye. A.: Cytological characteristics of the nasal secretion in influenza and seasonal catarrhs of the upper respiratory tract (Russian). Zh. Mikrobiol. (Mosk.) 6, 40 (1947), and 12, 39 (1948).
Koldatitskaya, Ye. A.: Cytological characteristics of the nasal secretion in influenza and in cold rhinitis (Russian). Vop. Virus. 1, 283 (1948).
Kon, Y. S., S. G. Faiershtein, N. K. Kulichkova, A. S. Shapiro, and I.I. Mogilevskii: Preliminary epidemiological evaluation of live influenza vaccine of A2 type (Russian). Vop. Virus. 5, 122–125 (1958).
Kono, R., Y. Ashishara, M. Matumoto, T. Shimizu, and K. Okazaki: Studies on the experimental infection of swine with human influenza virus FM1 strain. Jap. J. exp. Med. 21, 419–424 (1951).
Koppel, Z., J. Vrtiak, M. Yasil, and S. Spiesz: Veterinarstri 6, 267 (1956).
Korbecki, M.: Changes in metabolic activity of KB cells infected with influenza virus A2. Bull. Acad. pol. Sci. 13, 391–393 (1965).
Kornyushenko, N. P.: Type B virus influenza (Russian). Vrach. delo. 5, 431 (1952).
Kornyushenko, N. P.: Material on the study of the immunobiological reactivity of the body in virus influenza with different types of course (Kussian). Gripp. i OKVDP Tr. ob’yed. Sess. Inst. AMN SSSE 128 (1953).
Kornyushenko, N. P., and N. A. Maximovich: Intrauterine transmission of influenza infection in experimental animals. Acta virol. 5, 26–30 (1961).
Kornyushenko, N. P., M. K. Topchy, E. V. Sidorenko, and V. C. Baisheva: Study of various myxovirus components on cultivation in mouse fibroblast cells (line L) and on chick embryos. Abstr. 9th int. Congr. Microbiol. Moscow 504 (1966).
Korovin, A. A., and I. P. Dmitrovskaya: Experience in specific serum prophylaxis of influenza (Russian). “Gripp.” Tr. AMN SSSR, Moscow 28, 226 (1953).
Korych, B., and V. Frankova: Possibility of employing porcine kidney tissue cultures for quantitative determination of myxovirus influenza C. (Czech.). Čs. Epidem. 15, 135–140 (1966).
Kosyakov, P. N., and Z. I. Rovnova: Qualitative differences in antigenic properties of type B influenza virus isolated in different periods. Probl. virol. (Lond.) 5, 789–795 (1960).
Kosyakov, P. N., and Z. I. Rovnova: Antigenic components of the host in influenza virus (Kussian). Vop. Virus. 1, 17–23 (1965).
Kozinski, A. W.: A new method of absorption of influenza antibodies (Polish). Med. Sosw. Microbiol., Warsaw 3, 71–82 (1951).
Kozinski, A. W.: The influence of cellular fractions from Salm. Typhi upon the agglutination of erythrocytes by influenza virus (Polish). Med. Dosw. Microbiol. Warsaw 3, 83–94 (1951).
Kozinski, A. W., and E. Mikulaszek: The purification of an influenza virus inhibitor from egg white. General properties of the inhibitor (Polish). Med. Dosw. Microbiol. Warsaw 3, 242–254 (1951).
Kravchenko, A. G., and P. M. Sekretta: The problem of methods of experimental investigation of the influenza virus (Kussian). Vop. Virus. 2, 178 (1949).
Kreuger, A. B., and others: Attempts to protect against influenza virus with various sulphonamides, acridines, and antibiotics. Science 98, 348–349 (1943).
Krizanova, O., and J. Lesko: Separation of gamma inhibitor on carboxymethyl-cellulose. Acta virol. 8, 179–182 (1964).
Krizanova, O., and F. Sokol: Purification of bovine serum beta-inhibitor by chromatographic methods and its reaction with A1 influenza virus. Acta virol. 10, 35–42 (1966).
Krizanova-Laucikova, O., J. Szanto, and P. Albrecht: Localisation of virus haemagglutination inhibitor in the chorioallantoic membrane. Virology 15, 501–503 (1961).
Krizanova-Laucikova, O., J. Szanto, and D. Kociskova: Purification and some properties of the thermostable inhibitor against avid A2 influenza viruses from horse serum. Acta virol. 5, 4–11 (1961).
Krizanova-Laucikova, O., J. Szanto, D. Kociskova, G. Ruttkay-Nedecky, and F. Sokol: Differences in the properties of two inhibitors against avid A2 influenza virus strains from horse serum. Acta virol. 5, 12–18 (1961).
Krizanova-Laucikova, O., J. Szanto, D. Kociskova, G. Ruttkay-Nedecky, and F. Sokol: Presence in horse serum of two inhibitors of avid A2 influenza virus strains. Nature (Lond.) 189, 513 (1961).
Kroeger, A. V.: Evidence for the absence of anaphylactogenic host protein in highly purified PR8 influenza virus. J. Immunol. 89, 136–144 (1962).
Kroeger, A. V., and J. E. Kempf: Inactivation of the influenza virus by low voltage Roentgen rays. J. Bact. 77, 237–246 (1959).
Krueger, A. P.: The effects of certain detergents on influenza virus (types A and B) U.S. Navy Med. Bull. 40, 622–631 (1942).
Kuchler, C., and W. Kuchler: Studies on antiviral activity of virothricin. Acta virol. 10, 195–199 (1966).
Kundin, W. D., M. L. Robbins, and P. K. Smith: Inhibition of influenza virus multiplication in tissue cultures by structural analogues of aminoacids. Virology 7, 1–27 (1959).
Kundin, W. D., M. L. Robbins, and P.K. Smith: Antiviral activity of 3,5-diiodo-4-hydroxybenzene sulphonamide in chick embryo lung tissue culture. Proc. Soc. exp. Biol. (N.Y.) 116, 425–427 (1964).
Kunze, F.: An investigation of the action of normal human serum on haemagglutination by influenza virus (German). Z. Hyg. Infekt.-Kr. 129, 233–252 (1949).
Kushnareva, E. E.: Laboratory diagnosis of influenza by cytological examination of conjunctival secretions (Kussian). Zh. Mikrobiol. (Mosk.) 30, 25–26 (1959).
Lackovic, V., and L. Borecky: The reticuloendothelial system and virus infection. 2. Production of interferon and antibody-like substances in mouse peritoneal cells infected with myxoviruses in vivo. Arch. ges. Virusforsch. 27, 619–630 (1965).
Lacorte, J. G., E. Monteiro, and J. C. Loures: The first strains of influenza virus isolated in Brazil (Portuguese). Hospital Rio de Janeiro 35, 211–213 (1949).
Lacorte, J. G., E. Monteiro, and J. C. Loures: Additional observations on the first strains of influenza virus isolated in Brazil (Portuguese). Hospital Kio de Janeiro 35, 357–359 (1949).
Lacorte, J. G., E. Monteiro, and J. C. Loures: Influence of X rays on the influenza virus (French). Abstr. 6th int. Congr. Microbiol. Rome 3, 104–106 (1953).
Lacorte, J. G., E. Monteiro, and J. C. Loures: Action of X rays on influenza virus (Portuguese). Hospital Kio de Janeiro 45, 243–250, 487-492, and 779-783 (1954).
Lacorte, J. G., E. Monteiro, and J. C. Loures: Resistance of influenza virus to intermittent action of X rays (Portuguese). Hospital Kio de Janeiro 48, 437–443 (1955).
Lacorte, J. G., E. Monteiro, and J. C. Loures: Neurotropism of influenza virus (Portuguese). Hospital Rio de Janeiro 48, 203–207 (1955).
Lacorte, J. G., E. Monteiro, and J. C. Loures: Action of X rays on the neurotropism of influenza virus DL strain of Rio de Janeiro (Portuguese). Hospital Rio de Janeiro 48, 343–346 (1955).
Lacorte, J. G., E. Monteiro, and J. C. Loures: Resistance of influenza virus to the silver oligodynamic action (Portuguese). Mem. Inst. Osw. Cruz 53, 537–544 (1955).
Lacorte, J. G., E. Monteiro, and J. C. Loures: The complement fixation test in studies of Asian influenza virus (Portuguese). Mem. Inst. Osw. Cruz 58, 89–101 (1960).
Lafferty, K. J.: The interaction between virus and antibody. 1. Kinetic studies.
2. Mechanism of the reaction. Virology 21, 61-75, and 76-90 (1963).
Lahelle, O., and F. L. Horsfall: Multiplication of influenza virus in dead chick embryos. Proc. Soc. exp. Biol. (N.Y.) 70, 547–551 (1949).
Laidlaw, P. P.: Epidemic influenza: A virus disease. Lancet 1118-1124 (1935).
Laidlaw, P. P., W. Smith, C. H. Andrewes, and G. W. Dunkln: Influenza: The preparation of immune sera in horses. Brit. J. exp. Path. 16, 275–290 (1935).
Lampson, G. P., A. A. Tytell, M. M. Nimes, and M. E. Hilleman: Purification and characterisation of chick embryo interferon. Proc. Soc. exp. Biol. (N.Y.) 112, 469–478 (1963).
Lang, G., and C.G. Wells: Wilmot virus. A new influenza virus infecting turkeys. Arch. ges. Yirusforsch. 19, 81–90 (1966).
Lange, F. C.: Immunologic properties of haemagglutinating subunits and S antigen preparations obtained from influenza virus after treatment with ether. Arch. ges. Yirusforsch. 19, 70–74 (1966).
Lanni, F., and Y. T. Lanni: A quantitative theory of influenza virus haemagglutination-inhibition. J. Bact. 64, 865–882 (1952).
Lanni, F., and Y. T. Lanni: Influenza virus as enzyme: Mode of action against inhibitory mucoprotein from egg white. Virology 1, 40–57 (1955).
Lanni, F., Y. T. Lanni, and J. W. Beard: Inhibitory effect of cow’s milk on influenza virus haemagglutination. Proc. Soc. exp. Biol. (N.Y.) 72, 227–232 (1949).
Lanni, Y. T., F. Lanni, and J. W. Beard: Dialysable factor in allantoic fluid affecting virus haemagglutination-inhibition reactions. Proc. Soc. exp. Biol. (N.Y.) 73, 229–235 (1950).
Lanni, F., Y. T. Lanni, and J. W. Beard: The egg-white inhibitor of influenza virus haemagglutination. 3. Stability in relation to the preparation of a standard of activity.
4. Production of modified (Weak) inhibitor by influenza viruses: An interpretation of virus-induced changes in the character of the inhibition curve.
7. Inhibitor gradient for influenza viruses. J. Immunol. 66, 269-279 (1950) and 66, 169-179 and 213-224 (1951).
Lanni, F., D. G. Sharp, E. A. Eckert, E. S. Dillon, D. Beard, and J. W. Beard: The egg-white inhibitor of influenza virus haemagglutination. 1. Preparation and properties of semi-purified inhibitor. J. biol. Chem. 179, 1275–1287 (1949).
Larin, N. M., M. P. Copping, R. H. Herbst-Laier, B. Roberts, and K. B. M. Wenham: Antiviral activity of gliotoxin. Chemotherapia (Basel) 10, 12–23 (1965).
Laucikova, O.: Purification and some properties of the inhibitor of virus haemagglutination from chorioallantoic membranes of the chick embryo. Acta virol. 1, 2–11 (1957).
Laucikova, O.: The influence of the inhibitor of virus haemagglutination from chorioallantoic membrane on the multiplication of the influenza virus strain PR8. Acta virol. 2, 7–11 (1958).
Laucikova, O.: Enzymatic split product of influenza virus haemagglutination inhibitor. Acta virol. 3, 139–144 (1959).
Lauer, D. V., and G. M. Lozova: Pathological morphology of experimental influenza (Russian). Tr. Kiyevskogo sanitarno-bakteriolog. Inst. Kiev. 2 (1939).
Lauffer, M. A., and G. L. Miller: The mouse infectivity titration of influenza virus. J. exp. Med. 79, 197–203 (1944).
Lauffer, M. A., and W.M. Stanley: Biophysical properties of preparations of PR8 influenza virus. J. exp. Med. 80, 531–548 (1944).
Lauffer, M. A., and M. Wheatley: Destruction and denaturation of influenza A virus. Arch. Biochem. 32, 436–447 (1951).
Laver, W. Gr.: A micromethod for the N-terminal aminoacid analysis proteins. Biochim. biophys. Acta (Amst). 53, 469–475 (1961).
Laver, W. G.: Purification, N-terminal aminoacid analysis, and disruption of an influenza virus. Virology 14, 499–502 (1961).
Laver, W. G.: The structure of influenza viruses. 1. N-terminal aminoacid analyses.
2. C-terminal aminoacid analyses.
3. Disruption of the virus particle and separation of neuraminidase activity. Virology 18, 19-32 (1962); 20, 20-28, and 251-262 (1963).
Laver, W. G.: Structural studies on the protein subunits from three strains of influenza virus. J. molec. Biol. 9, 109–124 (1964).
Laver, W. G., and E. D. Kilbourne: Identification in a recombinant influenza virus of structural proteins derived from both parents. Virology 30, 493–501 (1966).
Laver, W. G., J. Pye, and G.L. Ada: The molecular size of neuraminidase from vibrio cholerae (strain 4Z). Biochim. biophys. Acta (Amst.) 81, 177–180 (1964).
Laver, W. G., and E. G. Webster: The structure of influenza viruses. 4. Chemical studies of the host antigen. Virology 30, 104–115 (1966).
Lavrov, S. V., and G. A. Galegov: Inhibitory effect of 5-fluorouracil on the strain WSN influenza A virus reproduction in tissue culture. Abstr. 9th int. Congr. Microbiol. Moscow 531-532 (1966).
Lazarus, A. S.: Isolation of three strains of type B influenza virus incompletely related to LEE. Proc. Soc. exp. Biol. (N.Y.) 71, 317–319 (1949).
LeClerc, J.: Action of ribonuclease on the multiplication of influenza virus. Nature (Lond.) 177, 578–589 (1956).
LeClerc, J.: The action of ribonuclease on the influenza virus synthesis (French). Ann. Inst. Pasteur 93, 772–785 (1957).
Ledinko, N.: Production of plaques with influenza viruses. Nature (Lond.) 175, 999–1000 (1955).
Ledinko, N.: Studies with influenza virus B of recent human origin. 2. Genetic interaction with MIL strain of influenza B virus. J. Immunol. 74, 380–386 (1955).
Ledinko, N.: An analysis of the process of adaptation of influenza virus B of recent human origin to the mouse lung. J. gen. Microbiol. 15, 47–60 (1956).
Ledinko, N., V.V. Bergs, and W. Henle: Evaluation of suspended chick embryo lung cells as a host system for influenza virus. Virology 4, 109–125 (1957).
Ledinko, N., and B. Perry: Studies with influenza virus B of recent human origin. 1. Adaptation to the mouse lung. J. Immunol. 74, 371–379 (1955).
Lehmann-Grube, F.: A sensitive plaque assay for influenza viruses. Virology 21, 520–522 (1963).
Lehmann-Grube, F.: Influenza viruses in cell cultures. 1. Preparation and use of fetal pig lungs for quantal assay.
2. Use of calf kidney cells for quantal assay.
3. Propagation in calf kidney cells. Arch. ges. Virusforsch. 14, 1-14, and 177-188 (1964); 17, 534-548 (1965).
Lennette, E. H., and F. L. Horsfall: Studies on epidemic influenza virus. The nature and properties of the complement fixing antigen. J. exp. Med. 72, 233–246 (1940).
Lennette, E. H., and F. L. Horsfall: Studies on influenza virus. The complement fixing antigen of influenza A and swine influenza viruses. J. exp. Med. 73, 581–599 (1941).
Leonidova, S. L., M. I. Mikhailova, V. V. Ritova, and A. G. Kalinkina: Characteristics of virus strains contained in the anti-influenza vaccines in 1958 and 1959 (Russian). “Problemy grippa i ostrykh respiratornykh zabolevanii.” Tez. dokl. nauch. Sess. Inst. AMN SSSR, Moscow 126-127 (1959).
Lepine, P., V. Sautter, L. Rsceinic, and J. Maurin: Influenza epidemic of 1948–49: Serological and experimental study of the virus (French). Ann. Inst. Pasteur 77, 108–126 (1949).
Lepine, P., V. Sautter, L. Reinic, and J. Maurin: The influenza epidemic in France. Studies of the antigenic type of the virus responsible for the epidemic. (French). Bull. Inst. nat. Hyg. (Paris) 4, 107–109 (1949).
Leshchinskaya, Ye. V.: Phagocytic activity of leucocytes in influenza and acute catarrhs of the upper respiratory tract (Russian). Zh. Mikrobiol. (Mosk.) 12, 26–28 (1955).
Lester, W.: The influence of relative humidity on the infectivity of air-borne influenza virus (P R 8). J. exp. Med. 88, 361–368 (1948).
Leuchtenberger, C., E. Leuchtenberger, T. Brunner, D. Norlin, and S. Weiss: Transformation induced by PR8 virus in primary cultures of mouse kidney and bronchus, and production of malignant kidney tumours in mice by subcultures. Proc. nat. Acad. Sci. (Wash.) 53, 694–701 (1965).
Levine, A. S., P. H. Bond, and H. C. Rouse: Modification of viral synthesis in tissue culture by substituting pyruvate for glucose in the medium. Proc. Soc. exp. Biol. (N.Y.) 93, 233–235 (1956).
Levine, A. S., P.H. Bond, A. E. Scala, and M. D. Eaton: Studies on the relationship of potassium to influenza virus multiplication. J. Immunol. 76, 386–392 (1956).
Levine, A. S., T. T. Puck, and B. P. Sagik: An absolute method for assay of virus haemagglutinins. J. exp. Med. 98, 521–531 (1953).
Levy, A. H., and E. E. Wagner: Increased avidity of antibody for Baltimore 1957 strains of Asian influenza virus (PQR variation). Proc. Soc. exp. Biol. (N.Y.) 98, 357–361 (1958).
Lewis, P. A., and R. E. Shope: Swine influenza. 2. A haemophilic bacillus from the respiratory tract of infected swine. J. exp. Med. 54, 361–372 (1931).
Libikova, H., and D. Blaskovic: Properties of an influenza virus of type B isolated in Slovakia in the epidemic of 1949 (Czech.). Čas. Lék. ces. 89, 1224–1229 (1950).
Lief, F. S.: Antigenic analysis of influenza viruses by complement fixation. 7. Further studies on production of pure anti-S serum and on specificity of type A S antigens. J. Immunol. 90, 172–177 (1963).
Lief, F. S.: Toxicity, pathogenicity, and antigenicity of inhibitor-sensitive and nonsensitive substrains of influenza A2 isolates. J. Immunol. 92, 286–298 (1964).
Lief, F. S., and D. Cohen: Equine influenza. Studies of the virus and of antibody patterns in convalescent, interepidemic and post-vaccination sera. Amer. J. Epidem. 82, 225–246 (1966).
Lief, F. S., A. Fabiyi, and W. Henle: Antigenic analyses of influenza viruses by complement fixation. 1. The production of antibodies to the soluble antigen in guineapigs. J. Immunol. 80, 53–65 (1958).
Lief, F. S., and W. Henle: Studies on the soluble antigen of influenza virus. 1. The release of S antigen from elementary bodies by treatment with ether.
2. A comparison of the effects of sonic vibration and ether treatment of elementary bodies.
3. The decreased incorporation of S antigen into elementary bodies of increasing incompleteness. Virology 2, 753-771, 772-781, and 782-797 (1956).
Lief, F. S., and W. Henle: Methods and procedures for use of complement fixation technique in type and strain-specific diagnosis of influenza. Bull. Wld Hlth Org. 20, 411–420 (1959).
Lief, F. S., and W. Henle: Antigenic analysis of influenza viruses by complement fixation. 6. Implications of age distribution of antibodies to heterologous strains following infection and vaccination. J. Immunol. 85, 494–510 (1960).
Lief, F. S., W. Henle, and W. D. Schrack: Antigenic analysis of influenza viruses by complement fixation. 5. Homologous antibody responses in man following vaccination with A 2 virus. J. Immunol. 85, 483–493 (1960).
Lief, F. S., M. Ostapiak, A. Fabiyi, and W. Henle: Antigenic analysis of influenza viruses by complement fixation. 3. Rapid identification of new isolates. J. Immunol. 81, 478–483 (1958).
Likar, M.: Some factors influencing the development of soluble antigen for influenza A virus grown on chorioallantoic membranes of chick embryos. Acta med. iugosl. 9, 19–27 (1955).
Lind, P. E., and F. M. Burnet: Back-recombination of influenza A strains obtained in recombination experiments. Aust. J. exp. Biol. med. Sci. 31, 361–371 (1953).
Lind, P. E., and F. M. Burnet: Kecombination between neurotropic and non-neurotropic influenza virus strains. Aust. J. exp. Biol. med. Sci. 32, 437–452 (1954).
Lind, P. E., and F. M. Burnet: Kecombination between virulent and non-virulent strains of influenza virus. 1. The significance of heterozygosis.
2. The behaviour of virulence markers on recombination. Aust. J. exp. Biol. med. Sci. 35, 57-66, and 67-78 (1957).
Lindenmann, J.: The staining of influenza virus. J. gen. Microbiol. 15, 759–763 (1957).
Lindenmann, J.: Resistance of mice to mouse-adapted influenza A virus. Virology 16, 203–204 (1962).
Lindenmann, J., D. C. Burke, and A. Isaacs: Studies on the production mode of action and properties of interferon. Brit. J. exp. Path. 3S, 551–562 (1957).
Lindh, H.F., and M. Forbes: Protective effect of 2-diethylaminoethyl-4-methylpiperazine-1-carboxylate in mice infected with influenza virus. Proc. Soc. exp. Biol. (N.Y.) 121, 65–68 (1966).
Link, F., D. Blaskovic, and J. Raus: Studies on the effect of antiviral substances on experimental virus infections. 1. The effect of urethane on influenza virus infection.
2. Dose response relationship between concentration and antiviral effect of urethane in mice. Acta virol. 5, 89-90 and 245-249 (1961).
Link, F., J. Szanto, and O. Krizanova: A quantitative assay of the in vivo protective effect of gamma inhibitor against inhibitor sensitive A 2 influenza virus strains. Acta virol. 8, 71–75 (1964).
Lippelt, H., and G. Brand: Enrichment of influenza virus on primary isolation (German). Arch. ges. Virusforsch. 5, 277–287 (1954).
Lippelt, H., and E. Mannweiler: The behaviour of influenza virus in chick embryo kidney tissue cultures. 1. Virus adsorption (German). Arch. ges. Virusforsch. 10, 636–646 (1961).
Lippelt, I.I., and W. Wirth: Unspecific inhibitors of influenza virus in normal guineapig serum (German). Arch. ges. Virusforsch. 9, 497–509 (1959).
Lisitsa, F. M.: Neurologic complications of influenza in 1957 (Russian). Klin. med. (Mosk.) 37, 47–53 (1959).
Liu, C.: Studies on influenza infection in ferrets by means of fluorescein-labelled antibody. 1. The pathogenesis and diagnosis of the disease.
2. The role of soluble antigen in nuclear fluorescence and cross-reactions. J. exp. Med. 101, 665-675 and 677-685 (1955).
Liu, O. C., H. Blank, J. Spizizen, and W. Henle: The incorporation of radioactive phosphorus into influenza virus. J. Immunol. 73, 415–425 (1954).
Liu, O. C., J. E. Carter, K. G. Malsberger, A. N. DeSanctis, and B. Hampill Studios on the chemotherapy of viral infections. 2. The effect of caprochlorone on influenza virus infections in mice. J. Immunol. 78, 222–227 (1957).
Liu, O. C., and W. Henle: Studies on host-virus interactions in the chick embryo influenza virus system. 4. The role of inhibitors of haemagglutination in the evaluation of viral multiplication.
5. Simultaneous serial passage of the agents of influenza A and B in relation to variations in the growth cycle of influenza B virus.
7. Data concerning the significance of infectivity titration end points and the separation of clones at limiting dilution. J. exp. Med. 94, 269-289, and 291-304 (1951); 97, 889-902 (1953).
Liu, O. C., R. G. Malsberger, J. E. Carter, A. N. DeSanctis, F. P. Wiener, and B. Hampill: Studies on the chemotherapy of viral infections. 1. The activity of caprochlorone on influenza viral infection in the de-embryonated egg. J. Immunol. 78, 214–221 (1957).
Liu, O. C., K. Paucker, and W. Henle: Studies on host-virus interactions in the chick embryo influenza virus system. 3. Some aspects of non-infectious virus production. J. exp. Med. 103, 777–797 (1956).
Loban, K. M.: The problem of treating influenza with a combination of ecmoline and penicillin (Russian). Antibiotiki 181-188 (1954).
Lobodzinska, M., and B. Klubinska: Segregation of influenza A, A 2, and B virus strains into strains with varying sensitivity to horse serum inhibitor. Arch. Immunol. Terap. Dosw. Warsaw 8, 687–694 (1960).
Lobodzinska, M., and O. Krizanova: Purification and properties of an influenza virus inhibitor isolated from mouse lungs. Acta virol. 10, 28–34 (1966).
Löffler, H.: Haemagglutination by Asian influenza virus (German). Schweiz. Z. allg. Path. 21, 1002–1007 (1958).
Löffler, H., G-. Henle, and W. Henle: Attempts to influence the incomplete reproductive cycle of influenza virus in HeLa cells by antibodies. J. Immunol. 88, 763–776 (1962).
Lofstrom, G.: Complement fixation and mouse protection tests in routine serologic studies on influenza. Acta path. microbiol. scand. 24, 315–325 (1947).
Lofstrom, G: Comparison between two Swedish influenza virus strains and virus A strain PR8. Acta med. scand. 133, 162–170 (1949).
Loosli, G. C., D. Hamre, and P. Gerber: Antigenic variants of influenza A virus (PR8 strain). 5. Virulence, antigenic potency and cross-protection tests in mice of the original and second series. J. exp. Med. 107, 857–868 (1958).
Loosli, G. C., M. H. Lemon, O. H. Robertson, and E. Appel: Experimental air-borne influenza infection. 1. Influence of humidity on survival of virus in air. Proc. Soc. exp. Biol. (N.Y.) 53, 205–206 (1943).
Loosli, G. C., O. H. Robertson, and T. T. Puck: The production of experimental influenza in mice by inhalation of atmospheres containing influenza virus dispersed as fine droplets. J. infect. Dis. 72, 142–153 (1943).
Low, I. E., M. D. Eaton, and S. B. Uretsky: Formation of incomplete influenza virus in ascites tumor cells. Studies on complement-fixing S antigen. J. Immunol. 89, 414–421 (1962).
Lozhkina, A. N.: Study of washings from volunteers vaccinated with type A prime influenza TchE virus (Russian). Vop. Virus. 4, 269 (1954).
Lozhkina, A. N.: A study of A2 influenza virus strains isolated in Moscow in October–November 1957 (Russian). Vop. Virus. 5, 45–48 (1958).
Lozhkina, A. N.: Study of the biological characteristics of A2 influenza virus strains in Moscow during January–March 1959 (Russian). “Problemy grippa i ostrykh respiratornykh zabolevanii.” Tez. dokl. nauch. Sess. Inst. AMN SSSK, Moscow 17 (1959).
Lozhkina, A. N., V. M. Stakhanova, and V. B. Olli: Removal of non-specific inhibitors for the A 2 strains from human and animal sera by V. cholerae filtrate (Russian). “Problemy grippa i ostrykh respiratornykh zabolevanii.” Tez. dokl. nauch. Sess. Inst. AMN SSSK, Moscow 54 (1959).
Lozovaya, A. N.: The etiology of influenza outbreaks and experimental material on the adaptation of the influenza virus to new species of animals (Russian). Zh. Mikrobiol. (Mosk.) 7, 60 (1942).
Lozinskaya, T. M.: Biological, immunogenic and reactogenic properties of influenza virus thermovariants. Abstr. 9th int. Congr. Microbiol. Moscow 375 (1966).
Lukashevich, S. I.: Methods of adaptation of type B influenza virus (Russian). Anno. rabot Inst, virusol. AMN SSSK za 1949 (1950).
Luksch, F.: Pathologic anatomy of influenza. Keview based chiefly on German sources. Arch. Path. 5, 448–491 (1928).
Lush, D., and F. M. Burnet: Influenza virus in the developing egg. 6. Complement fixation with egg membrane antigens. Aust. J. exp. Biol. med. Sci. 15, 375–383 (1937).
Luzyanina, G. YA.: Material on the serological variability of the influenza virus (Russian). Bibl. kand. rapot. otdela. virusol. Inst. Eksper. med. AMN SSSK za 1947–1949, Leningrad 22 (1950).
Luzyanina, G. Ya.: Study of the antigenic and biological properties of influenza virus strains isolated in 1949 (Russian). Problemy grippa i OKVDP Tr. ol’yed. Sess. Inst. AMN SSSK, Moscow 10 (1952).
Luzyanina, G. Ya.: Change in the biological properties of the mouse strains influenza virus when passaged in white rats (Russian). Problemy grippa i OKVDP Tez. dokl. ob’yed. Sess. Inst. AMN SSSK, Moscow 13 (1952).
Luzyanina, G. Ya.: Material on the mechanism of serological variability of the influenza virus. (Russian). Trudy. AMN SSSR XXVIII, 20 (1953).
Luzyanina, T. J.: The protective role of the thermolabile virus-neutralising inhibitors in resistance to influenza. Abstr. 9th int. Congr. Microbiol. Moscow 374 (1966).
Luzyanina, T. I., A. L. Salminen, and A. A. Smorodintsev: Peculiarities of the interaction of the thermostable inhibitors from normal sera with type A2 influenza viruses of the 1957 epidemic. Acta virol. 4, 137–145 (1960).
Lyarskaya, T. A.: The blood picture and rhinocytoscopic findings in influenza patients during the outbreak in the winter of 1959 (Russian). “Problemy grippa i ostrykh respiratornykh zabolevanii.” Tez. dokl. nauch. Sess. Inst. AMN SSSR, Moscow 38-39 (1959).
Lycke, E.: A factor in bovine amniotic fluid inhibiting influenza virus haemagglutination. Arch. ges. Virusforsch. 5, 425–431 (1954).
Lytle, R. I., and R. L. Woolridge: Purification and stabilisation of influenza virus antigens for use in haemagglutination-inhibition or complement-fixation antibody titrations. J. Lab. clin. Med. 41, 290–295 (1953).
Maassab, H. F.: An infectious ribonucleic acid derived from influenza infected cells. Proc. nat. Acad. Sci. (Wash.) 45, 877–881 (1959).
Maassab, H. F.: The propagation of multiple viruses in chick kidney cultures. Proc. nat. Acad. Sci. (Wash.) 45, 1035–1039 (1959).
Maassab, H. F.: Further studies on the infectivity of ribonucleic acid prepared from influenza-infected cells. J. Immunol. 90, 265–270 (1963).
Maassab, H. F.: Adaptation of influenza virus to growth at 26° C. Abstr. 9th int. Congr. Microbiol. Moscow 375 (1966).
Maassab, H. F., and W. W. Ackermann: Nucleic acid metabolism of virus-infected HeLa cells. Ann. N.Y. Acad. Sci. 81, 29–37 (1959).
Macpherson, I. A., J. F. Wilkinson, and R. H. A. Swain: The effect of Klebsiella aerogenes and Klebsiella cloacae polysaccharides on haemagglutination by and multiplication of the influenza group of viruses. Brit. J. exp. Path. 34, 603–615 (1953).
Madoff, M. A., E. H. Eylar, and L. Weinstein: Serological studies of the neuraminidases of vibrio cholerae, diplococcus pneumoniae, and influenza virus. J. Immunol. 85, 603–613 (1960).
Magill, T. P.: The sorption of influenza virus by chicken erythrocytes. J. exp. Med. 94, 31–43 (1951).
Magill, T. P.: Propagation of influenza virus in “immune” environments. J. exp. Med. 102, 279–289 (1955).
Magill, T. P.: Indications of hereditary, spatial rearrangement of antigen complexes in the influenza virus. J. exp. Med. 114, 441–447 (1961).
Magill, T. P., and T. Francis: Studies with human influenza virus cultured in artificial medium. J. exp. Med. 63, 803–811 (1936).
Magill, T. P., and T. Francis: Antigenic differences in strains of epidemic influenza virus. 1. Cross-neutralisation tests in mice. Brit. J. exp. Path. 19, 273–284 (1938).
Magill, T. P., and A. C. Jotz: A pattern of influenza virus variation. J. Bact. 64, 619–628 (1952).
Magill, T. P., N. Plummer, W. G. Smillie, and J. Y. Sugg: An evaluation of vaccination against influenza. Amer. J. Hyg. 42, 94–105 (1945).
Magill, T. P., and J. Y. Sugg: Antigenically different strains of virus from a localised influenza outbreak. Proc. Soc. exp. Biol. (N.Y.) 53, 104–106 (1943).
Magill, T. P., and J. Y. Sugg: The significance of antigenic differences among strains of the A group of influenza viruses. J. exp. Med. 80, 1–7 (1944).
Magill, T. P., and J. Y. Sugg: Physical-chemical factors in agglutination of sheep erythrocytes by influenza virus. Proc. Soc. exp. Biol. (N.Y.) 66, 89–92 (1947).
Magill, T. P., and J. Y. Sugg: The reversibility of the O-D type of influenza virus variation. J. exp. Med. 87, 535–546 (1948).
Magnus, P. von: Studies on interference in experimental influenza. 1. Biological observations. Ark. Kemi Mineral. Geol. 24B, No. 7 (1946).
Magnus, P. von: Propagation of the PR8 strain of influenza virus in chick embryos. 1. The influence of various experimental conditions on virus multiplication.
2. The formation of “incomplete” virus following the inoculation of large doses of seed virus.
3. Properties of the incomplete virus produced in serial passages of undiluted virus.
4. Studies on the factors involved in the formation of incomplete virus upon serial passage of undiluted virus. Acta path. microbiol. scand. 28, 250-277, and 278-293 (1951), also 29, 157-181 (1951), and 30, 311-335 (1952).
Magnus, P. von: The in ovo production of incomplete virus by B/Lee and A/PR8 influenza viruses. Arch. ges. Virusforsch. 17, 414–423 (1965).
Magrassi, F.: Study of epidemic influenza in the autumn of 1948. Origin, clinical and etiological characteristics of the epidemic in Sardinia (Italian). Minerva Med. 1, 565–569 (1949).
Magrassi, F., P. Altucci, G. A. Buonanno, R. Buoniconti, A. Di Simone, G. Lorenzutti, V. Pecori, and U. Sapio: The use in man of Xenalamine, a synthetic drug (a keto-aldehyde derivative of biphenyl) with protective activity in various virus infections. 2. Its chemotherapeutic activity in human influenzal infection (Italian). G. Mal. infett. 12, 131–142 (1960).
Magrassi, F., P. Altucci, G. P. Jori, G. Lorenzutti, U. Sapio, and G. Tarro: Properties of an avirulent influenza A virus variant derived from drug-treated mice infected with PR8 virus. Arch. ges. Virusforsch. 18, 422–432 (1966).
Magrassi, F., G. Cavallini, and E. Massarini: Drugs active against influenza virus infection in mice. Arch. ges. Virusforsch. 10, 19–30 (1960).
Makower, H., and Z. Skurska: Experimental investigations on haemagglutination by influenza viruses. 3. The influence of temperature on the Hirst-Salk test (Polish). Med. Dosw. i Microbiol. Warsaw 3, 277–288 (1951).
Maksianovich, M. I., and T. S. Ilyina: Isolation and study of a new type of influenza virus (Russian). Dokl. Akad. Nauk. Usbekskoy SSR 2, 47 (1951).
Maksianovic H. M. I., N. A. Leonova, and T. Kuz’mina: The etiology of the 1946 influenza outbreak in Tashkent (Russian). Zh. MEI 12, 76 (1948).
Malomuzh, F. F.: Clinical aspects and histopathology of the mucous membrane of the upper respiratory tract in virus influenza and acute colds (Russian). Tr. Inst. ukha, gorla i nosa, Moscow 176 (1952).
Manire, G. P.: Studies on the toxicity for mice of incomplete influenza virus. Acta path. microbiol. scand. 40, 501–510 (1957).
Manire, G. P.: Studies on the modification of response of mice to toxic influenza virus preparations. Acta path. microbiol. scand. 40, 511–520 (1957).
Mannweiler, E.: The influenza virus in tissue cultures (German). Zbl. Bakt. I. Abt. Orig. 176, 375–376 (1959).
Mannweiler, E.: The behaviour of influenza viruses in chick embryo tissue cultures (German). 2. Virus multiplication.
3. The passage of prototype strains of influenza virus, the cytopathic effect of A/Singapore/1/57 and comparative ID50 titrations. Arch. ges. Virusforsch. 10, 647-660, and 661-671 (1961).
Marcus, P. I., J. M. Salb, and V. G. Schwartz: Nuclear surface N-acetylneuraminic acid terminating receptors for myxovirus attachment. Nature (Lond.) 208, 1122–1124 (1965).
Marcuse, K., and G. M. Becke: The behaviour of human red cells in the Hirst test with influenza virus (German). Arch. ges. Virusforsch. 4, 659–662 (1952).
Marennikova, S. S.: Variability of the influenza virus (Russian). Byull. éksp. Biol. Med. 8, 65 (1952).
Marennikova, S. S., N. I. Kalinina, N. A. Ponomareva, and Z. I. Pospelova: Production and experimental study of anti-influenza gamma ad beta globulins (Russian). “Problemy grippa i ostrykh respiratornykh zabolevanii.” Tez. dokl. nauch. Sess. Inst. AMN SSSR, Moscow 144 (1959).
Marinescu, G., D. Sareteanu, E. Nastac, N. Draganescu, and B. Muset: A study of the resistance to influenza infection in suckling mice born to immunised mice (Rumanian). Stud. Cercet. Inframicrobiol. 10, 315–326 (1959).
Marmion, B. P., C. C. Curtain, and J. Pye: The effect of human bronchial secretions (sputum) on the haemagglutinin and infectivity of influenza virus. Aust. J. exp. Biol. med. Sci. 31, 505–518 (1953).
Masurel, N., and J. Mulder: Studies on the content of haemagglutinin-inhibiting antibody for swine influenza virus A. Verk. Inst. prev. Geneesk. 52, 1 (1962).
Matheka, H. D., and O. Armbruster: Gradient elution of influenza viruses from anion exchange resin and a demonstration of a biological difference between the three components obtained from the PR 8 strain. Virology 6, 584–600 (1958).
Mathieu, P., L. Colobert, O. Creach, and O. Fontanger: Kinetics of the hydrolysis of 3 lactose-lactaminic acid by influenza B (Lee strain). (French). Ann. Inst. Pasteur 101, 817–833 (1961).
Matsumoto, T., and I. Nagata: Studies on the variation of influenza virus. 1. The haemagglutination-inhibiting action of normal mouse lung suspensions. Nagoya J. med. Sci. 14, 62–68 (1951).
Mawson, J., and C. Swan: Intranasal vaccination of humans with living attenuated influenza virus strains. Med. J. Aust. 1, 394–396 (1943).
Maximovich, N. A., and V. P. Mitchenko: Study of cellular and viral nucleic acids in experimental influenza infection using fluorescence microscopy. Acta virol. 4, 227–232 (1960).
Maximovich, N. A., and O. G. Petrovskaya: Further studies of viral inclusions in experimental influenza using fluorescence microscopy. Acta virol. 6, 127–131 (1962).
Matron, L. W., B. Robert, R. J. Winzler, and M. E. Rafelson: Studies on the neuraminidase of influenza virus. 1. Separation and some properties of the enzyme from Asian and PR 8 strains. Arch. Biochem. 92, 475–483 (1961).
Mazzacca, G., and A. R. Blanchi: Growth characteristics of A PR8 influenza virus in monkey kidney cell cultures (Italian). Rev. Ist. Sieroter. ital. 36, 312–321 (1961).
McCarroll, J. E., and E. D. Kilbourne: Immunisation with Asian-strain influenza vaccine. Equivalence of the subcutaneous and intradermal routes. New Engl. J. Med. 259, 618–621 (1958).
McClelland, L., and R. Hare: The adsorption of influenza virus by red cells and a new in vitro method of measuring antibodies for influenza virus. Canad. J. publ. Hlth 32, 530–538 (1941).
McClelland, L., and C. E. Van Rooten: Studies on the effect of some aromatic amidines and other chemical compounds on the growth of influenza virus in the embryonated egg. Canad. J. Res. E 27, 177–185 (1949).
McCrea, J. F.: Non-specific serum inhibition of influenza haemagglutination. Aust. J. exp. Biol. med. Sci. 24, 283–291 (1946).
McCrea, J. F.: Mucins and mucoids in relation to influenza virus infection. 2. Isolation and characterisation of the serum mucoid inhibitor of heated influenza virus. Aust. J. exp. Biol. med. Sci. 26, 355–370 (1948).
McCrea, J. F.: Studies on influenza virus receptor substance and receptor substance analogues. 1. Preparation and properties of a homogeneous mucoid from the salivary gland of sheep.
2. Isolation and purification of a mucoprotein receptor substance from human erythrocyte stroma treated with pentane. Biochem. J. 55, 132-140 (1953), and Yale J. Biol. Med. 26, 191-210 (1953).
McCrea, J. F.: Turbidity-reducing activity of influenza virus and receptor-destroying enzyme on sheep submandibular mucoid. Nature (Lond.) 172, 912 (1953).
McKee, A. P.: Non-toxic influenza virus. J. Immunol. 66, 151–167 (1951).
McKee, A. P., and W. M. Hale: Reactivation of over-neutralised mixtures of influenza virus and antibody. J. Immunol. 54, 233–243 (1946).
McKee, A. P., and W. M. Hale: A search for human carriers of influenza virus. J. Immunol. 61, 369–372 (1949).
McLean, I. W., D. Beard, A. E. Taylor, D. G. Sharp, J. W. Beard, A. E. Feller, and J. H. Dingle: Influence of temperature of incubation on the increase of influenza B virus (Lee strain) in the chorioallantoic fluid of chick embryos. J. Immunol. 48, 305–316 (1944).
McQueen, J. L., and F. M. Davenport: Experimental influenza in sheep. Proc. Soc. exp. Biol. (N.Y.) 112, 1004–1006 (1963).
McQueen, J. L., F. M. Davenport, R. J. Kerran, and H. A. Dawson: Studies of equine influenza in Michigan. 2. Epizootiology. Amer. J. Epidem. 83, 280–286 (1963).
McQueen, J. L., F. M. Davenport, and E. Minuse: Studies of equine influenza in Michigan. 1. Etiology. Amer. J. Epidem. 83, 271–279 (1963).
Medical Eesearch Council Eeport: Antibody response and clinical reactions with saline and oil adjuvant influenza vaccines. Brit. med. J. 1229-1232 (1955).
Medical Eesearch Council: Clinical trials of influenza vaccine. Third progress report to the Medical Eesearch Council by its Committee on clinical trials of influenza vaccine. Brit. med. J. ii, 1–7 (1957).
Medill-Brown, M., and B. A. Briody: Mutation and selection pressure during adaptation of influenza virus to mice. Virology 1, 301–312 (1955).
Meenan, P. N., M. E. Boyd, and E. Mulvaney: Human influenza virus in Domesticated animals. Brit. med. J. ii, 86–89 (1962).
Meiklejohn, G.: Observations on live influenza vaccine. J. Amer. med. Ass. 172, 1354–1356 (1960).
Meiklejohn, G., and A. J. Morris: Influenza vaccination. Ann. intern. Med. 49, 529–535 (1958).
Melander, B.: N,N-anhydrobis-(B hydroxyethyl) biguanide hydrochloride (ABOB) in prophylaxis and suppression of experimental influenza. Antibiot. and Chemother. N.Y. 10, 34–45 (1960).
Mellanby, H., C. H. Andrewes, J. A. Dudgeon, and D. G. Mackay: Vaccination against influenza A. Lancet 978-982 (1948).
Melnikova, N. A.: Isolation of influenza virus from nasopharyngeal washings of patients by means of passages through X-irradiated embryos (Russian). Vop. Virus. 5, 70–71 (1958).
Melnotte, P., C. Jolibois, G. Cateigne, M. Thibon, J. Cheve, and S. Adams: Anti-influenza vaccination (French). Sén. Hôp. Paris 35, 3353–3358 (1959).
Merigan, T. C., D. F. Gregory, and J. K. Petralli: Physical properties of human interferon prepared in vitro and in vivo. Virology 29, 515–522 (1966).
Merkulova, Z. I.: Periods of preservation of the influenza viruses on surfaces and in air (Russian). Zh. Mikrobiol. (Mosk.) 10, 68 (1953).
Merkulova, S. T., and I. A. Kazanskiy: Viruscopic method of diagnosing influenza in people (Russian). Annotatsii rabot Inst. virusol. AMN SSSE za 1949, Moscow 18 (1950).
Merkulova, S. T., I. A. Kazanskiy, and V. Khomazyuk: Method of diagnosing influenza in people on the basis of viroscopy (Russian). Vop. Virus. 4, 183 (1954).
Metcalf, T. G.: The serological reactivity of influenza virus precipitated and concentrated by zinc solutions. J. infect. Dis. 101, 40–47 (1957).
Meyer, H. M., M. E. Hilleman, M. L. Miesse, I. P. Crawford, and A. J. Bankiiead: New antigenic variant in Far East influenza epidemic. Proc. Soc. exp. Biol. (N.Y.) 95, 609–616 (1957).
Miller, F. A., W. A. Rightsel, B. J. Sloan, J. Ehrlich, J. C. French, and Q. E. Bartz: Antiviral activity of Tenuazonic acid. Nature (Lond.) 200, 1338–1339 (1963).
Miller, G. L.: A study of conditions for the optimum production of PES influenza virus in chick embryos. J. exp. Med. 79, 173–183 (1944).
Miller, G. L.: Influence of pH and of certain other conditions on the stability of the infectivity and red cell agglutinating activities of influenza virus. J. exp. Med. 80, 507–520 (1944).
Miller, G. L.: Improved measurement of influenza virus haemagglutinin titre. J. Immunol. 95, 336–344 (1965).
Miller, G. L., M. H. Lauffer, and W. M. Stanley: Electrophoretic studies on PR8 influenza virus. J. exp. Med. 80, 549–559 (1944).
Miller, G. L., and W. M. Stanley: Quantitative aspects of the red blood cell agglutination test for influenza virus. J. exp. Med. 79, 185–195 (1944).
Miller, H. K.: The nucleic acid content of influenza virus. Virology 2, 312–320, (1956).
Miller, H. K., and R. W. Schlesinger: Differentiation and purification of influenza viruses by adsorption on aluminium phosphate. J. Immunol. 75, 155–160 (1955).
Mills, R. F. N.: The effect of infecting the cells of the de-embryonated egg with influenza virus on their uptake of glucose and aminoacids. J. gen. Microbiol. 19, 473–481 (1958).
Mims, C. A.: An analysis of the toxicity for mice of influenza virus. 1. Intracerebral toxicity. 2. Intravenous toxicity. Brit. J. exp. Path. 41, 586–598 (1960).
Mims, C. A.: Aspects of the pathogenesis of vims diseases. Bact. Rev. 28, 30–71 (1964).
Minuse, E., and F. M. Davenport: Simultaneous recovery of type A1 and type C influenza viruses from a patient. J. Lab. clin. Med. 38, 747–750 (1951).
Minuse, E., J. L. McQueen, F. M. Davenport, and T. Francis: Studies of antibodies to 1956 and 1963 equine influenza viruses in horses and man. J. Immunol. 94, 563–566 (1965).
Minuse, E., J. J. Quilligan, and T. Francis: Type C influenza virus. 1. Studies of the virus and its distribution.
2. Intranasal inoculation of human individuals. J. Lab. clin. Med. 43, 31-42, and 43-47 (1954).
Minuse, E., P. W. Willis, F. M. Davenport, and T. Francis: An attempt to demonstrate viraemia in cases of Asian influenza. J. Lab. clin. Med. 59, 1016–1019 (1962).
Myamoto, H., K. Akama, and E. Morita: The influence of nucleic acid on haemagglutination by influenza virus and its mechanism. Gunma J. med. Sci. 2, 69–75 (1953).
Mizutani, H., T. Beals, A. V. Hennessy, and F. M. Davenport: A simple procedure for purification of viral haemagglutinin. Virology 17. 210–211 (1962).
Mizutani, H., and H. Mizutani: Action of phospholipase C on influenza virus. Nature (Lond.) 204, 781–782 (1964).
Mizutani, H., and H. Mizutani: Small haemagglutinin of influenza virus and its responses to antibodies and inhibitor. Virology 26, 761–763 (1965).
Mogabgab, W. J.: Influenza C virus in monkey kidney tissue cultures. J. Bact. 83, 209–210 (1962).
Mogabgab, W. J., I. J. Green, and O. C Dierkhising: Primary isolation and propagation of influenza viruses in cultures of human embryonic renal tissue. Science 120, 320–321 (1954).
Mogabgab, W. J., I. J. Green, O. C Dierkhising, and I. A. Phillips: Isolation and cytopathogenic effect of influenza B viruses in monkey kidney cultures. Proc. Soc. exp. Biol. (N.Y.) 89, 654–659 (1955).
Mogabgab, W. J., B. Holmes, and W. Pelon: Influenza A and B viruses in monkey kidney cultures. 1. Properties of the viruses. J. infect. Dis. 108, 315–323 (1961).
Mogabgab, W. J., and F. L. Horsfall: Effect of sodium monofluoroacetate on the multiplication of influenza virus, mumps virus, and pneumonia virus of mice (PVM). J. exp. Med. 96, 531–547 (1952).
Mogabgab, W. J., W. Pelon, G. E. Burch, and B. Holmes: Characteristics of the Asian strain of influenza A. Proc. Soc. exp. Biol. (N.Y.) 99, 116–120 (1958).
Mogabgab, W. J., G. I. Simpson, and I. J. Green: Growth characteristics and cytopathogenic effects of influenza A and B in cultures of human embryo tissues. J. Immunol. 76, 314–327 (1956).
Monto, A. S., and F. Olazabal: Asian influenza in the Panama canal zone: Isolation of a virus variant and protective effect of a vaccine containing A2/Japan/305/57. Amer. J. Epidem. 83, 101–112 (1966).
Moore, D. H., M. C. Davies, S. Levine, and M. E. Englert: Correlation of structure with infectivity of influenza virus. Virology 17, 470–479 (1962).
Morgan, C., K. C. Hsu, E. A. Rifkind, A. W. Knox, and H. M. Eose: The application of ferritin-conjugated antibody to electron microscopic studies of influenza virus in infected cells. 1. The cellular surface.
2. The interior of the cell. J. exp. Med. 114, 825-832, and 833-836 (1961).
Morgan, C., K. C Hsu, and H. M. Rose: Structure and development of viruses as observed in the electron microscope. 7. Incomplete influenza virus. J. exp. Med. 116, 553–564 (1962).
Morgan, C., R. A. Rifkind, and R. M. Rose: The use of ferritin-conjugated antibodies in electron microscope studies of influenza and vaccinia viruses. Cold Spr. Harb. Symp. quant. Biol. “Basic mechanisms in animal virus biology” 28, 57–66 (1962).
Morgan, C., and H. M. Rose: Electron-microscopic observations on adenoviruses and viruses of the influenza group. Symp. Soc. gen. Microbiol. “Virus growth and variation” 256-272 (1959).
Morgan, C., H. M. Rose, and D. H. Moore: Structure and development of viruses observed in the electron microscope. 3. Influenza virus. J. exp. Med. 104, 171–182 (1956).
Morgan, C., H. M. Rose, and D. H. Moore: An evaluation of host cell changes accompanying viral multiplication as observed in the electron microscope. Ann. N.Y. Acad. Sci. 68, 302–323 (1957).
Morgan, H. E., M. W. Barnes, and M. Finland: Antigenic differences among influenza A viruses, including serologic response of patients. J. Lab. clin. Med. 33, 1212–1219 (1948).
Morgan, H. R., and M. Finland: Simplified technique for titrating influenza virus neutralising antibody in the chick embryo. Proc. Soc. exp. Biol. (N.Y.) 68, 618–619 (1948).
Mori, R., J. H. Schieble, and W. W. Ackermann: Eeaction of polyoma and influenza viruses with receptors of erythrocytes and host cells. Proc. Soc. exp. Biol. (N.Y.) 109, 685–690 (1962).
Morosov, M. A.: Instructions on the use of the viroscopic method after M. A. Morosov (Russian). Ofitsial’noye izd. Min. zdravoskht. SSSE (1951).
Morosov, M. A.: A new method of viroscopy (Russian). Tez. dokl. 6-y Sess. Inst. virusol. AMN SSSE, Moscow 19 (1953).
Morozenko, M. A.: Serological characteristics of influenza in infancy. (Russian). Gripp. Tr. AMN SSSE, XXVIII, 164 and 209 (1953).
Morozenko, M. A.: Experimental data on the mechanism of occurrence of passive anti-influenzal immunity (Russian). Gripp, i OKVDP Tr. ob’yed. Sess. Inst. AMN SSSE, Moscow 139 (1953).
Morozenko, M. A., and L. S. Vlastelitsa: Virological and serological characteristics of type A influenza in adults and children (Russian). “Virusnyye Infektsi.” Tr. Leningradskogo inst. epidem. i bakteriol. imeni. Pastera XIII, 64 (1950).
Morozkin, N. I., R. Ya. Khersonskaya, and M. I. Slobodyanyuk: Modern methods of treating influenza patients (Russian). Vrach. delo. 3, 229–323 (1954).
Morrison, A. P., D. E. Shaw, A. S. Kenney, and J. Stokes: Complement fixation studies on the sera of individuals vaccinated with active virus of human influenza. Amer. J. med. Sci. 197, 253–260 (1939).
Mosley, V. M., and E. W. G. Wyckoff: Electron micrography of the virus of influenza. Nature (Lond.) 157, 263 (1946).
Mote, J. R.: Human and swine influenza. “Virus and Rickettsial diseases” Harvard Univ. Press (1943).
Mote, J. E., and L. D. Fothergill: The effect of human strains of haemophilus influenzae on influenza virus infection of swine. J. Bact. 40, 505–516 (1940).
Mulder, J.: Broad aspects of the problem of human virulence in influenza viruses. Ciba Found. Study group No. 4 “Virus virulence and Pathogenicity” 43-57 (1960).
Mulder, J., and L. M. Brans: Studies on the antigenic behaviour of egg and egg-mouse-egg lines of strains of influenza virus with the aid of the haemagglutination inhibition test. Antonie v. Leeuwenhoek 18, 139–151 (1952).
Mulder, J., L. M. Brans, and J. F. Ph. Hers: Studies on the increase of antibodies in nasal secretions of human beings after intracutaneous vaccination with influenza virus, with the aid of the haemagglutination inhibition technique. Antonie v. Leeuwenhoek 18, 131–138 (1952).
Mulder, J., L. M. Brans, and I. DeNooyer: The antigenic composition of the influenza virus B strains isolated during the epidemic of influenza B in the winter 1951–52 in the Netherlands. Antonie v. Leeuwenhoek 19, 189–196 (1953).
Mulder, J., L. M. Brans, and N. Masurel: Studies on the antigenic composition of the influenza virus A strains isolated in the Netherlands in the period 1947–1953. Onderz. Meded. u. Ned. Inst. v. praev. Geneesk. No. 15 H. E. Stenfert Kroese Leiden (1956).
Mulder, J., and W. E. O. Goslings: Simplified micro-Hirst test. Acta brev. neerl. Physiol. 16, 27–29 (1948).
Mulder, J., and N. Masurel: Pre-epidemic antibody against the 1957 strain of Asiatic influenza in the serum of older persons living in the Netherlands. Lancet 810 (1958).
Mulder, J., I. DeNooiyer, and L. M. Brans: The influence of treating ferret influenza antisera with enzymes of crude filtrate of V Cholerae on the titre of the antibodies. Antonie v. Leeuwenhoek 18, 128–130 (1952).
Mulder, J., and C. H. Stuart-Harris: Influenzal pneumonia: Causation and treatment. Bull. Wld Hlth Org. 8, 743–753 (1953).
Mulder, J., J. Van der Veen, J. J. Brans, and S. W. Enserink: Neutralisation of the non-specific inhibitor in influenza immune titrations after Hirst with an enzyme of vibrio cholerae. Acta brev.neerl. Physiol. 16, 57–61 (1948).
Mulder, J., J. Van der Veen, J. J. Brans, and S. W. Enserink: Eapid diagnosis of the sub-group of influenza A virus strains isolated during the epidemic of 1949 in the Netherlands. Antonie v. Leeuwenhoek 15, 125–128 (1949).
Mulder, J., J. Van der Veen, L. M. Brans, and S. W. Enserink: Antibody response against strains of influenza A virus in ferrets with basic immunity. Antonie v. Leeuwenhoek 15, 162–166 (1949).
Mulder, J., J. Van der Veen, S. W. Enserink, and J. J. Brans: Isolation of a strain of influenza A virus from the trachea in a case of influenzal pneumonia in the winter of 1947. Antonie v. Leeuwenhoek 14, 184–192 (1948).
Mulder, J., and G. J. Verdonk: Studies on the pathogenesis of a case of influenza A pneumonia of 3 days duration. J. Path. Bact. 61, 55–61 (1949).
Muller, R. H., and H. M. Kose: Concentration of influenza virus (PK8 strain) by a cation exchange resin. Proc. Soc. exp. Biol. (N.Y.) 80, 27–29 (1952).
Munk, K., and W. Schafer: Properties of animal viruses studied with fowl plague as a model. 2. Serological studies on fowl plague virus and on its realtion with a normal cell protein (German). Z. Naturforsch. 6b, 372–379 (1951).
Murphy, A. M.: The use of purified RDE in the destruction of non-specific inhibitor in serum. Aust. J. exp. Biol. med. Sci. 30, 363–368 (1952).
Murphy, J. S., D. T. Karzon, and F. B. Bang: Studies of influenza A (PK8) infected tissue cultures by electron microscopy. Proc. Soc. exp. Biol. (N.Y.) 73, 596–599 (1950).
Nagler, F. P., M. M. Burr, and A. L. Gillen: The influenza virus epidemic in Canada during January–February 1951. Canad. J. publ. Hlth 42, 367–374 (1951).
Nagler, F. P., C. E. Van Rooyen, and J. H. Sturdy: An influenza virus epidemic at Victoria island N.W.T. Canada. Canad. J. publ. Hlth 40, 457–465 (1949).
Nakagi, D., T. Haga, K. Iwasaki, Y. Nakasi, and T. Uchiyama: Studies on the influenza virus. 4. Studies on the influenza virus vaccine. Immunisation experiment of man with vaccine inactivated with sodium ethylmercurithiosalycylate. Kitasato Arch. exp. Med. 27, 1–7 (1954).
Nakagi, D., K. Iwasaki, S. Homini, Y. Nakasa, and T. Uchiyama: Studies on influenza virus. 3. Studies on the influenza virus vaccine. Immunisation experiment on mice with the influenza virus vaccine inactivated with sodium ethylmercurithiosalycylate. Kitasato Arch. exp. Med. 26, 209–215 (1953).
Nartsissov, N. V.: Complement fixation reaction in influenza (Russian). Zh. Mikrobiol. (Mosk.) 12, 47 (1948).
Nayak, D. P., W. G. Kelley, G. A. Young, and N. E. Underdahl: Progressive descending infection in mice determined by immunofluorescence. Proc. Soc. exp. Biol. (N.Y.) 116, 200–206 (1964).
Nayak, D. P., and A. F. Rasmussen: Influence of mitomycin C on the replication of influenza viruses. Virology 30, 673–683 (1966).
Nechayev, A. V.: Evaluation of the efficiency of specific serum therapy with the inhalation of influenza antiserum (Russian). Sovetsk. Med. 7, 25–29 (1940).
Nechayev, A. V., O. S. Korshunova, and M. I. Baru: Evaluation of the therapeutic effect of inhalations of anti-influenzal immune serum in epidemic influenza (Russian). Arkh. biol. nauk. 52, 155–161 (1938).
Negroni, Gr., and D. A. J. Tyrrell: Morphological observations on tissue cultures of epithelial cells infected with influenza A viruses. J. Path. Bact. 77, 497–504 (1959).
Nekhludova, L. I.: Characteristic features of cases of influenza (Russian). Zh. Mikrobiol. (Mosk.) 6, 39 (1951).
Nekhludova, L. I., G. F. Kornyeva, N. V. Pikel, and V. A. Kuznitsova: Peculiarities of influenza and influenza-like diseases in 1959 in Krasnoder (Russian). “Problemy grippa i ostrykh respiratornykh zabolevani.” Tez. dokl. nauch. Sess. Inst. AMN SSSR, Moscow 101-103 (1959).
Nelson, M., and F. A. Lewis: A relationship between swine and Asian strains of influenza A virus. Aust. J. exp. Biol. med. Sci. 36, 505–510 (1958).
Nelson, A. A., and J. W. Oliphant: Histopathological changes in mice inoculated with influenza virus. Publ. Hlth Rep. (Wash.) 54, 2044–2054 (1939).
Neumayer, E. M., R. F. Haff, and C. E. Hoffmann: Antiviral activity of amantadine hydrochloride in tissue culture and in ovo. Proc. Soc. exp. Biol. (N.Y.) 119, 393–396 (1965).
Neumuller, C.: Chemical studies on the (influenza) haemagglutination inhibitor of normal allantoic fluid. Arch. ges. Virusforsch. 5, 242–249 (1953).
Nicholas, R. V., and W. Henle: Vaccination as primary contact with influenza A and B viruses. Pediatrics 208-213 (1949).
Nicolle, C., and C. Lebailly: Experimental researches in influenza (French). Ann. Inst. Pasteur 33, 395 (1919).
Nicoulesco, I., L. Cretesco, E. Zilisteanu, and I. Nafta: Separation of two types of influenza virus particles from the same antigenically homogeneous viral population by means of ultraviolet rays (French). Abstr. 9th int. Congr. Microbiol. Moscow 390 (1966).
Nigg, C., J. H. Crowley, and D. E. Wilson: The use of chick embryo tissues and fluid as antigen in the complement fixation reaction in influenza. J. Immunol. 42, 51–70 (1941).
Nigg, C., C. M. Eklund, D. E. Wilson, and J. H. Crowley: Study of an epidemic of influenza B. Amer. J. Hyg. 35, 265–284 (1942).
Nigg, C., D. E. Wilson, and J. H. Crowley: Studies on the cultivation of influenza virus. Amer. J. Hyg. 24, 138–147 (1941).
Nihoul, E.: The action of filtrates of cultures of V. cholerae on influenza virus receptors (French). C. R. Soc. Biol. (Paris) 145, 1887–1891 (1951).
Nihoul, E.: Mucopolysaccharide of egg white and inhibition of influenza virus haemagglutination (French). C. R. Soc. Biol. (Paris) 146, 1275–1277 (1952).
Nihoul, E.: Enzymatic action of influenza virus on ovomucin (French). C. R. Soc. Biol. (Paris) 146, 1277–1280 (1952).
Noll, H., T. Aoyagi, and J. Orlando: Intracellular synthesis of neuraminidase following infection of chorioallantoic membranes with influenza virus. Virology 14, 141–143 (1961).
Noll, H., T. Aoyagi, and J. Orlando: The structural relationship of sialidase to the influenza virus surface. Virology 18, 154–157 (1962).
Noll, H., and J. S. Younger: Virus-lipid interactions. 2. The mechanism of adsorption of lipophilic viruses to water-insoluble polar lipids. Virology S, 319–343 (1959).
Novin, J. S. F., J. A. Armstrong, B. M. Balfour, and D. A. J. Tyrrell: Cellular changes accompanying the growth of influenza viruses in bovine cell cultures. J. Path. Bact. 84, 1–18 (1962).
Obrosova-Serova, N. P.: Mutants of influenza A and A2 viruses induced by nitrous acid and preparation W4. Abstr. 9th int. Congr. Microbiol. Moscow 384 (1966).
O’Connell, D. J., A. L. Bakron, F. Melgrom, and E. Witebsky: Haemadsorption to sections of virus-infected tissues. Proc. Soc. exp. Biol. (N.Y.) 117, 403–407 (1964).
O’connell, C J., and F. Milgrom: Demonstration of tissue receptors for viruses. Proc. Soc. exp. Biol. (N.Y.) 122, 1255–1258 (1966).
O’connor, S., and R. R. Wagner: Age and susceptibility to neurotropic influenza virus. Proc. Soc. exp. Biol. (N.Y.) 86, 332–334 (1954).
Ogasawara, K., M. Aida, and I. Nagata: Lowered resistance to influenza infection of mice following immunisation with mercurial inactivated influenza virus. J. Immunol. 86, 599–605 (1961).
Okada, Y., and T. Suzuki: Interaction between influenza virus and Ehrlich’s tumor cells. 2. Fate of the virus particles adsorbed onto Ehrlich’s tumor cells. Med. J. Osaka Univ. 6, 987–994 (1956).
Oleinik, I. I., and V. N. Iagodinsky: Specific prophylaxis of influenza (Russian). “Problemy grippa i ostrykh respiratornykh zabolevanii.” Tez. dokl. nauch. Sess. Inst. AMN SSSE, Moscow 131-132 (1959).
Olitsky, P. K., and F. L. Gates: Experimental studies of the nasopharyngeal secretions from influenza patients. J. exp. Med. 33, 713 (1921).
Onodera, Y., Y. Hinuma, and N. Ishida: Ineffectiveness of antibody on the intracellular development of influenza virus WS strain in Ehrlich ascites cells in mice. J. Immunol. 92, 648–656 (1964).
Opie, E. L.: Pathologic anatomy of influenza, based chiefly on American and British sources. Arch. Path. 5, 285–303 (1928).
Orlov, G. A., and M. M. Kanstler: Modern laboratory methods of diagnosing virus influenza (Russian). Sovetsk. Med. 11, 20 (1950).
Orlova, N. N.: Experimental evaluation of the efficiency of combined influenza vaccines (Russian). Vop. Virus. 1, 166 (1948).
Orlova, N. N.: Effect of stimulators on immunogenic properties of influenza formol vaccine (Russian). Tez. dokl. 3-y Sess. Inst. Virusol. AMN SSSE, Moscow 12 (1950).
Orlova, N. N.: Massive scale serum prophylaxis of influenza during the 1959 epidemic (Russian). “Problemy grippa i ostrykh respiratornykh zabolevani.” Tez. dokl. nauch. Sess. Inst. AMN SSSE, Moscow 134-136 (1959).
Orlova, N. N., and L. I. Kalinina: Perfection of methods of producing influenza horse antiserum (Russian). Vop. Virus. 4, 356 (1954).
Orlova, N. N., and L. D. Knyazeva: Characteristics of an influenza outbreak in the summer of 1957 in Kemerovo. (Russian). Vop. Virus. 5, 19–21 (1958).
Orlova, T. G., and L. S. Diskina: Investigation on infectious ENA from A 2 influenza virus (Russian). Proc. 3rd Conf. Inst. Viral Preparations, Moscow 40 (1962).
Orlova, T. G., J. N. Tatarinova, L. M. Mentkewicz, and V. M. Stakhanova: Studies on the infectious process in the chick embryo cells infected with influenza virus. Abstr. 9th int. Congr. Microbiol., Moscow 495 (1966).
Osato, T., and N. Ishida: The labelling of influenza virus with radiophosphorus in Maitland-type tissue culture. Growth characteristics of myxoviruses in tissue culture. Tohoku J. exp. Med. 72, 322–327 (1960).
Ostrovskaya, S. M., O. M. Chalkina, and S. B. Olekiinovich: The resistance of the influenza virus to various physical and chemical agents (Russian). Arkh. biol. nauk. 52, 19 (1938).
Overman, J. E., and W. F. Friedewald: Cold haemagglutination reaction with influenza virus. J. Immunol. 62, 415–424 (1949).
Paccaud, M. F., M. Couard, F. Burki, I.I. Gerber, and J. Lohrer: Outbreak of influenza A/Equi/2 in Switzerland. Nature (bond.) 211, 101–102 (1964).
Pachaly, L., and E. Scheuermann: Influenza and congenital malformations (German). Beitr. path. Anat. 121, 309–319 (1959).
Packaleu, T.: Quantitative studies with influenza A virus in tissue culture. Acta path. microbiol. scand. 23, 512–520 (1946).
Padgett, B. L., and D. L. Walker: Enzymatic variants of influenza virus. 1. Isolation and characterisation of slowly reacting enzymatic variants of influenza B virus.
2. Effect of environmental factors on enzymic characteristics of a variant of influenza B virus. J. exp. Med. 106, 53-67 (1957), and 108, 651-664 (1958).
Panthier, R., G. Cateigne, and C. Hannoun: Experimental evidence of inapparent influenzal infections in mice (French). C. E. Soc. Biol. (Paris) 142, 1470–1471 (1948).
Panthier, R., G. Cateigne, and C. Hannoun: A new technique for the study of influenza virus. First practical application (French). Ann Inst. Pasteur 75, 338–350 (1948).
Panthier, R., G. Cateigne, and C. Hannoun: Adaptation to the egg and mouse of a strain of virus recently isolated from a case of influenza (French). Bull. Inst. nat. Hyg. (Paris) 4, 109–112 (1949).
Panthier, E., G. Cateigne, and C. Hannoun: Isolation of a strain of influenza virus. Eeaction of young monkeys to the intranasal inoculation of this virus. Bull. Inst. nat. Hyg. (Paris) 4, 112–113 (1949).
Panthier, R., C. Hannoun, and G. Cateigne: The interference phenomenon and the multiplication of influenza virus in the allantoic cavity of the chick embryo (French). C. E. Soc. Biol. (Paris) 142, 1215–1218 (1948).
Parizh, B. M.: Freeze-drying of influenza virus. Abstr. 9th int. Congr. Microbiol., Moscow 388 (1966).
Parker, E. R., W. B. Dunham, and W. J. MacNeal: Resistance of the Melbourne strain of influenza virus to desiccation. J. Lab. clin. Med. 29, 37–42 (1944).
Parker, E. R., and W. J. MacNeal: Persistence of influenza virus on the human hand. J. Lab. clin. Med. 29, 121–126 (1944).
Parnes, V. A.: The contagiousness of experimental iufluenza in mice (Russian). Zh. Mikrobiol. (Mosk.) 9, 33 (1950).
Parodi, A., and J. Fontaine: The advantages of Smorodintsev’s influenza vaccine (French). Rev. Lyon Med. 8, 57–68 (1959).
Paucker, K.: Apparent antigenic change in a laboratory line of influenza A virus during continued propagation in chick embryos. J. Immunol. 85, 148–162 (1960).
Paucker, K., A. Birch-Andersen, and P. von Magnus: Studies on the structure of influenza virus. 1. Components of infectious and incomplete particles. Virology 8, 1–20 (1959).
Paucker, K., and W. Henle: Studies on host-virus interaction in the chick embryo influenza virus system. 11. The effect of partial inactivation of standard seed virus at 37° C upon the progeny.
12. Further analysis of yields derived from heat-inactivated standard seeds. J. exp. Med. 101, 479-492, and 493-506 (1955).
Paucker, K., and W. Henle: Interference between inactivated and active influenza viruses in the chick embryo. 2. Interference by incomplete forms of influenza virus. Virology 6, 198–214 (1958).
Paucker, K., F. S. Lief, and W. Henle: Studies on the soluble antigen of influenza virus. 4. Fractionation of elementary bodies labelled with radioactive phosphorus. Virology 2, 798–810 (1956).
Pavlovskii G. T.: Eesults of the rhinocytoscopic diagnosis of influenza in the 1959 epidemic (Russian). “Problemy grippa i ostrykh respiratornykh zabolevani.” Tez. dokl. nauch. Sess. Inst. AMN SSSE, Moscow 37-38 (1959).
Payne, A. M. M.: Some aspects of the epidemiology of the 1957 influenza pandemic. Proc. roy. Soc. Med. 1009-1015 (1958).
Payne, A. M. M.: Global epidemiology today. Symp. “Perspectives in epidemiology” Yale J. Biol. 32, 4–15 (1959).
Payzin, S., and S. Okkan: The 1949 influenza epidemic in Ankara, the nature of the epidemic and the virus. Turk Ijiyen ve Tecr. Biyoloji Derg. 9, 1–6 (1949).
Pearson, H. E., and J. F. Enders: Cultivation of influenza A virus in roller tubes. Proc. Soc. exp. Biol. (N.Y.) 48, 140–143 (1941).
Pecenka, J., K. Skvrnova, I. Hana, A. Izbicky, B. Tumova, O. Markvart, L. Louda, Z. Hartl, J. Helcl, and V. Kleinbauer: Contribution to the evaluation of vaccines against influenza (Czech). Čs. Epidem. 7, 365–373 (1958).
Pelon, W., W. J. Mogabgab, L. Dietlein, G. E. Burch, and B. Holmes: Antibody response to Asian influenza vaccination in man. Proc. Soc. exp. Biol. (N.Y.) 99, 120–124 (1958).
Penttinen, K.: The effect of low temperatures on vaccines of influenza virus and on purified influenza virus. J. Immunol. 64, 165–171 (1950).
Penttinen, K.: Effect of polyphloroglucinol phosphate on influenza virus and on chicken red cells. Ann. Med. exp. Fenn. 34, 88–94 (1956).
Penttinen, K., V. Tommila, and K. Cantell: Variation in the results of haemagglutination and haemagglutination-inhibition tests with influenza and mumps viruses caused by red cells of different fowls. Ann. Med. exp. Fenn. 33, 159–168 (1955).
Pereira, M. S.: Typing of Q phase influenza A virus by serum neutralisation tests in monkey kidney cultures. Lancet 668-669 (1958).
Pereira, H. G., M. S. Pereira, and V. G. Law: Antigenic variants of influenza A2 virus. Bull. Wld Hlth Org. 31, 129–132 (1964).
Pereira, H. G., and B. Tumova: Specific serum neutralisation of the reactivating activity of influenza A2 viruses. J. gen. Virol. 1, 131–133 (1967).
Pereira, H. G., B. Tumova, and V. G. Law: Avian influenza A viruses. Bull. Wld Hlth Org. 32, 855–860 (1965).
Perez, J. E., and G. Arbona: An outbreak of influenza due to type A-prime virus at Coamo Puerto Rico. Puerto Eico J. publ. Hlth 25, 377–381 (1950).
Perez, J. E., J. Baralt-Perez, and M. Klein: The reversal in vivo by BAL of HgCl2-inactivated influenza A virus in the chick embryo. J. Immunol. 62, 405–413 (1949).
Perlina, F. I.: Clinical syndromes of neurologic involvement during influenza (Russian). Sovetsk. Med. 24, 82–89 (1960).
Perry, B., and F. M. Burnet: Recombination studies with two influenza virus B strains. Aust. J. exp. Biol. med. Sci. 31, 519–528 (1953).
Perry, B. T., M. Van den Ende, and F. M. Burnet: Recombination with two influenza B strains in the de-embryonated egg. Aust. J. exp. Biol. med. Sci. 32, 469–479 (1954).
Pershin, G. N., N. S. Bogdenova, S. M. Makin, and V. M. Likhoslerstov: The antivirus activity of 2:6 dialkoxypyrans and 2-alkoxy Δ 5-dihydropyrans (Cyclic acetals of derivatives of glutaric aldehyde) (Russian). Farmakol. i Toksikol. 28, 66 (1965).
Personnel of Naval Lab. Res. Unit 1.: Experimental human influenza. Amer. J. med. Sci. 207, 306–314 (1944).
Personnel of Naval Res. Unit 1.: The inhalatory route for prophylaxis and treatment of experimental influenza. 1. The distribution of inhaled material.
2. Immune serum in prophylaxis and treatment. Amer. J. med. Sci. 207, 40-47, and 47-60 (1944).
Personnel of Naval Res. Unit 1.: Studies on the primary isolation of influenza viruses. U.S. Navy med. Bull. 46, 369–374 (1946).
Peters, D.: Morphology of viruses pathogenic for man and animals (German). Zbl. Bald, I. Abt. Orig. 176, 259–294 (1959).
Petersen, K. B., and P. von Magnus: Isolation of a new virus from a child with an influenza-like disease. Danish med. Bull. 5, 157–159 (1958).
Peterson, O. P.: Dynamics of influenza antigen in the respiratory tract of infected animals (Russian). Zh. Mikrobiol. (Mosk.) 10/bd11, 29 (1943).
Peterson, O. P.: Methods of laboratory diagnosis of influenza and their significance in clinical practice (Russian). Dokl. 1-y Sess. Inst. Virusol. AMN SSSR po grippa, Moscow (1948).
Peterson, O. P.: Concentration of the influenza virus in nasopharyngeal washings of patients (Russian). Vop. Virus. 1, 177 (1948).
Peterson, O.P.: The effect of the temperature factor and ultraviolet irradiation of the influenza virus on the Hirst reaction (Russian). Vop. Virus. 2, 227 (1949).
Peterson, O. P., and S. A. Semashko: Quick diagnosis of influenza by the detection of the antigen in nasopharyngeal washings (Russian). Zh. Mikrobiol. (Mosk.) 3, 22 (1945).
Peterson, O. P., and G. V. Yeremeyev: Properties of soluble antigens of influenza virus (Russian). Vop. Virus. 2, 209 (1949).
Peterson, W. D., F. M. Davenport, and T. Francis: A study in vitro of components in the transmission cycle of swine influenza virus. J. exp. Med. 114, 1023–1033 (1961).
Petrescu, A., D. Prodan, and V. Gheorghe: Study on the influence of high frequency electric and magnetic fields on influenza virus type A. Morphologic alterations. Rev. roum. Inframicrobiol. 2, 339–342 (1965).
Petrov, Yu. K.: Methods of production of highly active diagnostic, therapeutic, and prophylactic anti-influenza sera and sera against some influenza-like diseases (Russian). “Problemy grippa i ostrykli respirâtornykh zabo-levani.” Tez. dokl. nauch. Sess. Inst. AMN SSSR, Moscow 218-219 (1959).
Pettit, H., S. Mudd, and D. S. Pepper: The Philadelphia and Alaska strains of influenza virus. Epidemic influenza in Alaska in 1935. J. Amer. med. Assoc. 106, 890–892 (1936).
Pfeiffer, R.: Provisional communication on the cause of influenza (German). Dtsch. med. Wschr. 18, 28 (1892).
Philip, R. N., J. A. Bell, D. J. Davis, M. O. Beem, and P. M. Beigelmann: Epidemiological studies on influenza in familial and general population groups. 1. Preliminary report on studies with adjuvant vaccines. Amer. J. publ. Hlth 44, 34–42 (1954).
Piccioto, L.: Serologic response of subjects vaccinated with a single dose of Asian influenza vaccine (Italian). Riv. 1st. Sieroter. ital. 33, 80–83 (1958).
Pigarevskiy, V. Ye.: Morphological study of the reactive processes in virus influenza (Russian). Probl. obshch. virusol. Tez. dokl. 6-y Sess. Inst. Virusol. AMN SSSR, Moscow 23 (1953).
Pigarevskiy, V. Ye.: Cellular factors in the defence of the host in influenza. Acta virol. 1, 30–35 (1957).
Pigarevskiy, V. Ye., and O. M. Chalkina: New data on the methods of diagnosing influenza by means of rhinocytoscopy (Russian). Vop. Virus. 4, 210 (1957).
Pilcher, K. S., K. F. Soike, V. H. Smith, F. Trosper, and B. Folston: Inhibition of multiplication of Lee influenza virus by canavanine. Proc. Soc. exp. Biol. (N.Y.) 88, 79–86 (1955).
Pille, E. R.: Age characteristics of immunity in experimental influenza (Russian). Annot. rabot. Inst. virusol. AMN SSSR za 1949, Moscow 14 (1950).
Pille, E. R.: Experimental data on age immunology in influenza (Russian). Tr. 3-y Sess. Inst. Virusol. AMN SSSR, Moscow 16 (1950).
Plachinska, J.: Detection of influenza virus in cell culture by immuno-fluorescence. Med. Dosw. Mikrobiol. Warsaw 17, 245–249 (1965).
Polley, J. R.: Factors influencing inactivation of infectivity and haemagglutinin of influenza virus by gamma radiation. Canad. J. Microbiol. 7, 535–541 (1961).
Polley, J. R., M. Burr, and A. Gillen: Preparation of a stable non-infective soluble influenza A antigen. Proc. Soc. exp. Biol. (N.Y.) 76, 330–332 (1951).
Pollex, J. E., and M. M. Guerin: The use of B-propiolactone for the preparation of virus vaccines. 1. Selection of reaction conditions.
2. Antigenicity. Canad. J. Microbiol. 3, 863-870, and 871-877 (1957).
Polyak, R. J., and A. A. Smorodintsev: Electrophoretic investigations on thermostable inhibitors of type A 2 influenza virus in normal animal sera. Acta virol. 5, 1–3 (1961).
Porterfield, B. M.: The effect of calcium and electrolytes on the enzymic action of influenza viruses and V. cholerae extract. Brit. J. exp. Path. 33, 196–201 (1952).
Portocala, R., and M. Andriescu: The reproduction of influenza virus by means of virus ribonucleic acid. 5. The influence of the purity of the phenol upon the activity of the ribonucleic acid. Stud. Cercet. Inframicrobiol. 12, 77–81 (1961).
Portocala, E., V. Boeru, and J. Samuel: Eeproduction of influenza virus from purified virus ribonucleic acid (Eumanian). Stud. Cercet. Inframicrobiol. 10, 51–57 (1959).
Portocala, R., V. Boeru, and J. Samuel: On the biosynthesis of influenza virus from a ribonucleic acid extract of the virus.
2. Properties of the recovered isolates and of the ribonucleic acid (French). C. E. Acad. Sci. (Paris) 249, 201-202, and 848-849 (1959).
Portocala, E., V. Boeru, and J. Samuel: Biosynthesis of influenza virus starting from an ether-phenol virus extract. Acta virol. 3, 172–174 (1959).
Portocala, E., V. Boeru, and J. Samuel: Role of ribonucleic acid in the infectivity of the influenza virus (Eumanian). Stud. Cercet. Inframicrobiol. 11, 41–45 (1960).
Portocala, E., V. Boeru, J. Samuel, and M. Andriescu: The reproduction of influenza virus by means of virus ribonucleic acid. 4. Investigation of ribonuclease in fertile eggs of different ages. Stud. Cercet. Inframicrobiol. 12, 71–75 (1961).
Potel, J., S. Hlawatsch, and L. Degen: The photometric haemagglutination test for the antigen determination of viruses and bacteria (German). Zbl. Bakt. I. Abt. Orig. 176, 331–334 (1959).
Powell, W. F., and E. C. Pollard: The effect of ionising radiation on the interfering property of influenza virus. Virology 2, 321–336 (1956).
Powell, W. F., and E. B. Setlow: The effect of monochromatic ultraviolet radiation on the interfering property of influenza virus. Virology 2, 337–343 (1956).
Prose, P. H., S. D. Balk, H. Liebhaber, and S. Krugman: Studies of a myxo-virus recovered from patients with infectious hepatitis. J. exp. Med. 122, 1151–1160 (1965).
Przesmycki, F., E. Walkowska, H. Dobrowalska, Z. Zych, A. Feltnowski, Z. Przybtlkiewicz, and J. Zanski: Anti-influenza vaccinations (Polish). Szczepieniz przeciwgrypowe Med. Dosw. Mikr. 4 (1954).
Pumper, R. W., and H. M. Yamashiriya: The isolation and virus cytopathogenicity of a line of cells from human keratoacanthoma. Amer. J. Hyg. 72, 284–288 (1960).
Pye, J.: Assay of inhibitors of influenza virus haemagglutination by electrophoresis. Aust. J. exp. Biol. med. Sci. 33, 323–334 (1955).
Pye, J., H. F. Holden, and H. B. Donald: Sedimentation behaviour and electron microscopic examination of purified influenza virus. J. gen. Microbiol. 14, 634–636 (1956).
Quilligan, J. J., R. D. Boche, E. J. Carruthers, S. L. Axtell, and J. C. Trivedi: Continuous cobalt-60 irradiation and immunity to influenza virus. J. Immunol. 90, 506–511 (1963).
Quilligan, J. J., and T. Francis: Serological response to intranasal administration of inactive influenza virus in children. J. clin. Invest. 26, 1079–1087 (1947).
Quilligan, J. J., T. Francis, and E. Minuse: Eeactions to an influenza virus vaccine in infants and children. Amer. J. Dis. Child. 78, 295–301 (1949).
Quilligan, J. J., T. Francis, E. J. Eowe, D. G. Traggis, J. D. Adcock, and H. Kurtz: The action of terramycin on the growth of strains of influenza, herpes simplex, and rabies viruses in chick embryos and mice. Ann. N.Y. Acad. Sci. 53, 407–411 (1950).
Quilligan, J. J., E. Minuse, and T. Francis: Homologous and heterologous antibody response of infants and children to multiple injections of a single strain of influenza virus. J. clin. Invest. 27, 572–579 (1948).
Quilligan, J. J., E. Minuse, and T. Francis: Type C influenza virus. 2. Intranasal inoculation of human beings. J. Lab. clin. Med. 43, 43–49 (1954).
Raettig, H.: Investigations on immunity and serology in influenza (German).
Zbl. Bakt. I. Abt. Orig. 152, 159-203, and 381-402 (1947).
Raettig, H.: Investigations on immunity to influenza virus. 2. The titre of haemagglutination-inhibition in normal human sera (German). Z. Immun.-Forsch. 106, 146–153 (1949).
Raettig, H.: The possibilities of vaccination against influenza and the vaccine developed in the Eobert Koch Institute (German). Zbl. Bakt. I. Abt. Orig. 167, 85–86 (1958).
Rappoport, E. S.: Characteristics of influenza B of children in an enclosed area (Russian). Bibl. i annot. rabot. otdela. virusol. Inst. Eksper. med. AMN SSSE za 1947–1949, Leningrad (1950).
Rappoport, E. S., A. G. Gulamov, and O. M. Chalkina: Material on the virological and serological study of influenza type B (Russian). Gripp. Tr. AMN SSSE, Moscow XXVIII, 151 (1953).
Raska, K.: The 1959 influenza epidemic (Czech). Čas. Lék. čes. 98, 353–355 (1959).
Rasmussen, A. F., and J. C. Stokes: Chemical inhibition of the growth of the virus of influenza in the embryonated egg, J. Immunol. 66, 237–247 (1951).
Rathova, V., L. Borecky, and D. Kociskova: An attempt to influence in vivo the serum levels of myxovirus inhibitors. 3. The effect of the administration of some vitamins on inhibitors and some other serum factors in guineapigs and mice (Czech). Bratislavske lekarske listy 43, 31–40 (1963).
Rathova, V., D. Kociskova, and O. Krizanova: An attempt to prepare an immune serum against gamma-inhibitor of influenza virus. Acta virol. S, 551-554 (1964).
Rathova, V., D. Kociskova, and O. Krizanova: The use of indirect haemagglutination for evaluating antibody formation against purified gamma-inhibitor. Acta virol. 10, 82 (1966).
Ratner, B., and S. Untracht: Allergy to virus and rickettsial vaccines. 1. Allergy to influenza A and B vaccines in children. J. Amer. med. Ass. 132, 899–905 (1946).
Reda, I. M., E. Rott, and W. Schafer: Fluorescent antibody studies with NDV infected cell systems. Virology 22, 422–425 (1964).
Reed, L. J., and H. Muench: A simple method of estimating 50% end points. Amer. J. Hyg. 27, 493–497 (1938).
Reginster, M.: Inactivation of influenza virus by caseinase C from streptomyces albus G culture filtrate. J. gen. Microbiol. 40, 157–169 (1965).
Reginster, M.: Eelease of influenza virus neuraminidase by caseinase C of streptomyces albus G. J. gen. Microbiol. 42, 323–331 (1966).
Reginster, M.: Effects of pronase on influenza virus. Acta virol. 10, 111–116 (1966).
Reimer, C. B., R. S. Baker, J. E. Newlin, and M. L. Havens: Influenza virus purification with the zonal ultracentrifuge. Science 152, 1379–1381 (1966).
Reinicke, V., and F. V. Hahnemann: The influence of interferon and hydrocortisone on the production of incomplete influenza virus in ovo. Acta path. microbiol. scand. 63, 51–58 (1965).
Reznikova, O. Yu., and A. P. Marisova: Material characterising the influenza morbidity rate in 1949 and the laboratory diagnosis of influenza (Bussian). Zh. Mikrobiol. (Mosk.) 9, 32 (1950).
Rheins, M., and J. Finlay: The effect of ultrasonic irradiation on certain properties of influenza virus. J. infect. Dis. 95, 79–85 (1954).
Rhian, M., A. S. Evans, and J. L. Melnick: The interaction of influenza virus and intact human erythrocytes observed by replica technique in the electron microscope. J. Immunol. 67, 513–521 (1951).
Rice, C. E.: Studies of the complement fixation reaction in virus systems. 2. Activities of influenza virus antigens and antisera. J. Immunol. 56, 343–356 (1947).
Rickard, E. B., and T. Francis: The demonstration of lesions and virus in the lungs of mice receiving large intraperitoneal inoculations of epidemic influenza virus. J. exp. Med. 67, 953–972 (1938).
Rickard, E. B., M. P. Thigpen, and J. M. Adams: Antibody response to strains of influenza A and swine influenza viruses in the serums of infants experiencing their first infection with influenza virus A. J. infect. Dis. 76, 203–207 (1945).
Rickard, E. B., M. Thigpen, and J. H. Crowley: The isolation of influenza A virus by the intra-allantoic inoculation of chick embryos with untreated throat washings. J. Immunol. 49, 263–271 (1944).
Rickard, E. B., M. Thigpen, and J. H. Crowley: Vaccination against influenza at the university of Minnesota. Amer. J. Hyg. 42, 12–20 (1945).
Rifkind, B. A., K. C. Hsu, C. Morgan, B. C. Seegal, A. W. Knox, and H. M. Rose: Use of ferritin-conjugated antibody to localise antigen by electron microscopy. Nature (Lond.) 187, 1094–1095 (1960).
Rightsel, W. A., H. G. Schneider, B. J. Sloan, P. R. Graf, F. A. Miller, Q. R. Bartz, J. Ehrlich, and G. J. Dixon: Antiviral activity of gliotoxin and gliotoxin acetate. Nature (Lond.) 204, 1333–1334 (1964).
Ritova, V. V.: The etiology of influenza and of acute catarrh in young children (Bussian). Problemy. grippa i OKVDP, Moscow II (1952).
Ritova, V. V.: Influenza in infants (Bussian). Tr. ob’yed. Sess. Inst. AMN SSSB, Moscow 133 (1953).
Ritova, V. V.: Characterisation of influenza virus strains isolated in 1953 and improvement of the methods of isolating them (Bussian). Vop. Virus. 4, 45 (1954).
Ritova, V. V.: Problems and perspectives in specific influenza prophylaxis (Bussian). “Problemy grippa i ostrykh respiratornykh zabolevanii” Tez. dokl. nauch. Sess. Inst. AMN SSSB, Moscow 78-80 (1959).
Ritova, V. V., K. F. Artemenko, and A. K. Svetlova: The treatment of A 2 influenza in children by a fluid anti-influenza A2 serum (Bussian). Vop. Virus. 5, 197–199 (1958).
Ritova, V. V., and N. A. Evsteyneeva: Live tissue culture influenza vaccine. Bull. Wld Hilth Org. 27, 729–734 (1962).
Ritova, V. V., and A. F. Stefanskaya: Doses of influenza vaccine for the vaccination of infants (Bussian). Vop. Virus. 4, 397 (1954).
Ritova, V. V., and L. Ya. Zakstel’skaya: Improvement in the methods of preparing vaccine strains of the influenza A prime and B viruses (Russian). Zh. Mikrobiol. (Mosk.) 5, 55 (1954).
Robbins, F. C., and J. F. Enders: Tissue culture techniques in the study of animal viruses. Amer. J. med. Sci. 220, 316–338 (1950).
Roberts, D. H.: The isolation of an influenza A virus and a mycoplasma associated with duck sinusitis. Vet. Rec. 76, 470–473 (1964).
Robertson, O. H., C. G. Loosli, T. T. Puck, E. Bigg, and B. F. Miller: The protection of mice against infection with air-borne influenza virus by means of propylene glycol vapour. Science 93, 612–613 (1941).
Robinson, B. Q., W. B. Yarbrough, R. H. Gorrie, and W. B. Dowdle: Antigenic relationship of 1961–62 type B influenza viruses to earlier type B strains. Proc. Soc. exp. Biol. (N.Y.) 112, 658–661 (1963).
Rodrigues da Silva, G., and H. A. Feldman: Formalin-treated chicken erythrocytes as indicators of influenza A virus (Asian) and its antibody. Proc. Soc. exp. Biol. (N.Y.) 101, 241–245 (1959).
Rolla, G.: Lack of chick allantoic antigen in influenza virus passed in chick kidney monolayers. Acta path. microbiol. scand. 62, 417–420 (1964).
Rolla, G.: Investigations of some effects of human saliva on influenza virus. 3. Virus antibodies in saliva. Acta path. microbiol. scand. 65, 111–116 (1965).
Rolly, H.: Substituted isonicotinic acid diphenylalkylamides with antiviral activity (German). Zbl. Bakt. I. Abt. Orig. 188, 335–344 (1963).
Romanenko, N. N.: Virological and serological characterisation of influenza in Leningrad (Bussian). Tez. dokl. 3-y, Sess. Inst. Virusol. AMN SSSB, Moscow (1950).
Romanenko, N. N., and E. A. Fridman: A new serological variety of the influenza B virus (Bussian). Zh. Mikrobiol. (Mosk.) 7, 50 (1954).
Romanenko, N. N., and K. M. Khayt: Experiments on the study of the mechanism of virus haemagglutination (Bussian). Tr. Inst. Epidem. i bakteriol. imeni. Pastera, Vol. XIII, “Virusnyye Infektsii” Leningrad 75, 84 (1953).
Romanovska, E.: Studies on blood group antigens M and N. 5. The M and N blood group substances as inhibitors of influenza virus haemagglutination. Arch. Immun. Terap. Dosw. Warsaw 7, 749–757 (1959).
Romvary, J., G. Takatsy, K. Barb, and E. Farkas: Isolation of influenza virus strains from animals. Nature (Lond.) 193, 907–908 (1962).
Romvary, J., G. Takatsy, and E. Farkas: Serological evidence of the incidence of influenza equine A1 virus infections among horses in Hungary. Acta microbiol. Acad. Sci. hung. 12, 289–294 (1965).
Rose, H. M., and A. Gellkorn: Inactivation of influenza virus with sulphur and nitrogen mustards. Proc. Soc. exp. Biol. (N.Y.) 65, 83–85 (1947).
Rose, H. M., E. Molloy, and E. O’neill: Effect of penicillin on bacterial contamination of eggs and tissue cultures inoculated with unfiltered Sputums. Proc. Soc. exp. Biol. (N.Y.) 60, 23–25 (1945).
Rose, H. M., and C. Morgan: Fine structure of virus-infected cells. Ann. Rev. Microbiol. 14, 217–240 (1960).
Rose, M. A.: Influenza in horses. Vet. Rec. 77, 404 (1965).
Rose, M. A.: Equine influenza viruses isolated at Cambridge in 1963 and 1965. Proc. roy. Soc. Med. 59, 5–6 (1966).
Rosenbaum, M. J., and R. L. Woolridge: The use of soluble antigen for the serological diagnosis of influenza in vaccinated populations. J. infect. Dis. 99, 275–281 (1956).
Rosenberg, M.: Morphology of some strains of influenza viruses of the A-Fe group as compared with influenza virus type A strain PR8 (Czech). Biol. Prace 4, 9–11 (1958).
Rosenberg, A., C. Howe, and E. Chargaff: Inhibition of influenza virus haemagglutination by a brain lipid fraction. Nature (Lond.) 177, 234–235 (1956).
Rott, B., and R. Drzeniek: Host-induced modification of lipid-containing BNA viruses. Abstr. 9th int. Congr. Microbiol. Moscow 467 (1966).
Rott, R., R. Drzeniek, S. M. Saber, and E. Reichert: Blood group substances, Forssman and mononucleosis antigens in lipid-containing RNA viruses. Arch. ges. Virusforsch. 19, 273–288 (1966).
Rott, R., S. Saber, and C. Scholtissek: Effect on myxovirus of mitomycin C, actinomycin D, and pre-treatment of the host cell with ultraviolet light. Nature (Lond.) 205, 1187–1190 (1965).
Rott, R., and W. Schafer: Studies of the non-infectious haemagglutmating particle of influenza virus (German). Z. Naturforsch. 16b, 310–321 (1961).
Rott, K., and W. Schafer: Behaviour of the antigenic and other biological properties of human and animal viruses on treatment with nitrous acid (German). Z. Naturforsch. 17b, 160–164 (1962).
Rott, R., and W. Schafer: The various virus-specific units produced by myxovirus-infected cells. Ciba Found. Symp. “Cellular biology of myxovirus infections” 27-50 (1964).
Rott, R., and C. Scholtissek: Investigations about the formation of incomplete forms of fowl plague virus. J. gen. Microbiol. 33, 303–312 (1963).
Rott, E., and C. Scholtissek: Influence of actinomycin on the growth of myxo-viruses (German). Z. Naturforsch. 19b, 316–323 (1964).
Rozee, K. E., G. L. Williams, and C. E. Van Rooyen: Detection and titration of Asian influenza A virus by HeLa cell and monkey kidney cell cultures. Science 128, 591–592 (1958).
Rubini, J. R., A. F. Rasmussen, and M. A. Stahnann: Inhibitory effect of synthetic lysine polypeptides on growth of influenza virus in embryonated eggs. Proc. Soc. exp. Biol. (N.Y.) 76, 662–665 (1951).
Ruttkay-Nedecky, G., and S. Ivanicova: Electrophoretic control of influenza A 2 virus purification and demonstration of an additional virus-specific electrophoretic component in the purified virus preparations. Acta virol. 9, 508–518 (1965).
Rybakov, N.: Prevention of influenza with an atebrine aerosol (Russian). Med. rabotn. 50, 1274 (1954).
Rykowska, R., and L. Sawicki: The gamma inhibitor of normal horse serum. 2. The protective properties of the serum and its fractions against infection of mice and tissue cultures with the Singapore strain of influenza virus (Russian). Med. Dosw. i Mikrob. Warsaw 15, 47–54 (1963).
Rytel, M. W., E. E. Shope, and E. D. Kilbourne: An antiviral substance from penicillium funiculosum. 5. Induction of interferon by Helenine. J. exp. Med. 123, 577–584 (1966).
Sagik, B., T. Puck, and S. Levine: Quantitative aspects of the spontaneous elution of influenza virus from red cells. J. exp. Med. 99, 251–260 (1964).
Sakharov, P. P.: “Inheritance of acquired characteristics” (Russian). Moscow (1952).
Salk, J. E.: Partial purification of the virus of epidemic influenza by adsorption on calcium phosphate. Proc. Soc. exp. Biol. (N.Y.) 46, 709–712 (1941).
Salk, J. E.: A simplified procedure for titrating haemagglutinating capacity of influenza virus and the corresponding antibody. J. Immunol. 49, 87–98 (1944).
Salk, J. E.: The immunising effect of calcium phosphate adsorbed influenza virus. Science 101, 122–124 (1945).
Salk, J. E.: Variation in influenza viruses. A study of heat stability of the red cell agglutinating factor. Proc. Soc. exp. Biol. (N.Y.) G3, 134–139 (1946).
Salk, J. E.: Effect of formalin in increasing heat stability of influenza virus haemagglutinin. Proc. Soc. exp. Biol. (N.Y.) 63, 140–143 (1946).
Salk, J. E.: Studies on the antigenicity in man of calcium phosphate adsorbed influenza virus; with comments on the question of dose of virus needed in vaccines for human use. J. Immunol. 57, 301–321 (1947).
Salk, J. E., M. L. Bailey, and A. M. Laurent: The use of adjuvants in studies on influenza immunisation. 2. Increased antibody formation in human subjects inoculated with influenza virus vaccine in water-in-oil emulsion. Amor. J. Hyg. 55, 439–456 (1952).
Salk, J. E., M. Contakos, A. M. Laurent, M. Sorensen, and A. J. Rapalski: The use of adjuvants in studies on influenza immunisation. 3. Degree of persistence of antibody in human subjects 2 years after vaccination. J. Amer, med. Assoc. 151, 1169–1175 (1953).
Salk, J. E., and A. M. Laurent: The use of adjuvants in studies on influenza immunisation. 1. Measurement in monkeys of the dimensions of antigenicity of virus-mineral oil emulsions. J. exp. Med. 95, 429–447 (1952).
Salk, J. E., A. M. Laurent, and M. L. Bailey: Direction of research on vaccination against influenza. New studies with immunologic adjuvants. Amer. J. publ. Hlth 41, 669–677 (1951).
Salk, J. E., W. J. Menke, and T. Francis: A clinical, epidemiological, and immunological evaluation of vaccination against epidemic influenza. Amer. J. Hyg. 42, 57–93 (1945).
Salk, J. E., H.E. Pearson, P.N. Brown, and T. Francis: Protective effect of vaccination against induced influenza B. Preliminary report. Proc. Soc. exp. Biol. (N.Y.) 55, 106–107 (1944).
Saltsam, J. H., F. Lanni, and J. W. Beard: Inhibitory effect of human saliva on haemagglutination by influenza virus A (PES) and the swine influenza virus. J. Immunol. 63, 261–267 (1949).
Sampaio, A. A. C.: Inhibitors of influenza virus haemagglutination in normal animal sera. Bull. Wld Hlth Org. 6, 467–472 (1952).
Sampaio, A. A. C.: Antigenic analysis of influenza viruses by the haemagglutination-inhibition technique. Eesults of the use of different animal sera. Bull. Wld Hlth Org. 6, 473–480 (1952).
Sampaio, A. A. C., and A. Isaacs: The action of trypsin on normal serum inhibitors of influenza virus haemagglutination. Brit. J. exp. Path. 34, 152–158 (1953).
Samvelova, S. A.: Experience in mass prophylactic vaccination against influenza (Russian). Zh. Mikrobiol. (Mosk.) 9, 9 (1954).
Samvelova, S.A., and G. Ya. Kuzminskaya: Peculiarities of the epidemiology of influenza in Moscow in 1957 (Russian). Vop. Virus. 5, 8–14 (1958).
Sanders, M., I. Kiem, and D. Lagunoff: Cultivation of viruses. A critical review. Arch. Path. 56, 148–225 (1953).
Saslaw, S., and H. Carlisle: Aerosol exposure of monkeys to influenza virus Proc. Soc. exp. Biol. (N.Y.) 119, 838–843 (1965).
Saslaw, S., H.E. Wilson, C. A. Doan, O. C. Woolpert, and J.L. Schwab: Eeactions of monkeys to experimentally induced influenza virus A infection. An analysis of the relative roles of humoral and cellular immunity under conditions of optimal and deficient nutrition. J. exp. Med. 84, 113–125 (1946).
Sawicki, L., S. Baron, and A. Isaacs: Influence of increased oxygenation on influenza virus infection in mice. Lancet 680-682 (1961).
Sawicki, L., and H. Grzelakowa: The growth of influenza virus in monkey kidney tissue culture investigated with the haemadsorption technique (Polish). Med. Dosw. i. Mikrob. Warsaw 12, 241–249 (1960).
Schaeffer, M.: Preparation of purified influenza virus. Proc. Soc. exp. Biol. (N.Y.) 51, 32–34 (1942).
Schaeffer, M., F. F. Silver, and C. C. Pi: Studies on the chemotherapy of virus infections. 1. General anaesthetics and other drugs ineffective against experimental virus infection in mice. J. Immunol. 63, 109–115 (1949).
Schäfer, W.: Properties of animal viruses. 1. The complement fixing antigen of classical fowl plague (German). Z. Naturforsch. 6b, 207–212 (1951).
Schäfer, W.: Comparative sero-immunologic studies on the viruses of influenza and classical fowl plague (German). Z. Naturforsch. 10b, 81–91 (1955).
Schäfer, W.: Sero-immunologic studies on incomplete forms of the virus of classical fowl plague (German). Arch. exp. Vet.-Med. 9, 218–230 (1955).
Schäfer, W.: The significance of electron microscopy for virus studies (German). Dtsch. tierärztl. Wschr. 63, 15–16 (1956).
Schäfer, W.: Units isolated after splitting fowl plague virus. Ciba Found. Symp. “The nature of viruses.” 91-103 (1957).
Schäfer, W.: Some observations concerning the reproduction of ENA-containing animal viruses. 9th Symp. Soc. gen. Microbiol. “Virus growth and variation.” 61-81 (1959).
Schäfer, W.: Structure of some animal viruses and significance of their components. Bact. Rev. 27, 1–17 (1963).
Schäfer, W., and K. Munk: Purification and properties of soluble antigens of classical fowl plague (German). Z. Naturforsch. 7b, 573–574 (1952).
Schäfer, W., and K. Munk: Properties of animal viruses. 4. Studies of the latent phase in the growth of fowl plague virus (German). Z. Naturforsch. 7b, 608–619 (1952).
Schäfer, W., K. Munk, and O. Armbruster: Properties of animal viruses. 3. Studies on the physicochemical and morphological properties of fowl plague virus (German). Z. Naturforsch. 7b, 29–33 (1952).
Schäfer, W., and E. Rott: The preparation of virus vaccines with hydroxylamine. Course of inactivation and the effect of hydroxylamine upon various properties of certain viruses (German). Z. Hyg. Infekt.-Kr. 148, 256–268 (1962).
Schäfer, W., and G. Schramm: On the isolation and characterisation of the virus of classical fowl plague (German). Z. Naturforsch. 5b, 91–102 (1950).
Schäfer, W., G. Schramm, and E. Traub: Studies of the virus of atypical fowl plague (German). Z. Naturforsch. 4b, 157–167 (1949).
Schäfer, W., and W. Zillig: On the structure of the elementary bodies of fowl plague virus. 1. Preparation, physicochemical and biological properties of split products (German). Z. Naturforsch. 9b, 779–788 (1954).
Schäfer, W., W. Zillig, and K. Munk: Isolation and characterisation of the non-infectious haemagglutinin of fowl plague (German). Z. Naturforsch. 9b, 329–340 (1954).
Schaffer, F. L.: Physical and chemical properties and infectivity of RNA from animal viruses. Cold Spr. Harb. Symp. quant. Biol. “Basic mechanisms in animal biology.” 27, 89–99 (1962).
Schild, G. C., and C. H. Stuart-Harris: Serological epidemiological studies with influenza A viruses. J. Hyg. (Lond.) 63, 479–490 (1965).
Schild, G. C., and E. N. P. Sutton: Inhibition of influenza viruses in vitro and in vivo by l-adamantanamine hydrochloride. Brit. J. exp. Path. 46, 263–273 (1965).
Schlesinger, R. W.: Production of incomplete influenza virus in mouse brain. Proc. Soc. Amer. Bacteriologists 71 (1950).
Schlesinger, R. W.: Incomplete growth cycle of influenza virus in mouse brain. Proc. Soc. exp. Biol. (N.Y.) 74, 541–548 (1950).
Schlesinger, R. W.: Immunological barriers to viral growth. Ann. N.Y.Acad. Sci. 54, 953–959 (1952).
Schlesinger, R. W.: The relation of functionally deficient forms of influenza virus to viral development. Cold Spr. Harb. Symp. quant. Biol. 18, 55–59 (1953).
Schlesinger, R. W.: Interference between animal viruses. “The viruses.” Acad. Press N.Y. 3, 157–194 (1959).
Schlesinger, R. W., and H. V. Karr: Influenza virus and its mucoprotein substrate in the chorioallantoic membrane of the chick embryo. 1. Characterisation and quantitative assay of soluble substrate and studies on its relation to allantoic cells.
2. Stepwise inactivation of substrate and its relation to the mode of viral multiplication. J. exp. Med. 103, 309-332 and 333-349 (1956).
Schlesinger, E. W., and G. H. Werner: Quantitative and morphological aspects of the incomplete growth cycle of influenza virus in mouse brain. Fed. Proc. 11, 480 (1952).
Schmidt, G.: Experiences with Drescher’s photometric method for the determination of viruses in the case of different myxoviruses (German). Zbl. Bakt. I. Abt. Orig. 176, 334–340 (1959).
Schmidt, B., and K. Grossgebauer: Observations on mixtures of virus and red cells in sedimentation tubes (German). Z. Hyg. Infekt.-Kr. 144, 549–554 (1958).
Schmidt, B., and K. Grossgebauer: Myxovirus haemagglutination experiments with erythrocytes from different species (German). Z. Hyg. Infekt.-Kr. 146, 26–47 (1959).
Schmidt, B., D. Hartmann, and K. Grossgebauer: The isolation of different haemagglutinin fractions from influenza virus with DEAE cellulose ion exchanger (German). Arch. ges. Virusforsch. 10, 361–367 (1960).
Schmidt, J. E. A., and A. F. Easmussen: Inhibitory effect of cobaltous ions on multiplication of influenza virus. Proc. Soc. exp. Biol. (N.Y.) 81, 244–246 (1952).
Scholtens, E. G., and J. H. Steele: U.S. epizootic of equine influenza 1963. Epizootiology. Publ. Hlth Eep. (Wash.) 79, 393–398 (1964).
Scholtissek, C.: Biochemical studies on the cytopathic effect of influenza viruses. Abstr. 9th int. Congr. Microbiol. Moscow 373 (1966).
Scholtissek, C., R. Drzeniek, and R. Rott: Stepwise inactivation of an influenza virus by serial undiluted passages. Virology 30, 313–318 (1966).
Scholtissek, C., and R. Rott: Influence of p-fluorophenylalanine on the production of viral ribonucleic acid and on the utilisability of viral protein during multiplication of fowl plague virus. Nature (Lond.) 191, 1023–1024 (1961).
Scholtissek, C., and R. Rott: Studies on the growth of fowl plague virus (German). Z. Naturforsch. 16b, 109–115 (1961).
Scholtissek, C., and R. Rott: Connection between the synthesis of ribonucleic acid and protein in the growth of a virus of the influenza group. (Fowl plague virus.) (German). Z. Naturforsch. 16b, 663–673 (1961).
Scholtissek, C., and R. Rott: Synthesis of viral ribonucleic acid by a chemically inactivated influenza virus. Nature (Lond.) 199, 200–201 (1963).
Scholtissek, C., and R. Rott: Binding of proflavine to deoxyribonucleic acid and its biological significance. Nature (Lond.) 204, 39 (1964).
Scholtissek, C., and E. Rott: Behaviour of virus-specific activities in tissue cultures infected with myxoviruses after chemical changes of the viral ribonucleic acid. Virology 22, 169–176 (1964).
Scholtissek, C., R. Rott, P. Hausen, H. Hausen, and W. Schäfer: Comparative studies of ENA and protein synthesis with a myxovirus and a small polyhedral virus. Cold Spr. Harb. Symp. quant. Biol. 27, 245–257 (1962).
Sciioyen, E., A. Harboe, and L. Wang: Influenza virus HI antibody combining with normal chick material and produced in hens immunised with chick-grown influenza virus. Acta path. microbiol. scand. 68, 103–107 (1966).
Schulman, J. L., and E. D. Kilbourne: Experimental transmission of influenza virus infection in mice. 1. The period of transmissibility.
2. Some factors affecting the incidence of transmitted infection. J. exp. Med. 118, 257-266 and 267-275 (1963).
Schulman, J. L., and E. D. Kilbourne: Induction of viral interference in mice by aerosols of inactivated influenza virus. Proc. Soc. exp. Biol. (N.Y.) 113, 431–435 (1963).
Schulman, J. L., and E. D. Kilbourne: Induction of partial specific heterotypic immunity in mice by a single infection with influenza A virus. J. Bact. 89, 170–174 (1965).
Seal, J. E., and B. F. Gundeleinger: Efficacy of immunisation against Asian influenza in the United States Navy. U.S. armed Forces med. J. 9, 1720–1735 (1958).
Segal, L. S.: The efficacy of immunisation with live allantoic influenza vaccine in the epidemic experiment (Russian). Dissertation, Moscow (1952).
Selimov, M. A.: A comparative study of the haemagglutinating properties of mumps and influenza (Russian). Byull. éksp. Biol. med. 38, 60 (1954).
Selivanov, Ya. M.: Peculiarities of the spread of influenza in Byelorussia in 1957 (Russian). Vop. Virus. 5, 51–53 (1958).
Sellers, T. F., J. Schulman, C. Bouvier, E. McCune, and E. D. Kilboukne: The influence of influenza virus infection on exogenous staphylococcal and endogenous murine bacterial infection of the bronchopulmonary tissues of mice. J. exp. Med. 114, 237–255 (1961).
Semashko, S. A.: Treatment of virus influenza with atabrine (Kussian). Annot rabot. Inst. Virusol. AMN SSSE Leningrad 40 (1952).
Sen, H. G., G. W. Kelley, N. E. Underdahl, and G. A. Young: Transmission of swine influenza virus by lungworm migration. J. exp. Med. 113, 517–520 (1961).
Sereda, Y. N.: Influence of influenza virus on the electrokinetic potential of erythrocytes (Russian). Problemy grippa i OKVDP. Tez. dold. ob’yed. Sess Inst. AMN SSSE, Leningrad 40 (1952).
Sery, V., J. Eadovsky, V. Tumova, F. Lobkowicz, and S. Chobot: The use of horse anti-influenza serum in the prophylaxis of influenza (Czech). Čs. Epidem. 6, 309–317 (1957).
Seth, E., and S. L. Kalra: Viruses in respiratory infections in Delhi. Indian. J. med. Res. 53, 1109–1111 (1965).
Seto, J. T.: Sialidase (Neuraminidase) activity of standard and incomplete virus. Biochim. biophys. Acta (Amst.) 90, 420–422 (1964).
Seto, J. T.: Effect of sialidase antiserum on toxicity of influenza virus. Proc Soc. exp. Biol. (N.Y.) 118, 1043–1046 (1965).
Seto, J. T., E. Drzeniek, and E. Rott: Isolation of a low molecular weight siahdase (Neuraminidase) from influenza virus. Biochim. biophys Acta (Amst.) 113, 402–404 (1966).
Seto, J. T., B. J. Hickey, and A. F. Easmussen: Sialidase activity and related properties of influenza A2 viruses. Virology 9, 598–611 (1959).
Seto, J. T., and Y. Hokama: Disc electrophoresis analysis of sialidase from influenza virus. Ann. N.Y. Acad. Sci. 121, 640–650 (1964).
Seto, J T., Y. Nishi, B. J. Hickey, and A. F. Easmussen: Eolation of sialidase of influenza A viruses to virus particles as determined by electron microscopy. Virology 13, 13–18 (1961).
Seto, J. T., and E. Rott: Functional significance of sialidase during influenza virus multiplication. Virology 30, 731–737 (1966).
Shadrin, A. S.: Use of blood donors serum and of gamma globulin for influenza prophylaxis (Russian). “Problemy grippa i ostrykh respiratornykh zabolevanii” Tez. dokl. nauch. Sess. Inst. AMN SSSE, Moscow 138-139 (1959).
Shakiimaliyeva, Z. M., and K. M. Odina: The course of infection in white mice infected with A and A 2 influenza virus (Russian). “Problemy grippa i ostrykh respiratornykh zabolevanii” Tez. dokl. nauch. Sess. Inst AMN SSSE, Moscow 178-179 (1959).
Shakiinazarova, N. G., and P. P. Sakiiarov: The neurotoxic influenza factor (Russian). Byull éksp. Biol. Med. 22, 48 (1946).
Sharp, D. G., F. Lanni, and J. W. Beard: The egg-white inhibitor of influenza virus haemagglutination. 2. Electron microscopy of the inhibitor. J. biol. Chem. 185, 681–688 (1950).
Sharp, D. G., A. E. Taylor, I. W. McLean, D. Beard, J. W. Beard, A. E. Feller, and J. H. Dingle: Isolation and characterisation of influenza virus B (Lee strain). J. Immunol. 48, 129–153 (1944).
Shaw, D. E., A. S. Kenney, and J. Stokes: Serologic and immunologic studies relative to the viruses of human and swine influenza. Amor. J. med Sci 197, 247–253 (1939).
Shear, H. H., H. D. Heath, D. T. Imagawa, M. H. Jones, and J. M. Adams: Neutralisation of teratogenic and lethal effects of influenza A virus in chick embryos. Proc. Soc. exp. Biol. (N.Y.) 89, 523–528 (1955).
Sheffield, F. W., W. Smith, and G. Belyavin: Purification of influenza virus by red-cell adsorption-elution. Brit. J. exp. Path. 35, 214–222 (1954).
Shelokov, A., J. E. Vogel, and L. Chi: Haemadsorption (adsorption-haemagglutination) test for viral agents in tissue culture with special reference to influenza. Proc. Soc. exp. Biol. (N.Y.) 97, 802–809 (1958).
Shimojo, H., A. Sugiura, T. Akao, and C. Enomoto: Studies of a non-specific haemagglutination inhibitor of influenza A/Asian/57 virus. Bull. Inst. publ. Hlth Tokyo 7, 219–224 (1958).
Shimshelevich, S. B., and D. N. Fadeyeva: Treatment of influenza with ecmoline (Russian). Novisti med. 25, 21–24 (1952).
Shimshelevich, S. B., and F. Y. Smolyanskaya: Outbreaks of influenza B in a children’s group (Russian). Zh. Mikrobiol. (Mosk.) 1, 29 (1949).
Shiota, O.: Studies on the incomplete form of influenza virus. 1. Eolations between growth curve of the virus and the yield of incomplete particles.
2. The morphological characteristics of so-called incomplete particles of the virus.
3. Nucleic acid content of complete and incomplete particles (Japanese). Yirus 6, 141-145, 193-206, and 207-213 (1956).
Shiskina, O. I., and I. A. Yubikas: Comparative evaluation of the methods of laboratory diagnosis in type B influenza (Russian). Tr. AMN SSSE, Moscow XXYIII, 122 (1953).
Shope, R. E.: Swine influenza. 1. Experimental transmission and pathology.
3. Filtration experiments and etiology. J. exp. Med. 54, 349-360, and 373-380 (1931).
Shope, R. E.: The infection of mice with swine influenza. J. exp. Med. 62, 561–572 (1935).
Shope, R. E.: The incidence of neutralising antibodies for swine influenza virus in the sera of human beings of different ages. J. exp. Med. 63, 669–684 (1936).
Shope, R. E.: Immunological relationship between the swine and human influenza viruses in swine. J. exp. Med. 66, 151–168 (1937).
Shope, R. E.: Serological evidence for the occurrence of infection with human influenza viruses in swine. J. exp. Med. 67, 739–748 (1938).
Shope, R. E.: Serological studies of swine influenza viruses. J. exp. Med. 69, 847–856 (1939).
Shope, R. E.: An intermediate host for the swine influenza virus. Science 89, 441–442 (1939).
Shope, R. E.: The swine lungworm as a reservoir and intermediate host for swine influenza virus. 1. The presence of swine influenza virus in healthy and susceptible pigs.
2. The transmission of swine influenza virus by the swine lungworm.
3. Facts influencing transmission of the virus and the provocation of influenza.
4. The demonstration of masked swine influenza virus in lungworm larvae and swine under natural conditions. J. exp. Med. 74, 41, and 49 (1941); and 77, 111, and 127 (1943).
Shope, R. E.: The provocation of masked swine influenza virus by infection with human influenza virus. T. Diergeneesk. 76, 414–420 (1951).
Shope, R. E.: An antiviral substance from pénicillium funiculosum. 1. Effect upon infection in mice with swine influenza virus and Columbia SK encephalomyelitis virus.
2. Effect of Helenine upon infection of mice with Semliki forest virus.
3. General properties and characteristics of Helenine.
4. Inquiry into the mechanism by which Helenine exerts its antiviral effect. J. exp. Med. 97, 601-625, 627-638, and 636-650 (1953), and J. exp. Med. 123, 213-227 (1966).
Shope, R. E.: The swine lungworm as a reservoir and intermediate host for swine influenza virus. 5. Provocation of swine influenza by exposure of prepared swine to adverse weather. J. exp. Med. 102, 567–572 (1955).
Shope, R. E., and T. Francis: The susceptibility of swine to the virus of human influenza. J. exp. Med. 64, 791 (1936).
Shroit, I. G., and V. S. Dakova: Data on the epidemiology, laboratory diagnosis and prophylaxis of influenza in the Moldavian SSSE (Russian). “Problemy grippa i ostrykh respiratornykh zabolevanii” Tez. dokl. nauch. Sess. Inst. Inst. AMN SSSR, Moscow 103-104 (1959).
Shubladze, A. K.: The susceptibility of animals to influenza (Russian). Dokl. Akad. Nauk. SSSR 32, 674 (1941).
Shubladze, A. K., and V. P. Solov’yev: Study of the phenomenon of erythrocyte agglutination by the influenza virus (Russian). Zh. Mikrobiol. (Mosk.) 10–11, (17) 21 (1943).
Sidorenko, E. V.: The importance of the complement fixation reaction in the diagnosis of fatal influenza cases (Russian). Gripp. Sborn. nauch. rabot. Kiev 3, 58–64 (1959).
Siegert, R., and P. Braune: The pyrogens of myxoviruses. 1. Induction of hypothermia and its tolerance.
2. Resistance of influenza A pyrogens to heat, ultraviolet, and chemical treatment. Virology 24, 209-217, and 218-224 (1964).
Sigel, M. M.: Differences in the haemagglutinating and antigenic properties of strains of influenza virus isolated in one outbreak. J. Immunol. 62, 81–95 (1949).
Sigel, M. M., E. G. Allen, D. J. Williams, and A. J. Girardi: Immunologic response of hamsters to influenza virus strains. Proc. Soc. exp. Biol. (N.Y.) 72, 507–510 (1949).
Sigel, M. M., A. W. Kitts, A. B. Light, and W. Henle: The recurrence of influenza A-prime in a boarding school after 2 years. J. Immunol. 64, 33–38 (1950).
Sigel, M. M., F. W. Shaffer, M. W. Kirber, A. B. Light, and W. Henle: Influenza A in a vaccinated population. J. Amer. med. Assoc. 136, 437–441 (1948).
Sigurdsson, B., and O. Bjarnason: Immunological studies on an epidemic of influenza in Iceland. Amer. J. publ. Hlth 36, 130–134 (1946).
Silver, R. K., G. Braun, E. Zilliken, G. H. Werner, and P. Gyorgi: Factors in human milk interfering with influenza virus activities. Science 123, 932–933 (1956).
Simpson, R. W.: Genetic studies with influenza A virus. Ciba Found. Symp. “Cellular biology of myxovirus infections” 187-217 (1964).
Simpson, R. W., and R. E. Hauser: Structures associated with influenza virus suspensions treated with phospholipase C. Virology 27, 642–646 (1965).
Simpson, R. W., and R. E. Hauser: Influence of lipids on the viral phenotype. 1. Interaction of myxoviruses and their lipid constituents with phospholipases. Virology 30, 684–697 (1966).
Simpson, R. W., and G. K. Hirst: Genetic recombination among influenza viruses. 1. Cross reactivation of plaque-forming capacity as a method for selecting recombinants from the progeny of crosses between influenza A strains. Virology 15, 436–451 (1961).
Simpson, G. I., and W. J. Mogabgab: Reactivity of influenza A and B viruses propagated in cultures of human embryo tissues and in the chick embryo. J. Immunol. 78, 456–464 (1957).
Siniak, K. M., S. D. Klyusko, M. B. Maksimovich, N. G. Ezhova, A. A. Oikhberg, and I. A. Vinogradov: Efficacy of blood donors anti-influenza serum in the prophylaxis of influenza in children’s homes and schools (Russian). “Problemy grippa i ostrykh respiratornykh zabolevanii” Tez. dokl. nauch. Sess. Inst. AMN SSSR, Moscow 141-142 (1959).
Sincovics, J.: Virus neutralisation experiments with lymphoid coll and lymph node extracts. Acta microbiol. Acad. Sci. hung. 2, 385–400 (1955).
Sinz, W.: Experimental observations on the interference of influenza viruses (German). Zbl. Bakt. I. Abt. Orig. 197, 165–195 (1965).
Siverskaya, P. I., and A. V. Chudnova: Antibodies to influenza virus in the blood of donors and in sera produced industrially (Russian). “Problemy grippa i ostrykh respiratornykh zabolevanii” Tez. dokl. nauch. Sess. Inst. AMN SSSR, Moscow 157-159 (1959).
Sjoberg, B.: Flumidin, a new chemotherapeutic agent for the prophylaxis and suppression of influenza. Svenska Läk.-Tidu. 42, (1959).
Sjoberg, B.: Experiments on prophylaxis and suppression of epidemic influenza with N’, N’-anhydrobis-(B-hydroxyethyl) biguanide-HCl (ABOB). A double-blind study. Antibiot. et Chemother. (Basel) 10, (1960).
Sklyanskaya, E., and O. Peterson: Study of the nature of early increase in RNA synthesis in the mouse lung infected in vivo with influenza virus. Abstr. 9th int. Congr. Microbiol., Moscow 506 (1966).
Skurska, Z., H. Makower, A. Sypulowa, M. Lobodzinska, and T. Kidankiewicz: Early and late strains of influenza virus in tissue cultures of the chicken embryo (Polish). Arch. Immun. ter. Dosw. 8, 101–110 (1960).
Slepushkin, A. N.: Comparative studies of the biological properties of vaccine strains of the influenza virus (Russian). Dissertation, Moscow (1954).
Slepushkin, A. N.: The efficacy of prophylactic measures during influenza outbreaks in 1957 (Russian). Vop. Virus. 5, 103–109 (1958).
Slepushkin, A. N.: Some epidemiological and etiological peculiarities of the 1957 influenza epidemic (Russian). Vop. Virus. 5, 33–36 (1958).
Slepushkin, A. N.: The effect of a previous attack of Al influenza on susceptibility to A2 virus during the 1957 outbreak. Bull. Wld Hlth Org. 20, 297–301 (1959).
Slepushkin, A. N.: Data on the efficiency of live influenza vaccine. Abstr. 9th int. Congr. Microbiol., Moscow 379-380 (1966).
Slobodianiuk, M. I.: Rhinocytoscopic investigations in A/Asia/57 influenza (Russian). Aziatiksii Gripp (Sborn nauch. rabot.) Kiev 201-205 (1958).
Smadel, J. E.: Influenza vaccine. Publ. Hlth Rep. (Wash.) 73, 2 (1958).
Smart, K. M., and E. D. Kilbourne: The influence of cortisone on experimental viral infection. 6. Inhibition by hydrocortisone of interferon synthesis in the chick embryo.
7. Kinetics of interferon formation and its inhibition with hydrocortisone in relation to viral strain and virulence. J. exp. Med. 123, 299-307, and 309-325 (1966).
Smith, D. H., and H. R. Morgan: A cytopathogenic effect of influenza virus (PR 8 strain) for mouse fibroblastic (L) cells in vitro. J. Immunol. 85, 180–189 (1960).
Smith, W.: Cultivation of the virus of influenza. Brit. J. exp. Path. 16, 508–512 (1935).
Smith, W.: The complement fixation reaction in influenza. Lancet 1256-1259 (1936).
Smith, W.: Host and tissue specificity in infective disease. Proc. roy. Soc. Med. 42, 11–18 (1949).
Smith, W.: The structural and functional plasticity of influenza virus. Lancet 885 (1952).
Smith, W.: Progress in viral immunology. Brit. med. Bull. 9, 176–179 (1953).
Smith, W., and C. H. Andrewes: Serological races of influenza virus. Brit. J. exp. Path. 19, 293–314 (1938).
Smith, W., C. H. Andrewes, and P. P. Laidlaw: A virus obtained from influenza patients. Lancet 66-68 (1933).
Smith, W., C. H. Andrewes, and P. P. Laidlaw: Influenza. Experiments on the immunisation of ferrets and mice. Brit. J. exp. Path. 16, 291–302 (1935).
Smith, W., G. Belyavin, and F. W. Sheffield: A host-protein component of influenza viruses. Nature (Lond.) 172, 669 (1953).
Smith, W., G. Belyavin, and F. W. Sheffield: The host-tissue component of influenza viruses. Proc. roy. Soc. B. 143, 504–522 (1955).
Smith, W., and A. Cohen: The enzymic activity of influenza viruses. Brit. J. exp. Path. 37, 612–624 (1956).
Smith, W., H. Cohen, G. Belyavin, and J. C. N. Westwood: The effects of ethyl ether on some biological properties of influenza virus. Brit. J. exp. Path. 34, 512–524 (1953).
Smith, W., and C. H. Stuart-Harris: Influenza infection of man from the ferret. Lancet 121-123 (1936).
Smith, W., and M. A. Westwood: Factors involved in influenza haemagglutination reactions. Brit. J. exp. Path. 30, 48–61 (1949).
Smith, W., and J. C. N. Westwood: Influenza virus haemagglutination. The mechanism of the Francis phenomenon. Brit. J. exp. Path. 31, 725–738 (1950).
Smith, W., J. C. N. Westwood, and G. Belyavin: Influenza. A study of four virus strains isolated in 1951. Lancet 1189 (1951).
Smith, W., M. A. Westwood, J. C. N. Westwood, and G. Belyavin: Spontaneous mutation of influenza virus A during routine egg passage. Brit. J. exp. Path. 32, 422–432 (1951).
Smorodintsev, A. A.: Prohlem of the etiology and specific prophylaxis of influenza in the light of the latest data (Russian). Arkh. biol. nauk. 52, 3–18 (1938).
Smorodintsev, A. A.: Etiology and prophylaxis of influenza and seasonal catarrhs (Russian). Zh. Mikrobiol. (Mosk.) 10/11, 4 (1943).
Smorodintsev, A. A.: The latest in the epidemiology and specific prophylaxis of influenza (Russian). Vop. Virus. 1, 102 (1948).
Smorodintsev, A. A.: Methods of laboratory diagnosis of influenza (Russian). Zh. Mikrobiol. (Mosk.) 12, 31 (1948).
Smorodintsev, A. A.: Problems of current importance in the laboratory diagnosis, epidemiology, and specific prophylaxis of influenza (Russian). Vestn. AMN SSSR 3, 16 (1951).
Smorodintsev, A. A.: Mechanism of virus destruction in the bodies of resistant animals (Russian). “Sovremennyye voprosy meditinskoy nauchi.” Moscow (1951).
Smorodintsev, A. A.: New system of performing the complement fixation reaction for the rapid diagnosis of influenza and other virus infections (Russian). Probl. grippa i OKVDP Tez. dokl. ob’yed. Sess. AMN SSSR, Moscow 27 (1952).
Smorodintsev, A. A.: Results of specific influenza prophylaxis with live vaccine (Russian). Gripp. Tr. AMN SSSR, Moscow XXVIII, 217 (1953).
Smorodintsev, A. A.: Problems of controlling influenza in the light of the latest data (Russian). Zh. Mikrobiol. (Mosk.) 9, 22 (1954).
Smorodintsev, A. A.: Morphological studies on reactive processes in viral influenza in the respiratory tract of white mice exposed to the effect of roentgen rays (Russian). Vop. Virus. 2, 290–296 (1957).
Smorodintsev, A. A.: Specific prophylaxis and treatment of influenza. Proc. 3rd int. Meet. Biol. Standard. Opatija 463-480 (1957).
Smorodintsev, A. A.: The effect of X ray irradiation on the course of experimental influenza infection in white mice and rats. Acta virol. 1, 145–155 (1957).
Smorodintsev, A. A.: Results and problems of the specific prevention and treatment of influenza (Russian). Vest. Akad. med. nauk. SSSR 13, 20–30 (1958).
Smorodintsev, A. A.: Results of the study of etiology and laboratory diagnosis of type A 2 influenza during the 1957 and 1959 epidemics (Russian). “Problemy grippa i ostrykh respiratornykh zabolevanii” Tez. dokl. nauch. Sess. Inst. AMN SSSR, Moscow 8-12 (1959).
Smorodintsev, A. A.: Specific prophylaxis of influenza with a live vaccine (Russian). “Problemy grippa i ostrykh respiratornykh zabolevanii” Tez. dokl. nauch. Sess. Inst. AMN SSSR, Moscow 82-84 (1959).
Smorodintsev, A. A.: Cellular and humoral factors of defence against virus infection. Ciba Found. Symp. “Cellular biology of myxovirus infections” 317-343 (1964).
Smorodintsev, A. A., G. L. Alexandrova, T. J. Lousanina, M. A. Morozenko, and A. A. Selivanov: Virological and serological characteristics of the 1957 influenza pandemic. Ann. Inst. Pasteur 97, 385–397 (1959).
Smorodintsev, A. A., G. I. Alexandrova, B. A. Mikutskaya, R. A. Pleshanova, E. A. Sirotenko, T. E. Braun, and E. W. Kallas: Results and perspectives of live influenza vaccine for the active immunisation of children. Abstr. 9th int. Congr. Microbiol., Moscow 380-381 (1966).
Smorodintsev, A. A., and O. M. Chalkina: Active immunisation against influenza with vaccine from live attenuated virus (Russian). Sov. vrach. sbornik. 15, 16 (1949).
Smorodintsev, A. A., and O. M. Chalkina: Material on the specific prophylaxis of influenza (Russian). Probl. grippa i ostrykh katar. verkhn. dykh. put. Tr. ob’yed. Sess. Inst. AMN SSSR, Moscow 59 (1952).
Smorodintsev, A. A., and O. M. Chalkina: Results of specific influenza prophylaxis with live vaccine (Russian). “Virusnyye Infektsii” Tr. Leningrad Inst. Epidem. Mikrobiol. i gig. imeni Pastera i Inst. eksper. med. AMN SSSR, Leningrad 142-160 (1953).
Smorodintsev, A. A., O. M. Chalkina, and M. Ansheles: Experience in the useof Hvevaccineagainstinfluenza(Russian). Zh.Mikrobiol.(Mosk.) 10, 52 (1953).
Smorodintsev, A. A., A. I. Drobyshevskaya, S. M. Ostrovskaya, and O. I. Shishkina: The etiology of influenzal diseases (Russian). Sov. vrach. zhurn. 16, 1455 (1936), also (English) Lancet 2, 1381 (1936).
Smorodintsev, A. A., A. I. Drobyshevskaya, S. M. Ostrovskaya, and O. I. Shishkina: Experimental material on the etiology of epidemic influenza (Russian). Sov. vrach. zhurn. 6, 403–419 (1937).
Smorodintsev, A. A., A. I. Drobyshevskaya, and O. I. Shishkina: On the aetiology of the 1936influenza epidemic in Leningrad. Lancet 1383-1385 (1936).
Smorodintsev, A. A., A. G. Gulamov, and O. M. Chalkina: Experience in the specific prophylaxis of experimental influenza with inhalation of influenza antiserum (Russian). Sov. vrach. zhurn. 4, 255 (1940).
Smorodintsev, A. A., and O. I. Shishkina: Experimental analysis of the prophylactic and therapeutic effect of influenza immune serum on virus infection of mice with different methods of application of it (Russian). Arkh. biol. nauk. 52, 132–154 (1938).
Smorodintsev, A. A., and O. I. Shishkina: Natural and acquired immunity to influenza. Amer. Rev. soviet Med. 3, 400–413 (1946).
Smorodintsev, A. A., and O. I. Shishkina: Mechanism of acquired and natural immunity to influenza infection (Russian). Arkh. biol. nauk. 59, 20 (1940), also Zh. Mikrobiol. (Mosk.) 43, 49 (1945), Zh. Mikrobiol. (Mosk.) 26 (1946), Zh. Mikrobiol. (Mosk.) 2 (1947).
Smorodintsev, A. A., and O. I. Shishkina: The effect of normal laboratory animal sera on the influenza virus. Zh. Microbiol. (Mosk.) 6, 16 (1951).
Smorodintsev, A. A., and O. I. Shishkina: The effect of tissue enzymes on the influenza virus (Russian). Gripp. Tr. AMN SSSR XXXVIII, 5 (1953).
Smorodintsev, A. A., and A. A. Yabrov: The mechanism of enhanced activity of anti-influenza virus neutralising antisera on their interaction with native serum from normal animals. Acta virol. 7, 193–208 (1963).
Smorodintsev, A. A., and V. M. Zhdanov: Results and immediate tasks of the study of live influenza vaccine (Russian). Vop. Virus. 2, 67–72 (1957).
Smorodintseva, O. A.: The effect of ultraviolet rays on the influenza virus (Russian). Zh. Mikrobiol. (Mosk.) 10-11, 17 (1943).
Smorodintseva, O.A.: The effect of ultraviolet rays and ozone on the influenza virus (Russian). Gripp. Tr. AMN SSSR, Moscow XXVIII, 49 (1953).
Sohier, R.: Some conceptions on the epidemiology and prophylaxis of virus infections (French). Rev. Hyg. Méd. soc. 2, 699–748 (1954).
Sokol, F., and S. Schramek: An improved method for the isolation of ribonucleic acid from myxoviruses. Acta virol. S, 193-199 (1964).
Sokol, F., and J. Szurman: Isolation of ribonucleic acid from purified influenza virus by phenol extraction. Acta virol. 3, 175–180 (1959).
Sokolov, M. I.: Concentration and purification of influenza virus by adsorption onto erythrocytes (Russian). Zh. Mikrobiol. (Mosk.) 1, 41 (1949).
Sokolov, M. I.: The efficacy of active immunisation against influenza (Russian). Yrach. delo. 10, 929 (1950).
Sokolov, M. I.: Live dry influenza vaccine (Russian). Zh. MEI 10, 57 (1953).
Sokolov, M. I.: Active influenza immunisation (Russian). Medgiz., Moscow (1954).
Sokolov, M. I.: Protective vaccination against influenza (Russian). Vrach. delo. 10, 893 (1954).
Sokolov, M. I., and K. S. Kulikova: Immunogenic properties of a concentrated vaccine against influenza (Russian). Medgiz., Moscow (1954).
Sokolov, M. I., K. S. Kulikova, S. Ya. Kiioleva, and N. B. Azadova: Factors facilitating preservation of vitality of influenza viruses during drying and prolonged preservation (Russian). Vop. Virus. 3, 239–241 (1958).
Sokolov, M. I., K. S. Kulikova, and A. H. Samvelova: Intranasal immunisation with live influenza vaccine (Russian). Zh. MEI 7, 28 (1951).
Sokolov, M. I., T. M. Lozinskaya, N. P. Obrosova-Serova, and E. Y. Podchernyeva: Experimental data on inherited variation of influenza viruses. Abstr. 9th int. Congr. Microbiol., Moscow 374 (1966).
Sokolov, M. I., S. B. Shimshelevich, and K. S. Kulikova: Specific prophylaxis of influenza (Russian). Zh. Mikrobiol. (Mosk.) 6, 45 (1951).
Sokolov, M. I., and P. Tu: Experimental studies on the method of obtaining live influenzal vaccine. I. Biological and immunological variability of influenza virus A 57 during its adaptation to chick embryo and mice (Russian). Zh. Mikrol. Moskva. 30, 11–16 (1959).
Sokolova, N. N., and I. N. Gaylonskaya: Comparative study of survival of liquid and powder for vaccines in human tissues (Russian). Vop. Virus. 4, 367 (1953).
Sokovikh, L. I., and A. S. Gorbunova: Sensibilizin; a peculiar influenza virus antigen in passive haemagglutination test. Abstr. 9th int. Congr. Microbiol., Moscow 389 (1966).
Solov’yev, V. D.: The problem of local antibody production in lung tissue (Russian). Annot. rabot. Inst. virusol. AMN SSSE Za, 1949, Moscow 13 (1950).
Solov’yev, V. D.: Current problems of the epidemiology and inoculation prophylaxis of influenza (Russian). Vo.-med. Zh. 3, 18 (1954).
Solov’yev, V. D.: The current state of the problems of the etiology and epidemiology of influenza (Russian). Zh. Mikrobiol. (Mosk.) 8, 3 (1956).
Solov’yev, V. D., and A. K. Alekseyeva: Comparison of the sensitivity of Sot’s and monkey kidney epithelial cells to type A 2 influenza virus (Russian). Vop. Virus. 4, 136–142 (1959).
Solov’yev, V. D., and A. K. Alekseyeva: The method of detection of influenza virus in tissue cultures (Russian). Zh. Mikrol. Moskva. 30, 16–20 (1959).
Solov’yev, V. D., and N. E. Gutman: Variability of influenza A prime virus in the course of adaptation to chick embryos (Russian). Zh. Mikrobiol. (Mosk.) 10, 65 (1953).
Solov’yev, V. D., and S. S. Marennikova: Variability of the influenza virus (Russian). Byull. éksp. Biol. Med. 12, 434 (1949), 9, 59 (1952), 12, 58-64 (1953).
Solov’yev, V. D., and S. S. Marennikova: Adaptation of the influenza virus to the body of a new host (Russian). Annot. rabot. Inst. Virusol. AMN SSSE za, 1949, Moscow (1950).
Solov’yev, V. D., and S. S. Marennikova: Variation of the influenza virus under natural conditions and in experiment (Russian). Problemy grippa i OKVDP. Tez. dokl. ob’yed. Sess. Inst. AMN SSSE, Moscow (1952).
Solov’yev, V. D., S. S. Marennikova, and N. E. Gutman: Variability of the influenza virus under natural conditions (Type A prime influenza virus) (Russian). Zh. Mikrobiol. (Mosk.) 8, 52 (1952).
Solov’yev, V. D., and L. M. Mentkevich: The effect of colchicine on viral interference and interferon formation. Acta virol. 9, 308–312 (1965).
Solov’yev, V. D., V. V. Eitova, and D. I. Dudkina: Significance of passive immunity to influenza in infancy (Russian). Pediatr. 5, 28 (1949).
Solov’yev, V. D., A. K. Shubladze, and N. Mel’tser: Study of the phenomenon of erythrocyte agglutination by the influenza virus (Russian). Zh. Mikrobiol. (Mosk.) 3, 22 (1943).
Solov’yev, V. D., and M. I. Sokolov: Immunological effectiveness of influenza vaccine (Russian). Zh. Mikrobiol. (Mosk.) 12, 77 (1948).
Solov’yev, V. D., and L. Ya. Zakstelskaya: Serological characterisation of virus influenza B (Russian). Zh. Mikrobiol. (Mosk.) 9, 20 (1950).
Solov’yev, V. D., L. Ya. Zakstelskaya, and B. N. Tarasov: Significance of the toxic factor in the pathogenesis of influenzal infection (Russian). Annot. rabot. Inst. Virusol. AMN SSSE za, 1949g, Moscow 13 (1950).
Somma, E. E., H. C. Tosi, A. Valtona, E. Salsamundi, and E. Gianbruno: Rev. urug. Pat. clin. 1, 43 (1963).
Sovinova, O., and J. Ludvik: Electron microscopic study of the influenza virus A/Equi/Prague/56. Acta virol. 3, 59–60 (1959).
Sovinova, O., B. Tumova, F. Poutska, and J. Nemec: Isolation of a virus causing respiratory disease in horses. Acta virol. 2, 52–61 (1958).
Spence, L.: Kaolin treatment of sera for removal of non-specific inhibitors to Asian strains of influenza virus. Proc. Soc. exp. Biol. (N.Y.) 103, 425–427 (1960).
Sprecher-Goldberger, S.: The existence of two different metabolic patterns for the synthesis of ENA viruses. Arch. ges. Virusforsch. 18, 198–209 (1966).
Sprossig, M., and H. Meicke: Inactivation of influenza viruses by α-dicarbonyl compounds. Acta virol. 7, 472–474 (1963).
Sprossig, M., and H. Urbach: A serologic study of influenza virus strains of the Asian type (German). Acta biol. med. germ. 1, 641–651 (1958).
Staiger, H. E.: Plaque-type recombination in fowl plague virus. Virology 22, 419–422 (1964).
Stakhanova, V. M.: Different sensitivity of human and chicken erythrocytes to the action of non-specific inhibitors of haemagglutination (Russian). Vop. Virus. 5, 77–80 (1958).
Stakhanova, V. M.: The antigenic structure of influenza-like respiratory viruses of horses, swine and ducks (Russian). “Problemy grippa i ostrykh. respiratornykh zabolevanii” Tez. dokl. nauch. Sess. Inst. AMN SSSE, Moscow 48-49 (1959).
Stakhanova, V. M., A. N. Loziikina, and A. S. Gorbunova: The effect of potassium periodate on thermostable serum inhibitors to A2 virus (Russian). “Problemy grippa i ostrykh. respiratornykh zabolevanii” Tez. dokl. nauch. Sess. Inst. AMN SSSE, Moscow 55 (1959).
Stakhanova, V. M., E. M. Zhantieva, and V. V. Vsahkova: Mechanism of myxovirus genetic interaction. Abstr. 9th int. Congr. Microbiol., Moscow 477-478 (1966).
Stanley, E. D., E. E. Muldoon, L. W. Akers, and G. G. Jackson: Evaluation of antiviral drugs: The effect of amantadine on influenza in volunteers. Ann. N.Y. Acad. Sci. 130, 44–51 (1965).
Stanley, W. M.: An evaluation of methods for the concentration and purification of influenza virus. J. exp. Med. 79, 255–266 (1944).
Stanley, W. M.: The size of the influenza virus. J. exp. Med. 79, 267–283 (1944).
Stanley, W. M.: The preparation and properties of influenza virus vaccines concentrated and purified by differential centrifugation. J. exp. Med. 81, 193–218 (1945).
Stanley, W. M.: The precipitation of purified concentrated influenza virus and vaccine by calcium phosphate. Science 101, 332–335 (1945).
Stenkula, F.: Eesults of treatment of influenza type B with N, N-anhydrobis-(B-oxyethyl) biguanide-HCl (ABOB) (German). Fortschr. Med. 11, 318 (1959).
Stern, H., and K. C. Tippett: Primary isolation of influenza viruses at 33°C. Lancet 1301-1302 (1963).
Stewart, R. B., and P. H. Frickey: Studies on cytotropism in animal viruses. 3. Growth of influenza virus in epithelial-like and fibroblastic cells derived from chick embryo lung. J. Bact. 92, 972–977 (1966).
Stewart, R. B., and H. R. Morgan: Studies on cytotropism in animal viruses. 1. Growth of influenza virus in lung cells derived from hatched chicks and chick embryos. J. Immunol. 82, 264–273 (1959).
2. A comparison of the growth of four influenza virus strains in vivo and in vitro in hatched chick and chick embryo lung tissue. J. Immunol. 85, 465-468 (1960).
Stewart, F. S., and J. J. Quilligan: A method for estimating the capacity of influenza virus to effect antigenic modification of red blood cells. J. Immunol. 66, 411–419 (1951).
Stock, C. C., and T. Francis: Additional studies of the inactivation of the virus of epidemic influenza by soaps. J. Immunol. 47, 303–308 (1943).
Stokes, J., and D. R. Shaw: Production of passive immunity against influenza virus by introducing immune serum into the respiratory tract. Amer. J. Dis. Child. 58, 653 (1939).
Stone, J. D.: Enzymic modification of the reaction between influenza virus and susceptible tissue cells. Nature (Lond.) 159, 780–781 (1947).
Stone, J. D.: Prevention of virus infection with enzyme of V. cholerae. 1. Studies with viruses of the mumps-influenza group in chick embryos.
2. Studies with influenza virus in mice. Aust. J. exp. Biol. med. Sci. 26, 49-64, and 287-298 (1948).
Stone, J. D.: Tryptic inactivation of the receptor destroying enzyme of V. cholerae and of the enzymic activity of influenza virus. Aust. J. exp. Biol. med. Sci. 27, 229–244 (1949).
Stone, J. D.: Inhibition of influenza virus haemagglutination by mucoids. 1. Conversion of virus to indicator for inhibitor.
2. Differential behaviour of mucoid inhibitors with indicator viruses. Aust. J. exp. Biol. med. Sci. 27, 337-352, and 557-567 (1949).
Stone, J. D.: Adsorptive and enzymic behaviour of influenza virus during the O-D change. Brit. J. exp. Path. 32, 367–376 (1951).
Stone, J. D., and G. L. Ada: Additive effect of viruses of the influenza group and the receptor destroying enzyme of V Cholerae. Brit. J. exp. Path. 31, 275–284 (1950).
Stone, J. D., and G. L. Ada: Electrophoretic studies of virus-red cell interaction; relationship between agglutinability and electrophoretic mobility. Brit. J. exp. Path. 33, 428–439 (1952).
Stone, J. D., and F. M. Burnet: The action of halogens on influenza virus with special reference to the action of iodine vapour on virus mists. Aust. J. exp. Biol. med. Sci. 23, 205–212 (1945).
Strandli, O. K., K. Mortenssen-Egnund, and A. Harboe: Purification of the normal allantoic fluid antigen which reacts with influenza virus HI antibody to host material. Acta path. microbiol. scand. 60, 265–270 (1964).
Straub, M.: The microscopical changes in the lungs of mice infected with influenza virus. J. Path. Bact. 45, 75–98 (1937).
Straub, M.: The histology of catarrhal influenzal bronchitis and collapse of the lung in mice infected with influenza virus. J. Path. Bact. 50, 31–36 (1940).
Straub, M., and J. Mulder: Epithelial lesions in the respiratory tract in human influenzal pneumonia. J. Path. Bact. 40, 429–434 (1948).
Stuart-Harris, C. H.: Transmission of influenza virus to hedgehogs. Brit. J. exp. Path. 17, 324–328 (1936).
Stuart-Harris, C. H.: Influenza virus infection of rats and guinea pigs. Brit. J. exp. Path. 18, 485–492 (1937).
Stuart-Harris, C. H.: A neurotropic strain of human influenza virus. Lancet 497-499 (1939).
Stuart-Harris, C. H.: Observations on the agglutination of fowl red cells by influenza viruses. Brit. J. exp. Path. 24, 33–40 (1943).
Stuart-Harris, C. H.: Influenza epidemics and the influenza viruses. Lectures 1 and 2. Brit. med. J. 209-216, and 251-257 (1945).
Stuart-Harris, C. H.: Twenty years of influenza epidemics. Amer. Rev. resp. Dis. 83, 54–57 (1961).
Stuart-Harris, C. H.: “Influenza and other virus infections of the respiratory tract.” Edward Arnold London 2nd Edit. (1965).
Stuart-Harris, C. H., C. H. Andrewes, and W. Smith: Study of epidemic influenza with special reference to the 1936–37 epidemic. Med. Res. Counc. Eep. No. 228 (1938).
Stuart-Harris, C. H., and T. Francis: Studies on the nasal histology of epidemic influenza virus infection in the ferret. 2. The resistance of regenerating respiratory epithelium to reinfection and to physicochemical injury. J. exp. Med. 68, 803–812 (1938).
Stuart-Harris, C. H., and M. H. Miller: Vagaries of the agglutination-inhibition reaction with newly isolated strains of influenza virus. Brit. J. exp. Path. 28, 394–403 (1947).
Stuart-Harris, C. H., W. Smith, and C. H. Andrewes: The influenza epidemic of January–March 1939. Lancet 205-211 (1939).
Stulberg, C. S., and B. Schapira: Virus growth in tissue culture fibroblasts. 1. Influenza A and herpes simplex viruses. J. Immunol. 70, 51–59 (1953).
Styk, B.: Epidemic outbreak of influenza due to type C influenza virus (Czech). Čs. Epidem. 3, 137–145 (1953).
Styk, B.: Non-specific inhibitors in normal rat sera for the influenza C type virus. The relation between the influenza C type virus, Newcastle disease, and epidemic parotitis. Folia biol. (Praha) 1, 207–213 (1955).
Styk, B.: Selection and preparation of strains of influenza virus for a live vaccine of Smorodintsev type (Czech). Čs. Epidem. 6, 303–308 (1957).
Styk, B.: Co-factor and specific antibodies against influenza viruses. 1. Method of co-factor titration, co-factor content of various animal sera.
2. The effect of substances destroying non-specific inhibitors on the co-factor and on specific A2 antibodies. Acta virol. 5, 334-341, and 342-450 (1961).
3. The potentiating effect of co-factor on specifie antibodies of early immune and hyperimmune sera and the differences in the character of these antibodies. Acta virol. 6, 327-337 (1962).
S30a_Styk, B.: Sensibilisation by means of potassium periodate of inhibitor resistant A 2 influenza virus strains to non-specific serum inhibitors. Nature (Lond.) 193, 954–955 (1962).
Styk, B.: Effect of some inhibitor-destroying substances on the non-specific inhibitor of C influenza virus present in normal rat serum. Acta virol. 7, 88–89 (1963).
Styk, B.: Viral antibodies and the serum co-factor (Czech). Biol. Prace 11, 1–142 (1965).
Styk, B., and L. Hana: Investigations into specific antibodies against A 2 influenza viruses and the thermolabile co-factor by means of paper electrophoresis. Acta virol. 4, 365–370 (1960).
Styk, B., and L. Hana: The effect of inhibitor-destroying substances on the co-factor and specific antihaemagglutinins against A 2 influenza viruses. Acta virol. 5, 194 (1961).
Styk, B., and L. Hana: Formation of 19S and 7S type viral antibodies. Symp. “Molecular and cellular basis of antibody formation” Prague 261-268 (1964).
Styk, B., and L. Hana: Immunodiffusion studies on the reaction of influenza virus with specific antibody and non-specific serum beta inhibitor. Acta virol. 10, 281–290 (1966).
Styk, B., L. Hana, F. Franek, F. Sokol, and J. Mensik: Investigations
on co-factor and influenzal antibodies by density gradient zonal centrifugation. Acta virol. 6, 478 (1962), and 7, 25-36 (1963).
Styk, B., L. Hana, and B. Rada: Antiviral and co-factor-like activities of some dextran sulphates. Acta virol. 7, 480 (1963).
Styk, B., L. Hana, V. Rathova, and D. Kociskova: Investigations of the complement components and the antibody co-factor by gel filtration on Sephadex G-200. Science Tools 12, 37 (1965).
Styk, B., and D. Kociskova: in vivo and in vitro effects of dextran sulphates, heparin, and pelantan on guinea pig complement, antibody co-factor, and non-specific viral inhibitors. J. Hyg. Epidem. 8, 485–496 (1964).
Styk, B., D. Kociskova, and L. Hana: Co-factor and specific antibodies against influenza viruses. 8. On the different nature of antibody co-factor and complement. Acta virol. 8, 496–506 (1964).
Styk, B., V. Rathova, and D. Blascovic: Thermostability of specific haemag-glutination-inhibiting antibodies against the FE influenza virus and their reactivation by addition of fresh serum. Acta virol. 2, 179–187 (1958).
Subrahmanyan, T., and C. Mims: Fate of intravenously administered interferon and the distribution of interferon during virus infections in mice. Information Exchange Group No. 6, Memo 116 (1965).
Sugg, J. Y.: An influenza virus pneumonia of mice that is non-transferable by serial passage. J. Bact. 57, 399–403 (1949).
Sugg, J. Y.: The variation of antigenic pattern and mouse virulence in an influenza virus culture. J. Bact. 58, 399–406 (1949).
Sugg, J. Y.: The relation of the concentration of unadapted and adapted influenza virus in the mouse lung to the death or survival of the infected host. J. Bact. 60, 489–497 (1950).
Sugg, J. Y.: Further studies on serial passage of a mixture of influenza viruses in embryonated eggs. Proc. Soc. exp. Biol. (N.Y.) 76, 199–202 (1951).
Sugg, J. Y.: Effect of intranasally administered immune serum on influenza virus present in mouse lung. Proc. Soc. exp. Biol. (N.Y.) 77, 728–731 (1951).
Sugg, J. Y., and E. Cleeland: Differences in trypsin susceptibility among influenza viruses and relationship of the susceptibility to the antigenic type or subtype of the virus. J. Immunol. 88, 369–376 (1962).
Sugg, J. Y., and T. P. Magill: Susceptibility of convalescent ferrets to reinfection with influenza virus in absence of specific antibodies. Proc. Soc. exp. Biol. (N.Y.) 65, 233–235 (1947).
Sugg, J. Y., and T. P. Magill: The serial passage of mixtures of different strains of influenza virus in embryonated eggs and in mice. J. Bact. 56, 201–206 (1948).
Sugg, J. Y., and D. Nagaki: Tissue tropism of a strain of influenza A virus in ferrets. J. Immunol. 74, 46–50 (1955).
Sugiura, A., and E. D. Kilbourne: Genetic studies of influenza viruses. 2. Plaque formation by influenza viruses in a clone of a variant human hetero-ploid cell line.
3. Production of plaque-type recombinants with A and A 1 strains. Virology 26, 478-488 (1965), and 29, 84-91 (1966).
Sugiura, A., H. Shimojo, and C. Enomoto: Studies of the non-specific haemag-glutination inhibitor against influenza A 2 viruses (gamma inhibitor). 2. Physicochemical properties of the gamma inhibitor.
3. Destruction of gamma inhibitor by virus enzyme. Jap. J. exp. Med. 31, 159-167, and 169-177 (1961).
Sulkin, S. E.: The effect of environmental temperature on experimental influenza in mice. J. Immunol. 51, 291–300 (1945).
Sulkin, S. E., J. E. Smith, and D. D. Douglass: Experimental study of an institutional outbreak of epidemic influenza. J. infect. Dis. 69, 278–284 (1941).
Svec, F. A., and G. F. Forster: Inhibition of the Hirst haemagglutination reaction by pneumococcal extracts, normal serums, and blood cell esterases. Proc. Soc. exp. Biol. (N.Y.) 66, 20–23 (1947).
Svedmyr, A.: Studies on a factor in normal allantoic fluid inhibiting influenza virus haemagglutination. Ark. Kemi Mineral. Geol. 24b, 1–8 (1947).
Svedmyr, A.: Studies on a factor in normal allantoic fluid inhibiting influenza virus haemagglutination. 1. Occurrence, physicochemical properties and mode of action.
2. Virus-inhibitor interaction.
3. Precipitation-dissolution reaction in mixtures of active virus and inhibitor.
4. The effect of active virus, proteolytic enzymes and periodate on the inhibitor.
5. Precipitation reaction in mixtures of inactive virus and inhibitor. Brit. J. exp. Path. 29, 295-308, and 309-321 (1948), also 30, 237-247, 248-254, and 255-266 (1949).
Svedmyr, A.: Studies on a factor in normal allantoic fluid inhibiting influenza virus haemagglutination. Upsala Läk.-Fören. Förh. 54, 365–380 (1949).
Svedmyr, A., P. von Magnus, and E. A. Freundt: Influenza in Scandinavia during 1950–51. Acta path. microbiol. scand. 29, 96–108 (1951).
Svet-Moldavsky, G. I., and I. Z. Ghendon: Demonstration of influenza virus using gel diffusion method of precipitation directly in tissue culture. Acta virol. 2, 120–122 (1958).
Svet-Moldavsky, G. Ya., and L. S. Lozovskaya: Change in the properties of erythrocytes of animals after injection of influenza virus into them (Russian). Problemy. grippa i OKVDP. Tez. dokl. ob’yed. Sess. Inst. AMN SSSR, Moscow 47 (1952).
Szanto, J.: The cultivation of some A-FE influenza virus strains in tissue cultures. 2. Comparison of the multiplication of various strains of A-FE influenza in tissue cultures (Czech). Biol. Prace 4, 63–71 (1958).
Szanto, J., O. Krizanova, and F. Link: Interaction of gamma-inhibitor with A2 influenza virus. Acta virol. 6, 524–530 (1962).
Szanto, J., O. Laucikova, D. Kociskova, and Y. Eathova: Preparation of anti-inhibitor serum and its effect on the multiplication of influenza virus. Folia microbiol. (Praha) 5, 105–111 (1960).
Szanto, J., O. Laucikova, D. Kociskova, and V. Eathova: The effect of anti-inhibitor serum on the multiplication of influenza virus. Virology 10, 149 (1960).
Szanto, J., and N. Valentova: The cultivation of some A-FE influenza virus strains in tissue cultures (Czech). Biol. Prace 4, 59–62 (1958).
Szollosy, E., G. Ivanovics, and S. Horvath: Distribution of the receptor substance of influenza and related viruses in tissue elements of different animal species. 2. The virus-adsorbing capacity of the respiratory tract of various vertebrates. Acta physiol. hung. 3, 431–440 (1952).
Szurman, J.: An attempt to isolate ribonucleic acid from chorioallantoic membranes of chick embryos infected with influenza virus (Polish). Med. Dosw. Mikrob. 12, 175–181 (1960).
Takagi, A., K. Tavaka, and E. Takao: On the influences of ox bile and one of its components, mucin, on the haemagglutinability of influenza viruses. Yonago Acta med. 1, 87–93 (1954).
Takano, K., J. Warren, K. E. Jensen, and A. L. Neal: Nucleic acid induced resistance to viral infection. J. Bact. 90, 1542–1547 (1965).
Takátsy, G.: Purified precipitated virus obtained by a new simple method. Acta med. Acad. Sci. hung. 3, 185–191 (1952).
Takátsy, G., and K. Barb: On the normal serum inhibitors for the avid Asian strains of influenza virus. Acta virol. 3, 71–77 (1959).
Takátsy, G., K. Barb, and E. Farkas: The antigenic structure of the influenza virus strains isolated in Hungary in 1957. Acta microbiol. Acad. Sci. hung. 5, 287–296 (1958).
Takátsy, G., K. Barb, and E. Farkas: A new erythrocyte receptor with exclusive affinity to avid Asian strains of influenza virus. Acta virol. 3, 79–84 (1959).
Takátsy, G., and J. Furész: On the antigenic variation of the influenza A virus. Arch. ges. Virusforsch. 7, 344–354 (1957).
Takátsy, G., and M. Hamar: Recent studies of the antigenic structure of influenza virus by the antibody absorption test. Acta microbiol. Acad. Sci. hung. 3, 203–212 (1955).
Takemoto, K.: Use of a cation exchange resin for isolation of influenza virus. Proc. Soc. exp. Biol. (N.Y.) 85, 670–672 (1954).
Takemoto, K. K., and A. M. Lerner: Human amnion cell cultures; susceptibility to viruses and use in primary virus isolations. Proc. Soc. exp. Biol. (N.Y.) 94, 179–182 (1957).
Takemoto, K. K., E. K. Lynt, W. P. Eowe, R. J. Huebner, J. A. Bell, G. W. Mellin, and D. J. Davis: Primary isolation of influenza A, B, and C viruses in monkey kidney tissue cultures. Proc. Soc. exp. Biol (N.Y.) 89, 308–311 (1955).
Takemoto, K. K., M. L. Bobbins, and P. K. Smith: The experimental chemotherapy of influenza viruses. J. Immunol. 72, 139–145 (1954).
Tamm, I.: Inhibition of influenza and mumps virus multiplication by 456 or 567 trichloro-1-b-D-ribofuranosylbenzimidazole. Science 120, 847–848 (1954).
Tamm, I.: Influenza virus-erythrocyte interaction. 1. Eeversible reaction between Lee virus and cat erythrocytes.
2. Effect of egg passage on the reaction between a recently recovered influenza A virus and sheep erythrocytes. J. Immunol. 73, 180-189, and 190-198 (1954).
Tamm, I., and D. J. Fluke: The effect of monochromatic ultraviolet irradiation on infectivity and haemagglutinating ability of the influenza virus type A strain PR8. J. Bact. 59, 449–461 (1950).
Tamm, I., K. Folkers, and F. L. Horsfall: Inhibition of influenza virus multiplication by 2, 5-dimethylbenzimidazole. Yale J. Biol. Med. 24, 559–567 (1952).
Tamm, I., K. Folkers, and F. L. Horsfall: Inhibition of influenza virus multiplication by alkyl derivatives of benzimidazole. 1. Kinetic aspects of inhibition by 2, 5-dimethylbenzimidazole as measured by infectivity titrations.
2. Measurement of inhibitory activity by haemagglutination titration. J. exp. Med. 98, 219-227, and 229-243 (1953).
Tamm, I., K. Folkers, C. H. Shunk, D. Heyl, and F. L. Horsfall: Inhibition of influenza virus multiplication by alkyl derivatives of benzimidazole. 3. Relationship between inhibitory activity and chemical structure. J. exp. Med. 98, 245–259 (1953).
Tamm, I., K. Folkers, C. H. Shunk, and F. L. Horsfall: Inhibition of influenza virus multiplication by N-glycosides of benzimidazoles. J. exp. Med. 99, 227–249 (1954).
Tamm, I., H. S. Ginsberg, and F. L. Horsfall: Antigenic similarity between the first and later egg passage strains of freshly recovered influenza A viruses. Proc. Soc. exp. Biol. (N.Y.) 81, 94–98 (1952).
Tamm, I., and F. L. Horsfall: Characterisation and separation of an inhibitor of viral haemagglutination present in urine. Proc. Soc. exp. Biol. (N.Y.) 74, 108–114 (1950).
Tamm, I., E. D. Kilbourne, and F. L. Horsfall: Comparison of influenza B virus strains from the 1950 epidemic with strains from earlier epidemics. Proc. Soc. exp. Biol. (N.Y.) 75, 89–92 (1950).
Tamm, I., and D. A. J. Tyrrell: Influenza virus multiplication in the chorioallantoic membrane in vitro. Kinetic aspects of inhibition by 5,6 dichloro 1-B-D-ribofuranosylbenzimidazole. J. exp. Med. 100, 541–562 (1954).
Tang, F. F.: The transmission of influenza virus WS to the Chinese mink and to David’s squirrel. Brit. J. exp. Path. 19, 179–183 (1938).
Tani, T., and T. Hayashi: Proliferation and preservation of egg adapted influenza viruses. Jap. J. med. Sci. Biol. 7, 435–443 (1954).
Tateno, I., and O. Kitamoto: Rapid diagnosis of influenza by a fluorescent antibody technique. 2. Eelation between immunocytological serological and clinical findings.
3. Some new aspects of influenza infection revealed by the fluorescent antibody technique (Japanese). Jap. J. exp. Med. 35, 401-410, and 411-417 (1965).
Tateno, I., O. Kitamoto, and J. A. Kawamura: Diverse immunocytologic findings of nasal smears in influenza. New Engl. J. Med. 274, 237–242 (1966).
Tateno, I., S. Suzuki, A. Kawamura, and S. Nakamura: Eapid diagnosis of influenza by a fluorescent antibody technique. 1. Some basic information (Japanese). Jap. J. exp. Med. 35, 383–400 (1965).
Taverne, J., J. H. Marshall, and F. Fulton: The purification and concentration of viruses and soluble antigens on calcium phosphate. J. gen. Microbiol. 19, 451–461 (1958).
Taylor, A. R.: Chemical analysis of the influenza viruses A (PR8 strain) and A (Lee strain) and the swine influenza virus. J. biol. Chem. 153, 675–686 (1944).
Taylor, A. E., D. G. Sharp, D. Beard, J. W. Beard, J. H. Dingle, and A. E. Feller: Isolation and characterisation of influenza A virus (PR8 strain). J. Immunol. 47, 261–282 (1943).
Taylor, A. E., D. G. Sharp, I. W. McLean, D. Beard, and J. W. Beard: Concentration and purification of influenza virus for the preparation of vaccines. J. Immunol. 50, 291–316 (1945).
Taylor, C. E.: Interference between influenza and equine encephalitis viruses in tissue culture. J. Immunol. 71, 125–133 (1953).
Taylor, R. M.: Experimental influenza with influenza A virus in mice. The increase in intrapulmonary virus after inoculation and the influence of various factors thereon. J. exp. Med. 73, 43–55 (1941).
Taylor, R. M.: Passive immunisation against experimental infection of mice with influenza A virus. Comparative effect of immune serum administered intranasally and intraabdominally. J. Immunol. 41, 453–462 (1941).
Taylor, R. M.: Studies on survival of influenza virus between epidemics and antigenic variations of the virus. Amer. J. publ. Hlth 39, 171–178 (1949).
Taylor, R. M.: A further note on 1233 (influenza C) virus. Arch. ges. Virus-forsch. 4, 485–500 (1951).
Taylor, E. M., M. Dreguss, and F. De Ritis: Antigenic behaviour of certain Hungarian strains of epidemic influenza virus. Amer. J. Hyg. 31, 36–45 (1940).
Taylor, E. M., and A. S. Parodi: Use of hamster (Cricetus auratus) for detection of influenza virus in throat washings. Proc. Soc. exp. Biol. (N.Y.) 49, 105–108 (1942).
Taylor, R. M., A. S. Parodi, R.B. Fernandez, and E. J. Chialvo: An aetiological study of influenza A in Argentina during 1941; comparison of the epidemiology of types A and B (Spanish). Rev. Inst. Bact. Buenos Aires 11, 44–57 (1942).
Terzin, A. L.: Glycerine as a stabiliser of some complement fixing antigens of viral and rickettsial origin. Proc. Soc. exp. Biol. (N.Y.) 84, 215–218 (1953).
Terzin, A. L., M. N. Bordjosk, M. Y. Milovanovic, L. Y. Stojkovic, and M. M. Dimic: Some viral, rickettsial and leptospiral infections diagnosed in Serbia. A serological study. J. Hyg. (Lond.) 52, 129–150 (1954).
Thibon, M.: Action of benzododecinium on influenza virus (French). Ann. Inst. Pasteur 99, 414–420 (1960).
Thomson, D., and E. Thomson: Influenza. Influenza with special reference to the complications and sequelae, bacteriology of influenzal pneumonia, pathology, epidemiological data, prevention and treatment. Monograph 16, parts 1 and 2. Ann. Pickett-Thomson Res. Lab. 1933 and 1934.
Titova, S.M.: Experimental influenzal infection in dogs (Russian). Yop. Med. Yirus 4, 114 (1954).
Todd, C., and J. P. Rice: Fowl plague. Med. Res. Counc. “System of Bacteriology” 7, 219–231 (1930).
Tommila, Y.: Studies of the demonstration of influenza viruses by their capacity to inactivate inhibitors of virus haemagglutination. Ann. Med. exp. Fenn. 34, Suppl. 2 (1956).
Topciu, Y., P. Diosi, Gr. Bran, A. Elias, O. Nevinglovsci, and N. Csaky: Investigations on the nature of influenza haemagglutination inhibitors found in animal sera. Abstr. 9th int. Congr. Microbiol. Moscow 391 (1966).
Tovarnitskiy, Y. I.: Methods of purification and concentration of viruses (Russian). Yop. Yirus. 1, 24 (1948).
Tovarnitskiy, Y. I.: Chemistry and biochemistry of the influenza virus. (Russian). Uspekhi khim. 20, 231 (1951).
Tovarnitskiy, Y. I., and O. M. Chalkina: Purification and concentration of the influenza virus (Russian). Zh. Mikrobiol. (Mosk.) 10-11, 13 (1943).
Tovarnitskiy, Y. I., and M. I. Karlina: Yirus-protein complexes (Russian). Biokhimiya 2, 10 (1945); Yop. Yirus. 1, 59 (1948); Yop. Yirus. 3,20 (1950).
Tovarnitskiy, Y. I., and O. I. Shishkina: Electrophoretic investigations on the influenza virus (Russian). Zh. Mikrobiol. (Mosk.) 10-11, 16 (1943).
Toyosiiima, S., S. Kano, and T. Ueda: Search for effective synthetic agents against influenza virus. Keio J. Med. (Tokyo) 12, 149–159 (1963).
Traub, E.: Active immunity of chickens from virus infected eggs. (German). Zbl. Bakt. I. Abt. Orig. 164, 412–423 (1955).
Travassos, J., and M. Bruno-Lobo: Studies on Asian influenza in Rio de Janiero. 5. Antibodies in the pre-epidemic period (Portuguese). An. Microbiol. (Eio de J.) 6, 107–150 (1958).
Traver, M. L., E. L. Northrop, and D.L. Walker: Site of intracellular antigen production by myxoviruses. Proc. Soc. exp. Biol. (N.Y.) 104, 268–273 (1960).
Tsauzmer, G. M., L. Y. Ebert, S. B. Nozik, and N. G. Tsauzmer: Serological diagnosis of influenza in Cheliabinsk, in 1957 (Russian). Yop. Yirus. 5, 81–83 (1958).
Tsunoda, H., H. F. Maassab, K. W. Cochran, and W. C. Eveland: Antiviral activity of a-methyl-1-adamantane-methylarnine hydrochloride. “Antimicrobial agents and chemotherapy.” Amer. Soc. Microbiol. 553-560 (1965).
Tsurumi, M., K. Ogasawara, and K. Fujil: On the isolation of the influenza virus. Kitasato Arch. exp. Med. 18, 39–51 (1941).
Tsurumi, M., K. Ogasawara, and H. Takagi: Studies on influenza virus. Nagoya, J. med. Sci. 13, 61–67 (1939).
Tsvetkova, I.Y., and M. A. Lipkind: Neuraminidase activity of myxoviruses in their interaction with susceptible and nonsusceptible cells. Abstr. 9th int. Congr. Microbiol. Moscow 387 (1966).
Tumova, B. K.: The biological properties of influenza virus and their variability (Czech). Čs. Epidem. 3, 218–230 (1954).
Tumova, B., D. Fedova, D. Boscova, J. Yolenikova, Y. Prochazkova, and J. Ludvik: The incidence and spread of a new variant of type B influenza virus in the population of Czechoslovakia in 1959-61. 2. Properties of the strains isolated. Acta virol. 7, 156–175 (1963).
Tumova, B., and O. Fisero-Sovinova: Properties of influenza viruses A/Asia/ 57 and A/Equi/Praha/56. 1. Agglutination of red blood cells. Bull. Wld Hlth Org. 20, 445–454 (1959).
Tumova, B., and O. Fisero-Sovinova: The comparison of some propertis of influenza A-57/FE and A/Equi/Praha/56 viruses. Abstr. 7th int. Congr. Microbiol. Uppsala 280 (1958).
Tumova, B., and H. G. Pereira: Genetic interaction between influenza A viruses of human and animal origin. Yirology 27, 253–261 (1965).
Tusiiinskiy, M. D., Y. D. Stavskaya, A. I. Iaroshevskiy, E. F. Davidenkova, E. S. Skarlato, E. L. Kan, and E. A. Skriabina: Clinical aspects of pandemic of influenza in 1957 (Russian). Klin. Med. (Mosk.) 36, 43–48 (1958).
Twyble, E., and U.C. Mason: Haemagglutination by products of influenza virus using infected mouse lung and chick embryo as the sources of virus. J. Immunol. 49, 73–85 (1944).
Tyrrell, D. A. J.: Separation of inhibitors of haemagglutination and specific antibodies for influenza viruses by starch zone electrophoresis. J. Immunol. 72, 494–502 (1954).
Tyrrell, D. A. J.: New tissue culture systems for influenza, Newcastle disease and vaccinia viruses. J. Immunol. 74, 293–305 (1955).
Tyrrell, D. A. J., M. L. Bynoe, and B. Hoorn: Studies on the antiviral activity of 1-adamantanamine. Brit. J. exp. Path. 46, 370–375 (1965).
Tyrrell, D. A. J., and A. H. Cameron: The pathogenicity of influenza viruses for suckling mice. J. Path. Bact. 74, 37–48 (1957).
Tyrrell, D. A. J., and B. Hoorn: The growth of some myxoviruses in organ cultures. Brit. J. exp. Path. 46, 514–518 (1965).
Tyrrell, D. A. J., and F. L. Horsfall: Neutralisation of viruses by homologous immune serum. 1. Quantitative studies on factors which affect the neutralisation reaction with Newcastle disease, influenza A and bacterial virus T3. J. exp. Med. 97, 845–861 (1953).
Tyrrell, D. A. J., and F. L. Horsfall: Disruption of influenza virus. Properties of degradation products of the virus particle. J. exp. Med. 99, 321–342 (1954).
Tyrrell, D. A. J., I. Tamm, O. C. Forssman, and F. L. Horsfall: A new count of allantoic cells of the 10-day chick embryo. Proc. Soc. exp. Biol. (N.Y.) 86, 594–598 (1954).
Tyrrell, D. A. J., and R. C. Valentine: The assay of influenza virus particles by haemagglutination and electron microscopy. J. gen. Microbiol. 16, 668–675 (1957).
Uiiler, M., and S. Gard: Lipid content of standard and incomplete influenza A virus. Nature (Lond.) 173, 1041 (1954).
Unanov, S. S., L. Y. Yasil’ev, and A. A. Lebedov: The epidemiological efficacy of the monovalent A2 influenza vaccine (Russian). Zh. Mikrobiol. (Mosk.) 30, 31–37 (1959).
Underdahl, N. E., and Gr. A. Young: Effect of dietary intake of fat-soluble vitamins on the intensity of experimental swine influenza virus infection of mice. Yirology 2, 415–429 (1956).
Undrits, V. F., and A. M. Koldobskiy: The problem of the differential diagnosis of influenza and the condition of the ENT organs in this disease (Russian). “Virusnyye Infektsii.” Tr. Leningrad Inst. Epid. Mikrobiol. i g. Imuni Pastera Leningrad 13, 232 (1953).
Utz, J. P.: Studies on the inactivation of influenza and Newcastle disease viruses by a specific lipid fraction of normal animal sera. J. Immunol. 63, 273–279 (1949).
Uys, C. J., and W. B. Becker: The pathology of tern virus infection of chickens. S. Afr. J. Lab. clin. Med. 9, 93–94 (1963).
Valentine, R. C.: Structure and particle counts of the influenza virus and the adenovirus. 4th int. Congr. Electron Microscopy (Berlin) 577-586 (1958).
Valentine, R. C., and A. Isaacs: The structure of influenza virus filaments and spheres. J. gen. Microbiol. 16, 195–204 (1957).
Valentine, R. C., and A. Isaacs: The structure of viruses of the Newcastle disease-mumps-influenza (myxovirus) group. J. gen. Microbiol. 16, 680–685 (1957).
Van den Ende, M.: The utilisation of aminoacid solutions by Virus-infected eggs, studied by paper chromatography. J. gen. Microbiol. 4, 277–279 (1950).
Van den Ende, M., H. S. Myers, D. McKenzie, A. J. Walt, R. Hoffenberg, and A. Swanepoel: The 1950 influenza epidemic in Capetown. S. Afr. med J. 25, 445–449 (1951).
Van den Ende, M., G. S. Turner, G. Selzer, and W. T. Naude: Antigenic comparison of influenza virus strains isolated in Capetown during 1952. S. Afr. med. J. 27, 975–980 (1953).
Van Eooyen, C. E., L. McClelland, and E. K. Campbell: Influenza in Canada during 1949. Studies on Eskimos. Canad. J. publ. Hlth 40, 447–456 (1949).
Van Rooyen, C. E., and A. J. Ehodes: “Virus diseases of man.” Oxford Univ. Press. Humphrey Milford, London (1940).
Van der Veen, J., and J. Mulder: Studies on the antigenic composition of human influenza virus A strains. Onderz. Meded. Inst. Praev. Greneesk. No. 6, Stenfert Kroese, Leiden (1950).
Vashkov, V. I., and A. K. Astafyeva: Viricidal properties of lactic acid and glycerin vapours (Russian). Tr. Tsentral’nogo nauchno-issledovatel’skogo dezinfektsionogo. Inst. Moscow 6, 104 (1950).
Vashkov, V. I., and A. K. Astafyeva: Viricidal and bactericidal effect of certain
chemicals in air (Russian). Tr. Tsentral’nogo nauchno-issledovatel’skogo dezinfektsionogo. Inst. Moscow 7, 20 (1951) and 8, 27 (1954).
Vasilyeva, L. V.: Dynamics of influenzal antibodies against Type A and B in the adult population (Russian). Zh. Mikrobiol. (Mosk.) 3, 26 (1954).
Vaynberg, B. G., and L. M. Kharmats: Influenza virus reproduction in the body of Suslik (Russian). Zh. Mikrobiol. (Mosk.) 12, 28 (1949).
Vdovina, L. A.: An outbreak of influenza in the Taldy-Kurgan district. (Russian). Zdravookhr. Kazakhstana 18, 30–31 (1958).
Veeraraghavan, N., M. W. Kirtikar, and T. Sreevalsan: Studies on the cultivation of influenza virus in vitro. Bull. Wld Hlth Org. 24, 711–722 (1961).
Veeraraghavan, N., and T. Sreevalsan: Evaluation of some methods of concentration and purification of influenza virus. Bull. Wld Hlth Org. 24, 695–702 (1961).
Verlinde, J. D., and O. Makstanieks: An experimental investigation into the prophylactic value of influenza vaccine as used during the winter of 1952-63 (Dutch). Ned. T. Geneesk. 98, 2589–2591 (1954).
Verlinde, J. D., O. Makstanieks, and C. A. G. Nass: Results of a protective vaccine against influenza in the winter 1952-53 (Dutch). Ned. T. Geonesk. 98, 559–564 (1954).
Versteeg, J., E. P. Mouton, and J. D. Verlinde: Asian influenza in horses (Dutch). T. Diergeneesk. 83, 608–613 (1958).
Vieuchange, J.: Protection of white mice against experimental influenza (French). C. E. Soc. Biol. (Paris) 134, 391 (1939).
Vieuchange, J.: On the susceptibility of certain species of monkeys to the influenza virus (French). Bull. Acad. Méd. (Paris) 121, 100 (1939).
Vilches, A., and G. K. Hirst: Interference between neurotropic and other unrelated viruses. J. Immunol. 57, 125–140 (1947).
Vinson, J. W., and F. T. Walsh: The effect of terramycin on the PE8 strain of influenza A virus in chick embryos and mice. J. Immunol. 65, 129–134 (1950).
Vogel, L., and A. Shelokov: Adsorption-haemagglutination test for influenza virus in monkey kidney tissue cultures. Science 126, 358–359 (1957).
Volakova, N., and L. Jandasek: A thermostable inhibitor of newly isolated influenza virus strains in guineapig serum. Acta virol. 3, 109–112 (1959).
Volukskaya, E. N.: Carbohydrate metabolism in experimental influenzal infection (Russian). Probl. obsch. virusol. Tez. Dokl. 6-y Sess. Inst. Virusol. AMN SSSE Moscow 60, also Vop. Virus. 4, 138 (1954).
Volukskaya, E. N., V. I. Tovarnitsky, and A. M. Byelikova: The effect of the properdin system on the influenza virus. J. Hyg. epidem. (Praha) 2, 404–407 (1958).
Vonka, V.: Plaque technique with influenza A 2 virus in rubber stoppered bottle cultures from monkey kidney cells. Arch. ges. Virusforsch. 15, 514–524 (1965).
Voorspuij, A. J. Z.: A new and simple method for the purification and concentration of influenza virus. Experientia (Basel) 12, 474 (1949).
Vorob’yeva, M. M.: The role of polyphosphates in influenza virus multiplication (Russian). Probl. obshch. virusol. Tez. dokl. 6-y Sess. Inst. virusol. AMN SSSE Moscow 1 (1953).
Vorob’yeva, M. M.: The significance of adenosine triphosphoric acid in influenza virus multiplication (Russian). Dissertation, Moscow (1954).
Voss, H., and E. Wengel: Forms of influenza virus (German). Zbl. Bakt. I. Abt. Orig. 162, 225–235 (1955).
Voth, D. W., and H. A. Feldman: Aqueous, repository, and placebo influenza vaccines in an elderly population. Amer. J. publ. Hlth 53, 1512 (1963).
Waddell, G. H., M. B. Teigland, and M. M. Sigel: A new influenza virus associated with equine respiratory disease. J. Amer. vet. med. Ass. 143, 587–590 (1963).
Wagner, R. R.: Acquired resistance in mice to the neurotoxic action of influenza viruses. Brit. J. exp. Path. 33, 157–167 (1952).
Wagner, R. R.: Influenza virus multiplication in homologously transplanted mouse fetal tissues. J. Immunol. 71, 253–260 (1953).
Wagner, R. R.: A pantropic strain of influenza virus. Generalised infection and viraemia in the infant mouse. Virology 1, 497–515 (1955).
Wagner, R. R.: Influenza virus infection of transplanted tumours. 2. The relation of host immunity to virus action.
3. Effect of passive immunisation on infections of the Ehrlich ascites tumour. J. Immunol. 74, 439-445 and 446-454 (1955).
Wagner, R. R.: Studies on the pathogenesis of influenzal pneumonitis. Intranasal vs. intravenous infection of mice. Yale. J. Biol. Med. 28, 598–614 (1956).
Wagner, R. R.: Viral interference. Some considerations of basic mechanisms and their potential relationship to host resistance. Bact. Rev. 24, 151–166 (1960).
Wagner, R. R., I. L. Bennett, and V. S. LeQuire: The production of fever by influenza viruses. 1. Factors influencing the febrile response to single injections of virus.
2. Tolerance in rabbits to the pyrogenic effect of influenzal viruses. J. exp. Med. 90, 321-334 and 335-347 (1949).
Walker, D. L., and F. L. Horsfall: Lack of identity in neutralising and haemagglutination-inhibiting antibodies against influenza viruses. J. exp. Med. 91, 65–86 (1950).
Walker, D. L., and N. Khoobyarian: Eeduced resistance in mice to the intravenous toxicity of influenza virus following cortisone administration. Eep. Naval Med. Res. Inst. Bethesda, Maryland, 15, 173–180 (1957).
Wallace, D. G., and K. E. Kissling: Studies in swine of Asian influenza virus. Bull. Wld Hlth Org. 20, 455–463 (1959).
Wallis, C., N. Sakurada, and J. L. Melnick: Influenza vaccine prepared by photodynamic inactivation of virus. J. Immunol. 91, 677–682 (1963).
Walter, G., and O. Jarnin: Investigations on the increase in agglutinability of red blood corpuscles produced by enzymes from viruses and bacteria (German). Z. Hyg. Infekt.-Kr. 131, 407–422 (1950).
Wang, C. I.: The relation of infectious and haemagglutinin titres to the adaptation of influenza virus to mice. J. exp. Med. 88, 515–519 (1948).
Wang, S.-P., and T. Y. Lin: Laboratory studies on some biological properties of the Far East influenza virus. J. infect. Dis. 103, 178–182 (1958).
Ward, T. G., and B. E. Eddy: An antigenically distinct subtype of influenza virus A which is virulent for mice in primary passage of allantoic fluid. Science 112, 501–503 (1950).
Ward, T. G., and M. Salch: Laboratory studies on the relation between influenza antibody and immunity in the mouse. Amer. J. Hyg. 61, 82–88 (1955).
Warren, J., A. Neal, and D. Rennels: Adsorption of myxoviruses on magnetic iron oxides. Proc. Soc. exp. Biol. (N.Y.) 121, 1250–1253 (1966).
Waterson, A. P.: Two kinds of myxovirus. Nature (Lond.) 193, 1163–1164 (1962).
Waterson, A. P., J. M. W. Hurrell, and K. E. Jensen: The fine structure of influenza A, B, and C viruses. Arch. ges. Virusforsch. 12, 487–495 (1960).
Watson, B. K.: Immunocytological effects of varied inocula of influenza virus. J. exp. Med. 114, 13–27 (1961).
Watson, B. K., and A. H. Coons: Studies of influenza virus infection in the chick embryo using fluorescent antibody. J. exp. Med. 99, 419–427 (1954).
Webster, R. G.: The immune response to influenza virus. 1. Effect of the route and schedule of vaccination on the time course of the immune response as measured by three serological methods. Immunology 9, 501–519 (1965).
Webster, R. G.: Original antigenic sin in ferrets. The response to sequential infections with influenza viruses. J. Immunol. 97, 177–183 (1966).
Webster, B. G., and W. G. Laver: Influenza virus subunit vaccines. Immunogenicity and lack of toxicity for rabbits of ether and detergent disrupted virus. J. Immunol. 96, 596–605 (1966).
Webster, R. G., and W. G. Laver: Influenza virus subunit vaccines. Abstr. 9th int. Congr. Microbiol. Moscow 380 (1966).
Wecker, E.: The distribution of P32 in fowl plague virus by different ways of production (German). Z. Naturforsch. 12b, 208–210 (1957).
Wecker, E., and W. Schafer: Uptake of radioactive phosphorus in fowl plague virus (German). Z. Naturforsch. 11b, 181–187 (1956).
Weinberger, H. L., E. L. Buescher, and V.M. Edwards: Extent of antigenic variation of A 2 influenza viruses from prototype strains. J. Immunol. 94, 47–54 (1965).
Weller, T. H., and J. F. Enders: Production of haemagglutinin by mumps and influenza A viruses in suspended cell tissue cultures. Proc. Soc. exp. Biol. (N.Y.) 69, 124–128 (1948).
Wells, R. J. H.: An outbreak of fowl plague in turkeys. Vet. Roc. 75, 783–786 (1963).
Wells, W. F., and W. Henle: Experimental air-borne disease. Quantitative inoculation by inhalation of influenza virus. Proc. Soc. exp. Biol. (N.Y.) 48, 298–301 (1941).
Wen, H. S., and S.-P. Wang: Mouse adaptation of the Asian influenza virus. J. infect. Dis. 105, 9–17 (1959).
W3G_Werner, G. H.: Quantitative studies on influenza virus infection of the chick embryo by the amniotic route. J. Bact. 71, 505–515 (1956).
Werner, G. H., and B.W. Schlesinger: Morphological and quantitative comparison between infectious and non-infectious forms of the influenza virus. J. exp. Med. 100, 203–215 (1954).
Wesslen, N., S. Hermodsson, and L. Philipson: Interference between influenza and poliomyelitis viruses in tissue culture. Arch. ges. Virusforsch. 9, 31–44 (1959).
Westwood, J. C. N.: A study of chick embryo lesions produced by influenza viruses. Brit. J. exp. Path. 33, 610–619 (1952).
Wheelock, E. F., and I. Tamm: Mitosis and division in HeLa cells infected with influenza or Newcastle disease viruses. Virology 8, 532–536 (1959).
Whipple, H. E., and P. E. Van Reyen: Antiviral substances. Ann. N.Y. Acad. Sci. 130, 1–482 (1965).
White, D.O.: The mechanism of natural resistance of the allantois to influenza infection. Virology 9, 680–690 (1959).
White, D. O.: Some aspects of influenza virus multiplication in the surviving allantois-on-shell system. Virology 10, 21–28 (1960).
White, D. O., and I. M. Cheyne: Early events in the eclipse phase of influenza and parainfluenza virus infection. Virology 29, 49–59 (1966).
White, D. O., H. M. Day, E. J. Batchelder, I. M. Cheyne, and A. J. Wansbrough: Delay in the multiplication of influenza virus. Virology 25, 289–302 (1965).
W4G_White, D. O., and S. Fazekas De St Groth: Variation of host resistance to influenza viruses in the allantois. J. Hyg. (Lond.) 57, 123–133 (1959).
White, J.: The position of Taylor’s 1233 strain of virus in the Human red cell receptor gradient. Brit. J. exp. Path. 34, 668–673 (1953).
Whitten, W. K.: Inactivation of gonadotrophins. 1. Inactivation of serum gonadotrophs by influenza virus and receptor-destroying enzyme of V. cholerae.
2. Inactivation of pituitary and chorionic gonadotrophins by influenza virus and receptor-destroying enzyme. Aust. J. Sci. Res. Ser. B 1, 271-277 and 388-390 (1948).
Wielgosz, G. S.: Pyruvate metabolism of chorioallantoic membrane infected with influenza A. Virology 3, 475–484 (1957).
Wiener, M., W. Henle, and G. Henle: Studies on the complement fixation antigens of influenza viruses types A and B. J. exp. Med. 83, 259–279 (1941).
Wilcox, W. C., E.M. Wood, J. O. Oh, N.B. Everett, and C. A. Evans: Morphological and functional changes in corneal epithelium caused by the toxic effects of influenza and Newcastle disease viruses. Brit. J. exp. Path. 39, 601–609 (1958).
Williams, R. C., and K. W. G. Wyckoff: Electron shadow micrography of virus particles. Proc. Soc. exp. Biol. (N.Y.) 58, 265–270 (1945).
Williamson, A. P., L. Simonsen, and K. J. Blattner: Specific organ defects in early chick embryos following inoculation of influenza virus. Proc. Soc. exp. Biol. (N.Y.) 92, 334–337 (1956).
Winternitz, M. C., I. M. Wason, and F. P. McNamara: “The pathology of influenza.” Yale Univ. Press. New Haven, Connecticut (1920).
Witzler, J. D., and A. V. Hennessy: The epidemiological significance of serologically determined attack rates of Asian influenza among personnel of naval vessels. University of Michigan Med. Bull. 24, 133–137 (1958).
Wolff, H. L.: The use of the haemagglutination-inliibition test in epidemiological influenza virus studies. J. Hyg. (bond.) 47, 396–397 (1949).
Wong, S. C., and E. D. Kilbourxe: Changing viral susceptibility of a human cell line in continuous cultivation. 1. Production of infective virus in a variant of the Chang conjunctival cell following infection with swine or NWS influenza viruses. J. exp. Med. 113, 95–110 (1961).
Wood, T.R.: Methods useful in evaluating 1-adamantanamine hydrochloride, a new orally active synthetic antiviral agent. Ann. N.Y. Acad. Sci. 130, 419–431 (1965).
Woodhour, A. F., and K.E. Jensen: Adsorption characteristics of influenza viruses to cholesterol and fatty acids. Proc. Soc. exp. Biol. (N.Y.) 100, 561–564 (1959).
Woodhour, A. F., K.E. Jensen, and J. Warren: Antibody response to influenza vaccines combined with hexadecylamine. Proc. Soc. exp. Biol. (N.Y.) 103, 200–204 (1960).
Woodhour, A. F., K.E. Jensen, and J. Warren: Development and application of new parenteral adjuvants. 5. Comparative potencies of influenza vaccines emulsified in various oils. J. Immunol. 86, 681–689 (1961).
Woodhour, A. F., D. P. Metzgar, G. P. Lampson, E. A. Machlowitz, A. A. Tytell, and M. R. Hilleman: New metabolisable immunologic adjuvant for human use. 4. Development of highly purified influenza virus vaccine in adjuvant 65. Proc. Soc. exp. Biol. (N.Y.) 123, 778–782 (1966).
Woodhour, A. F., D. P. Metzgar, T. B. Stein, A. A. Tytell, and M. E. Hilleman: New metabolisable immunologic adjuvant for human use. 1. Development and animal immune response. Proc. Soc. exp. Biol. (N.Y.) 116, 516–523 (1964).
Woolley, D.W.: Purification of an influenza virus substrate, and demonstration of its competitive antagonism to apple pectin. J. exp. Med. 89, 11–22 (1949).
Woolley, J. G., H. W. Bond, and T. D. Perrine: The effect of chemical substances in mice infected with St. Lous encephalitis, PR8 strain of influenza or the Lansing strain of poliomyelitis virus. J. Immunol. 68, 621–626 (1952).
Woolridge, E. L., and Y. E. Crawford: Serological diagnosis of influenza. Antibody levels in relation to the concentration of virus used in the haemagglutination-inliibition test. J. infect. Dis. 91, 159–164 (1952).
Woolridge, E. L., J. L. DeMeio, J. E. Whiteside, and J. E. Seal: Epidemic influenza B and C in Navy recruits 1953-54. A. antigenic studies on influenza virus type B. Proc. Soc. exp. Biol. (N.Y.) 88, 430–435 (1955).
Wyckoff, R. W. G.: Electron microscopy of chick embryo membrane infected with PR8 influenza. Nature (Lond.) 168, 651–652 (1951).
Wyckoff, R. W. G.: Formation of the particles of influenza virus. J. Immunol. 70, 187–196 (1953).
Yakhno, M. A.: Changes in A2/57 influenza virus during adaptation to mice (Russian). “Problemy grippa i ostrykh respiratornykh zabolovanii.” Tez. dokl. nauch. Sess. Inst. AMN SSSE, Moscow 181-182 (1959).
Yakhno, M. A., and L. Ya. Zakstelskaya: Agglutinating activity of type A 2 influenza viruses for animal and human erythrocytes (Russian). Vop. Virus. 5, 68–70 (1958).
Yakovlev, A. I., and S. G. Zvyagin: The effect of phytoncides of onion and garlic on the influenza virus (Russian). Annot. rabot. Inst. Virusol. AMN, SSSE za 1949g, Moscow 6 (1950).
Ykgokov, L. I., and O.D. Novoshilov: Experience in treatment of patients with virus influenza (Russian). Vo.-med. Zh. 8, 74–75 (1953).
Yeremeyev, G. V.: Purification and concentration of the influenza A and B viruses (Russian). Tez. dokl. ob’yed Sess. Inst. AMN, SSSE, Moscow 33 (1952).
Yeremeyev, G. V.: Mechanism of elution of influenza virus from erythrocytes (Russian). Problemy grippa i OKVDP. Tez. dokl. ob’yed Sess. Inst. AMN SSSE, Moscow 37 (1952).
Yeremeyev, G. V.: Rules and regulations of influenza virus adsorption by erythrocytes (Russian). Problemy grippa i OKVDP. Tez. dokl. ob’yed. Sess. Inst. AMN SSSE, Moscow 35 (1952).
Yeremeyev, G. V., and O. M. Chalkina: New method of purification and concentration of type A influenza virus (Russian). Gripp, i OKVDP, Moscow 43 (1953).
Yeremeyev, G. V., and N. N. Orlova: Immunogenic properties of the separate fractions of the influenza virus (Russian). Vop. Virus. 2, 209 (1949).
Yermol’yeva, Z. V., A. K. Shubladze, S. Ya. Gaydamovich, and L. K. Valedinskaya: The study of ecmoline in experimental influenza (Russian). Zh. Mikrobiol. (Mosk.) I, 64–67 (1952).
Young, G. A., and W. E. Underdahl: Neutralisation and haemagglutinin inhibition of swine influenza virus by serum from suckling swine and milk from their dams. J. Immunol. 65, 369–373 (1950).
Yurikas, I. A.: Complement fixation reaction in the diagnosis of influenza (Russian). Bibl. i annot. rabot. otdela virusol. Inst. Eksper. Med. AMN SSSE za 1947-49 Leningrad (1950).
Yurikas, I.A.: Early diagnosis of influenza by the method of detecting the specific antigen in the washing from the pharynx by the complement fixation reaction (Russian). Gripp. Tr. AMN SSSE 28, 138 (1953).
Zakstelskaya, L. Ya.: The toxic properties of influenza virus (Russian). Tez. Dokl. 3-y Sess. Inst. AMN SSSE, Moscow 7 (1950).
Zakstelskaya, L. Ya.: Recovery of the virus from the urine in patients with epidemic influenza (Russian). Gripp. i OKVDP. Tr. ob’yed. Sess. Inst. AMN SSSE, Moscow, 72-74 (1953).
Zakstelskaya, L. Ya.: A simplified neutralisation test to show the presence of antibodies against a new strain of influenza virus (A/Asia/57) (Russian). Vop. Virus. 2, 373–375 (1957).
Zakstelskaya, L. Ya.: Experimental study of the efficacy of intranasal and subcutaneous methods of immunisation in influenza (Russian). Gripp, i OKVDP. Tr. ob’yed Sess. Inst. AMN SSSE, Moscow 135 (1953).
Zakstelskaya, L. Ya.: Phagocytic activity of leucocytes in influenza (Russian). Vop. Virus. 4, 133 (1954).
Zakstelskaya, L. Ya., V. A. Efimova, and S. L. Khayt: Humoral indices of the immunity to A 2 influenza viruses and special aspects of their study (Russian). “Problemy grippa i ostrykh respiratornykh zabolevanii.” Tez. dokl. nauch. Sess. Inst. AMN SSSE, Moscow 152-154 (1959).
Zakstelskaya, L. Ya., and V. V. Eitova: Change in the antigenic structure of the influenza A and A prime viruses over the course of 5 years (Russian). Zh. Mikrobiol. (Mosk.) 7, 43 (1954).
Zakstelskaya, L. Ya., and V. V. Eitova: Type specificity of immunological reactions in influenza (Russian). Zh. MEI 9, 49 (1954).
Zakstelskaya, L. Ya., and M. A. Yakiino: On labile antibodies against A2 influenza viruses. Acta virol. 5, 329–333 (1961).
Zalmanson, E. S., T. I. Balesina, N. I. Korabelnikova, E. P. Pilatskaya, Z. W. Ermolieva, and L. L. Fadeeva: On the possibility of stimulation of interferon production in the human body and its practical use. Abstr. 9th int. Congr. Microbiol. Moscow 543 (19G6).
Zellat, J., and W. Henle: Further studies in passive protection against the virus of influenza by the intranasal route. J. Immunol. 42, 239–249 (1941).
Zeytlenok, N. A., and O. S. Korsiiunova: Isolation of influenza virus from patients by means of direct infection of mice and chick embryos (Russian). Arkh. biol. nauk. 59, 38 (1940).
Zeytlenok, N. A., G. F. Nesterova, N. K. Krigsgaber, M. V. Eubtsov, L. N. Yakhontov, and V. M. Bernfeld: The study on antiviral and anticellular activity of styrylquinoline and related compounds in connection with their chemical structure. Abstr. 9th int. Congr. Microbiol. Moscow 532-533 (1966).
Zeytlenok, N. A., and V. A. Vagzdanova: Experience in the study of the physiology of multiplication of Type A virus in the developing chick embryo (Russian). Probl. obsheh. Virusol. Tez. dokl. 5-6 (1953).
Zhantieva, E. M., and V. M. Stakhanova: Studies on ENA synthesis in cells infected with fowl plague virus (Kussian). Byull. éksp. Biol. Med. 59, 66–68 (1965).
Zhdanov, V. M.: The perspectives of vaccination against influenza (Russian). Probl. grippa i ostrykh Katar. verkhn. dykhatel. put. Tez. dokl. ob’yed. Sess. Inst. AMN SSSE, Moscow 61 (1952).
Zhdanov, Y. M.: Certain rules and regulations in virus variability (Russian). Tez. dokl. 6-y Sess. Inst. Virusol. AMN SSSE, Moscow 31 (1953).
Zhdanov, V. M.: Lines of variation of influenza viruses (Russian). Zh. Mikrobiol. (Mosk.) 2, 34 (1953).
Zhdanov, V. M.: Eesults of three years work of the influenza department. (Russian). Yop. Virus. 4, 5 (1954).
Zhdanov, V. M.: Certain problems of influenza epidemiology (Russian). Zh. Mikrobiol. (Mosk.) 9, 56 (1954).
Zhdanov, V. M.: Certain problems of the variation and evolution of influenza viruses (Russian). Nasledstvennost’ i Izmenchivost 1, 317–323 (1959).
Zhdanov, V. M.: A suggested genetic map of influenza virus. Lancet 738-740 (1965).
Zhdanov, V. M.: The third type of nucleic acid-directed protein synthesis. Lancet 1017-1018 (1966).
Zhdanov, V. M., S. A. Demidova, and G. Ya. Svet-Moldavskiy: The inhibition of virus haemagglutination by S Typhosa Vi antigen (Russian). “Prohlemy grippa i ostrykh respiratornykh zabolevanii.” Tez. dokl. nauch. Sess. Inst. AMN SSSE, Moscow, 52-54 (1959).
Zhdanov, V. M., V. P. Hamburg, and G. Ya. Svet-Moldavskiy: Antigenicity of the inhibitor of influenza virus strain A/Asia/57. J. Immunol. 82, 9–11 (1959).
Zhdanov, V. M., L. B. Mekler, S. M. Kleminko, and V. C. Naumova: Chemical nature of substances forming the surface of influenza virus. Nature (Lond.) 198, 1326–1327 (1963).
Zhdanov, V. M., and I. I. Nikolayev: The result of study of influenza vaccines (Russian). Zh. Mikrobiol. (Mosk.) 10, 3 (1953).
Zhdanov, V. M., and V. V. Eitova: The pathogenesis of influenza (Russian). Klin. Med. (Moskva) 37, 45–48 (1959).
Zhdanov, V. M., V. V. Eitova, A. V. Orlova, N. N. Sokolova, and L. A. Golygina: The characteristics of influenza virus strains isolated in 1957. Lancet 735-736 (1957).
Zhdanov, V. M., and G. A. Smirnova: On the nature of the inactivating effect of animal tissue extracts against myxovirus haemagglutinin. Acta virol. 9, 137–143 (1965).
Zhdanov, V. M., and N.N. Sokolova: Immunological characteristic of the associated influenza-diphtheria-pertussis vaccine; experimental studies (Russian). “Problemy grippa i ostrykh respiratornykh zabolevanii.” Tez. dokl. nauch. Sess. Inst. AMN SSSE, Moscow 132-133 (1959).
Zhdanov, V. M., and V. D. Solovyev: The influenza problem (Russian). Zh. Mikrobiol. (Mosk.) 3, 6 (1951).
Zhdanov, V. M., and V. D. Solovyev: Principles of vaccination against influenza (Russian). Zh. Mikrobiol. (Mosk.) 1, 36 (1952).
Zhdanov, V. M., V. D. Solovyev, and F. G. Epshtein: “The study of influenza” (Translated from Ucheniye o grippe, Moscow Medgiz 1958). U.S. Dept. of Health, Education and Welfare (1960).
Zhilkina, A. S.: The study of the etiology and pathogenesis of “contagious coryza” and the so-called “sporadic” influenza in inter-epidemic periods (Russian). Tez. dokl. Sess. Tsentral. Inst. ukha, gorla i nosa, Moscow 5 (1952).
Zhumatov, Kh., and E. S. Isaeva: Isolation of infectious ENA from type A and B viruses and study of its properties (Russian). Abstr. Inst. All-Union Biochem. Congr. 11, 168 (1964).
Zhumatov, Kh. Zh., and E. K. Eeshetnikova: Influenza morbidity in the collectives of the city of Alma Ata and the effectiveness of certain prophylactic measures (Russian). Zdravooklr. Karzakhstana 18, 16–23 (1958).
Ziegler, J. E., and F. L. Horsfall: Interference between influenza viruses. 1. The effect of active virus upon the multiplication of influenza viruses in the chick embryo.
2. The effect of virus rendered non-infective by ultraviolet radiation upon the multiplication of influenza viruses in the chick embryo. J. exp. Med. 79, 361-377 and 379-400 (1944).
Zilber, L. A.: Certain lines of study of the influenza problem (Russian). Zh. Mikrobiol. (Mosk.) 12, 19 (1949).
Zilber, L. A., Z. L. Baydakova, and N. A. Blyumberg: The mechanism of antivirus immunity (Russian). Zh. Mikrobiol. (Mosk.) 1-2, 81 (1946).
Zilber, L. A., L. I. Falkovich, and Ye. A. Arkhina: Study of the virus of epidemic influenza (Russian). Zh. Mikrobiol. (Mosk.) 18, 554 (1937).
Zillig, W., W. Schafer, and S. Ullman: On the structure of the elementary bodies of fowl plague virus (German). Z. Naturforsch. 10b, 199–206 (1955).
Zilliken, F., G.H. Werner, E. K. Silver, and P. Gyorgy: Studies on the enzymatic properties of influenza viruses. The action of influenza B virus and RDE on the haemagglutinin-inhibitor of human Meconium. Virology 3, 464–474 (1957).
Zimmermann, T., and W. Schäfer: Effect of p-fluorophenylalanme on fowl plague virus multiplication. Virology 11, 676–698 (1966).
Addenda
Beare, A. S., D. A. J. Tyrrell, J. C. McDonald, T. M. Pollock, C. E. D. Taylor, C. H. L. Howells, and L. E. Tyler: Eeactions and antibody response to live influenza vaccine prepared from the Iksha A 2 strain. J. Hyg. (Lond.) 65, 245–254 (1967).
Brandon, F. B., F. Cox, G. O. Lease, E. A. Timm, E. Quinn, and I. W. McLean: Eespiratory virus vaccines. 3. Some biological properties of Sephadex purified ether-extracted influenza virus antigens. J. Immunol. 98, 800–805 (1967).
Bryans, J. T., W. W. Zent, E. E. Grunert, and D. C. Boughton: 1-adamantanamine hydrochloride prophylaxis for experimentally induced A/Equi/2 influenza virus infection. Nature (Lond.) 212, 1542–1544 (1966).
Cameron, T. P., R. H. Alford, J. A. Kasel, E. W. Harvey, E. J. Byrne, and V. Knight: Experimental equine influenza in Chincoteague ponies. Proc. Soc. exp. Biol. (N.Y.) 124, 510–515 (1967).
Ciieli, E., and M. U. Dianzani: Adsorption of PES influenza virus on the red colls of guineapigs treated with haemolytic serum. Acta Haemat. 14, 15–22 (1955).
Dardanoni, L., and C. Spano: Antigenic analysis of A 2 influenza virus isolated from 1957–1963 in the district of Palermo (Italian). Eiv. Ist. sieroter. ital. 39, 243 (1964).
Dorset, M., C. N. McBryde, and W. B. Niles: Eemarks on “Hog flu”. J. Amer. vet. med. Ass. 62, 162–171 (1922-23).
Eazekas De St Groth, S., A. Isaacs, and M. Edney: Multiplication of influenza virus under conditions of interference. Nature (Lond.) 170, 573 (1952).
Finland, M., M.W. Barnes, and E.B. Wells: Influenza virus infections in Boston. September 1947—August 1949. J. Lab. clin. Med. 37, 88–103 (1951).
Finter, N. B.: Interferons. Frontiers of Biology North Holland Publishing Co., Amsterdam (1966).
Fletcher, R. D., J. E. Hirschfield, and M. Forbes: A common mode of action of ammonium ions and various amines. Nature (Lond.) 207, 664–665 (1965).
Francis, T.: Eecent advances in the study of influenza. J. Amer. med. Assoc. 105, 251–254 (1935).
Francis, T.: Epidemiological studies in influenza. Amer. J. publ. Hlth 27, 211–225 (1937).
Francis, T.: Immunology of experimental influenza. Amer. J. Hyg. 28, 63–79 (1938).
Francis, T., and T. P. Magill: Vaccination of human beings with the virus of influenza. Proc. Soc. exp. Biol. (N.Y.) 33, 604–606 (1935-36).
Francis, T., and T.P. Magill: Direct isolation of human influenza virus in tissue cultures and in egg membranes. Proc. Soc. exp. Biol. (N.Y.) 36, 134–135 (1937).
Francis, T., and T. P. Magill: The antibody response of human subjects vaccinated with the virus of human influenza. J. exp. Med. 65, 251–259 (1937).
Green, E. G.: On nature of filterable viruses. Science 82, 443–445 (1935).
Hallauer, C.: Immunity studies in fowl plague. 4. On inherited immunity (German). Z. Hyg. Infekt.-Kr. 118, 605 (1936).
Hobson, D., E. A. Gould, and H. I. Flockton: Laboratory studies on a strain of Asian influenza virus used as a living vaccine. J. Hyg. (Lond.) 65, 255–262 (1967).
Horne, K. W., A. P. Waterson, P. Wildy, and A. E. Farnham: The structure and composition of myxoviruses. 1. Electron microscope studies of the structure of myxovirus particles by negative staining techniques. Virology 11, 79–98 (1960).
Hoyle, L.: An improved technique for inoculation of fertile eggs. J. Path. Bact. 59, 480–481 (1947).
Knight, C. A.: Titration of influenza virus in chick embryos. J. exp. Med. 79, 487–495 (1944).
Laidlaw, P. P.: The Rede Lecture. Cambridge University Press (1938).
Lobodinska, M., A. Morawiecki, and Z. Skurska: Studies on the inhibition of haemagglutination and infection of the influenza virus by orozomucoid and its polymers. Abstr. 9th int. Congr. Microbiol. Moscow 533 (1966).
Luria, S. E.: Eeactivation of irradiated bacteriophage by transfer of self-reduplicating units. Proc. nat. Acad. Sci. (Wash.) 33, 253–264 (1947).
McDonald, J. C., A. J. Zuckermann, A. S. Beare, and D. A. J. Tyrrell: Trials of live influenza vaccine in the Eoyal Air Force. Brit. med. J. i, 1036 (1962).
Nikolayev, I. I., and S. A. Samvexova: The problem of the effectiveness of intranasal vaccination against virus influenza with type A and B vaccines (Russian). Gripp i OKVDP. Tr. ob’yed. nauch. Sess. AMN SSSR Moscow 83 (1953).
Okuno, Y., and K. Nakamura: Prophylactic effectiveness of live influenza vaccine in 1965. Bikens J. 9, 89 (1966).
Pons, M. W.: Studies on influenza virus ribonucleic acid. Virology 31, 523–531 (1967).
Ritova, V. V., A. M. Zhukovsky, and N. A. Yevstigneyeva: Comparative study of the immunological properties of live influenza vaccine in volunteers. J. Hyg. Epidem. (Praha) 7, 272 (1963).
Scaddding, J. G.: Lung changes in influenza. Quart. J. Mod. 30, 425–465 (1937).
Schmidt, S., J. Oerskov, and E. Steenberg: Studies on experimental fowl plague (German). VI. Mitt. Z. Hyg. Infekt.-Kr. 118, 455 (1936).
Schulman, J. L.: Experimental transmission of influenza virus infection in mice. 3. Differing effects of immunity induced by infection and by inactivated influenza virus vaccine on transmission of infection.
4. Eelationship of transmissibility of different strains of virus and recovery of airborne virus in the environment of infector mice. J. exp. Med. 125, 467-478 and 479-488 (1967).
Soloviev, V. D., T. G. Orlova, L. A. Porubel, and I. N. Vasilieva: Study of the genetic characters of vaccine strains of type A 2 influenza virus. Probl. Virol. 6, 743 (1961).
Starke, G., I. Siebelist, and E. Heller: Studies on the question of the use of live influenza vaccine. 1. Results of tests of living influenza A 2 vaccine in a controlled experiment on volunteers (German). J. Hyg. Epidem. (Praha) 8, 37 (1964).
Takátsy, G., and K. Barb: New inhibitor and erythrocyte receptor substances for certain Asian strains of influenza virus. Nature (Lond.) 183, 52–53 (1959).
Zhdanov, V. M., and V. D. Soloviev: Some results of the study of Asian influenza. Amer. Rev. resp. Dis. 83, 211 178–187 (1961).
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 1968 Springer-Verlag Wien
About this chapter
Cite this chapter
Hoyle, L. (1968). The Influenza Viruses. In: The Influenza Viruses. Virology Monographs Die Virusforschung in Einzeldarstellungen, vol 4. Springer, Vienna. https://doi.org/10.1007/978-3-7091-2046-0_1
Download citation
DOI: https://doi.org/10.1007/978-3-7091-2046-0_1
Publisher Name: Springer, Vienna
Print ISBN: 978-3-7091-2048-4
Online ISBN: 978-3-7091-2046-0
eBook Packages: Springer Book Archive